16th Annual Scientific Meeting - Heart Failure Society of America

16th Annual 

Scientific Meeting 

2012 Program 

September 9 – 12, 2012 

Washington State Convention and 

Trade Center, Seattle, WA 

www.hfsa.org

HFSA DATES TO REMEMBER 

Held at the 16th Annual Scientific Meeting of the Heart Failure Society of America 

The Tao of the Right Ventricle: 

A WICKED PROBLEM 

Washington State Convention Center 

Ballroom 6C ~ 800 Convention Place, Seattle, WA 

Sunday, September 9, 2012 

Lunch 12:30 pm ~ Satellite Symposium 1:00 pm - 3:00 pm 

September 27-30, 2012 

HFSA Board Review Course 

Advanced HF/Transplant Cardiology 

Minneapolis, MN 

October 23, 2012 

Advanced HF/Transplant Cardiology Certification 

ABIM Certifying Exam 

April 8, 2013 (Monday) 

Abstract Deadline 

17th HFSA Annual Scientific Meeting 

September 22-25, 2013 

HFSA Annual Scientific Meeting 

Orlando, FL 

Supported by an educational grant 

from Actelion Pharmaceuticals US, Inc. 

Accredited Sponsor: 

Heart Failure Society of America 

Cover Design by Leir Design, Inc. 

and Jeff Post Design. 

This satellite symposium is not part of the scientific program as 

planned by the Heart Failure Society of America Program Committee

Table of Contents 

President’s Message. ...................................... 2 

About the HFSA. ........................................ 4 

Society Officers and Council. ............................... 5 

Scientific Program Committee. .............................. 6 

Meeting Content ......................................... 6 

General Meeting Information ............................... 7 

Complimentary Food Events. ............................... 9 

2012 HFSA Satellite/Scientific Program Activity Supporters. ..... 10 

2012 HFSA Corporate Members. ........................... 10 

Liability Statement ...................................... 10 

CME Information ....................................... 11 

Disclosure Information ................................... 12 

Scientific Program Learning Objectives. ..................... 12 

2012 Abstract Reviewers. ................................. 13 

2012 HFSA Faculty. ..................................... 15 

Program-at-a-Glance. .................................... 24 

September 9: (Sunday) 

Scientific Session (Clinical Fundamentals). ................. 32 

Satellite Symposia. .................................... 33 

Scientific Sessions. .................................... 35 


September 10: (Monday) 


Morning Scientific Program ............................. 41 

Rapid Fire Abstract Session . ............................ 47 

How To Sessions. ..................................... 49 

Afternoon Scientific Program. ........................... 50 

Posters. ............................................. 62 

September 11: (Tuesday) 

Satellite Symposium. .................................. 88 

Morning Scientific Program ............................. 89. 

Oral Abstract Session .................................... 96 

Rapid Fire Abstract Session . ........................... 104 

How-To Sessions . ................................... 106 

Afternoon Scientific Program. .......................... 107 

Posters ............................................ 115 

September 12: (Wednesday) 

Morning Scientific Program ............................ 145 

Exhibit Hall 

Hands-On Workshop (September 10)................................. 154 

Product Theaters (September 10 and September 11) ........... 155 

Clinical Trial Row ..................................... 156 

Exhibit Floor Plan ..................................... 158 

Exhibitors ............................................ 159 

Exhibitor Descriptions. .................................. 160 

Author Index. ......................................... 170 

Washington State Convention Center Floor Plan .............. 208 

Notes. ............................................... 210 

1

President’s Message 

On behalf of the Executive 

Council and the Program 

Committee of the Heart Failure 

Society of America it is my 

pleasure to welcome you to the 

15th Annual Scientific Meeting. 

Last year, my comments at 

this Opening Session focused 

on the quality and diversity of 

the program developed by the 

Program Co-Chairs and their 

hard-working colleagues on 

the Program Committee. I also 

noted that for the first time, 

we added a third Co-Chair, 

Barbara Riegel, to invigorate the 

program for nurses, a critical 

constituency with an expanding 

role in the management of heart failure patients. I would like to be 

able to say that this was a timely change, but many would consider it 

long-overdue. 

I’m sure everyone would agree that heart failure is an exciting field, 

characterized by remarkable scientific advances and innovative 

therapies. The optimal management of heart failure requires extensive 

collaboration among professionals. We have seen the roles of advanced 

practice nurses, pharmacists, nutritionists, exercise physiologists, 

rehabilitation specialists, and social workers burgeon with very positive 

results. This kind of collaboration is critical to our mission and to the 

lives of our patients. It is my hope that HFSA will support and continue 

to propagate this collaboration among these disciplines. 

For me, this meeting marks the end of my two-year term as HFSA 

President. As President, we saw a rapidly changing environment and 

were forced to make some tough changes to our organization. 

Last year, we commenced a strategic planning initiative. The resulting 

document, which was published in the February 2012 issue of the 

Journal of Cardiac Failure, outlined a number of goals intended to 

guide and measure the organization’s future success. A few years 

ago, recognizing the growing interest in and importance of heart 

failure, HFSA took the lead in pushing for a new subspecialty in 

Advanced Heart Failure and Transplantation, with its own certification 

examination. There was a great interest in this, and HFSA conducted 

several very well attended preparation courses. The pass rate was 

very high for those that took these courses, and our meetings now 

incorporate sessions devoted to maintenance of certification. 

Having created this new subspecialty, we have also commenced 

an extremely important initiative to advocate for appropriate 

reimbursement for consultations performed by heart failure specialists. 

At present, consultations by heart failure specialists are not reimbursed 

if the patient has previously been seen by a cardiologist. We are 

working actively to overcome this hurdle, which we believe will 

greatly benefit both heart failure patients and practitioners. 

1. Advocacy 

Goal: HFSA is recognized as the primary advocate for heart failure 

practitioners and patients. 

2. Membership 

Goal: HFSA will increase its membership by 10% per year for 3 years 

from all disciplines working in the area of heart failure. 

3. Education 

Goal: HFSA is recognized for its innovative approaches to educating 

and information dissemination on heart failure, targeting healthcare 

professionals and patients. 

4. Communications 

Goal: HFSA has increased awareness and recognition of the value of 

its services both within its membership and with external audiences. 

5. Collaboration: 

Goal: In the past HFSA has been seen by some as an organization 

that eschews collaboration. In the past two years, I have seen 

and encouraged a change to more openness in working with other 

organizations that share our goals and interests. Recent examples 

include reciprocal participation in meetings of organizations such as 

the AAHFN, ACC, AHA, and HRS. We have also jointly developed 

guidelines, performance measures, and topic-specific white papers. 

Similarly, we have worked collaboratively to ensure availability and 

appropriate use of new devices 

Recruitment of a CEO: 

Obviously, this is an ambitious agenda, and to implement it we 

are delighted to have recruited a CEO to oversee and support it. I’m 

delighted to introduce Michele Blair, who has assumed this position 

and will join us on the podium at the opening plenary session of our 

meeting. Michelle has a long record of administering organizations in 

the medical field. She arrived in March of 2012 and has proven to be 

a quick learner. 

I wish my successor, Tom Force, the best. Having worked closely with 

Tom over the last two years, I am confident that HFSA will continue to 

be in good hands. 

I would like to express my gratitude to the Program Committee, led by 

Lynne Stevenson, Steve Hauser, and Barbara Riegel. Whether you are 

a clinician or researcher, physician, nurse, or pharmacist, or a trainee, 

this program will cover topics that will be useful in your practice and 

work. 

Importantly, we view our meeting’s success not only by the knowledge 

gained, but also by the enjoyment that attendees have in gaining it. We 

hope you find this year’s program to be informative and rewarding. As 

always we welcome and encourage your feedback. 

I hope you enjoy Seattle, leave energized, and take home new 

ideas that will enhance your professional goals and continue you 

involvement with HFSA. 

HFSA’s Five-Year Goals 

Barry M. Massie, MD 

This strategic plan outlined 5 specific goals that represent anticipated 

President, Heart Failure Society of America 2011-12 

outcomes intended to guide and measure the organization’s future 

success. 

2 3

About the HFSA 

Executive Council 

The Heart Failure Society of America (HFSA) represents the first 

organized effort by heart failure experts from the Americas to provide a 

forum for all those interested in heart failure research and patient care. 

The HFSA is dedicated to: 

Promoting research related to all aspects of heart failure and to providing 

a forum for presentation of basic, clinical and population-based research. 

Educating health care professionals through programs, publications, 

and other media in the areas of basic science, clinical medicine, patient 

management, and social, ethical and economic issues to enable them to 

diagnose and treat heart failure and concomitant medical conditions more 

effectively. 

Encouraging primary and secondary preventive measures to reduce the 

incidence of heart failure; serving as a resource for government, private 

industry, and health care providers to facilitate the establishment of 

programs and policies that will better serve the patient. 

Enhancing quality and duration of life in those with heart failure. 

Promoting and facilitating the formal training of physicians, scientists 

and allied health care providers in the field of heart failure. 

Society Membership Information 

Membership in the Society is open to all health care professionals 

with an interest in cardiovascular medicine. For information about the 

HFSA or to become a member, call or write: 

Heart Failure Society of America, Inc. 

Court International 

Suite 240 South 

2550 University Avenue West 

St. Paul, MN 55114 

phone: 651-642-1633 

fax: 651-642-1502 

e-mail: info@hfsa.org 

Interested participants can also visit the HFSA exhibit booth (#601) or 

visit the HFSA web site at www.hfsa.org. 

Officers: 

President: 

Vice-President: 

Secretary: 

Treasurer: 

Immediate Past President: 

Members: 

Barry M. Massie, MD 

San Francisco, CA 

Thomas Force, MD 

Philadelphia, PA 

Hani N. Sabbah, PhD 

Detroit, MI 

Mandeep R. Mehra, MD 

Boston, MA 

Douglas L. Mann, MD 

St. Louis, MO 

Inder S. Anand, MD, PhD 


John C. Burnett, Jr., MD 

Rochester, MN 

John Chin, MD 

Sacramento, CA 

Steven R. Houser, PhD 


Sharon A. Hunt, MD 

Stanford, CA 

JoAnn Lindenfeld, MD 

Denver, CO 

Sara C. Paul, RN, MSN, DNP 

Hickory, NC 

Mariann R. Piano, RN, PhD 

Chicago, IL 

Heather J. Ross, MD 

Toronto, ON, Canada 

Randall C. Starling, MD, MPH 

Cleveland, OH 

James E. Udelson, MD 

Boston, MA 

Michael R. Zile, MD 

Charlotte, SC 

Ex Officio Members: 

Jay N. Cohn, MD 


Gary S. Francis, MD 


David A. Lathrop, PhD 

Bethesda, MD 

Isabella Liang, PhD 

Bethesda, MD 

4 5

2012 Scientific Program Committee 

Lynne Warner Stevenson, MD (Co-Chair) 

Steven R. Houser, PhD (Co-Chair) 

Barbara J. Riegel, RN, DNSc (Co-Chair) 

Larry A. Allen, MD, MHS 

Mark E. Anderson, MD, PhD 

Biykem Bozkurt, MD 

Haleah G. Buck, RN, PhD 

Akashay S. Desai, MD 

Daniel E. Forman, MD 

Jalal K. Ghali, MD 

Joshua I. Goldhaber, MD 

J. Thomas Heywood, MD 

Corrine Y. Jurgens, RN, PhD 

Christopher s. Lee, RN, PhD 

Annarosa Leri, MD 

Wayne C. Levy, MD 

Douglas W. Losordo, MD 

Leslie W. Miller, MD 

Robert Lee Page, II, PharmD, MSPH 

Michael G. Petty, RN, CCNS, ACNS 

Margaret M. Redfield, MD 

Paul B. Rosenberg, MD 

Douglas D. Schocken, MD 

Jagmeet P. Singh, MD, PhD 

Yibin Wang, PhD 

Meeting Content: 

The 2012 HFSA Annual Scientific Meeting Provides a forum for 

the open exchange and discussion of research results and scientific 

advancements in the field of heart failure; however HFSA makes no 

representation or warranty as to the truth, originality, or accuracy 

of the information presented. Nor are the views expressed by the 

individual speakers necessarily the view of HFSA. HFSA supports the 

ACCME’s policy on evidence-based content and encourages faculty to 

adhere to these standards when preparing a presentation. 

Seattle, WA 

General Meeting Information 

All activities listed in this program book will take place at the 

Washington State Convention Center. See pages 208 for floor plan of 

meeting space. 

CME Accreditation/Registration 


Court International, Suite 240 South 



651-642-1633; fax: 651-642-1502 

Registration Hours 

Meeting Registration Desk, 

Washington State Convention Center (4th floor) 

Saturday, September 8: 

Sunday, September 9: 

Monday, September 10: 

Tuesday, September 11: 

Wednesday, September 12: 

9:00 AM-4:00 PM 

8:00 AM-5:00 PM 

7:00 AM-5:00 PM 

7:00 AM-5:00 PM 

7:00 AM-10:00 AM 

What’s Included in Registration Fees 

The registration fee includes admittance to satellite programs, 

scientific sessions, poster sessions, commercial exhibits and activities, 

and the Opening Reception. 

Scientific Meeting Evaluation 

Evaluations for the satellite symposia and how-to sessions will 

be paper forms, as in the past. Evaluation of the main scientific 

meeting will be electronic-only. It will be available online throughout 

and after the meeting and will be accessible via computer, iPad, and 

smart phone. Additional comments about specific sessions and the 

meeting in general can be sent to eval@hfsa.org. In 2013 HFSA will 

require that evaluations be completed before credit certificates are 

issued. Please help us evaluate this meeting and plan future meetings 

through your evaluation of this 

E-Mail From the Exhibit Floor (Booth #125) 

During the meeting e-mail stations will be available in Exhibit Hall 4B 

for attendees to check their e-mail. Please note your e-mail account must 

be accessible through a web-based browser, e.g., Internet Explorer. 

No Smoking Policy 

HFSA prohibits smoking in all areas of the meeting and all hotel meeting 

rooms hosting HFSA functions. Thank you for your cooperation. 

Special Needs 

The HFSA strives to hold meetings that are accessible to all. Please tell 

us what you require to help make your participation more enjoyable and 

meaningful. Contact Gudrun Echterhoff, Global Meetings & Incentives 

at Gudrun@global-mtgs.com (201-850-7607) 

6 7

General Meeting Information (continued) 

Speaker Ready Room – Room 604 Convention Center 

Sunday, September 9 

8:00 AM-6:00 PM 

Monday, September 10 

6:30 AM-6:00 PM 

Tuesday, September 11 

6:30 AM-6:00 PM 

Wednesday, September 12 

6:30 AM-NOON 

Press Room – Room 620 Convention Center 





10:00 AM-5:00 PM 

7:00 AM-5:00 PM 

7:00 AM-5:00 PM 

7:00 AM-NOON 

Exhibit Hall Dates and Hours 

The exhibits are located in Exhibit Hall 4B (4th floor) Washington 

State Convention Center. See page 159 for list of exhibitors and 

location. 


6:00 PM-8:00 PM 


9:30 AM-7:00 PM 


9:30 AM-7:00 PM 


CLOSED 

Clinical Trial Row: 

Located in Exhibit Hall 4B. This provides an opportunity for 

attendees to learn more about ongoing clinical trials in heart failure. 

These boards have been rented by companies and organizations 

supporting clinical trials. The HFSA assumes no responsibility or 

liability for information posted about a clinical trial on these boards. 

Representatives will be at their posters from 5:45-6:45 pm Monday and 

Tuesday. 

Product Theater: 

Located in Exhibit Hall 4B. Product theaters are non-CME educational 

activities held in the Exhibit Hall. Product theaters are scheduled for 

12:45-1:30 PM on Monday and Tuesday. More information is available 

in the Exhibitors Section of this Program Book. 

Hands-on Workshop: 

Located in Exhibit Hall 4B. There will be a hands-on workshop on 

Monday, 10:00 AM - 4:00 PM. This is an opportunity for up-close 

learning about a heart failure treatment modality. More information is 

available in the Exhibitors Section of this Program Book. 

Poster Sessions 

Poster Sessions will be held in the Exhibit Hall 4B (Washington State 

Convention Center) These sessions represent new science in heart 

failure and range from basic science topics to clinical and outcomes 

studies. Please take advantage of this opportunity to see some of the 

newest activity in heart failure research. 

Poster Display: Presenters at their Posters: 

Monday, September 10 9:30 AM-7:00 PM 5:45 PM-6:45 PM 

Tuesday, September 11 9:30 AM-7:00 PM 5:45 PM-6:45 PM 

General Meeting Information (continued) 

Annual Business Meeting: 

The annual Business Meeting of the HFSA will be held on Wednesday, 

September 11, 8:15 AM, Room 608 

Questions? 

Look for staff wearing golf shirts with the HFSA logo. 

Complimentary Food Events 

The following complimentary food events will be offered. All food 

events will take place in the Washington State Convention Center 

Exhibit Hall 4B unless otherwise noted. 

SUNDAY, September 9 

Opening Reception 

(Wine & Hors d’oeuvres) 

MONDAY, September 10 

Continental Breakfast 

Meeting area foyers - 6th floor 

Refreshment Break 


Poster Session and Reception 

(Wine & Cheese) 

TUESDAY, September 11 


Meeting area foyers - 6th Floor 



Poster Session and Reception 

(Wine & Cheese) 

WEDNESDAY, September 12 





6:00 PM-8:00 PM 

6:30 AM-8:30 AM 

10:00 AM-10:30 AM 

3:30 PM-4:00 PM 

5:30 PM-7:00 PM 

6:45 AM-8:30 AM 

10:00 AM-10:30 AM 

3:30 PM-4:00 PM 

5:30 PM-7:00 PM 

6:45 AM-8:30 AM 

10:00 AM-10:30 AM 

8 9

2012 HFSA Satellite/Scientific Program 

Supporting Companies 

Abbott Vascular 

Actelion Pharmaceutical, Inc. 

Arbor Pharmaceutical, Inc. 

Boston Scientific 

Development LLC 

HeartWare 

Janssen Research 

Medtronic, Inc. 

Otsuka America Pharmaceutical, Inc. 

ResMed, Inc. 

SynCardia 

Thoratec 

2012 HFSA Corporate Members 


Janssen Research and Development LLC 

Medtronic, Inc. 

Otsuka America Pharmaceutical, Inc. 

Thoratec Corporation 

Liability Statement 

Disclaimer: The Heart Failure Society of America (HFSA) cannot accept, 

and hereby specifically disclaims, any liability for death, injury, any loss, 

cost or expense suffered or incurred by any person if such loss is caused 

by, arises from or results from the act, default or omission of any person 

other than an employee or agent of HFSA. In particular, neither HFSA 

nor its agents can accept, and hereby specifically disclaims, any liability 

for losses arising from, caused by, or resulting from, the provision or 

non-provision of services provided by the hotels, companies, or transport 

operators. Neither HFSA nor its agents can accept, and hereby specifically 

disclaims, liability for losses suffered by reason of war including threat of 

war, riots and civil strife, terrorist activity, natural disaster, weather, fire, 

flood, drought, technical, mechanical or electrical breakdown within any 

premises visited by delegates and/or participants in connection with the 

meeting, industrial disputes, government action, regulations or technical 

problems that affect or may affect the services provided in connection 

with the meeting. HFSA is not able to warrant and does not warrant 

that a particular person will appear as a speaker. As a condition to any 

participation in or attendance at the Annual Scientific Meeting or any 

function associated or affiliated herewith, each attendee and participant 

accepts the foregoing disclaimer. 

CREDIT STATEMENTS 

Scientific Program 

Physicians: The Heart Failure Society of America is accredited by the 

Accreditation Council for Continuing Medical Education to provide 

continuing medical education for physicians. 

The Heart Failure Society of America designates this live activity for a 

maximum of 25 AMA PRA Category 1 Credits. Physicians should claim 

only the credit commensurate with the extent of their participation in the 

activity. 

Nurses: This program has been approved by the American Association 

of Critical Care Nurses (AACN) for 24.5 contact hours, Synergy 

CERP Category A, File number 00017881. 

Two-Hour Satellite Symposia: 

Physicians: The Heart Failure Society of America is accredited by the 

Accreditation Council for Continuing Medical Education to provide 


The Heart Failure Society of America designates each live activity for 

a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should 

claim only the credit commensurate with the extent of their participation in 

the activity. 

Nurses: Each symposium has been designed to meet Minnesota Board 

of Nursing continuing education requirements and is acceptable for 

2.0 contact hours of continuing education. 

One-Hour Satellite Symposia: 

Physicians: TThe Heart Failure Society of America is accredited by 

the Accreditation Council for Continuing Medical Education to provide 


The Heart Failure Society of America designates each live activity for a 

maximum of 1.0 AMA PRA Category 1 Credit. Physicians should claim 

only the credit commensurate with the extent of their participation in the 

activity. 

Nurses: Each symposium has been designed to meet Minnesota Board 

of Nursing continuing education requirements and is acceptable for 

1.0 contact hour of continuing education. 

CME Certificates Available On-Site 

CME CERTIFICATES (SCIENTIFIC AND SATELLITE 

SESSIONS) WILL BE AVAILABLE ON-SITE. PLEASE 

VISIT THE CME KIOSK IN REGISTRATION AREA TO 

DOWNLOAD AND PRINT YOUR CME CERTIFICATE(S). 

All main entrances to meeting rooms for the scientific sessions 

and the satellite programs will be “gated” to capture attendee 

information. This is the only information that will be used to 

verify attendance for credit certificates. Please make sure you 

enter each session through a gated entrance. 

10 11

Presenter/Planner Disclosure Information 

2012 Abstract Reviewers 

The Heart Failure Society of America has a disclosure policy that 

requires oral presenters to disclose whether or not they have relevant 

financial relationships with any commercial interest and whether or 

not off-label or investigational drug/device use will be discussed. 

All oral and poster presenters’ disclosure information received is 

listed in the HFSA Presenter/Author Disclosure Booklet . A booklet 

is in each meeting congress bag. In addition, each oral presenter will 

have a disclosure slide at the beginning of his/her presentation. 

Scientific Program Learning Objectives 

Following this meeting, participants will be able to: 

1. Describe the epidemiology of HF, including environmental factors, 

and implement strategies for the prevention of HF. 

2. Describe current knowledge about the scientific basis of HF at the 

levels of cardiovascular physiology, neurohormones, tissue factors, 

and molecular biology and genetics. 

3. Identify the findings of basic science and current clinical trials and 

their implications for current and future HF therapy. 

4. Implement optimal guideline-based therapeutic options for HF, 

including pharmacologic agents, non-pharmacologic options, such 

as diet and exercise; and devices. 

5. Manage comorbidities including hypertension, diabetes, and 

cognitive issues. 

6. Demonstrate awareness of psychosocial, economic and ethical 

issues in the treatment of patients with HF. 

7. Implement strategies for effective management of the patient with 

HF, incorporating the family, encouraging self-care, and employing 

the medical home model. 

8. Outline strategies for transitioning patients from impatient to 

outpatient and for reducing hospital readmissions. 

9. Engage in performance measurement and other site-based research. 

10. Outline strategies for more effective communication with patients, 

families, and other health professionals. 

Scientific Session and Satellite Symposia learning objectives are listed 

at the end of each session in the program book. 

Nancy M. Albert, RN, PhD 

Cleveland, OH 

Larry A. Allen, MD, MHS 

Denver, CO 

Mark E. Anderson, MD, PhD 

Iowa City, IA 

J. Malcolm O. Arnold, MD 

London, ON, Canada 

Burns C. Blaxall, PhD 

Cincinnati, OH 

Guido Boerrigter, MD 

Rochester, MN 

Biykem Bozkurt, MD 

Houston, TX 

Harleah G. Buck, RN, PhD, CHPN 

University Park, PA 

Javed Butler, MD, MPH 

Atlanta, GA 

Horng H. Chen, MBBCh 

Rochester, MN 

James P. Daubert, MD 

Durham, NC 

Teresa De Marco, MD 


Prakash C. Deedwania, MD 

Fresno, CA 

David DeNofrio, MD 

Boston, MA 

Akshay S. Desai, MD 

Boston, MA 

Anita Deswal, MD, MPH 

Houston, TX 

Mark H. Drazner, MD 

Dallas, TX 

Justin A. Ezekowitz, MBBCh 

Edmonton, AB, Canada 

James C. Fang, MD 

Cleveland, OH 

G. Michael Felker, MD 

Durham, NC 

Jalal K. Ghali, MD 

Detroit, MI 

Michael M. Givertz, MD 

Boston, MA 

Joshua I. Goldhaber, MD 

Los Angeles, CA 

Steven Goldman, MD 

Tucson, AZ 

Roger J. Hajjar, MD 

New York, NY 

Paul A. Heidenreich, MD, MS 

Palo Alto, CA 

Adrian F. Hernandez, MD 

Durham, NC 

Ray E. Hershberger, MD 

Columbus, OH 

J. Thomas Heywood, MD 

La Jolla, CA 

Tamara B. Horwich, MD 


Steven R. Houser, PhD 


Corrine Y. Jurgens, RN, PhD 

Miller Place, NY 

David E. Lanfear, MD, MS 

Detroit, MI 

Christopher S. Lee, RN, PhD 

Portland, OR 

Terry A. Lennie, PhD, MS 

Lexington, KY 

Annarosa Leri, MD 

Boston, MA 

Ronglih Liao, PhD 

Boston, MA 

JoAnn Lindenfeld, MD 

Denver, CO 

Kenneth B. Margulies, MD 


Paul J. Mather, MD 


Dennis M. McNamara, MD 

Pittsburgh, PA 

Alan B. Miller, MD 

Jacksonville, FL 

Judith E. Mitchell, MD 

New York, NY 

Jeffery D. Molkentin, PhD 


12 13

Mark A. Munger, PharmD 

Salt Lake City, UT 

Robert Lee Page, II, PharmD, MSPH 

Aurora, CO 

Myung H. Park, MD 

Baltimore, MD 

Soon J. Park, MD 

Rochester, MN 

J. Herbert Patterson, PharmD 

Chapel Hill, NC 

Margaret M. Redfield, MD 

Rochester, MN 

Joseph G. Rogers, MD 

Durham, NC 

Paul Rosenberg, MD 

Durham, NC 

Stuart D. Russell, MD 

Baltimore, MD 

Hani N. Sabbah, PhD 

Detroit, MI 

Leslie A. Saxon, MD 


Douglas D. Schocken, MD 

Durham, NC 

Marc A. Silver, MD 

Oak Lawn, IL 

Jagmeet P. Singh, MD, PhD 

Boston, MA 

William G. Stevenson, MD 

Boston, MA 

Garrick C. Stewart, MD 

Boston, MA 

W.H. Wilson Tang, MD 

Cleveland, OH 

Patricia A. Uber, PharmD 

Baltimore, MD 

Hector O. Ventura, MD 

New Orleans, LA 

Mary N. Walsh, MD 

Indianapolis, IN 

Yibin Wang, PhD 


David J. Whellan, MD, MHS 


Michael R. Zile, MD 

Charleston, SC 

Keith D. Aaronson, M.D., MS 

University of Michigan 

Ann Arbor, MI 

William T. Abraham, M.D. 

The Ohio State University 

Columbus, OH 

Michael A. Acker, M.D. 

Hospital of the University of 

Pennsylvania 


Philip B. Adamson, M.D. 

Oklahoma Heart Hospital 

Oklahoma City, OK 

Felipe Aguel, Ph.D. 

Food and Drug Administration 

Silver Spring, MD 

David Aguilar, M.D. 

Baylor College of Medicine 

Houston, TX 

Ali Ahmed, M.D., MPH 

University of Alabama at 

Birmingham 

Birmingham, AL 

2012 HFSA Faculty 

16th Annual Scientific Meeting 

David E. Albert, M.D. 

Alivecor 

Oklahoma City, OK 

Nancy M. Albert, RN, Ph.D. 

Cleveland Clinic Foundation 

Cleveland, OH 

Larry A. Allen, M.D., MHS 

University of Colorado 

Denver, CO 

Inder S. Anand, M.D., Ph.D. 

Minneapolis VAMC 


Stefan D. Anker, M.D., Ph.D. 

Charité, Campus Virchow-Klinikum 

Berlin, Germany 

Francisco Arabia, M.D. 

Mayo Clinic and Foundation 

Rochester, MN 

Ross Arena, P.T., Ph.D. 

The University of New Mexico 

Albuquerque, NM 

Gust H. Bardy, M.D. 

Seattle Institute for Cardiac Research 

Bellevue, WA 

Denise D. Barnard, M.D. 

University of California, San Diego 

San Diego, CA 

Donald M. Bers, Ph.D. 

University of California, Davis 

Davis, CA 

Lenore J. Blank, RN, MSN, NP-C 

Mahwah, NJ 

Burns C. Blaxall, Ph.D. 

Cincinnati Children’s Hospital 

Medical Center 


John P. Boehmer, M.D. 

Penn State University 

Hershey, PA 

Ann Bolger, M.D. 

University of California, San 

Francisco 


Steven F. Bolling, M.D. 


Ann Arbor, MI 

Robert O. Bonow, M.D. 

Northwestern University 

Chicago, IL 

Jeffrey S. Borer, M.D. 

SUNY Downstate Medical Center 

Brooklyn, NY 

Robert C. Bourge, M.D. 

University of Alabama at Birmingham 

Birmingham, AL 

Steven W. Boyce, M.D. 

Washington Regional Cardiac 

Surgery, PC 

Washington, DC 

Biykem Bozkurt, M.D. 

Baylor College of Medicine 

Houston, TX 

Eugene Braunwald, M.D. 

Brigham and Women’s Hospital 

Boston, MA 

Michael R. Bristow, M.D., Ph.D. 


Aurora, CO 

14 

15

Harleah G. Buck, RN, PhD, 

CHPN 

The Pennsylvania State University 

University Park, PA 

Martin C. Burke, D.O. 

University of Chicago 

Chicago, IL 

Daniel Burkhoff, M.D., Ph.D. 

Columbia University 

New York, NY 

Javed Butler, M.D., MPH 

Emory University 

Atlanta, GA 

Peter Buttrick, M.D. 


Aurora, CO 

James H. Caldwell, M.D. 

University of Washington 

Seattle, WA 

Thomas P. Cappola, M.D., ScM 

University of Pennsylvania 


Blasé A. Carabello, M.D. 

VA Medical Center 

Houston, TX 

John D. Carroll, M.D. 


Aurora, CO 

Peter E. Carson, M.D. 

Washington VAMC 


Donald E. Casey, Jr., M.D., MPH, MBA 

NYU Langone Medical Center 

New York, NY 

Horng H. Chen, M.B., B.Ch. 

Mayo Clinic & Foundation 

Rochester, MN 

Suzanne Chillcott, BSN, RN 

Sharp Memorial Hospital 

San Diego, CA 

John Chin, M.D. 

Sutter Memorial Hospital 

Sacramento, CA 

Dawn M. Christensen, MS, 

FNP-BC, ACNP-BC 

Penn State Milton S. Hershey 


Hershey, PA 

Eugene S. Chung, M.D. 

The Ohio Heart and Vascular 

Center, Inc. 


John G.F. Cleland, M.D. 

University of Hull 

Kingston-Upon-Hull, UK 

Barbara A. Cockrill, M.D. 


Boston, MA 

Robert J. Cody, MBA, M.D. 

Janssen Research and 

Development, LLC 

Raritan, NJ 

Jay N. Cohn, M.D. 

University of Minnesota 


Billy Collins 

Steven Barclay Agency 

Petaluma, CA 

Monica M. Colvin-Adams, M.D., MS 



William G. Cotts, M.D. 


Chicago, IL 

Jennifer Cowger, M.D., MS 


Ann Arbor, MI 

Sharlene M. Day, M.D. 


Ann Arbor, MI 

Teresa De Marco, M.D. 

University of California, San Francisco 


Prakash C. Deedwania, M.D. 

VA Central California Health Care 

System 

Fresno, CA 

Colleen Delaney, RN, Ph.D., 

AHN-BC 

University of Connecticut 

Storrs, CT 

Mario C. Deng, M.D. 

UCLA 


Davi DeNofrio, M.D. 

Tufts Medical Center 

Boston, MA 

Akshay S. Desai, M.D. 


Boston, MA 

Michael G. Dickinson, M.D. 

West Michigan Heart 

Grand Rapids, MI 

Lynn V. Doering, DNSc 

UCLA 


Mark H. Drazner, M.D. 

University of Texas Southwestern 

Dallas, TX 

Daniel L. Dries, M.D., MPH 

Yale University 

New Haven, CT 

Anique Ducharme, M.D., MSc, 

FRCPC 

Montréal Heart Institute 

Montréal, QC, Canada 

Mark E. Dunlap, M.D. 

MetroHealth Medical Center 

Cleveland, OH 

Preston M. Dunnmon, M.D. 

Food and Drug Administration 

Silver Spring, MD 

Jean-Bernard Durand, M.D. 

University of Texas 

Houston, TX 

Victor J. Dzau, M.D. 

Duke University 

Durham, NC 

Uri Elkayam, M.D. 

University of Southern California 


Jill Howie Esquivel, RN, Ph.D., NP 


Francisco 


Lorraine S. Evangelista, RN, Ph.D. 

University of California, Irvine 

Irvine, CA 

Michael D. Ezekowitz, MB, 

ChB, DPhil 

Lankenau Medical Center 

Wynnewood, PA 

James C. Fang, M.D. 

Case Western University 

Cleveland, OH 

Arthur M. Feldman, M.D., Ph.D. 

Temple University 


G. Michael Felker, M.D. 


Durham, NC 

Mona Fiuzat, PharmD 


Durham, NC 

John S. Floras, M.D., D.Phil 

Mount Sinai Hospital 


Gregg C. Fonarow, M.D. 

UCLA 


Thomas Force, M.D. 



Paul R. Forfia, M.D. 



Daniel E. Forman, M.D. 


Boston, MA 

Gary S. Francis, M.D. 



Robert P. Frantz, M.D. 


Rochester, MN 

Marie Galvao, MSN, ANP-BC, 

CHFN 

Montefiore Medical Center 

New York, NY 

Lior Gepstein, M.D., Ph.D. 

Technion-Israel Institute of Technology 

Haifa, Israel 

Jalal K. Ghali, M.D. 

DMC Cardiovascular Institute 

Detroit, MI 

Mihai Gheorghiade, M.D. 


Chicago, IL 

Edward M. Gilbert, M.D. 

University of Utah 


Michael M. Givertz, M.D. 


Boston, MA 

16 

17

Thomas Goetz, MA, MPH 

BrightSight Group, LLC 

Princeton, NJ 

Tamara B. Horwich, M.D. 

UCLA 


Michelle M. Kittleson, M.D., Ph.D. 

California Heart Center 

Beverly Hills, CA 

Jane A. Leopold, M.D. 


Boston, MA 

Michael R. Gold, M.D., Ph.D. 

Medical University of South 

Carolina 

Mt. Pleasant, SC 

Joshua I. Goldhaber, M.D. 

Cedars-Sinai Heart Institute 


Steven Goldman, M.D. 

VA Medical Center 

Tucson, AZ 

Steven R. Goldsmith, M.D. 

Hennepin County Medical Center 


Sarah J. Goodlin, M.D. 

Portland VAMC 

Portland, OR 

Daniel J. Gottlieb, M.D., MPH 

Boston University 

Boston, MA 

Stephen S. Gottlieb, M.D. 

University of Maryland 

Baltimore, MD 

Barry H. Greenberg, M.D. 


La Jolla, CA 

Robert J. Gropler, M.D. 

Washington University 

St. Louis, MO 

Michele A. Hamilton, M.D. 

Cedars-Sinai Medical Center 


Paul J. Hauptman, M.D. 

St. Louis University 

St. Louis, MO 

Adrian F. Hernandez, M.D. 


Durham, NC 

Ray E. Hershberger, M.D. 

Ohio State University 

Columbus, OH 

J. Thomas Heywood, M.D. 

Scripps Clinic 

La Jolla, CA 

Katherine J. Hoercher, RN 


Cleveland, OH 

Leora I. Horwitz, M.D., MHS 


New Haven, CT 

Steven R. Houser, Ph.D. 



Jonathan G. Howlett, MD 

University of Calgary 

Calgary, AB , Canada 

Sharon A. Hunt, M.D. 

Stanford University 

Stanford, CA 

Claire Hunter, M.D. 

Creighton University 

Omaha, NE 

Timothy B. Icenogle, M.D. 

Northwest Cardiothoracic and 

Transplant Surgeons, PS 

Spokane, WA 

Daniel L. Jacoby, M.D. 


New Haven, CT 

Alan Jansujwicz, M.D. 

Northeast Cardiology Associates 

Bangor, ME 

Mariell L. Jessup, M.D. 



Ranjit John, M.B.B.S. 



Jacob Joseph, M.B., B.S., M.D. 


Boston, MA 

Corrine Y. Jurgens, RN, Ph.D. 

Stony Brook University 

Stony Brook, NY 

Annemarie Kaan, MCN, RN 

The University of British Columbia 

Vancouver, BC, Canada 

Stuart D. Katz, M.D. 

New York University 

New York, NY 

James N. Kirkpatrick, M.D. 



Jon A. Kobashigawa, M.D. 

California Heart Center 

Beverly Hills, CA 

Walter J. Koch, Ph.D. 



Marvin A. Konstam, M.D. 


Boston, MA 

Robert L. Kormos, M.D. 

University of Pittsburgh 


Stuart Kupfer, M.D. 

Takeda Pharmaceuticals 

International 

Deerfield, IL 

Neal Lakdawala, M.D. 


Boston, MA 

Rachel J. Lampert, M.D. 


New Haven, CT 

Michael J. Landzberg, M.D. 

Harvard Medical School 

Boston, MA 

David E. Lanfear, M.D. 

Henry Ford Hospital 

Detroit, MI 

Ann S. Laramee, APRN 

Fletcher Allen Healthcare 

South Burlington, VT 

Christopher S. Lee, RN, Ph.D. 

Oregon Health & Science University 

Portland, OR 

Daniel Lee, M.D. 


Chicago, IL 

Carl V. Leier, M.D. 

The Ohio State University 

Columbus, OH 

Daniel J. Lenihan, M.D. 

Vanderbilt University 

Nashville, TN 

Terry A. Lennie, Ph.D., MS 

University of Kentucky 

Lexington, KY 

Annarosa Leri, M.D. 


Boston, MA 

Wayne C. Levy, M.D. 


Seattle, WA 

E. Douglas Lewandowski, Ph.D. 

University of Illinois at Chicago 

Chicago, IL 

Eldrin F. Lewis, M.D., MPH 


Boston, MA 

Gregory D. Lewis, M.D. 

Massachusetts General Hospital 

Boston, MA 

Ronglih Liao, Ph.D. 


Boston, MA 

Joseph R. Libonati, Ph.D. 



Giuseppe Licata, M.D. 

Università degli Studi di Palermo 

Palermo, Italy 

Kelly Ann Light-McGroary, M.D. 

University of Iowa Hospitals and 

Clinics 

Iowa City, IA 

JoAnn Lindenfeld, M.D. 


Denver, CO 

Peter P. Liu, M.D. 

University of Toronto 


Douglas W. Losordo, M.D. 

Baxter Healthcare Corporation 

Deerfield, IL 

W. Robb MacLellan, M.D. 


Seattle, WA 

Calum A. MacRae, M.D., Ph.D. 


Boston, MA 

Alan S. Maisel, M.D. 


La Jolla, CA 

18 

19

Douglas L. Mann, M.D. 


St. Louis, MO 

Eduardo Marbán, M.D., Ph.D. 

Cedars-Sinai Medical Center 


Kenneth B. Margulies, M.D. 



Frederick A. Masoudi, M.D., 

M.S.P.H. 


Aurora, CO 

Barry M. Massie, M.D. 


Francisco 


Simon W. Maybaum, M.D. 

Montefiore Medical Center 

Bronx, NY 

John T. McDevitt, Ph.D. 

Rice University 

Houston, TX 

Edwin C. McGee, Jr., M.D. 


Chicago, IL 

Elizabeth M. McNally, M.D., 

Ph.D. 

The University of Chicago 

Chicago, IL 

Mandeep R. Mehra, M.D. 


Boston, MA 

JonDavid Menteer, M.D. 



Theo E. Meyer, M.D., Ph.D. 

University of Massachusetts 

Medical School 

Worcester, MA 

Alan B. Miller, M.D. 

University of Florida 

Jacksonville, FL 

Leslie W. Miller, M.D. 

University of South Florida 

Tampa, FL 

Gordon W. Moe, M.D. 

St. Michael’s Hospital 


Jeffery D. Molkentin, Ph.D. 

Cincinnati Children’s Hospital 



Debra K. Moser, RN, DNSc 


Lexington, KY 

Gia Mudd-Martin, Ph.D., MPH, RN 


Lexington, KY 

Mark A. Munger, Pharm.D. 



Michael D. Murray, Pharm.D., 

MPH 

Regenstrief Institute, Inc. 


Charles E. Murry, M.D., Ph.D. 


Seattle, WA 

Sanjiv M. Narayan, M.D., Ph.D. 


La Jolla, CA 

Tien M.H. Ng, Pharm.D. 



Anju Nohria, M.D. 


Boston, MA 

John B. O’Connell, MD 

Heart Failure Consultants 

Sunset, SC 

Christopher M. O’Connor, M.D. 


Durham, NC 

Eric N. Olson, Ph.D. 


Dallas, TX 

Linda J. Ordway, RN, MSN, ACNP 


Boston, MA 

Milton Packer, M.D. 


Dallas, TX 

Peter S. Pang, M.D. 


Chicago, IL 

Myung H. Park, M.D. 


Baltimore, MD 

Myung H. Park, M.D. 


Baltimore, MD 

Soon J. Park, M.D. 


Rochester, MN 

Ayan R. Patel, M.D. 


Boston, MA 

J. Herbert Patterson, Pharm.D. 

University of North Carolina 


Sara C. Paul, RN, MSN, DNP 

Western Piedmont Heart Centers 

Hickory, NC 

Pamela N. Peterson, M.D., 

MSPH 


Denver, CO 

Michael G. Petty, RN, CCNS, PhD 



George J. Philippides, M.D. 

Boston University 

Boston, MA 

Mariann R. Piano, RN, Ph.D. 

University of Illinois 

Chicago, IL 

Philippe Pibarot, DVM, Ph.D. 

University Institute of Cardiology 

& Pneumology of Quebec 

Québec, QC, Canada 

Ileana L. Piña, M.D. 

Albert Einstein College of 

Medicine 

Bronx, NY 

Peipei Ping, Ph.D. 

UCLA 


Bertram Pitt, M.D. 


Ann Arbor, MI 

Piotr Ponikowski, M.D., Ph.D., 

FESC 

Medical University 

Wroclaw, Poland 

Jeanne E. Poole, M.D. 


Seattle, WA 

20 

21 

Michael A. Portman, M.D. 

Seattle Children’s 

Seattle, WA 

Susan J. Pressler, RN, Ph.D. 


Ann Arbor, MI 

J. Eduardo Rame, M.D. 



Margaret M. Redfield, M.D. 

Mayo Clinic and Foundation 

Rochester, MN 

Shelby D. Reed, Ph.D., RPh 


Durham, NC 

Michael W. Rich, M.D. 


St. Louis, MO 

Barbara J. Riegel, RN, DNSc 



Jo Ellen Rodgers, Pharm.D. 

The University of North Carolina 

at Chapel Hill 


Joseph G. Rogers, M.D. 


Durham, NC 

Paul Rosenberg, M.D. 


Durham, NC 

Denis Roy, M.D. 



Stuart D. Russell, M.D. 

Johns Hopkins University 

Baltimore, MD 

Jason W. Ryan, M.D. 

University of Connecticut Health Center 

Farmington, CT 

Hani N. Sabbah, Ph.D. 

Henry Ford Health System 

Detroit, MI 

Mitchell T. Saltzberg, M.D. 

Christiana Care Hospital 

Newark, DE 

William H. Sauer, M.D. 


Aurora, CO

Douglas B. Sawyer, M.D., Ph.D. 

Vanderbilt University 

Nashville, TN 

Leslie A. Saxon, M.D. 



Kristen G. Schaefer, M.D. 

Dana-Farber Cancer Institute 

Boston, MA 

Douglas D. Schocken, M.D. 


Durham, NC 

Marc J. Semigran, M.D. 


Boston, MA 

Soko Setoguchi-Iwata, M.D., MPH 


Durham, NC 

Marc A. Silver, M.D. 

Christ Hospital and Medical Center 

Oak Lawn, IL 

Jagmeet P. Singh, M.D., Ph.D. 


Boston, MA 

Jared L. Skillings, Ph.D., ABPP, 

FACHP 

Pine Rest Northeast Clinic 

Grand Rapids Charter Township, MI 

Mark S. Slaughter, M.D. 

University of Louisville 

Louisville, KY 

Michael J. Sole, M.D. 

Toronto General Hospital 


Randall C. Starling, M.D., MPH 


Cleveland, OH 

Josef Stehlik, M.D., MPH 



Lynne Warner Stevenson, M.D. 

Brigham & Women’s Hospital 

Boston, MA 

William G. Stevenson, M.D. 


Boston, MA 

Garrick C. Stewart, M.D. 


Boston, MA 

Wendy Gattis Stough, PharmD 

Expert Medical Communications 

& Consulting, LLC 

Cary, NC 

Mark D. Sullivan, M.D., Ph.D. 


Seattle, WA 

Nancy K. Sweitzer, M.D., Ph.D. 

University of Wisconsin 

Madison, WI 

Mario Talajic, M.D. 



W.H. Wilson Tang, M.D. 


Cleveland, OH 

David O. Taylor, M.D. 


Cleveland, OH 

John R. Teerlink, M.D. 

San Francisco VAMC 


Andre Terzic, M.D., Ph.D. 


Rochester, MN 

Jeffrey J. Teuteberg, M.D. 

University of Pittsburgh 


Rong Tian, Ph.D., M.D. 


Seattle, WA 

Robin J. Trupp, RN, Ph.D., 

APRN-BC 

Comprehensive CV Consulting 

Tampa, FL 

Emily J. Tsai, M.D. 



Carsten Tschöpe, M.D. 

Charité - University Medicine Berlin 

Berlin, Germany 

Patricia A. Uber, Pharm.D. 


Baltimore, MD 

Joseph G. Verbalis, M.D. 

Georgetown University 


James E. Udelson, M.D. 


Boston, MA 

Mary N. Walsh, M.D. 

St. Vincent Heart Center of Indiana 


Thomas J. Wang, M.D. 


Boston, MA 

Yibin Wang, Ph.D. 

UCLA 


Robert G. Weiss, M.D. 

Johns Hopkins University 

Baltimore, MD 

Cheryl A. Westlake, RN, Ph.D. 

Azuza Pacific University 

Azuza, CA 

Bruce L. Wilkoff, M.D. 

The Cleveland Clinic 

Cleveland, OH 

Suzanne J. Wingate, RN, Ph.D. 

Gaithersburg, MD 

Ronald M. Witteles, M.D. 


Stanford, CA 

Mary A. Woo, RN, DNSc. 

UCLA 


Joseph Wu, M.D. 


Stanford, CA 

Toshitaka Yajima, M.D., Ph.D. 


Diego 

La Jolla, CA 

Clyde W. Yancy, M.D., MSc 


Chicago, IL 

Michael R. Zile, M.D. 

Medical University of South Carolina 


Mark T. Ziolo, Ph.D. 

Geisinger Center for Clinical Studies 

Columbus, OH 

Mark J. Zucker, M.D., J.D. 

Newark Beth Israel Medical Center 

Newark, NJ 

22 23

Sunday, September 9, 2012 HFSA 16th Annual Scientific Meeting-September 9-12, 2012 Seattle, WA 

Ballroom 6A Ballroom 6C Meeting Rooms 612 

Meeting Room 616 

10:30AM-1:00PM Clinical Fundamentals: 

Initial Evaluation and 

Standard Therapies 

1:00-3:00 PM Satellite: The Tao of 

the Right Ventricle: A 

Wicked Problem 

2:00-3:00 PM Satellite: Mechanically 

Assisted Circulation: 

Therapeutic Options 

Across the Spectrum of 

Advanced Heart 

Disease 

3:30-6:00 PM Special Sunday 

Scientific Session 

Rebuilding the 

Failing Heart 

4:00-6:00 PM Satellite: Achieving 

Treatment Success in 

Patients with Heart 

Failure Complicated by 

Hyponatremia 

Satellite: The Impact 

of New Rhythm 

Device Technology on 

Patient Management 

Options 

Symposium: Joint 

Session with ICCAC- 

VAD 

6:00-8:00 PM Open Reception 16th Annual Scientific Meeting - Poster-Exhibit Area (Exhibit Hall 4B) Washington State 

Convention Center 

Monday, September 10, 2012 HFSA 16th Annual Scientific Meeting – September 9-12, 2012 – Seattle, WA 

Ballroom 6A Ballroom 6B Ballroom 6C Meeting Room 

603 

6:30-7:00AM Continental Breakfast (xxx) 

6:45-7:45 AM Satellite: 

Hydralazine and 

Isosorbide Dinitrate 

Therapy in Heart 

Failure: Past, 

Present, and Future 

Meeting Room 

608/609 

Satellite: Sleep 

Disordered 

Breathing in 

Heart Failure: 

Challenges and 

Opportunities 

8:00 AM Welcome/Opening Remarks 

8:40 AM Opening Plenary Session: 

Communication in a New World 

10:00 AM Coffee Break - Exhibit Hall 4B (Opens at 9:30 AM; See page 62 for Monday Posters; visit posters until 7:00 PM) 

10:30 AM-NOON Late Breaking 

News 

Symposium 

Windows Into 

the Heart 


612 

Symposium 

Stem Cell 

Controversies 


616 


619 

Nursing 

Investigator 

Research Award 

24 

25

Monday, September 10, 2012 HFSA 16th Annual Scientific Meeting – September 9-12, 2012 – Seattle, WA 


603 


608/609 

NOON Lunch Break - Exhibit Hall opens at 9:30 AM; see page 62 for Monday posters; visit posters until 7:00 PM 

12:30-1:30 PM How To Session: 

How-to 5: Difficult 

12:30-1:45 PM Rapid Fire Oral 

Abstract Session 

2:00-3:30 PM Symposium 

Next Generation 

Beta-Blocker 

Therapy for 

Heart Failure: 

Genes, Targets, 

and Mechanisms 

Symposium 

A Day in the Life 

Symposium 

Management in 

Nursing Homes 

3:30 PM Coffee Break - Exhibit Hall 4B (Posters display 9:30 AM-7:00 PM) 


U Shaped 

Curves in Heart 

Failure 

Symposium 

Guideline Update: 

Mineralocorticoid 

Receptor 

Antagonists 

(MRAs) 

Symposium 

The Transition 

from Hospital to 

Home 

Conversations 

About Prognosis 

Jay N. Cohn New 

Investigator 

Award: 

Clinical/Integrative 

Physiology 

Jay N. Cohn New 

Investigator 

Award: 

Basic Science 

5:30 PM Wine and Hors d'oeuvres in Poster Area Exhibit Hall (presenters at their posters 5:45-6:45 PM) 

7:00 PM Exhibits Close (Exhibit Hall re-opens Tuesday 9:30 AM-7:00 PM) 

How To Session: 

How-to 3: How to 

Maximize 

Adherence to HF 

Performance 

Measures in the 

In- & Out-patient 

Settings 


612 


How-to 1: How 

to Identify 

Treatable Causes 

of HF 

Symposium 

Pharmacology 

and 

Pharmokinetics 

101: Applying 

Theory to Patient 

Care 

Symposium 

The Human 

Genome Comes 

Home 


616 


How-to 2: How 

to Bridge 

Patients to 

Transplantation 

with VADS 


619 


How-to 4: Using 

Tools for 

Economic 

Analysis of 

Management 

Interventions 

HFSA Study 

Session for 

MOC: 


Failure and 

Transplant 

Cardiology 

Part I 

HFSA Study 

Session for 

MOC: 


Failure and 

Transplant 

Cardiology 

Part II 

Tuesday, September 11, 2012 HFSA 16th Annual Scientific Meeting – September 9-12, 2012 – Seattle, WA 


603 


608/609 

6:30-7:00AM Continental Breakfast available in foyer areas 

7:00-8:00 AM Satellite: 

Current and 

Emerging Therapies 

for Heart Failure 

Patients with Mitral 

Regurgitation 

7:00-8:15 AM Symposium 

Strategies for 

National Heart 

Failure Care 


Restricting Sodium: 

Truth or 

Tradition? 

Symposium 

Atrial Fibrillation 

in Heart Failure 

Symposium 

Advanced 

Therapy: Getting 

It Right 

Symposium 

How Should We 

Improve Pump 

Function? 

Symposium 

Connecting the 

Dots Between 

The Disease and 

The Symptoms 

10:00 AM Coffee Break - Exhibit Hall 4B (Opens at 9:30 AM; See page 115 for Tuesday Posters; visit posters until 7:00 PM) 

10:30 AM-NOON Symposium 

Approach to 

Myocarditis/Strategy 

to Recover LV 

with LVAD 

Case Discussion Symposium 

The Patient with 

Heart Failure 

and Severe 

Valvular Heart 

Disease 

Symposium 

Why and How 

to Develop New 

Drugs and 

Devices for 


Symposium 

Windows Into 

the Heart 


612 

Clinical 

Fundamentals : 

Management of 

Arrhythmia 

Devices, and 

Pulmonary 

Hypertension 

Featured Oral 


Symposium 

Cardiac 

Metabolism in 



616 


619 

26 

27

Tuesday, September 11, 2012 HFSA 16th Annual Scientific Meeting – September 9-12, 2012 – Seattle, WA 


603 


608/609 

NOON Lunch Break - Exhibit Hall opens at 9:30 AM; see page 115 for Tuesday posters; visit posters until 7:00 PM 

12:30-1:30 PM Rapid Fire Oral 


1:45 PM Announcement of Awards 

2:00-3:30 PM Symposium From Left to 

Right 

Hyde Park Symposium 

Back in the 

Hospital 

3:30 PM Coffee Break - Exhibit Hall 4B (Posters display 9:30 AM-7:00 PM) 


Drugs Don’t 

Work in Patients 

Who Don’t Tak e 

Them: Why 

Aren’t Patients 

Adherent? 

Debate Session : 

Oral Inotropic 

Agents Should be 

Available for 

Palliative Care; 

Clinical Care 

Symposium 

Revised 

AHA/ACC 

Performance 

Measures and 

Evidence That 

Supports 

Changes 


How-to 8: How 

to Read and 

Interpret the 

Results of 

Genetic Testing 

5:30 PM Wine and Hors d'oeuvres in Poster Area Exhibit Hall (presenters at their posters 5:45-6:45 PM) 

7:00 PM Exhibits Close 


How-to 10: HF 

Physicians Learn 

to Read the 

ICD/CR Device 

Reports 


612 


How-to 7: 

Cardiotoxicity of 

Chemotherapy: 

Evaluation and 

Therapy 

Symposium 

Therapies in 

Development 

Symposium 

Remodeling in 

Reverse 


616 


How-to 6: Using 

Apps for Self- 

Care 


619 


How-to 9: How 

to Identify and 

Use Simple 

Tools for 

Assessment of 

Health Literacy 

Wednesday, September 12, 2012 HFSA 16th Annual Scientific Meeting 

Ballroom 6A Meeting Room Meeting Room 612 

608/609 

7:00 AM Continental Breakfast (available in foyer areas) 

7:00-8:30 AM Clinical 

Fundamentals: 

Options for 


Failure and Clinical 

Pearls 


Cardiotoxicity 

10:00 AM Coffee Break 

10:30 AM-NOON Symposium 

Envisioning 

Therapy in Heart 


Symposium 

Advances in 

Diagnosis and 

Targeted 

Management 

Strategies of Specific 

Cardiomyopathies 

Symposium 

Re-defining 

Success 

Symposium 

Decreasing 

Readmission from 

Home 

Symposium 

Common Sense and 

Personalized 

Medicine 

28 

29

Welcome to the 

16th Annual 

Scientific Meeting 

September 9 – 12, 2012 

Washington State Convention 

and Trade Center 

Seattle, WA 

www.hfsa.org 

31

Sept. 9 

Sunday 

AM 

Clinical fundamentals 


10:30 AM-1:00 PM 

Ballroom 6A 

SATELLITE SYMPOSIUM 


1:00-3:00 PM 

Ballroom 6C 

Sept. 9 

Sunday 

PM 

sunday 

Clinical Fundamentals: 

Initial Evaluation and Standard Therapies 

The Tao of the Right Ventricle: A Wicked 

Problem 

Sunday 

Moderators: Larry A. Allen, Denver, CO 

Akshay M. Desai, Boston, MA 

10:30 Introduction: The “Typical” Patient 

Akshay M. Desai, Boston, MA 

10:35 History and Clinical Assessment 

Mark H. Drazner, Dallas, TX 

10:45 Family History and Evolving Role of Genetic Testing 

Neal Lakdawala, Boston, MA 

10:55 Imaging and Invasive Assessment for New Heart Failure 

James E. Udelson, Boston, MA 

11:05 Questions 

11:15 Initial Medical Therapy: Selection, Initiation, and 

Titration of ACE-Inhibitors, Angiotensin Receptor 

Antagonists and Beta-Blockers 

Michelle M. Kittleson, Beverly Hills, CA 

11:30 The ‘Third Drug’: Aldosterone Antagonist, Isordil/ 

Hydralazine, or ARB? 

William G. Cotts, Chicago, IL 

11:40 Other Medical Therapy: Diuretics, Digoxin, 

Supplements 

Denise D. Barnard, San Diego, CA 

11:50 Questions and Answers 

Faculty 

Noon 

Risk Assessment: Assessment of Functional Capacity 

and Role for Cardiac Biomarkers 

Daniel L. Dries, New Haven, CT 

12:10 HF-PEF: Workup, Pathophysiology and Management 

Justin A. Ezekowitz – invited 

12:25 Acute Decompensated Heart Failure: Practical 

Considerations and Approach to Management 

Steven R. Goldsmith, Minneapolis, MN 


Faculty 

Learning Objective: Describe methods for evaluating and managing 

chronic and acute HF, including standard drug therapy. 

Chair: 

Mandeep R. Mehra, Boston, MA 

1:00 Welcome and Introduction 


1:05 The Orphan Right and the Abundant Left 

Milton Packer, Dallas, TX 

1:25 Question and Answer with Audience Response 

1:30 Evaluating the Right Ventricle: Opening the Oyster 

Paul R. Forfia, Philadelphia, PA 


2:00 Right Ventricular Malfeasance in PAH: Righting A 

Wrong 

Teresa De Marco, San Diego, CA 


2:30 Repaired Congenital Heart Defect: Not Free and Clear 

Michael Landzberg, Boston, MA 


3:00 Adjourn 

Learning Objectives: 

1. Describe the unique pathology of right ventricle (RV) 

failure and differentiate it from left ventricular failure 

2. Use appropriate hemodynamic assessment in the 

identification of RV failure 

3. Describe effective strategies for managing pulmonary 

arterial hypertension (PAH) 

4. Evaluate and manage adult patients with repaired 

congenital heart defects 

Supported by an educational grant from Actelion 

Pharmaceuticals 

This symposium is not part of the scientific 

program as planned by the HFSA Scientific 

Program Committee. 

32 

33

Sept. 9 

Sunday 

PM 



2:00-3:00 PM 

Ballroom 6A 

SCIENTIFIC SESSIoN 


3:30-6:00 PM 


Sept. 9 

Sunday 

PM 

sunday 

Chairs: 

Mechanically Assisted Circulation: Therapeutic 

Options Across the Spectrum of Advanced 


Joseph G. Rogers, Durham, NC 

Randall C. Starling, Cleveland, OH 

2:00 Introduction and Overview 


2:05 Who Should Receive Mechanically Assisted Circulation 

in 2012: Lessons Learned from INTERMACS and 

MEDAMACS? 

Lynne W. Stevenson, Boston, MA 

2:17 Short-Term Device Strategies for Acute Cardiac Failure: 

What to Do When Medications Fail? 

Mark S. Slaughter, Louisville, KY 

2:29 Contemporary Results with Durable Mechanical 

Circulatory Support 

J. Eduardo Rame, Philadelphia, PA 

2:41 Bi-Ventricular Heart Failure: Assessing the Right 

Ventricle and Available Treatment Options 

Francisco Arabia, Scottsdale, AZ 

Excellence in Basic Science: 

Rebuilding the Failing Heart 

Moderators: Steven R. Houser, Philadelphia, PA 

Jeffrey D. Molkentin, Cincinnati, OH 

3:30* Strategies to Repair the Failing Heart 

6th Distinguished Lecture in Basic Science 

Eric N. Olson, Dallas, TX 

(award to be presented immediately following lecture) 

4:30* Cardiac-Derived Stem Cells to Rebuild the Failing Heart 

Eduardo Marban, Los Angeles, CA 

5:00* Embryonic Stem Cells to Rebuild the Failing Heart 

Charles E. Murry, Seattle, WA 

5:30* Induced Pluripotent Stem Cells for Cardiac Repair 

Andre Terzic, Rochester, MN 

*includes 5 minute audience discussion 

Learning Objective: Describe emerging strategies using 

stem cells or fibroblasts to repair the failing heart. 

Sunday 

2:53 Q&A and Panel Discussion 

Moderator: Randall C. Starling, Cleveland, OH 

3:00 Adjourn 


1. Identify appropriate candidates for mechanically 

assisted circulation. 

2. Outline short-term device strategies for acute heart 

failure when medications are not sufficient. 

3. Describe current results with durable mechanical 

circulatory support. 

4. Assess the right ventricle and identify available 

treatment options 

Supported by educational grants from Thoratec, HeartWare, SynCardia 




6:00 Opening Reception 

2012 HFSA Annual Scientific Meeting 

Exhibit Hall 4B 




34 35

Sept. 9 

Sunday 

PM 

SCIENTIFIC SESSION 


Sept. 9 


3:30-6:00 PM 



4:00-6:00 PM 

Ballroom 6C 

Sunday 

PM 

sunday 

Joint Session with ICCAC-VAD 

Moderators: Michael G. Petty, Minneapolis, MN 

Timothy B. Icenogle, Spokane, WA 

Chair: Leslie A. Saxon, Los Angeles, CA 


Leslie A. Saxon, Los Angeles, CA 

The Impact of New Rhythm Device Technology on 

Patient Management Options 

Sunday 

Obtaining Consent: What Do You Tell Patients and Families 

Considering VAD Therapy? 

3:30 Setting Expectations: Education or Sales? 

Jeffrey J. Teuteberg, Pittsburgh, PA 

3:40 What if They Say No? Palliative Care Options 

Kristen G. Schaefer, Boston MA 

3:50 Caregiver Commitment: What Does Support Entail? 

AnneMarie Kaan, Vancouver, BC, Canada 

4:00 Discussion 

How High is The Bar For a “Good” Destination? 

4:10 What Predicted Survival is a “Good” Destination? 

Michael M. Givertz, Boston, MA 

4:05* The Incidence and Management of Inappropriate Shocks 

in Patients with Heart Failures 

Michael R. Gold, Charleston, SC 

4:30* The Role of ICDs With and Without Leads in the 

Management of Patients with Heart Failure 

Martin C. Burke, Chicago, IL 

4:55* A New Look at Device Diagnostics: What Should We Be 

Measuring? 

John P. Boehmer, Hershey, PA 

5:15* Could an ICD with Monitoring Features Prevent Heart 

Failure Progression? 

Lynne W. Stevenson, Boston, MA 

4:20 What Level of Adverse Events is Acceptable? 

Robert L. Kormos, Pittsburgh, PA 

4:30 What Quality of Life makes a “Good” Destination? 

Suzanne Chillcott, San Diego, CA 

5:20 Clinical Implications: Approaches to Managing Patients 

with Heart Failure and Hyponatremia 

Barry H. Greenberg, San Diego, CA 

5:35 Patient Management Case 1: Patient Monitoring 

John P. Boehmer, Hershey, PA 

5:45 Patient Management Case 2: A Heart Failure Patient 

with Arrhythmia 


5:55 Final Comments and Discussion 

Faculty 

*Includes 5 minute question-and-answer 


Going Home: Support Outside the Hospital 

4:50 The VAD Community on Line: MyAD.com 

Steven W. Boyce, Washington, DC 

5:00 What is the Social Support Necessary For VAD Success? 

Michael G. Petty, Minneapolis, MN 


Programmatic Issues 

5:20 Adjusting Anticoagulation: Striking a Balance to Prevent 

Embolic Stroke And GI Bleeds 

Ranjit John, Minneapolis, MN 


1. Manage and avoid complications with inappropriate 

ICD shocks 

2. Explain the rationale for the use of subcutaneous ICD 

devices in suitable patients with severe heart failure 

3. Identify the benefits and pitfalls of remote physiologic 

monitoring with implantable devices 

4. Outline a strategy for the use of remote monitoring in 

patients with heart failure 

5. Choose appropriate devices for patients with heart 

failure at high risk for arrhythmic death 

5:30 What is a Sustainable Ratio of VAD Coordinators to 

Patients: In New and Established Programs 

Dawn M. Christensen, Hershey, PA 

Supported by an educational grant from Boston Scientific 

Corporation, Inc. 


Learning Objective: Identify factors important to the success of 

VAD therapy and how to manage them. 










36 37

Sept. 9 

Sunday 

PM 



4:00-6:00 PM 

Ballroom 6A 



6:45-7:45 AM 

Meeting Room 608/609 

Sept. 10 

Monday 

AM 

sunday 

Achieving Treatment Success for Patients with 

Heart Failure Complicated by Hyponatremia 

Sleep Disordered Breathing in Heart Failure: 

Challenges and Opportunities 

Chair: John R. Teerlink, San Fancisco, CA 


John R. Teerlink, San Francisco, CA 

4:10 Hypervolemic Hyponatremia in Patients with Heart 

Failure: Pathogenesis and Treatment Options 

Joseph G. Verbalis, Washington, DC 

4:40 Lessons from Clinical Trials of Vasopressin Receptor 

Antagonists in Heart Failure 

Marvin A. Konstam, Boston, MA 

5:05 Current and Emerging Treatment Options for 

Improving Outcomes in the Heart Failure Patient with 

Hyponatremia (Case #1) 

Paul J. Hauptman, St. Louis, MO 

5:30 Caring for the Heart Failure Patient with Hyponatremia: 

A Nursing Perspective (Case #2) 

Linda J. Ordway, Boston, MA 

5:50 Discussion with Faculty 


6:00 Adjourn 


1. Review the role of arginine vasopressin in the 

pathogenesis of hypervolemic hyponatremia in patients 

with heart failure 

2. Assess the safety and efficacy of current and emerging 

therapies for the management of hyponatremia in patients 

with heart failure 

3. Discuss evidence-based guidelines and strategies on the 

management of hyponatremia in acute decompensated 

heart failure 

4. Apply evidence-based guidelines on the management of 

hypervolemic hyponatremia in acute decompensated heart 

failure 

5. Discuss strategies to achieve treatment success for 

patients with heart failure and hyponatremia 

Chair: 

Christopher M. O’Connor, Durham, NC 

6:45 Introduction and Epidemiology of Sleep Disordered 

Breathing in Heart Failure 


6:50 The Pathophysiology of Sleep Apnea in the Heart Failure 

Patient 

Daniel J. Gottlieb, Boston, MA 

7:05 Sleep Apnea in Heart Failure: Key Elements of the 

Diagnostic Evaluation 

William T. Abraham, Columbus, OH 

7:15 Treatment Strategies for Sleep Disordered Breathing in 


John S. Floras, Toronto, ON, CA 

7:30 Troubleshooting 

Sara C. Paul, Hickory, NC 

7:35 Panel Discussion and Questions 

Faculty 

7:45 Adjourn 


1. Identify the epidemiology and risk factors for sleep 

disordered breathing in heart failure patients. 

2. Discuss the mechanisms and pathophysiology of sleepdisordered 

breathing in patients with heart failure. 

3. Conduct an effective diagnostic work-up 

4. Use appropriate treatment strategies for heart failure 

patients with sleep-disordered breathing 

Supported by an educational grant from ResMed, Inc. 

Monday 

Supported by an educational grant from Otsuka America 

Pharmaceuticals, Inc 







38 

This program is not part of the scientific program 

as planned by the HFSA Scientific Program 

Committee. 

39

Sept. 10 

Monday 

AM 

Monday 



6:45-7:45 AM 

Ballroom 6A 

Hydralazine and Isosorbide Dinitrate Therapy in 

Heart Failure: Past, Present, and Future 

Chair: Javed Butler, Atlanta, GA 

6:45 Introduction 

Javed Butler, Atlanta, GA 

6:50 Nitric Oxide Pathobiology and Heart Failure 

Douglas L. Mann, St. Louis, MO 

7:00 Evidence Supporting the Benefit of H-ISDN in the 

Treatment of HF 

Eldrin F. Lewis, Boston, MA 

7:10 Guideline Recommendations and Clinical Use of H-ISDN 

Gregg C. Fonarow, Los Angeles, CA 

7:20 Unanswered Questions and Future Research 


7:35 Panel Discussion 

Faculty 

OPENING PLENARY SESSION 


8:00-10:00 AM 

Ballrooms 6B and 6C 

8:00 Opening and Welcome Remarks 

Steven R. Houser, Philadelphia, PA 

Lynne Warner Stevenson, Boston, MA 

Barbara J. Riegel, Philadelphia, PA 

8:10 2012 HFSA Lifetime Achievement Award 

Presented by Jay N. Cohn 

8:25 Presidential Address 

Barry M. Massie, San Francisco, CA 

Communication in a New World 

Moderators: Lynne W. Stevenson, Boston, MA 

Thomas Force, Philadelphia, PA 

8:40 Feedback Loops Wired to Change Biology 

Thomas Goetz, Princeton, NJ 

9:20 Reaching Out for the Words 

Billy Collins, Winter Park, FL 

Sept. 10 

Monday 

AM 

Monday 


1. Describe clinical trial evidence and practice guidelines 

supporting the use of H-ISDN in patients with heart 

failure 

2. Describe nitric oxide pathobiology in heart failure 

3. Identify potential barriers to the effective use of H-ISDN 

in patients with heart failure and strategies for addressing 

these barriers 

4. Describe the role of H-ISDN in the treatment of nonblacks 

and women with HF, pulmonary hypertension, and 

acute HF 

5. Describe bioequivalence data of combination H-ISDN 

and generic preparations 

6. Discuss ongoing research and quality of care initiatives 

with H-ISDN 

Learning Objective: Describe ways in which communication 

at the personal, biological, and technological levels affect 

healthcare. 

Supported by an educational grant from Arbor 

Pharmaceuticals, Inc. 

This symposium is not part of the scientific program as planned by 

the HFSA Scientific Program Committee. 

40 41

Sept. 10 

Monday 

AM 

POSTERS DISPLAYED 


9:30 AM-7:00 PM 


SYMPOSIUM 


10:30 AM-NOON 

Ballroom 6A 

Sept. 10 

Monday 

AM 

PRESENTERS AT POSTERS 5:45 PM-6:45 PM 

Late Breaking News 

Categories Poster # 

Moderators: Jay N. Cohn, Minneapolis, MN 

Barry H. Greenberg, La Jolla, CA 

Monday 

Cardiovascular Physiology 019-023, 025, 027-038 

Cardiovascular Structure 062-068 

Neurohormones/Cytokines 077-081, 083-085 

Molecular Biology and Genetics 096-103 

VADs/transplant/surgery 112-133 

Electrophysiology and rhythm devices 155-156, 158-167 

Clinical Trials 182, 185-188 

10:30* Warfarin versus Aspirin in Patients with Reduced 

Cardiac Ejection Fraction (WARCEF) Trial 

Shunichi Homma, New York, NY 

10:47 Commentary: 

John G.F. Cleland, Kingston-Upon-Hull, UK 

10:52* A Phase 2, Randomized, Double-Blind, Multi- 

Center Placebo-Controlled Study of a Cross-Linked 

Polyelectrolyte (CLP vs. Placebo in Heart Failure 

Patients with Chronic Kidney Disease) 



Steven S. Gottlieb, Baltimore, MD 

11:09* Current Clinical Experience with the Synergy® Micro- 

Pump System in Chronic Ambulatory 

Daniel Burkhoff, New York, NY 

Monday 

Cardiovascular Pharmacology 198-203 

11:21 Commentary 


Epidemiology, Prevention 209-214 

Outcomes 222-225, 227-229, 231-254 

Clinical Care/ 288,290-297, 299-322 

Management Strategies 

11:26* Improving Self Care Behavior and Clinical Outcomes in 

Rural Patients with Heart Failure 

Kathleen A. Dracup, San Francisco, CA 

11:38 Commentary 


11:43* PARAMOUNT for Preserved EF Heart Failure 

Scott D. Solomon, Boston, MA 

Listing for Monday posters begins on page 62 

Listing for Tuesday posters begins on page 115 


Margaret M. Redfield, Rochester, MN 

* 12 minutes presentation, 5 commentary 

Learning Objective: Describe the results of recent trials and 

discuss their implications for the care of patients with heart 

failure. 

10:00 Coffee Break 

Refreshments served in Exhibit Hall 4B 

42 43

Sept. 10 

Monday 

AM 

NURSING INVESTIGATOR SESSION 


10:30 AM-NOON 


SYMPOSIUM 


10:30 AM-NOON 


Sept. 10 

Monday 

AM 

Nursing Investigator Research Award 

Windows Into the Heart 

Monday 

Moderators: Victoria Vaughan Dickson, New York, NY 

Susan J. Pressler, Ann Arbor, MI 

10:30* Discordance between Self-Reported and 24-Hour 011 

Urine Sodium Intake and Predictors of Sodium Non- 

Adherence 

Ruth M. Masterson Creber, Youjeong Kang, Maxim Topaz, 

Terry A. Lennie and Barbara Riegel. School of Nursing, 

University of Pennsylvania, Philadelphia, PA and School of 

Nursing, University of Kentucky, Lexington, KY 

10:48* The Relationships between Uric Acid and 012 

Inflammatory Markers Differ between Heart Failure 

Patients with and without Central Obesity 

Kyoung Suk Lee, Debra K. Moser and Terry A. Lennie. 

College of Nursing, University of Kentucky, Lexington, KY 

11:06* Patients with Biventricular Mechanical Support 013 

Can Be Safely Discharged to Home To Await Heart 

Transplant 

J. W. Creaser, D. Rourke, T. Harrison, E. Vandenbogaart, 

N. Livingston, E. Howell, N. Huie, A. Baas, A. Hickey, A. 

Nsair, M. Deng, G. C. Fonarow, R. Cheng, R. Shemin and 

W. R. MacLellan. UCLA, Westwood, CA 

11:24* Superior Perceived Control Comes with 014 

Improved Health Related Quality of Life in Younger 

Heart Failure Patients 

Tsuey-Yuan Huang, Hui-Chu Yu, Ming-Fen Tsai, Shiow- 

Li Hwang, Mei-Ling Yeh, Terry A. Lennie and Debra K. 

Moser. Nursing, Chang Gung University of Science and 

Technology, Taoyuan, Taiwan; Nursing, National Taiwan 

University Hospital, Taipei, Taiwan; Nursing, National 

Taipei University of Nursing & Health Sciences, Taipei, 

Taiwan and Nursing, University of Kentucky, Lexington, 

KY 

11:42* Lactic Acidosis after Cardiac Transplantation: 015 

Foe or Common Innocent Bystander? 

Jennifer L. Nixon, Abdallah G. Kfoury, Kim Brunisholz, 

Tami Bair, Kyle Balling, Ramin Razaei, Deborah Budge, 

John Doty, Brad Rasmusson, Bruce Reid, Hildegard Smith, 

George Thomsen, Mark Goddard and Rami Alharethi. 

Intermountain Heart Institute, Salt Lake City, UT 

*10 minute presentation, 8 minute audience discussion 

Learning Objective: Discuss results of recent nursing 

research and its implications for the care of pts with HF 

Moderators: Marvin A. Konstam, Boston, MA 

W. Robb MacLellan, Seattle, WA 

10:30 A Perfect Cycle 

Ann Bolger, San Francisco, CA 

10:40 Metabolism Through NMR 

Rong Tian, Seattle, WA 

10:55 Shifting Substrates-PET 

James H. Caldwell, Seattle, WA 

11:05 Cardiac Magnetic Resonance Imaging Determines 

Etiology and Viability 

Daniel Lee, Chicago, IL 

11:15 MIBG Imaging to Track Therapies and Prognosis 

James H. Caldwell, Seattle, WA 

11:30 The Picture of Myocardial Inflammation 

Peter P. Liu, Toronto, ON, Canada 


Faculty 

Learning Objective: Identify imaging modalities and their 

appropriate use in the evaluation and management of 

patients with heart failure. 

Monday 

44 45

Sept. 10 

Monday 

AM 

SYMPOSIUM 


10:30 AM-NOON 


ORAL ABSTRACT SESSION 


12:30-1:45 PM 

Ballroom 6A 

Sept. 10 

Monday 

PM 

Stem Cell Controversies 

Rapid Fire Abstracts 

Monday 

Moderators: Annarosa Leri, Boston, MA 

Douglas W. Losordo, Chicago, IL 

Controversy 

10:30 Why Do We Need iPS Cells if We Have Adult Cardiac 

Stem Cells? 

Ronglih Liao, Boston, MA 

10:40 Why Do We Need Adult Cardiac Stem Cells if We Have 

iPS Cells? 

Charles E. Murry, Seattle, WA 


11:00* Human iPS Cell-Based Therapy: Considerations Before 

Clinical Applications 

Joseph Wu, Chapel Hill, NC 

11:18* Alternative Use of Human iPS Cells: Drug Screening 

and Disease Modeling 

Lior Gepstein, Haifa, Israel 

11:36* Can We Reprogram Cardiac Fibroblasts Into New 

Cardiac Myocytes 

Victor J. Dzau, Durham, NC 

*15 minute presentation, 2-3 minute audience discussion 

Learning Objective: Describe the role and importance of iPS 

cells and adult stem cells in heart failure research and drug 

testing. 

Moderators: Gary S. Francis, Minneapolis, MN 


12:30* The Frequency and Prognosis of Cardiotoxicity 199 

from Trastuzumab 

Jennifer R. Brown, Stephen S. Gottlieb; Cardiology, 

University of Maryland Medical Center, Baltimore, MD 

12:35* Do Risk Models in Advanced Heart Failure 222 

Need To Be Sex-Specific? 

Jennifer Chyu, Chi-Hong Tseng, Tamara B. Horwich; 

Ahmanson-UCLA Cardiomyopathy Center, Los Angeles, 

CA; Biostatistics, David Geffen School of Medicine at 

UCLA, Los Angeles, CA 

12:40* Sex Differences in Mortality on Waiting List 123 

for Heart Transplantation 

Eileen Hsich, Randall C. Starling, Eugene H. Blackstone, 

David O. Taylor, Jesse D. Schold; Cleveland Clinic, 

Cleveland, OH 

12:45* Antibody-Mediated Rejection in Heart 124 

Transplantation: Does Induction and the 

Type Matter? 

Z. Lill, J. Stehlik, G. Snow, P. Revelo, R. Alharethi, M. 

Everitt, D. Miller, F. Bader, D. Budge, K. Brunisholz, 

K. Molina, E. Gilbert, M. Hammond, A.G. Kfoury; Utah 

Transplantation Affiliated Hospitals (U.T.A.H.) Cardiac 

Transplant Program, Salt Lake City, UT 

12:50* Therapeutic Targeted Delivery of 097 

AAV9 Sh BNIP3 Reverses Cardiac Remodeling 

and Improves Diastolic and Systolic Function 

in a Rat Model of Pressure Overload Induced 


Antoine H. Chaanine, Ronald E. Gordon, Ludovic Benard, 

Erik Kohlbrenner, Roger J. Hajjar; Cardiovascular Institute, 

Mount Sinai School of Medicine, New York, NY; Pathology 

Department, Mount Sinai School of Medicine, New York, 

NY 

12:55* HDAC Inhibition Reduces Infarct Size in 101 

Large Animal Ischemia/Reperfusion by 

Normalizing Cardiomyocyte Autophagy 

Min Xie, Yongli Kong, Wei Tan, Herman May, Pavan 

Battiprolu, Nan Jiang, Aslan Turer, Joseph Hill; Internal 

Medicine (Cardiology), and Molecular Biology, UT 

Southwestern Medical Center, Dallas, TX 

1:00* Altered Forms of Brain Natriuretic Peptide 288 

in Cardiac Disease 

Jeffrey Chan, Arrash Fard, Navaid Iqbal, John Butterfield, 

Alan Maisel,; University of California, San Diego, La Jolla, 

CA; Cardiology, Veterans Affairs Medical Center, La Jolla, 

CA; University of Western Sydney, Sydney, Australia 

1:05* Acute Subcutaneous and Oral Delivery of 198 

Cenderitide, a Novel Dual Natriuretic Peptide 

Receptor Agonist, Is Readily Absorbed and 

Activates the Second Messenger CGMP 

Guido Boerrigter, Elizabeth C. Costello, Prateek Bhargava, 

Gary I. Riley, John C. Burnett; Cardiovascular Diseases, 

Mayo Clinic, Rochester, MN; Emisphere Technologies, 

Cedar Knolls, NJ 

(continued next page) 

*3 minutes to present, 2 minute discussion 

Monday 

46 

47

Sept. 10 

Monday 

PM 

ORAL ABSTRACT SESSIONS 


12:30-1:45 PM 

Ballroom 6A 

How To sessions 


12:30-1:30 PM 

Sept. 10 

Monday 

PM 

Location 

Monday 

Rapid Fire Abstracts (cont.) 

1:10* Cognitive Function in Older Heart Failure 210 

Patients Is Similar to Older Patients Following Stroke 

Karen Harkness, Gail MacKenzie, Emma MacLean, George 

Heckman, Demetrios J. Sahlas, Wieslaw Oczkowski, Robert 

McKelvie; McMaster University, Hamilton, ON, Canada; 

Hamilton Health Sciences, Hamilton, ON, Canada; University of 

Waterloo, Waterloo, ON, Canada 

1:15* Pumped up, but Not Prepared: Examining 117 

LVAD-DT Patients’ Comprehension of Advance 

Directive Specifications 

James Kirkpatrick, Sarah Hull, Katherine Kellom, Rebecca 

Henderson, Frances Barg; University of Pennsylvania, 

Philadelphia, PA; Yale University, New Haven, CT 

1:20* Patient Perception of Physician-Patient 295 

Communication At Time of Implantable 

Defibrillator Implant Decision 

Paul J. Hauptman, John Chibnall, Camille Guild, Eric Armbrecht; 

Medicine, Saint Louis University School of Medicine, St. Louis, 

MO; Neurology and Psychiatry, Saint Louis University School of 

Medicine, St. Louis, MO; Center for Outcomes Research, Saint 

Louis University School of Medicine, St. Louis, MO 

1:25* Lipopolysaccharide Responsiveness Is an 080 

Independent Predictor of Death in Chronic 


Nicole Ebner, Gabor Foldes, Lutz Schomburg, Anja Sandek, 

Jochen Springer, Ewa Jankowska, Sabine Genth-Zotz, Wolfram 

Doehner, Stefan D. Anker, Stephan von Haehling; Department of 

Cardiology, Applied Cachexia Research, 

Charité –University Medical School, Campus Virchow-Klinikum, 

Berlin, Germany; National Heart and Lung Institute Imperial 

College, London, United Kingdom; Charité- University Medical 

School, Campus Virchow-Klinikum, Institut für Experimentelle 

Endokrinologie, Berlin, Germany; Department of Cardiology, 

Military Hospital, Wroclaw, Poland; Department of Medical 

Immunology, Charité –University Medical School, Campus 

Virchow-Klinikum, Berlin, Germany 

1:30* Quantifying Circadian Variation of Multiple 294 

Physiologic Signals in Ambulatory Heart 

Failure Patients 

John Boehmer, Yi Zhang, Robert Sweeney, Ramesh Wariar, Qi 

An, Pramodsingh Thakur, Viktoria Averina, Julie Thompson; Penn 

State Milton S. Hershey Medical Center, Hershey, PA; Boston 

Scientific, St. Paul, MN 

1:35* Short and Long-Term Outcome of Impedance-Guided 185 

Preemptive Therapy Provided To Prevent Pulmonary 

Congestion-Edema in the Course of Acute Myocardial 

Infarction 

Michael Shochat, Avraham Shotan, Mark Kazatsker, Aya Asif, Iris 

Dahan, Elena Shochat, Yaniv Levy, David Blondheim, Simcha 

Meisel; Cardiology, Hille Yaffe Heart Institute, Hadera, Israel 

1:40* Night-Time Elevation Angles in MultiSENSE 020 

Study Are Related to Symptoms of Orthopnea & Paroxysmal 

Nocturnal Dyspnea 

John Hatlestad, Sharda Mehta, Joan Whelan-Schwartz, Ravi 

Shankar, John P. Boehmer; Cardiac Rhythm Management, Boston 

Scientific Corporation, St. Paul, MN; Heart and Vascular Institute, 

Penn State Milton S. Hershey Medical Center, Hershey, PA 


Learning Objective: Discuss findings from recent clinical research 

in heart failure. 

1. How to Identify Treatable Causes of Heart Failure Room 612 

Michael M. Givertz Boston, MA 

David E. Lanfear, Detroit, MI 

Learning Objective: List treatable causes of heart failure 

and describe clinical techniques and procedures to identify them. 

2. How to Bridge Patients to Transplantation with VADS Room 616 

Michael A. Acker, Philadelphia, PA 

Josef Stehlik, Salt Lake City, UT 

Learning Objective: Identify clinical issues in the management 

of patients with VADs awaiting transplant and how they can 

best be managed. 

3. How to Maximize Adherence to Heart Failure Room 608/609 

Performance Measures in the Inpatient and 

Outpatient Settings 

Marc A. Silver, Oak Lawn, IL 

Mary N. Walsh, Indianapolis, IN 

Learning Objective: Identify heart failure performance 

measures and describe strategies for maximizing adherence 

in the inpatient and outpatient settings. 

4. Using Tools for Economic Analysis of Room 619 

Management Interventions 

Shelby D. Reed, Durham, NC 

Sara C. Paul, Hickory, NC 

Learning Objective:Use tools to analyze the cost and 

cost-effectiveness of management interventions in heart failure. 

5. Difficult Conversations About Prognosis Room 603 

Kristen G. Schaefer, Boston 

Harleah G. Buck, University Park, PA 

Learning Objective: Describe strategies for productive 

discussions with heart failure patients facing a 

difficult prognosis. 

Monday 

48 49

Sept. 10 

Monday 

PM 

SYMPOSIUM 


2:00-3:30 PM 

Ballroom 6C 

SYMPOSIUM 


2:00-3:30 PM 


Sept. 10 

Monday 

PM 

Monday 

Management in Nursing Homes 

Moderators: James N. Kirkpatrick, Philadelphia, PA 

Corrine Y. Jurgens, Miller Place, NY 

2:00* Where Does Disease Management Take Place? 

John B. O’Connell, Atlanta, GA 

2:18* Device Management 

Rachel J. Lampert, New Haven, CT 

2:36* When to Hold, When to Fold 

Ali Ahmed, Birmingham, AL 

2:54* Exercise Guidelines for Heart Failure in Nursing Homes 

Ross Arena, Albuquerque, NM 

3:12* Promoting Self-Care in Patients Discharged Home From 

a Skilled Nursing Facility 

Colleen Delaney, Storrs, CT 


Learning Objective: Describe strategies for the effective 

evaluation and management of patients with heart failure in 

nursing homes. 

Pharmacology and Pharmokinetics 101: 

Applying Theory to Patient Care 

Moderators: Jo Ellen Rodgers, Chapel Hill, NC 

Mona Fiuzat, Durham, NC 

2:00* Testing New HF Drugs in Animal Models 

Hani N. Sabbah, Detroit MI 

2:15* Pharmacokinetics: Heart Failure Impacts on Drug 

Metabolism 

Jo Ellen Rodgers, Chapel Hill, NC 

2:30* Drug-Drug Interactions: Pumps, Proteins, and P-450s 

Jo Ellen Rodgers, Chapel Hill, NC 

2:45* Pharmacodynamics: Drug-induced QT Prolongation: Is 

It a Concern? 

Tien M.H. Ng, Rochester, NY 

3:00* Adapting Drug Regimens for the Elderly 

Michael W. Rich, St. Louis, MO 

3:15* Supplements or Prescriptions? PUFAs and Others 


*12 minute presentations, 3 minute discussion 

Learning Objective: Describe the pharmacology of heart 

failure drugs and its implications for patient management. 

Monday 





50 51

Sept. 10 

Monday 

PM 

MOc session 

JNC NEW INVESTIGATOR SESSION 

Sept. 10 


2:00-3:30 PM 



2:00-3:30 PM 


Monday 

PM 

HFSA Study Session for MOC: Advanced Heart 

Failure and Transplant Cardiology Part I 

Jay N. Cohn New Investigator Award: 

Clinical/Integrative Physiology 

(10 Knowledge Points: Must attend both sessions and complete a 

test to earn points) 

Moderators: Jay N. Cohn, Minneapolis, MN 


Monday 

Moderators: Ileana L. Piña, Bronx, NY 

Marc J. Semigran, Boston, MA 

HFSA has developed an ABIM-approved Self-Evaluation 

of Medical Knowledge Module on Advanced Heart Failure 

and Transplant Cardiology worth 10 points towards 

Maintenance of Certification (MOC). This two-part 

session will review the 25 questions in that module. 

In order to receive MOC points, the module must be 

purchased at www.hfsa.org and successfully completed 

online. CME credit is also granted upon completion of the 

module. There is no CME credit for the review sessions. 

It is not necessary to be board certified in Advanced Heart 

Failure and Transplant Cardiology to complete the module 

or attend these sessions. 

Although there is no additional registration fee to attend 

this session, attendees must be preregistered in order to 

enter the session. 

Learning Objective: Discuss key questions in the 

epidemiology, pathophysiology, and treatment of patients 

with advanced heart failure. 

2:00* Diabetes and Left Ventricular Function: 

A Population Based Study in Olmsted County, MN 

006 

Sanjay Dandamudi, Aaron M. From, Joshua Slusser, 

Douglas W. Mahoney, Margret M. Redfield, Richard 

Rodeheffer and Horng H. Chen. Department of Internal 

Medicine, Mayo Clinic, Rochester, MN,; Department of 

Internal Medicine, Division of Cardiovascular Diseases, 

Mayo Clinic, Rochester, MN, and Division of Biomedical 

Statistics and Informatics, Mayo Clinic, Rochester, MN 

2:18* Circulating Molecular Forms of C-Type 007 

Natriuretic Peptide in Aging Humans and 

Their Biological Actions in Cultured Human 

Cardiac Fibroblasts: A Potential Therapeutic 

and Diagnostic Opportunity 

S. Jeson Sangaralingham, Denise M. Heublein, Brenda K. 

Huntley, Tomoko Ichiki, Sharon M. Sandberg and John C. 

Burnett, Jr. Mayo Clinic, Rochester, MN 

2:36* All Three NP Pre/Prohormones Are Processed 008 

in Normal Human Blood into Biologically 

Active Mature Peptides 

Tomoko Ichiki, Brenda K. Huntley, Sharon M. Sandberg 

and John C. Burnett. Cardiorenal Research Laboratory, 

Mayo Clinic, Rochester, MN 

2:54* Safety and Prognostic Value of Cerebral 009 

Oximetry Monitoring in Heart Failure Patients 

during Cardiopulmonary Exercise 

Luay Rifai, Kemisha Key, Winna Taylor and Marc A. 

Silver. Department of Medicine, University of Illinois at 

Chicago/Advocate Christ Medical Center, Oak Lawn, IL, 

and Heart Failure Institute, Advocate Christ Medical Center, 

Oak Lawn, IL 

Monday 

3:12* The Association between Nursing Home Care 010 

Quality and 30-Day Readmission Rates after 

Hospitalization for Heart Failure 

Owolabi Ogunneye, Michael Rothberg, Mara Slawsky, 

Jennifer Friderici, Taraka V. Gadiraju and Mihaela 

Stefan. Internal Medicine, Baystate Medical Center/ 

Tufts University School of Medicine, Springfield, MA; 

Cardiology, Baystate Medical Center/Tufts University 

School of Medicine, Springfield, MA, and Epidemiology 

& Biostatistics, Baystate Medical Center/Tufts University 

School of Medicine, Springfield, MA 


Learning Objective: Discuss results of recent research and 

their implications for the treatment of heart failure. 





52 53

Sept. 10 

Monday 

PM 

SYMPOSIUM 


2:00-3:30 PM 

Ballroom 6B 

SYMPOSIUM 


2:00-3:30 PM 

Ballroom 6A 

Sept. 10 

Monday 

PM 

Monday 

A Day in the Life 

Moderators: Eldrin F. Lewis, Boston, MA 

Mary A. Woo, Los Angeles, CA 

2:00 Night and Day: Hemodynamic Rhythms During 

Ambulatory Monitoring 

Philip B. Adamson, Oklahoma City, OK 

2:10 FEATURED LECTURE 

Diurnal Rhythms at the Translational (or Molecular) Level 

Michael J. Sole, Toronto, ON, Canada 

2:30 Medication Schedules to Optimize Adherence and Benefit 

Michael D. Murray, Indianapolis, IN 


2:45 Optimal Frequency and Intensity of Exercise 

Daniel E. Forman, Boston, MA 

3:00 Family Dynamics 

Susan J. Pressler, Ann Arbor, MI 

3:15 Circadian Rhythms and Sleep-Disordered Breathing 

James C. Fang, Cleveland, OH 


Learning Objective: Use circadian rhythms and other timebased 

strategies to maximize management of the patient 

with heart failure. 

Next Generation Beta-Blocker Therapy 

for Heart Failure: Genes, Targets, and 

Mechanisms 

Moderators: Walter J. Koch, Philadelphia, PA 

J. Herbert Patterson, Chapel Hill, NC 

2:00* Challenges in Beta-Blocker Utilization: 

Counting the Eligible 

Adrian F. Hernandez, Durham, NC 

2:18* Biased Downstream Signaling 

Burns C. Blaxall, Cincinnati, OH 

2:36* Next Generation Beta-Blockers for Heart Failure: 

Isoform Specific Targeting 

Michael R. Bristow, Denver, CO 

2:54* Genetic Diversity in Beta-Blocker Therapy 

David E. Lanfear, Detroit, MI 

3:12* Beta Blockers: A Class Effect? 

Steven S. Gottlieb, Baltimore, MD 


Learning Objective: Describe emerging ways in which the 

effectiveness of beta-blocker therapy for heart failure might 

be increased. 

Monday 





54 55

Sept. 10 

Monday 

PM 

GUIDELINE SYMPOSIUM 


4:00-5:30 PM 

Ballroom 6B 

SYMPOSIUM 


4:00-5:30 PM 

Ballroom 6A 

Sept. 10 

Monday 

PM 

Monday 

Guideline Update: Mineralocorticoid Receptor 

Antagonists (MRAs) 

Moderators: Peter E. Carson, Washington, DC 


4:00 Get with the Guidelines: Does Adherence Assure Quality 

Outcomes? 


4:15 MRAs: What is the Evidence to Support Their Use 

Bertram Pitt, Ann Arbor, MI 

4:30 MRAs: What are the Gaps in Adoption? 

Mary N. Walsh, Indianapolis, IN 

4:45 HFSA 2012 Recommendations on the use of MRA 


5:00 Panel Discussion and Case Studies 

Panelists: 


Peter E. Carson, Washington, DC 




Wendy Gattis Stough, Cary, NC 

Mary Walsh, Indianapolis, IN 

Cheryl A. Westlake, San Clemente, CA 

Case #1: A 70 yo African American male with EF 30%, 

NYHA Class III. What is the best to add next? 

Presenter: Nancy K. Sweitzer, Madison, WI 

Case #2: A 35 yo diabetic male post-MI with EF 36% 

Impaired renal function. What is the best to add next and 

how to monitor? 

Presenter: Monica Colvin-Adams, Minneapolis, MN 

U Shaped Curves in Heart Failure 

Moderators: John G.F. Cleland, Kingston-Upon-Hull, UK 

Mariann R. Piano, Chicago, IL 

4:00* HbA1C and Heart Failure: Targets for Diabetes in 


David Aguilar, Houston, TX 

4:15* BMI and Heart Failure: To Gain Weight or Lose it? 

Stefan D. Anker, Berlin, Germany 

4:30* Blood Pressure in Heart Failure: Sign of Pump or Sign 

of Load? 

Biykem Bozkurt, Houston, TX 

4:45* Contractility: It Has To Be Just Right 


5:00* ICD Benefit and Disease Severity in Heart Failure 


5:15* Iron and Erythropoietin in Heart Failure: 

What is Too Much? 

Inder S. Anand , Minneapolis, MN 

*12 minutes with 3 minute discussion after each presentation 

Learning Objective: Describe a common pattern in diverse 

management issues and how it provides guidance for 

optimum patient care. 

Monday 

Learning Objective: Identify updates and clinical 

applications of guidelines for the treatment of patients with 

heart failure. 

5:30 Poster Session and Reception 


Presenters at their Posters 5:45-6:45 PM 

Refreshments and Hors d’oeuvres Served 





56 57

Sept. 10 

Monday 

PM 

SYMPOSIUM 


4:00-5:30 PM 


SYMPOSIUM 


4:00-5:30 PM 

Ballroom 6C 

Sept. 10 

Monday 

PM 

The Human Genome Comes Home 

The Transition from Hospital to Home 

Moderators: Kenneth B. Margulies, Philadelphia, PA 

Thomas P. Cappola, Philadelphia, PA 

Moderators: Claire Hunter, Omaha, NE 

Alan Miller, Jacksonville, FL 

4:00* Common Heritable Mutations in CM 

Ray E. Hershberger, Columbus, OH 

4:00 Reducing Readmissions: What Can We All Agree On? 

Leora Horwitz, New Haven, CT 

Monday 

4:18* GWAs (Genome –Wide Association Studies) for Dummies 

Thomas J. Wang, Boston, MA 

4:10 Does Very Early Follow-up Make a Difference? 

Robin J. Trupp, Tampa, FL 

Monday 

4:36* Genes Causing both CM and Arrhythmias 

Calum A. MacRae, Boston, MA 

4:20 Paving the Road Through Rehabilitation 

Michael G. Dickinson, Grand Rapids, MI 

4:54* Correlating Genotype with Phenotype In 

Cardiomypathies 

Sharlene M. Day, Ann Arbor, MI 

5:12* Whole Genome Strategies for Cardiomyopathy 

Elizabeth M. McNally, Chicago, IL 


Learning Objective: Discuss current research in the role 

of genetics in the development of cardiomyopathy and its 

implications for clinical practice. 

4:30 Questions on the Transition 

4:50 Assessment and Impact of Frailty 

JoAnn Lindenfeld, Denver, CO 

5:00 Management in Montreal 

Anique Ducharme, Montreal, QC, Canada 

5:10 Where is the Medical Home for Medicare 

Patients With Heart Failure and Co-Morbidities? 

Douglas D. Schocken, Durham, NC 


Learning Objective: Identify factors affecting the transition 

from hospital to home for patients with heart failure and 

describe ways to manage them. 









58 59

Sept. 10 

Monday 

PM 

MOC SESSION 


4:00-5:30 PM 


jnc new investigator session 


4:00-5:30 PM 


Sept. 10 

Monday 

PM 

HFSA Study Session for MOC: Advanced Heart 

Failure and Transplant Cardiology Part II 

Jay N. Cohn New Investigator Award: Basic 

Science 

Monday 

(10 Knowledge Points: Must attend both sessions and complete 

the exam to earn points) 

Moderators: Ileana L. Piña, Bronx, NY 

Marc J. Semigran, Boston, MA 

HFSA has developed an ABIM-approved Self-Evaluation 

of Medical Knowledge Module on Advanced Heart Failure 

and Transplant Cardiology worth 10 points towards 

Maintenance of Certification (MOC). This two-part 

session will review the 25 questions in that module. 

In order to receive MOC points, the module must be 

purchased at www.hfsa.org and successfully completed 

online. CME credit is also granted upon completion of the 

module. There is no CME credit for the review sessions. 

It is not necessary to be board certified in Advanced Heart 

Failure and Transplant Cardiology to complete the module 

or attend these sessions. 

Although there is no additional registration fee to attend 

this session, attendees must be preregistered in order to 

enter the session. 

Learning Objective: Discuss key questions in the 

epidemiology, pathophysiology, and treatment of patients 

with advanced heart failure 





Moderators:Walter J. Koch, Philadelphia, PA 


4:00* Induction of Native Cardiomyocyte Cell Cycle 001 

Re-Entry by Transplanted Cells as a Novel 

Mechanism of Therapeutic Regeneration in the Heart 

Konstantinos Malliaras and Eduardo Marban. Cedars-Sinai 

Heart Institute, Los Angeles, CA 

4:18* Cardiac Specific Overexpression of Nrf2 Protects 002 

Against Pressure Overload-Induced Heart Failure 

Via Enhancing Autophagic Clearance of 

Ubiquitinated Proteins 

Wenjuan Wang, MS, Siying Li, MD, Yifan Xing, Gary 

Horvath, Qian Wang, and Taixing Cui. Cell Biology and 

Anatomy, University of South Carolina School of Medicine, 

Columbia, SC and Chemistry and Biochemistry, University 

of South Carolina, Columbia, SC 

4:36* MEK7-JNK1-Akt Signaling Axis Regulates 003 

Phospholamban- T17 Phosphorylation and 

Intracellular Calcium Levels in an Anthrax 

Model of Acute Diastolic Heart Failure 

Honey B Golden, Furqan Shah, Linley E. Watson, Donald 

M. Foster, David E. Dostal. Cardiovascular Research 

Institute, Texas A&M Health Science Center, Temple, TX; 

Scott & White Memorial Hospital, Temple, TX; Central 

Texas Veterans Health Care System, Temple, TX 

4:54* Metoprolol Enhances Caveolae- 004 

Localized NO-cGMP Signaling in Volume- 

Overloaded Hearts 

Emily J. Tsai,Yuchuan Liu, Louis Dell’Italia, Victor Rizzo 

and Abdelkarim Sabri. Cardiovascular Research Center, 

Temple University School of Medicine, Philadelphia, 

PA and University of Alabama Birmingham School of 

Medicine, Birmingham, AL 

5:12* Full Expression of Acute Non-Ischemic 005 

Cardiomyopathy in a Murine Model Is Dependent 

on Intact B Cell Function 

Andrea M. Cordero-Reyes, Keith A. Youker, Jose H. 

Flores-Arredondo, Alejandro R. Trevino, Christian Assad- 

Kottner, Jerry D. Estep, Arvind Bhimaraj and Guillermo 

Torre-Amione. Methodist DeBakey Heart and Vascular 

Center, The Methodist Hospital, Houston, TX; Cardiology, 

University of Texas Medical Branch, Galveston, TX and 

Catedra de Cardiologia y Medicina Vascular, Tecnologico 

de Monterrey, NL, Mexico 


Learning Objective: Discuss the results and implications of 

basic science research in heart failure. 





Monday 

60 61

Sept. 10 

Monday 

Posters 

Posters 

Cardiovascular Physiology 

Posters 


Sept. 10 

Monday 

Posters 

Monday 

019 MANP: A Novel Designer Natriuretic Peptide for 

Cardiometabolic Disease 

Valentina Cannone 1 , Brenda K. Huntley 1 , Denise M. 

Heublein 1 , Sharon M. Sandberg 1 , Gerald E. Harders 1 , 

Jeson S. Sangaralingham 1 , Fernando L. Martin 1 , John C. 

Burnett 1 ; 1 Cardiorenal Research Laboratory, Mayo Clinic, 

Rochester, MN 

020 Night-Time Elevation Angles in MultiSENSE Study 

Are Related to Symptoms of Orthopnea & Paroxysmal 

Nocturnal Dyspnea 

John Hatlestad 1 , Sharda Mehta 1 , Joan Whelan-Schwartz 1 , Ravi 

Shankar 1 , John P. Boehmer 2 ; 1 Cardiac Rhythm Management, 

Boston Scientific Corporation, St. Paul, MN; 2 Heart and Vascular 

Institute, Penn State Milton S. Hershey Medical Center, 

Hershey, PA 

021 Right Ventricular Outflow Tract Velocity Time Integral 

Is a Strong Predictor of Right Ventricular Dysfunction in 

Elderly Patients with Severe Aortic Stenosis 

Amresh Raina 1 , Zachary M. Gertz 2 , Paul R. 

Forfia 2 ; 1 Cardiovascular Institute, Allegheny General Hospital, 

Pittsburgh, PA; 2 Cardiovascular Division, Hospital of the 

University of Pennsylvania, Philadelphia, PA 

023 Genetic Variants in the Natriuretic Peptide Pathway 

Predict Protein Expression 

Bipin Sunkara 2 , Sharad Rastogi 1 , Jia Li 1 , Gupta C. Ramesh 1 , 

Hani N. Sabbah 1 , David E. Lanfear 1 ; 1 Cardiology, Henry Ford 

Hospital, Detoit, MI; 2 Wayne State University, Detroit, MI 

025 MT-102, a New Anabolic Catabolic Transforming Agent 

Improves Heart Function in a Rat Model of Cancer 

Cachexia 

Mareike Poetsch 1 , Anika Tschirner 1 , Sandra Palus 1 , John 

Beadle 2 , Andrew J.S. Coats 3 , Stefan D. Anker 1 , 3 , Jochen 

Springer 1 , 3 ; 1 Applied Cachexia Research, Department of 

Cardiology, Charite Medical School, Berlin, Germany; 2 PsiOxus 

Therapeutics Ltd, Oxford, United Kingdom; 3 Norwich Medical 

School, University of East Anglia, Norwich, United Kingdom 

027 Mitochondrial Function Is Preserved and Enhanced 

in Failing Human Myocardium: An Analysis of Paired 

Samples Obtained from Failing Right Ventricle (RV) and 

Normal Left Ventricle (LV) from Patients with PPH 

Andrea M. Cordero-Reyes 1 , Keith A. Youker 1 , Anisha 

Gupte 2 , Matthias Loebe 1 , Jerry D. Estep 1 , Arvind Bhimaraj 1 , 

Willa Hsueh 2 , Dale J. Hamilton 2 , Guillermo Torre- 

Amione 1 , 3 ; 1 Methodist DeBakey Heart and Vascular Center, The 

Methodist Hospital, Houston, TX; 2 The Methodist Hospital 

Research Institute, Diabetes and Metabolism, The Methodist 

Hospital, Houston, TX; 3 Catedra de Cardiologia y Medicina 

Vascular, Tecnologico de Monterrey, NL, Mexico 

028 Direction of the Mitral Regurgitation (MR) Jet Does Not 

Influence Response to Tailored Therapy in Advanced 

Decompensated Heart Failure 

Matthias Dupont 1 , Allen G. Borowski 1 , James D. Thomas 1 , W.H. 

Wilson Tang 1 ; 1 Heart and Vascular Institute, Cleveland Clinic 

Foundation, Cleveland, OH 

029 Natriuretic Peptide Processing Deficiency Is Associated 

Right Ventricular Diastolic Dysfunction and Adverse 

Outcomes in Advanced Decompensated Heart Failure 

Kevin Shrestha 1 , Allen G. Borowski 1 , James D. Thomas 1 , W.H. 

Wilson Tang 1 ; 1 Cleveland Clinic, Cleveland, OH 

030 Impaired Cardiorenal Adaptation to Acute Heart Failure 

and Volume Expansion in a Large Animal Model of Mild 

Renal Insufficiency: New Insights into the Kidney-Heart 

Connection 

Ingrid A. Andersen 1 , Sarah Mangiafico 1 , Guido Boerrigter 1 , Gail 

Harty 1 , Alessandro Cataliotti 1 , John C. Burnett, Jr 1 ; 1 Cardiorenal 

Research Laboratory, Mayo Clinic, Rochester, MN 

031 Resolution of Ventilatory Control Instability by Cardiac 

Resynchronization Therapy 

Ivan Cundrle 1 , Bruce D. Johnson 1 , Virend K. Somers 1 , Robert F. 

Rea 1 , Lyle J. Olson 1 ; 1 Mayo Clinic, Rochester, MN 

032 Brain Natriuretic Hormone Predicts Stress Induced 

Alterations in Diastolic Function 

Gaston Kapuku 1 , Harry Davis 1 , Pratik Choksy 1 , James Januzzi 2 , 

Gregory Harshfield 1 ; 1 Georgia Prevention Center, Georgia Health 

Science University, Augusta, GA; 2 Medicine, Massachusetts 

General Hospital, Boston, MA 

033 Implantation of a Cardiomyocyte Scaffold Improves Left 

Ventricular Ejection Fraction in Rats 18 Weeks after 

Implantation 

Jordan J. Lancaster 1 , Elizabeth Juneman 1 , Joseph Bahl 1 , Steven 

Goldman 1 ; 1 Cardiology, Southern Arizona VA Medical Center, 

Tucson, AZ 

034 Patients with Congestive Heart Failure and Narrow 

QRS Complex: Is Myocardial Dyssynchrony Clinically 

Significant and Rhythm Dependent? 

Maria A. Trukshina 1 , Maria Y. Sitnikova 1 , Dmitriy S. Lebedev 1 , 

Eugene V. Shlyakhto 1 ; 1 Heart Failure, Federal Almazov Heart, 

Blood and Endocrinology Center, St. Petersburg, Russian 

Federation 

Monday 

62 

63

Sept. 10 

Monday 

Posters 

Posters 


Posters 

Cardiovascular Structure 

Sept. 10 

Monday 

Posters 

035 Right Ventricular, Left Atrial, and Left Ventricular 

Strain Rates Are Associated with Renal Impairment in 

Chronic Systolic Heart Failure 

Kevin Shrestha 1 , Hirohiko Motoki 1 , Allen G. Borowski 1 , Richard 

W. Troughton 2 , Allan L. Klein 1 , W.H. Wilson Tang 1 ; 1 Cleveland 

Clinic, Cleveland, OH; 2 Christchurch School of Medicine and 

Health Sciences, Christchurch, New Zealand 

062 Favorable Changes in Echocardiographic Measures 

Following Renal Transplantation Despite Higher One- 

Year Mortality in Patients with Underlying Myocardial 

Dysfunction 

Nael Hawwa 1 , Daniel Yeo 2 , Richard Fatica 1 , W.H. Wilson 

Tang 1 ; 1 Cleveland Clinic, Cleveland, OH; 2 Tan Tock Seng 

Hospital, Singapore, Singapore 

Monday 

036 Elevated Blood Urea Nitrogen Is Associated with More 

Impaired Cardiac Performance and Poorer Long-Term 

Clinical Outcomes Independent of Glomerular Filtration 

Rate 

Kevin Shrestha 1 , Matthias Dupont 1 , Allen G. Borowski 1 , Richard 




037 Changes in Matrix Metalloproteinases (MMPs) and 

Tissue Inhibitors of MMPs Plasma Profiles in Stress- 

Induced Cardiomyopathy 

Essa M. Essa 1 , Michael R. Zile 2 , Robert E. Stroud 2 , Allison 

Rice 2 , Richard J. Gumina 1 , Carl V. Leier 1 , Francis G. 

Spinale 3 ; 1 The Ohio State University College of Medicine, 

Columbus, OH; 2 Medical University of South Carolina, 

Charleston, SC; 3 University of South Carolina School of 

Medicine, Columbia, SC 

063 Arrhythmia Burden in Takotsubo Cardiomyopathy 

Tushar A. Tuliani 1 , Maithili H. Shenoy 1 , Naga Venkata 

Pothineni 2 , Kevin Hayes 2 , Chaitanya Musham 2 , Sadip Pant 2 , 

Abhishek Deshmukh 3 ; 1 Department of Internal Medicine, 

Wayne State University/Detroit Medical Center, Detroit, MI; 

2 

Department Of Internal Medicine, University of Arkansas for 

Medical Sciences, Little Rock, AR; 3 Division Of Cardiology, 

Department Of Internal Medicine, University of Arkansas for 

Medical Sciences, Little Rock, AR 

064 Paradoxical Inverse Relationship between Regional 

Contractile Function in Compacted vs. Trabeculated 

Segments in Patients with Left Ventricular 

Noncompaction 

Guha Ashrith 1 , Dipti Gupta 1 , Janel Hanmer 1 , Robert 

Weiss 1 ; 1 Division of Cardiology, Department of Internal 

Medicine, University of Iowa, Carver College of Medicine, 

Iowa City, IA 

Monday 

038 Vaspin Activates Endothelial Nitric Oxide Synthase 

by Reducing Asymmetric Dimethylarginine 

Level through the Activation of Dimethylarginine 

Dimethylaminohydrolase in Human Aortic Endothelial 

Cells 

Chang Hee Jung 1 , Ki-Up Lee 1 , Woo Je Lee 1 , Jenie Hwang 1 , 

Joong-Yeol Park 1 ; 1 Department of Internal Medicine, University 

of Ulsan College of Medicine, Asan Medical Center, Seoul, 

Republic of Korea 

065 Heart Failure with Preserved and Reduced Ejection 

Fraction in the Elderly: Functional Mitral Regurgitation 

Is a Predictor of Adverse Outcomes 

Sakima A. Smith 1 , Shasha Bai 2 , Haikady Nagaraja 2 , William 

T. Abraham 1 ; 1 Department of Internal Medicine-Division 

of Cardiology, The Ohio State University, Columbus, OH; 

2 

Department of Public Health-Division of Biostatistics, The 

Ohio State University, Columbus, OH 

066 Cardiac Micro-CT Demonstrates Alterations in the 

Aging Coronary Vasculature in Association with 

Myocardial Fibrosis 

S. Jeson Sangaralingham 1 , Erik L. Ritman 1 , Paul M. McKie 1 , 

Tomoko Ichiki 1 , Amir Lerman 1 , Christopher G. Scott 1 , John C. 

Burnett, Jr 1 ; 1 Mayo Clinic, Rochester, MN 

067 A Novel Heart Failure Canine Model of Myocardial 

Infarction and Mitral Regurgitation Results in Sustained 

Remodeling and Autonomic Dysfunction 

Allen J. Keel 1 , Stuart Rosenberg 1 , Taraneh G. Farazi 1 , Marie 

Southerland 2 , Jeffrey L. Ardell 2 ; 1 Research, St. Jude Medical, 

Sunnyvale, CA; 2 Biomedical Sciences, East Tennessee State 

University, Johnson City, TN 

64 

65

Sept. 10 

Monday 

Posters 

Posters 


Posters 

Neurohormones/Cytokines 

Sept. 10 

Monday 

Posters 

Monday 

068 Myocardial Edema by Noncontrast T2 Mapping Is 

Increased in Acute Decompensated Heart Failure 

Gina G. Mentzer 1 , David Verhaert 1 , Shivraman Giri 1 , Sitaramesh 

Emani 1 , Beth McCarthy 1 , Orlando P. Simonetti 1 , Subha V. 

Raman 1 ; 1 Department of Cardiology, Wexner Medical Center-The 

Ohio State University, Columbus, OH 


077 Traditional and Novel Markers of Renal Function 

and Outcomes in Outpatients with Heart Failure: The 

Atlanta Cardiomyopathy Consortium (TACC) 

Andreas Kalogeropoulos 1 , Gregory Giamouzis 2 , Ali A. Azeem 1 , 

Song Li 1 , Catherine N. Marti 1 , Vasiliki Georgiopoulou 1 , Javed 

Butler 1 ; 1 Department of Medicine, Division of Cardiology, Emory 

University, Atlanta, GA; 2 Department of Medicine, Division of 

Cardiology, University of Thessaly, Larissa, Greece 

078 Response of Cystatin-C and IL-6 Is Sustained Following 

Nesiritide or Nitroglycerin Infusion 

Sheryl L. Chow 12 , Stephen A. O’Barr 1 , Eric Chew 2 , Firooz 

Pak 2 , Paryus Pate l2 , J. Herbert Patterson 3 , J. Thomas 

Heywood 4 ; 1 College of Pharmacy, Western University of Health 

Sciences, Pomona, CA; 2 Centinela Hospital Medical Center, 

Inglewood, CA; 3 University of North Carolina, Chapel Hill, NC; 

4 

Scripps Clinic, La Jolla, CA 

079 Effect of Ethnicity on Plasma Levels of proBNP, BNP 

and NTproBNP in Subjects at Risk for Cardiovascular 

Disease 

Elizabeth C. Costello 1 , Guido Boerrigter 1 , Maria A. Canossa- 

Terris 2 , Christopher G. Scott 1 , Ramila A. Mehta 1 , Paul A. 

Kurlansky 2 , John C. Burnett, Jr 1 ; 1 Mayo Clinic, Rochester, MN; 

2 

Florida Heart Research Institute, Miami, FL 

080 Lipopolysaccharide Responsiveness Is an Independent 

Predictor of Death in Chronic Heart Failure 

Nicole Ebner 1 , Gabor Foldes 2 , Lutz Schomburg 3 , Anja 

Sandek 1 , Jochen Springer 1 , Ewa Jankowska 4 , Sabine Genth- 

Zotz 5 , Wolfram Doehner 1 , Stefan D. Anker 1 , Stephan von 

Haehling 1 ; 1 Department of Cardiology, Applied Cachexia 

Research, Charité –University Medical School, Campus 

Virchow-Klinikum, Berlin, Germany; 2 National Heart and Lung 

Institute Imperial College, London, United Kingdom; 3 Charité- 

University Medical School, Campus Virchow-Klinikum, 

Institut für Experimentelle Endokrinologie, Berlin, Germany; 

4 

Department of Cardiology, Military Hospital, Wroclaw, Poland; 

5 

Department of Medical Immunology, Charité –University 

Medical School, Campus Virchow-Klinikum, Berlin, Germany 

081 N-Terminal pro-B-Type Natriuretic Peptide Level Is 

Useful To Predict Early Left Ventricular Hypertrophy 

Regression after Aortic Valve Replacement in Patients 

with Severe Aortic Stenosis 

Mirae Lee 1 , Jin-Oh Choi 1 , PyoWon Park 2 , Jae K. Oh 3 , Eun- 

Seok Jeon 1 ; 1 Division of Cardiology, Department of Medicine, 

Samsung Medical Center, Seoul, Korea; 2 Department of 

Thoracic and Cardiovascular Surgery, Samsung Medical Center, 

Seoul, Korea; 3 Division of Cardiovascular Diseases, Mayo 

Clinic College of Medicine, Rochester, MN 

083 The Newly Designed Dual Guanylyl Cyclase A and 

B Activator, CU-NP, Elicits Fibro-Suppressing and 

Favorable Cardiorenal Hemodynamic Actions 

Brenda K. Huntley 1 , Candace Lee 1 , Sharon M. Sandberg 1 , 

Guido Boerrigter 1 , Alessandro Cataliotti 1 , John C. Burnett, 

Jr 1 ; 1 Cardiorenal Research, Mayo Clinic, Rochester, MN 

084 FGF23: A New Trigger for Secondary 

Hyperparathyroidism in Heart Failure? 

Damien Gruson 1 , Anne-Catherine Pouleur 1 , Thibault Lepoutre 1 , 

Sylvie A. Ahn 1 , Michel F. Rousseau 1 ; 1 Division of Cardiology, 

University of Louvain, Brussels, Belgium 

085 Lack of Concordance between Worsening Renal 

Function Defined by Rise in Creatinine Versus Rise in 

Cystatin C 

Matthias Dupont 1 , Michael Finucan 1 , Kevin Shrestha 1 , Dhssraj 

Singh 1 , W.H. Wilson Tang 1 ; 1 Heart Failure, Heart and Vascular 

Institute, Cleveland Clinic Foundation, Cleveland, OH 

Molecular Biology and Genetics 

096 Exploring Novel Molecular Mechanisms of Restrictive 

Cardiomyopathy 

Anne-Cecile Huby 1 , Ken Takagi 1 , Nan Gong 1 , Jeanne James 1 , 

Ruben Martherus 1 , Kristen Kramer 1 , Zaza Khuchua 1 , Jeffrey 

Towbin 1 , Enkhsaikhan Purevjav 1 ; 1 Pediatrics, Cincinnati 

Children’s Hospital Medical Center, Cincinnati, OH 

097 Therapeutic Targeted Delivery of AAV9 Sh BNIP3 

Reverses Cardiac Remodeling and Improves Diastolic 

and Systolic Function in a Rat Model of Pressure 

Overload Induced Heart Failure 

Antoine H. Chaanine 1 , Ronald E. Gordon 2 , Ludovic Benard 1 , 

Erik Kohlbrenner 1 , Roger J. Hajjar 1 ; 1 Cardiovascular Institute, 

Mount Sinai School of Medicine, New York, NY; 2 Pathology 

Department, Mount Sinai School of Medicine, New York, NY 

Monday 

66 

67

Sept. 10 

Monday 

Posters 

Posters 


Posters 

VADS/Transplant/Surgery 

Sept. 10 

Monday 

Posters 

Monday 

098 Western Diet-Induced Insulin Resistance Leads to 

Cardiac Hypertrophy and Dysfunction Via Activation of 

FoxO3A in Murine Heart 

Lihong Cheng 1 , Jamie E. Mells 2 , Atsuko Tanaka 1 , Torahiro 

Matsuda 1 , Zhe Jiao 1 , Qianhong Qin 1 , Alexandru Barbulescu 1 , 

Frank A. Anania 2 , Dan Sorescu 1 ; 1 Division of Cardiology, 

Emory University School of Medicine, Atlanta, GA; 2 Division 

of Digestive Diseases, Emory University School of Medicine, 

Atlanta, GA 

099 FOXO3A Regulates Transforming Growth Factor-β1- 

Induced Smooth Muscle α-Actin Expression in Human 

Cardiac Fibroblasts 

Zhe Jiao 1 , Dan Sorescu 1 ; 1 Department of Medicine, Division of 

Cardiology, Emory University, Atlanta, GA 

100 MultiOrgan Dysfunction after Mechanical Support 

Is Linked to the Simultaneous Upregulation of Innate 

Immunity and Supression of Adaptive Immunity 

Nicholas Wisniewski 1 , Khurram Shahzad 2 , Richard K. Cheng 1 , 

Galyna Bondar 1 , Martin Cadeiras 1 , Shweta Shukradas 3 , Hirokazu 

Akashi 4 , Duygu Onat 4 , Farhana Latif 4 , Mario C. Deng 1 ; 1 UCLA 

David Geffen School of Medicine, Los Angeles, CA; 2 Brody 

School of Medicine, Granville, NC; 3 Strand Scientific 

Intelligence, San Francisco, CA; 4 Columbia University College 

of Physicians and Surgeons, New York, NY 

101 HDAC Inhibition Reduces Infarct Size in Large Animal 

Ischemia/Reperfusion by Normalizing Cardiomyocyte 

Autophagy 

Min Xie 1 , Yongli Kong 1 , Wei Tan 1 , Herman May 1 , Pavan 

Battiprolu 1 , Nan Jiang 1 , Aslan Turer 1 , Joseph Hill 1 ; 1 Internal 

Medicine (Cardiology), and Molecular Biology, UT 

Southwestern Medical Center, Dallas, TX 

102 Mesenchymal Stem Cells from Patients with Chronic 

Heart Failure Display Up-Regulation of Genes Coding 

for Proinflammatory and Proangiogenic Mediators 

Sergey Anisimov 1 , Izida Minullina 1 , Renata Dmitrieva 1 , Andrey 

Zaritskey 1 , Eugene Shlyakhto 1 ; 1 Almazov Federal Heart, Blood 

and Endocrinology Center, St. Petersburg, Russian Federation 

103 Caspase 1: A Novel Serum Marker of Myocardial 

Remodeling 

Cara Statz 1 , Aleksandra Ras 1 , Roja Mulamalla 1 , Christine 

Cosgrove 1 , Detlef Wencker 1 ; 1 Center for Advanced Heart Failure 

and Transplant, Hartford Hospital, Hartford, CT 

112 Muscarinic Receptor Subtype Analysis of the Failing 

Human Heart Following Left Ventricular Assist Device 

Support 

Wendy E. Sweet 1 , Jessica A. French 1 , Christine S. 

Moravec 1 ; 1 Kaufman Center for Heart Failure, Cleveland Clinic, 

Cleveland, OH 

113 Retransplantation for Coronary Artery Vasculopathy 

Is Associated with Improved Outcomes Compared to 

Retransplantation for Other Causes 

Veli K. Topkara 1 , Michael Yeung 1 , Pei-Hsiu Huang 1 , Gregory A. 

Ewald 1 ; 1 Cardiology, Washington University School of Medicine, 

Saint Louis, MO 

115 Unplanned Hospital Readmissions and Continuous Flow 

Pump Therapy 

Shelley Hall 1 , Gonzo Gonzalez-Stawinski 1 , Dan Meyer 2 , 

Brian Bethea 2 , Johannes Kuiper 1 , Brian Hardaway 1 ; 1 Cardiac 

Transplantation and Mechanical Assist Device Program, Baylor 

University Medical Center, Dallas, TX; 2 Cardiothoracic Surgery, 

UT Southwestern, Dallas, TX 

116 Left Ventricular Assist Device (LVAD) Thrombosis, a 

Diagnostic Dilemma and Therapeutic Challenge: Six 

Years of Experience at a Single Center 

Abdallah Kamouh 1 , Marc Pritzker 1 , Sameh Hozayen 1 , Ranjit 

John 2 , Peter Eckman 1 ; 1 Cardiovascular Division, University of 

Minnesota Medical Center, Minneapolis, MN; 2 Cardiothoracic 

Surgery Division, University of Minnesota Medical Center, 


117 Pumped up, but Not Prepared: Examining LVAD- 

DT Patients’ Comprehension of Advance Directive 

Specifications 

James Kirkpatrick 1 , Sarah Hull 2 , Katherine Kellom 1 , Rebecca 

Henderson 1 , Frances Barg 1 ; 1 University of Pennsylvania, 

Philadelphia, PA; 2 Yale University, New Haven, CT 

118 Clinical Outcomes after Ventricular Assist Device 

Implantation in Six Adult Patients with Complex 

Congenital Heart Disease 

Nishant R. Shah 1 , Fred H. Rodriguez 1 , Wilson Lam 1 , Peter 

R. Ermis 1 , Leo Simpson 1 , O. H. Frazier 1 , Wayne J. Franklin 1 , 

Dhaval R. Parekh 1 ; 1 Texas Heart Institute, Baylor College of 

Medicine, Houston, TX 

119 Current Clinical Experience with the Circulite® 

Synergy® System in Chronic Ambulatory Heart Failure 

Bart Meyns 1 , Filip Rega 1 , Alessandro Barbone 2 , Diego Ornaghi 2 , 

Martin Streuber 3 , Jan Schmitto 3 , Andre Simon 4 , Ettore Viltali 2 , 

Daniel Burkhoff 5 ; 1 University Hospital Leuven, Belgium; 

2 

Istitutio Clinico Humanitas, Rozzano, Italy; 3 Hannover Medical 

School, Hannover, Germany; 4 Harefield NHS, Harefield, United 

Kingdom; 5 Columbia University, New York, NY 

Monday 

68 

69

Sept. 10 

Monday 

Posters 

Posters 


Posters 


Sept. 10 

Monday 

Posters 

Monday 

120 Racial Differences in Patients with Left Ventricular 

Assist Devices 

Ashim Aggarwal 1 , Ankit Gupta 1 , Antone Tatooles 1 , Pat Pappas 1 , 

Geetha Bhat 1 ; 1 Center for Heart Transplant and Assist Devices, 

Advocate Christ Medical Center, Chicago, IL 

121 Mechanical Circulatory Support-Induced Early 

Improvement in Renal Function Is Transient and Differs 

by Device Flow: An INTERMACS Analysis 

Meredith A. Brisco 1 , Mariell Jessup 1 , Steve Coca 2 , Stephen 

Kimmel 1 , Jeffrey M. Testani 1 ; 1 Department of Medicine, 

Cardiovascular Division, University of Pennsylvania School 

of Medicine, Philadelphia, PA; 2 Department of Medicine, Yale 

University School of Medicine, New Haven, CT 

122 Biochemical Evidence of Liver Dysfunction Identifies 

Patients Likely To Have Improvement in Renal Function 

with Mechanical Circulatory Support: Insights from 

INTERMACS 

Meredith A. Brisco 1 , Mariell Jessup 1 , Steve Coca 2 , Stephen 





123 Sex Differences in Mortality on Waiting List for Heart 


Eileen Hsich 1 , Randall C. Starling 1 , Eugene H. Blackstone 1 , 

David O. Taylor 1 , Jesse D. Schold 1 ; 1 Cleveland Clinic, Cleveland, 

OH 

124 Antibody-Mediated Rejection in Heart Transplantation: 

Does Induction and the Type Matter? 

Z. Lill 1 , J. Stehlik 1 , G. Snow 1 , P. Revelo 1 , R. Alharethi 1 , M. 

Everitt 1 , D. Miller 1 , F. Bader 1 , D. Budge 1 , K. Brunisholz 1 , 

K. Molina 1 , E. Gilbert 1 , M. Hammond 1 , A.G. Kfoury 1 ; 1 Utah 

Transplantation Affiliated Hospitals (U.T.A.H.) Cardiac 

Transplant Program, Salt Lake City, UT 

125 Risk Factors for Cognitive Impairment in Children 

Undergoing Pediatric Heart Transplant 

Leslie B. Smoot 1 , Christina VanderPluym 1 , Melissa Oliva 2 , 

David N. Rosenthal 3 , Heather Bastardi 1 , Tajinder P. Singh 1 , 

Kimberlee Gauvreau 1 , Christopher S. Almond 1 ; 1 Dept. of 

Cardiology, Childrens Hospital, Harvard Med School, Boston, 

MA; 2 Dept of Pediatrics, Childrens Hospital, Harvard Med 

School, Boston, MA; 3 Dept of Pediatrics, Stanford University, 

Palo Alto, CA 

126 Elevated Pulmonary Vascular Resistance Is the Strongest 

Echocardiographic Parameter Associated with Clinical 

Heart Failure in Patients with Continuous-Flow Left 

Ventricular Assist Devices 

Rey P. Vivo 1 , 2 , Molham Aldeiri 1 , 2 , Juan C. Lopez-Mattei 1 , 

Andrea M. Cordero-Reyes 1 , Matthias Loebe 1 , Brian A. 

Bruckner 1 , Guillermo Torre-Amione 1 , Arvind Bhimaraj 1 , Jerry 

D. Estep 1 ; 1 Cardiology, Methodist DeBakey Heart & Vascular 

Center, Houston, TX; 2 Cardiology, University of Texas Medical 

Branch, Galveston, TX 

70 

127 Functional and Structural Effects of Continuous-Flow 

Left Ventricular Assist Device Unloading on the Failing 

Human Heart: A Prospective, Single-Center Study 

Omar Wever-Pinzon 1 , Abdallah G. Kfoury 1 , Craig H. Selzman 1 , 

Rami Alharethi 1 , Edward M. Gilbert 1 , Bruce B. Reid 1 , Deborah 

Budge 1 , Feras M. Bader 1 , Kimberley Brunisholz 1 , Rory Farnan 1 , 

Nikolaos Diakos 1 , Josef Stehlik 1 , Stavros G. Drakos 1 ; 1 UTAH 

Heart Failure and Transplant Program, Salt Lake City, UT 

128 Outcomes in Patients Older Than 65 Years of Age Post 

Heart Transplant (HT) 

Eugene C. DePasquale 1 , Daniel L. Jacoby 1 ; 1 Section of 

Cardiovascular Medicine, Yale University School of Medicine, 

New Haven, CT 

129 Electrical Coupling of a Biological Active Cardiomyocyte 

Patch 

Elizabeth Juneman 1 , 2 , Jordan Lancaster 2 , Russell Witte 2 , Joseph 

Bahl 2 , Steven Goldman 1 , 2 ; 1 Department of Cardiology, Southern 

Arizona VA Health Care System, Tucson, AZ; 2 Department of 

Cardiology, University of Arizona, Tucson, AZ 

130 Abnormal BNP Levels Predict Antibody Mediated 

Rejection in Pediatric Heart Transplants 

Kimberly Molina 1 , Cindy Weng 1 , Dylan Miller 1 , M. Elizabeth 

Hammond 1 , Josef Stelik 1 , Abdallah Kfoury 2 , Melanie 

Everitt 1 ; 1 University of Utah, Salt Lake City, UT; 2 Intermountain 

Medical Center, Salt Lake City, UT 

131 Success of LVAD Therapy in Heart Failure Patients 

Ineligible for Heart Transplantation Due to Psychosocial 

Considerations 

Navin Rajagopalan 1 , Mark Bradley 1 , Roh Yanagida 1 , Charles W. 

Hoopes 1 ; 1 University of Kentucky, Lexington, KY 

132 Is Strong Support the Key in Controlling the Incidence 

of Driveline Infections? 

Yazhini Ravi 1 , Sitaramesh Emani 2 , Simi M. Chacko 2 , Ahmet 

Kilic 1 , Juan Crestanello 1 , Robert Higgins 1 , Chittoor B. Sai- 

Sudhakar 1 ; 1 Surgery, The Ohio State University Wexner Medical 

Center, Columbus, OH; 2 Medicine, The Ohio State University 

Wexner Medical Center, Columbus, OH 

133 Utility of Extracorporeal Membrane Oxygenation for 

Graft Failure after Pediatric Heart Transplantation in 

the Unites States: Analysis of Organ Procurement and 

Transplant Network Database and Extracorporeal Life 

Support Organization Registry 

Christina J. VanderPluym 1 , Gary E. Piercy 1 , Tajinder P. Singh 1 , 

Satish K. Rajagopal 1 , Francis Fynn-Thompson 1 , Ravi R. 

Thiagarajan 1 , Christopher S. Almond 1 ; 1 Cardiology, Children’s 

Hospital Boston, MA 

71 

Monday

Sept. 10 

Monday 

Posters 

Posters 

Electrophysiology and Rhythm Devices 

Posters 


Sept. 10 

Monday 

Posters 

Monday 

155 Modulation of Ventilatory Control by Cardiac 

Resynchronization Therapy 

Ivan Cundrle 1 , Bruce D. Johnson 1 , Virend K. Somers 1 , Robert F. 

Rea 1 , Lyle J. Olson 1 ; 1 Mayo Clinic, Rochester, MN 

156 Acute Improvement of Mechanical Dyssynchrony and 

Contractility with Multisite LV Pacing Delivered Via a 

Novel Quadripolar Pacing System 

Aldo Rinaldi 1 , Wolfgang Kranig 2 , Christophe Leclercq 3 , Salem 

Kacet 4 , Tim Betts 5 , Pierre Bordachar 6 , Klaus-Juergen Gutleben 7 , 

Allen Keel 8 , Kyungmoo Ryu 8 , Taraneh Farazi 8 , Marcus Simon 8 , 

Tasneem Naqvi 9 ; 1 St. Thomas Hospital, London, United 

Kingdom; 2 Schuechtermann-Klinik, Bad Rothenfelde, Germany; 

3 

CHU Pontchaillou, Rennes, France; 4 Hopital Cardiologique, 

Lille, France; 5 John Radcliffe Hospital, Oxford, United 

Kingdom; 6 University Hospital of Bordeaux, France; 7 Herz- und 

Diabeteszentrum NRW, Bad Oeynhausen, Germany; 8 St. Jude 

Medical, Sylmar, CA; 9 University of Southern California, Los 

Angeles, CA 

158 Experience with the Wearable Cardioverter Defibrillator 

in Heart Transplant Candidates 

Douglas A. Horstmanshof 1 , Chingping Wan 2 , Steven 

Szymkiewicz 2 ; 1 INTEGRIS Advanced Cardiac Care, Oklahoma 

City, OK; 2 ZOLL, Pittsburgh, PA 

159 Can the Seattle Proportional Risk Model Identify 

Patients with a Greater ICD Benefit in HF-ACTION? 

Wayne C. Levy 1 , Yanhong Li 2 , Michael Zile 4 , Ramin Shadman 3 , 

Todd Dardas 1 , David Whellan 5 , Kevin Schulman 2 , Stephen Ellis 2 , 

Matthew Neilson 6 , Chris M. O’Connor 2 , Shelby Reed 2 ; 1 U of 

WA, Seattle, WA; 2 Duke U, Durham, NC; 3 So Ca Perm Med, 

Los Angeles, CA; 4 VAMC, Charleston, SC; 5 Jefferson Medical 

College, Philadelphia, PA; 6 University of Glasgow, United 

Kingdom 

160 Implantable Device Diagnostics on the Day of Discharge 

from a Heart Failure Hospitalization Can Predict 30 Day 

Readmission Risk 

Roy S. Small 1 , David J. Whellan 2 , Andrew Boyle 3 , Jodi 

Koehler 4 , Shantanu Sarkar 4 , Eduardo N. Warman 4 , William T. 

Abraham 5 ; 1 The Heart Group, Lancaster, PA; 2 Thomas Jefferson 

University, Philadelphia, PA; 3 St. Luke’s Medical Center, 

Milwaukee, WI; 4 Medtronic Inc., Mounds View, MN; 5 The Ohio 

State University, Columbus, OH 

161 Ablation of Premature Ventricular Contractions Lowers 

the Rate of Heart Failure Hospitalisation in Patients with 

Congestive Heart Failure 

Omid Souresafil 1 ; 1 SCH Cardiac Hospital/Sydney University, 

Maple Grove, MN 

162 Effect of Bucindolol on Heart Failure Outcomes in 

HFREF Patients with Permanent Atrial Fibrillation 

David Kao 1 , Gordon Davis 2 , Ryan Aleong 1 , William Sauer 1 , 

Michael R. Bristow 1 , 2 ; 1 Univ of CO, Aurora, CO; 2 ARCA 

biopharma, Broomfield, CO 

163 Dual-Site Left Ventricular Pacing Achieves Superior 

Electrical Resynchronization 

Imran Niazi 1 , Christopher Hayes 2 , Michelle Fedewa 2 , Mohamed 

Djelmami-Hani 1 , M. Eyman Mortada 1 , Vikram Nangia 1 , Anwer 

Dhala 1 , Ryan Cooley 1 , Indrajit Choudhuri 1 , Atul Bhatia 1 , Jasbir 

Sra 1 ; 1 Aurora Cardiovascular Services, Aurora Sinai/Aurora St. 

Luke’s Medical Centers, University of Wisconsin School of 

Medicine and Public Health, Milwaukee, WI; 2 Medtronic, Inc., 


164 Admittance Measurement for the Detection of Acute 

Decompensated HF (ADHF) 

John E. Porterfield 1 , Erik R. Larson 2 , Daniel Escobedo 3 , Jonathan 

W. Valvano 2 , John A. Pearce 2 , Marc D. Feldman 3 ; 1 Admittance 

Technologies, San Antonio, TX; 2 ECE, The University of 

Texas, Austin, TX; 3 Cardiology, University of Texas HSC, San 

Antonio, TX 

165 Effects of Periodic AV-VV Optimization during Sleep 

and Daytime on Central Sleep Apnea and Heart Failure 

Hospitalization 

Omid Souresafil 1 , Parviz Souresafil 2 ; 1 EP, SCH Cardiac Hospital/ 

University of Sydney, Minneapolis, MN; 2 Cardiovascular 

Medicine, SCH Cardiac Hospital, Sydney, NSW, Australia 

166 Evidence for the Disparity in Implantable Cardioverter 

Defibrillator Efficacy in Patients above 60 Years and 

below 60 Years 

R. Valadri 1 , E. Veledar 1 , R. Blanco 1 , R. Vest, R. Gutmann 3 , S. 

C. Dudley 2 , M. A. Zafari 1 , B. London 3 , H. L. Bloom 1 ; 1 Cardio, 

EU, Atlanta, GA; 2 Cardio, UIC, Chicago, IL; 3 Cardio, UPMC, 


167 Patients with New LV Leads Show a Bigger Change in 

Phrenic Nerve Stimulation Thresholds 

Mauro Biffi 1 , Brigitte Rotman 2 , Leonardo Calo 3 , Holly 

Rockweiler 4 , Sunipa Saha 4 , Aaron McCabe 4 , Michael 

Glikson 5 ; 1 Ospedale San Orsola-Malpighi, Bologna, Italy; 

2 

Medizinische Universitätsklinik Graz, Austria; 3 Policlinico 

Casilino, Rome, Italy; 4 Boston Scientific CRM, St. Paul, MN; 

5 

Sheba Medical Center, Tel Hashomer, Israel 

Monday 

72 

73

Sept. 10 

Monday 

Posters 

Posters 

Clinical Trials 

Posters 

Cardiovascular Pharmacology 

Sept. 10 

Monday 

Posters 

Monday 

182 Effect of Partial Fatty Acids Oxidation Inhibition with 

Trimetazidine on Mortality and Morbility in Heart 

Failure: Results from an International Multicentre 

Retrospective Cohort Study 

Sang Hong Baek 1 , Seok-Min Kang 2 , Gabriele Fragasso 3 , 

Giuseppe Rosano 4 , Hamayak Sisakian 5 , Pericle Di Napoli 6 , Luca 

Alberti 3 , Giliola Calori 3 , Laura Sahakyan 5 , Armen Sanosyan 5 , 

Cristina Vitale 4 , Giuseppe Marazzi 4 , Alberto Margonato 3 , 

Romualdo Belardinelli 7 ; 1 Division of Cardiovascular Medicine, 

Seoul St. Mary’s Hospital, The Catholic University of Korea, 

Seoul, Republic of Korea; 2 Department of Cardiology, 

Severance Hospital, Yonsei University, Seoul, Republic of 

Korea; 3 Heart Failure Unit, Ospedale San Raffaele, Milano, 

Italy; 4 Department of Medical Sciences, IRCCS San Raffaele, 

Roma, Italy; 5 Department of General and Invasive Cardiology, 

University Hospital 1 , Yerevan State Medical University, 

Yerevan, Armenia; 6 SMDN- Center for Cardiovascular Medicine 

and Cerebrovascular Disease Prevention, Sulmona, Italy; 

7 

Cardiac Rehabilitation, Cardiology Division, Azienda Ospedali 

Riuniti, Ancona, Italy 

185 Short and Long-Term Outcome of Impedance-Guided 

Preemptive Therapy Provided To Prevent Pulmonary 

Congestion-Edema in the Course of Acute Myocardial 

Infarction 

Michael Shochat 1 , Avraham Shotan 1 , Mark Kazatsker 1 , Aya Asif 1 , 

Iris Dahan 1 , Elena Shochat 1 , Yaniv Levy 1 , David Blondheim 1 , 

Simcha Meisel 1 ; 1 Cardiology, Hille Yaffe Heart Institute, Hadera, 

Israel 

186 NT-proBNP-Guided Preemptive Treatment of 

Outpatients with Chronic Heart Failure Followed in a 

out Hospital Clinic 

Michael Shochat 1 , Avraham Shotan 1 , Mark Kazatsker 1 , 

Aya Asif 1 , Iris Dahan 1 , Ilia Shochat 1 , Yaniv Levy 1 , David 

Blondheim 1 ; 1 Cardiology, Hillel Yaffe Heart Institute, Hadera, 

Israel 

187 LV Augmentation Leads to Lasting Improvement in LV 

Function and Decreased Ventricular Ectopy in Severe 


Randall J. Lee 1 , Andy Hinson 2 , Klaus Matschke 3 , Robert 

Bauernschmitt 4 ; 1 UCSF, San Francisco, CA; 2 LoneStar 

Heart, Inc., Laguna Hills, CA; 3 Herzzentrum Dresden, 

Universitätsklinik, Dresden, Germany; 4 Isar Herzzentrum, 

Munich, Germany 

188 A Pilot Study To Evaluate the Safety and Feasibility 

of Spinal Cord Stimulation in Patients with Advanced 


Guillermo Torre-Amione 1 , 3 , Jerry D. Estep 1 , Arvind Bhimaraj 1 , 

Nashwa Khalil 1 , Ken Alo 2 , Stuart P. Rosenberg 2 , Lanitia L. 

Ness 2 , Taraneh G. Farazi 2 ; 1 Methodist DeBakey Heart and 

Vascular Center, The Methodist Hospital, Houston, TX; 2 St. 

Jude Medical, CRMD, St. Jude Medical, CRMD, Sylmar, CA; 

3 

Catedra de Cardiologia y Medicina Vascular, Tecnologico de 

Monterrey, NL, Mexico 

74 

198 Acute Subcutaneous and Oral Delivery of Cenderitide, 

a Novel Dual Natriuretic Peptide Receptor Agonist, Is 

Readily Absorbed and Activates the Second Messenger 

CGMP 

Guido Boerrigter 1 , Elizabeth C. Costello 1 , Prateek Bhargava 2 , 

Gary I. Riley 2 , John C. Burnett 1 ; 1 Cardiovascular Diseases, Mayo 

Clinic, Rochester, MN; 2 Emisphere Technologies, Cedar Knolls, 

NJ 

199 The Frequency and Prognosis of Cardiotoxicity from 

Trastuzumab 

Jennifer R. Brown 1 , Stephen S. Gottlieb 1 ; 1 Cardiology, University 

of Maryland Medical Center, Baltimore, MD 

200 Evaluation of Vasomera, a Novel VPAC2-Selective 

Vasoactive Intestinal Peptide Agonist, in Rats with 

Doxorubicin-Induced Cardiomyopathy: Evidence for 

Chronic Cardio-Protection. 

Bradley Youngblood 1 , Steven T. Yeh 1 , Lynne Georgopoulos 2 , 

Sue Arnold 2 , Jeff Wallery 1 , Robert L. Hamlin 1 , 3 , Carlos L. del 

Rio 1 ; 1 QTest Labs, Columbus, OH; 2 PhaseBio Pharmaceuticals, 

Inc, Malvern, PA; 3 The Ohio State University, Columbus, OH 

201 Treatment with Angiotensin-Converting Enzyme 

Inhibitors Is Safe and Effective in Patients with Left 

Ventricular Dysfunction and Hyponatremia 

Louise Balling 1 , Lars Kober 1 , Morten Schou 1 , Christian Torp- 

Pedersen 2 , Finn Gustafsson 1 ; 1 The Heart Centre, Rigshospitalet, 

Copenhagen University Hospital, Copenhagen, Denmark; 

2 

Department of Cardiology, Gentofte Hospital, Copenhagen, 

Denmark 

202 Pharmacogenetics of Azathioprine: Efficacy and Toxicity 

in Thiopurine-S-Methyltransferase Heterozygotes 

Following Cardiac Transplant 

Jackson J. Liang 1 , Jennifer R. Geske 3 , Barry A. Boilson 2 , Walter 

K. Kremers 3 , Naveen L. Pereira 2 ; 1 Internal Medicine, Mayo 

Clinic, Rochester, MN; 2 Cardiovascular Diseases, Mayo Clinic, 

Rochester, MN; 3 Biomedical Statistics, Mayo Clinic, Rochester, 

MN 

203 Beta-Blocker Selectivity in Heart Failure (HF) Patients 

with Chronic Obstructive Pulmonary Disease (COPD): 

Insights from HF-A Controlled Trial Investigating 

Outcomes of Exercise Training (HF-ACTION) 

R. J. Mentz 1 , P. J. Schulte 1 , D. W. Kitzman 2 , M. Fiuzat 1 , W. E. 

Kraus 1 , I. L. Pina 3 , S. J. Keteyian 4 , J. L. Fleg 5 , S. J. Ellis 1 , D. J. 

Whellan 6 , C. M. O’Connor 1 ; 1 Duke Univ, DCRI, Durham, NC; 

2 

Wake Forest University, Winston-Salem, NC; 3 Montefiore 

Medical Center, New York, NY; 4 Henry Ford Hospital, Detroit, 

MI; 5 NHLBI, Bethesda, MD; 6 Thomas Jefferson University, 


75 

Monday

Sept. 10 

Monday 

Posters 

Monday 

Posters 

Epidemiology/Prevention Cardiovascular 

Pharmacology 

209 Heart Failure and Preserved Ejection Fraction in 

African-Americans: The ARIC Study 

Deepak K. Gupta 1 , Amil M. Shah 1 , Davide Castagno 2 , 

Madoka Takeuchi 1 , Laura R. Loehr 3 , Ervin Fox 4 , Kenneth R. 

Butler 5 , Thomas H. Mosley 5 , Dalane W. Kitzman 6 , Scott D. 

Solomon 1 ; 1 Cardiovascular Div., Brigham & Women’s Hosp, 

Boston, MA; 2 Div. of Cardiology, Univ. of Turin, Italy; 3 Univ. 

of North Carolina, Chapel Hill, NC; 4 Div. of Cardiovascular 

Dis., Univ. of Mississippi Med. Ctr., Jackson, MS; 5 Dept. of 

Medicine-Geriatrics, Univ. of Mississippi Med. Ctr., Jackson, 

MS; 6 Wake Forest University School of Medicine, Winston- 

Salem, NC 

210 Cognitive Function in Older Heart Failure Patients Is 

Similar to Older Patients Following Stroke 

Karen Harkness 1 , 2 , Gail MacKenzie 1 , 2 , Emma MacLean 2 , George 

Heckman 1 , 3 , Demetrios J. Sahlas 1 , 2 , Wieslaw Oczkowski 1 , 2 , 

Robert McKelvie 1 , 2 ; 1 McMaster University, Hamilton, ON, 

Canada; 2 Hamilton Health Sciences, Hamilton, ON, Canada; 

3 

University of Waterloo, Waterloo, ON, Canada 

211 Relationship between Diabetic Control and Diastolic 

Dysfunction in Elderly Patients with Type 2 Diabetes; Is 

Better Control Associated with Lower Risk of Diastolic 

Dysfunction? 

Cristina Bocirnea 1 , Mark Dunlap 1 ; 1 MetroHealth Medical Center, 

Cleveland, OH 

212 The ANP Genetic Variant RS5068 Is Associated 

with a Favorable Cardiometabolic Phenotype in a 

Mediterranean Population 

Valentina Cannone 1 , Angelo Baldassare Cefalu’ 2 , Davide Noto 2 , 

Christopher G. Scott 1 , Kent R. Bailey 1 , Giovanni Cavera 3 , 

Michele Pagano 4 , Michelangelo Sapienza 3 , Maurizio Averna 2 , 

John C. Burnett, Jr 1 ; 1 Mayo Clinic, Rochester, MN; 2 University of 

Palermo, Palermo, Italy; 3 Az. Osp. Ospedali Riuniti Villa Sofia- 

Cervello, Palermo, Italy; 4 Ingrassia Hospital, Palermo, Italy 

213 Right Ventricular Dysfunction in HIV 

Christopher D. Lacomis 1 , Alison M. Morris 2 , M. Patricia 

George 2 , Marc A. Simon 3 , 4 ; 1 Dietrich School of Arts and 

Sciences, University of Pittsburgh, PA; 2 Division of Pulmonary, 

Allergy, and Critical Care Medicine, University of Pittsburgh, 

PA; 3 Heart and Vascular Institute, University of Pittsburgh, PA; 

4 

Department of Bioengineering, University of Pittsburgh, PA 

214 Role of Obstructive Sleep Apnea in the Incidence of 

Atrial Fibrillation in Elderly Heart Failure Patients 

Harsha V. Ganga 1 , Sanjeev Nair 2 , Binoy Varghese 3 ; 1 Division of 

Cardiology, The Henry Low Heart Center, Hartford Hospital, 

Hartford, CT; 2 Division of Cardiology, The Henry Low Heart 

Center, Hartford Hospital, Hartford, CT; 3 Clinformix, LLC, 

Germantown, MD 

Posters 

Outcomes 

222 Do Risk Models in Advanced Heart Failure Need To Be 

Sex-Specific? 

Jennifer Chyu 1 , Chi-Hong Tseng 2 , Tamara B. 

Horwich 1 ; 1 Ahmanson-UCLA Cardiomyopathy Center, Los 

Angeles, CA; 2 Biostatistics, David Geffen School of Medicine at 

UCLA, Los Angeles, CA 

223 Predictors of In-Hospital Mortality in Patients 

Presenting with Cardiogenic Shock – Insights from the 

Romanian Acute Heart Failure Syndromes (RO-AHFS) 

Registry 

Ionela Codoiu 1 , Serban Bubenek 1 , Daniela Filipescu 1 , Andrew 

Ambrosy 3 , Cezar Macarie 1 , Mihai Gheorghiade 4 ; 1 Cadiology, 

Institute of Emergency for Cardiovascular Diseases C.C.Iliescu, 

Bucharest, Romania; 2 Medicine Department, Stanford University 

School of Medicine, Stanford, IL; 3 Center for Cardiovascular 

Innovation, Northwestern University, Feinberg School of 

Medicine, Chicago, IL 

224 Recovery of Left Ventricular Systolic Function in New 

Onset Heart Failure 

Michael Chiu 1 , Haissam Haddad 2 , Ross A. Davies 2 , 

Denise Cassan 2 , Sylvie Begin 2 , Sherry Coulas 2 , Lisa M. 

Mielniczuk 2 ; 1 University of Ottawa, ON, Canada; 2 University of 

Ottawa Heart Institute, Ottawa, ON, Canada 

225 Elevated Health ABC Heart Failure Risk Score Is 

Associated with Subclinical Myocardial Stress in Patients 

without Heart Failure 

Alaa Gabi 1 , Yenal Harper 1 , Matthias Dupont 1 , Michael Finucan 1 , 

Stanley L. Hazen 1 , W.H. Wilson Tang 1 ; 1 Cardiovascular 

Department - Heart Failure and Cardiac Transplantation, 

Cleveland Clinic Foundation, Cleveland, OH 

227 Heart Transplant Survival Outcomes in Adriamycin 

Dilated Cardiomyopathy 

Andrew J. Lenneman 1 , Haydar Frangoul 2 , Douglas B. Sawyer 1 , 

Carrie A. Geisberg 1 ; 1 Cardiovascular Medicine, Vanderbilt 

Medical University, Nashville, TN; 2 Pediatric Hematology, 

Vanderbilt Medical University, Nashville, TN 

Sept. 10 

Monday 

Posters 

228 In Non-Ischemic Cardiomyopathy (NICMP), the 

Presence of LV Scar Detected by Delayed Enhancement- 

CMR Is a Stronger Predictor of Cardiovascular Events 

Than Left Ventricular Ejection Fraction (LVEF) Carlos 

M. Orrego 1 , Andrea M. Cordero-Reyes 1 , Luis J. Garcia-Morales 1 , 

Venkateshwar R. Polsani 1 , Eric Yang 1 , Arvind Bhimaraj 1 , Jerry 

D. Estep 1 , Guillermo Torre-Amione 1 , 2 , Dipan Shah 1 ; 1 Methodist 

DeBakey Heart & Vascular Center, The Methodist Hospital, 

Houston, TX; 2 Catedra de Cardiologia y Medicina Vascular, 

Tecnologico de Monterrey, NL, Mexico 

229 Apolipoprotein A-1 Levels and Heart Failure Outcomes 

Vikas Bhalla 1 , Vasiliki Georgiopoulou 1 , Divya Gupta 1 , Catherine 

N. Marti 1 , Robert T. Cole 1 , Andreas Kalogeropoulos 1 , W.H. 

Wilson Tang 2 , Javed Butler 1 ; 1 Department of Medicine, Division 

of Cardiology, Emory University, Atlanta, GA; 2 Department 

of Cardiovascular Medicine, Cleveland Clinic Foundation, 

Cleveland, OH 

Monday 

76 

77

Sept. 10 

Monday 

Posters 

Posters 

Outcomes 

Posters 

Outcomes 

Sept. 10 

Monday 

Posters 

Monday 

231 Perceived Control Predicts Perceptions of Positive 

Changes in Life as a Result of Caring for a Patient with 


Misook L. Chung 1 , Debra K. Moser 1 , Terry A. 

Lennie 1 ; 1 University of Kentucky, College of Nursing, Lexington, 

KY 

232 Predicting All-Cause Death and Medical Hospitalization 

in Ambulatory Heart Failure Patients with Electronic 

Medical Record Data 

Hussam H. Ghalib 1 , Todd M. Koelling 1 , David P. Ratz 2 , Scott L. 

Hummel 1 , 2 ; 1 University of Michigan, Ann Arbor, MI; 2 Ann Arbor 

Veterans Affairs Health System, Ann Arbor, MI 

233 Chromogranin A Predicts 6 Years Mortality in Patients 

with Reduced Ejection Fractions 

Damien Gruson 1 , Anne-Catherine Pouleur 1 , Thibault 

Lepoutre 1 , Jean-Marie Ketelslegers 1 , Sylvie A. Ahn 1 , Michel 

F. Rousseau 1 ; 1 Division of Cardiology, University of Louvain, 

Brussels, Belgium 

234 Prognostic Utility of the Seattle Heart Failure Model To 

Predict Survival in Patients with Heart Failure 

Philip Jong 1 , Sylvie A. Ahn 2 , Shrikant I. Bangdiwala 3 , Michel 

F. Rousseau 2 ; 1 Division of Cardiology, University of Toronto, 

Toronto, ON, Canada; 2 Department of Biostatistics, University 

of North Carolina, Chapel Hill, NC; 3 Division of Cardiology, 

University of Louvain, Brussels, Belgium 

235 Heart Failure Related Hospitalizations in Children with 

Single Ventricle Heart Disease in the United States: 

Costly and Getting More Expensive 

J. W. Rossano 1 , D. J. Goldberg 1 , A. R. Mott 1 , K. Y. Lin 1 , R. E. 

Shaddy 1 , B. D. Kaufman 1 , J. Rychik 1 ; 1 Cardiology, The Children’s 

Hospital of Philadelphia, Philadelphia, PA 

236 BNP Did Not Predict Cardiac Events in Acute Dyspneic 

Patients with Severe Chronic Kidney Disease 

ByungSu Yoo 1 , MinSoo Ahn 1 , JangYoung Kim 1 , SeungHwan 

Lee 1 , KyungHoon Choe 1 ; 1 Cardiology, Yonsei University, Wonju 

College of Medicine, Wonju, Republic of Korea 

237 Admission Heart Rate and In-Hospital Outcomes in 

Patients Hospitalized for Heart Failure in Sinus Rhythm 

and Atrial Fibrillation 

Anh L. Bui 1 , Maria V. Grau-Sepulveda 2 , Adrian F. Hernandez 2 , 

Eric D. Peterson 2 , Clyde W. Yancy 3 , Deepak L. Bhatt 4 , Gregg 

C. Fonarow 5 ; 1 Kaiser Permanente Medical Center, Los Angeles, 

CA; 2 Duke University, Durham, NC; 3 Northwestern University, 

Chicago, IL; 4 VA Boston Healthcare System, Brigham and 

Women’s Hospital, and Harvard Medical School, Boston, MA; 

5 

University of California Los Angeles, CA 

238 Improved Physical Function Confers Greater Quality of 

Life Benefits for NYHA Class III Than for NYHA Class 

II Patients 

Rebecca Gary 1 , Melinda Higgins 1 , Elaine Cress 2 , Andrew Smith 3 , 

Sandra Dunbar 1 ; 1 Nursing, Emory University, Atlanta, GA; 

2 

Kinesiology, University of Georgia, Athens, GA; 3 Medicine, 

Emory University, Atlanta, GA 

239 Renal Function in Patients with Acute Decompensated 

Heart Failure Treated with Ultrafiltration 

Nicholas Haglund 1 , Michael Johnston 1 , Ioana Dumitru 1 , Joan 

Mack 2 , Brian Lowes 1 , Eugenia Raichlin 1 ; 1 Cardiology, University 

of Nebraska Medical Center, Omaha, NE; 2 Department of 

Nursing, University of Nebraska Medical Center, Omaha, NE 

240 Drug and Device Effects on Short Term Markers as 

Predictors of Long Term Therapeutic Effect on Mortality 

and Hospitalization for Heart Failure in Patients with 

Heart Failure and Reduced Ejection Fraction 

Kevin Morine 1 , Benjamin Wessler 1 , Daniel Kramer 1 , Marvin 

Konstam 1 , James Udelson 1 ; 1 Cardiology, Tufts Medical Center, 

Boston, MA 

241 Outcomes of ICU Patients with Cardiomyopathy and 

Severe Sepsis 

Monique Tanna 1 , Hyun Ah Yoon 1 , Caroline Kwon 1 , Yan Yan 

Sally Xie 1 , Darlene LeFrancois 1 , Sharon Leung 1 ; 1 Internal 

Medicine, Montefiore Medical Center, Bronx, NY 

242 Among Patients Admitted for Acute Systolic Congestive 

Heart Failure, Presence of Human Immunodeficiency 

Virus Is Associated with Increased Incidence of 

Readmissions for Heart Failure Exacerbation 

Maryam Afshar 1 , Raza Alvi 1 , Manjeet Singh 1 , Manoj Bhandari 1 , 

Jonathan Bella 1 , Narendra Bhalodkar 1 ; 1 Cardiology, Bronx- 

Lebanon Hospital Center, Bronx, NY 

243 Left Ventricular Systolic Function and Outcome after 

Cardiopulmonary Resuscitation in Patients Hospitalized 

for Acute Heart Failure Syndromes – Data from 

Romanian Acute Heart Failure Syndromes Study 

(RO-AHFS Study) 

Ionela Codoiu 1 , Anca Florian 1 , Serban Bubenek 1 , Daniela 

Filipescu 1 , Dragos Vinereanu 2 , Andrew Ambrosy 3 , Mihai 

Gheorghiade 4 , Cezar Macarie 1 ; 1 Institute of Emergency for 

Cardiovascular Diseases C.C.Iliescu, Bucharest, Romania; 

2 

Universitary Emergency Hospital, Bucharest, Romania; 

3 

Stanford University School of Medicine, Stanford, IL; 4 Center 

for Cardiovascular Innovation, Northwestern University, 

Feinberg School of Medicine, Chicago, IL 

Monday 

78 

79

Sept. 10 

Monday 

Posters 

Posters 

Outcomes 

Posters 

Outcomes 

Sept. 10 

Monday 

Posters 

Monday 

244 Heart Rate Variability Trend Predict 12- Month Cardiac 

Event-Free Survival and Health Related Quality of Life 

in Patients with Heart Failure 

Tsuey-Yuan Huang 1 , Hui-Chu Yu 2 , Mei-Ling Yeh 3 , Ming-Fen 

Tsai 1 , Shiow-Li Hwang 3 ; 1 Nursing, Chang Gung University of 

Science and Technology, Taoyuan, Taiwan; 2 Nursing, National 

Taiwan University Hospital, Taipei, Taiwan; 3 Nursing, National 

Taipei University of Nursing & Health Sciences, Taipei, Taiwan 

245 Comorbid Illness Profiles Predict Greater Costs: An 

Analysis of 417,477 Heart Failure Admissions 

Christopher S. Lee 1 , Julie T. Bidwell 1 , Quin E. Denfeld 1 , Ruth 

Masterson Creber 2 , Jill M. Gelow 1 , James O. Mudd 1 , Harleah 

G. Buck 3 ; 1 Oregon Health & Science University, Portland, 

OR; 2 University of Pennsylvania, Philadelphia, PA; 3 The 

Pennsylvania State University, University Park, PA 

246 Age, Clinical Characteristics and Outcomes of Patients 

with Acute Decompensated Heart Failure: Insights from 

the PROTECT Trial 

M. Metra 1 , K. Chiswell 2 , M. Fiuzat 2 , V. Lazzarini 2 , J. Horton 2 , 

B. Davison 3 , J. Cleland 4 , P. Ponikowski 5 , J. Teerlink 6 , A. 

Voors 7 , M. Givertz 8 , G. Mansoor 9 , B. Massie 6 , G. Cotter 3 , 

C. O’Connor 2 ; 1 University of Brescia, Italy; 2 Duke Clinical 

Research Institute, Durham, NC; 3 Momentum Research, 

Durham, NC; 4 University of Hull, United Kingdom; 5 Clinical 

Military Hospital, Wroclaw, Poland; 6 University of California, 

San Francisco, CA; 7 University Medical Center Groningen, 

Netherlands; 8 Brigham and Women’s Hospital, Boston, MA; 

9 

Merck Research Laboratories, Rahway, NJ 

247 Allograft Left Ventricular Hypertrophy after Cardiac 


Kimberly Parks 1 , Cristina Castrillo 2 , Angela Canteli-Alvarez 2 , 

Malissa Wood 1 , Asma Mahmud 1 , Rajeev Malhotra 1 , Marc J. 

Semigran 1 ; 1 Massachusetts General Hospital, Boston, MA; 

2 

Instituto de Formación e Investigación, University Hospital 

Marques de Valdecilla, Santander, Spain 

248 Differential Outcomes in Chronic Heart Failure Treated 

with the Angiotensin Receptor Blockers Candesartan, 

Valsartan, and Losartan 

Leticia Peh 1 , Kai Xin Ong 1 , Poh Shuan Daniel Yeo 2 ; 1 Pharmacy, 

Tan Tock Seng Hospital, Singapore, Singapore; 2 Cardiology, Tan 

Tock Seng Hospital, Singapore, Singapore 

249 The Impact of Heart Failure among In-Hospital 

Cardiopulmonary Arrest; from the Japanese Registry of 

CPR for In-Hospital Cardiac Arrest (J-RCPR) 

Taro Sasaoka 1 , Mitsuaki Isobe 1 , Naohiro Yonemoto 2 , Hiroyuki 

Yokoyama 3 , Hiroshi Nonogi 4 ; 1 Department of Cardiovascular 

Medicine, Tokyo Medical and Dental University, Tokyo, Japan; 

2 

Department of Epidemiology and Biostatistics, National Center 

of Neurology and Psychiatry, Tokyo, Japan; 3 Department of 

Cardiovascular Medicine, National Cerebral and Cardiovascular 

Center, Osaka, Japan; 4 Department of Cardiology, Shizuoka 

General Hospital, Shizuoka, Japan 

250 The Impact of Cerebrovascular Accidents on Outcomes 

among African Americans Hospitalized with Heart 


Maithili Shenoy 1 , Sandip Zalawadiya 2 , Hammam Zmily 2 , 

Suleiman Daifallah 1 , Omaima Ali 2 , Jareer Farah 1 , Jalal K. 

Ghali 2 ; 1 Internal Medicine, Detroit Medical Center/Wayne State 

University, Detroit, MI; 2 Cardiology, Detroit Medical Center/ 

Wayne State University, Detroit, MI 

251 Does Preparedness Planning Improve Attitudes and 

Completion of Advance Directives in Patients with 

Advanced Heart Failure? 

Lorraine Evangelista 1 , Jennifer Ballard-Hernandez 2 , Shaista 

Malik 3 , Marjan Motie 1 , JoAnn Prause 1 , Solomon Liao 3 , William 

Mitchell 4 , Eric Adler 4 , Dawn Lomardo 3 ; 1 UC Irvine, Irvine, CA; 

2 

Hoag Memorial Hospital Presbyterian, Newport Beach, CA; 

3 

UC Irvine Medical Center, Irvine, CA; 4 UC San Diego Medical 

Center, San Diego, CA 

252 Prognostic Impact of an Ischemic Etiology of Chronic 

Heart Failure across the Spectrum of Ejection Fractions 

in the CHARM Program 

Deepak K. Gupta 1 , Davide Castagno 2 , Christopher B. Granger 3 , 

Salim Yusuf 4 , Karl Swedberg 5 , John J.V. McMurray 6 , Marc A. 

Pfeffer 1 , Scott D. Solomon 1 ; 1 Cardiovascular Div., Brigham & 

Women’s Hosp, Boston, MA; 2 Div. of Cardiology, Univ. of 

Turin, Italy; 3 Div. of Cardiology, Duke Univ. Med. Ctr., Durham, 

NC; 4 Cardiovascular Med., McMaster University, Hamilton, 

ON, Canada; 5 Dept. of Cardiovascular Med, University 

of Gothenburg, Goteburg, Sweden; 6 Dept. of Cardiology, 

University of Glasgow, United Kingdom 

253 Initial Therapy Does Not Substantially Improve Dyspnea 

in Many ER Acute Heart Failure Patients 

Kori Sauser 1 , Sean Collins 2 , Judd Hollander 6 , Alan Storrow 2 , 

Richard Nowak 7 , Adin-Cristian Andrei 1 , Chad Miller 8 , Frank 

Peacock 9 , Miguel Tavares 5 , Alexander Mebazaa 4 , Mihai 

Gheorghiade 1 , Peter S. Pang 1 ; 1 Northwestern University, Chicago, 

IL; 2 Vanderbilt University, Nashville, TN; 3 Hopital Lariboisiere, 

Paris, France; 4 Hospital Geral de Santo Antonio, Porto, Portugal; 

5 

U. of Pennsylvania, Philadelphia, PA; 6 Henry Ford, Detroit, MI; 

7 

Wake Forest, Winston-Salem, NC; 8 Baylor U., Houston, TX 

254 Impact of Renal Function on Prognostic Utility of the 

Seattle Heart Failure Model 

Kairav Vakil 1 , Todd Dardas 1 , Sunil Dhar 1 , Alec Moorman 1 , 

Inder Anand 2 , Aldo Maggioni 3 , David Linker 1 , Dariush 

Mozaffarian 4 , Wayne Levy 1 ; 1 Division of Cardiology, University 

of Washington, Seattle, WA; 2 Division of Cardiology, University 

of Minnesota, Minneapolis, MN; 3 Division of Cardiology, 

Italian Association of Hospital Cardiologists Research Center, 

Florence, Italy; 4 Division of Cardiology, Brigham and Women’s 

Hospital and Harvard Medical School, Boston, MA 

Monday 

80 

81

Sept. 10 

Monday 

Posters 

Posters 

Clinical Care/Management Strategies 

Posters 


Sept. 10 

Monday 

Posters 

Monday 

288 Altered Forms of Brain Natriuretic Peptide in Cardiac 

Disease 

Jeffrey Chan 1 , Arrash Fard 2 , Navaid Iqbal 2 , John Butterfield 3 , 

Alan Maisel 1 , 2 ; 1 University of California, San Diego, La Jolla, 

CA; 2 Cardiology, Veterans Affairs Medical Center, La Jolla, CA; 

3 

University of Western Sydney, Sydney, Australia 

290 Importance of Lung Impedance Monitoring in the 

Outpatient Clinic for Predicting and Preventing of 

Hospitalizations Patients with Chronic Heart Failure 

Michael Shochat 1 , Avraham Shotan 1 , Mark Kazatsker 1 , Aya Asif 1 , 

Iris Dahan 1 , Elena Shochat 1 , Yaniv Levy 1 , David Blondheim 1 , 

Simcha Meisel 1 ; 1 Cardiology, Hillel Yaffe Heart Institute, Hadera, 

Israel 

291 Can the Cardiac ARIA Index Improve Cardiac Care for 

Australia’s Indigenous Population? 

Robyn A. Clark 1 , Neil Coffee 2 ; 1 School of Nursing/Institute of 

Health and Biomedical Science, Queensland University of 

Technology, Brisbane, QLD, Australia; 2 Social Epidemiology/ 

Sansom Institute, University of South Australia, Adelaide, SA, 

Australia 

292 Bridging Patients Using Balloon Valvuloplasty in 

Patients with Acutely Decompensated Heart Failure: A 

Single Center Experience 

Aalok D. Patel 1 , Jim Stewart 1 , Edward Clermont 1 , Kreton 

Mavromatis 1 , Vasilis Babaliaros 1 ; 1 Emory University, Atlanta, GA 

293 The Time Course of the Pulmonary Edema Development 

during ST Elevation Myocardial Infarction 

Michael Shochat 1 , Avraham Shotan 1 , Mark Kazatsker 1 , Aya 

Asif 1 , Iris Dahan 1 , Ilia Shochat 1 , Yaniv Levy 1 , David Blondheim 1 , 


Israel 

294 Quantifying Circadian Variation of Multiple Physiologic 

Signals in Ambulatory Heart Failure Patients 

John Boehmer 1 , Yi Zhang 2 , Robert Sweeney 2 , Ramesh 

Wariar 2 , Qi An 2 , Pramodsingh Thakur 2 , Viktoria Averina 2 , Julie 

Thompson 2 ; 1 Penn State Milton S. Hershey Medical Center, 

Hershey, PA; 2 Boston Scientific, St. Paul, MN 

295 Patient Perception of Physician-Patient Communication 

at Time of Implantable Defibrillator Implant Decision 

Paul J. Hauptman 1 , John Chibnall 2 , Camille Guild 3 , Eric 

Armbrecht 3 ; 1 Medicine, Saint Louis University School of 

Medicine, St. Louis, MO; 2 Neurology and Psychiatry, Saint 

Louis University School of Medicine, St. Louis, MO; 3 Center 

for Outcomes Research, Saint Louis University School of 

Medicine, St. Louis, MO 

296 Referral of Heart Failure Patients to Hospice: Is It Time 

for New Guidelines? 

Edward Martin 1 , Nora Reznickova 2 , Kristen Schafer 3 , Tina 

Smusz 4 , Sarah Goodlin 5 , 6 ; 1 Palliative Medicine, Home 

& Hospice Care of Rhode Island, Brown University, 

Providence, RI; 2 Geriatrics and Palliative Medicine, Colorado 

PermanenteMedical, Boulder, CO; 3 Palliative Medicine, 

Brigham and Women’s Hospital, Boston, MA; 4 Palliative 

Medicine, Carilion Clinic Hospice & Palliative Care, 

Christiansburg, VA; 5 Geriatrics, Portland VAMC, OHSU, 

Portland, OR; 6 Patient-centered Education and Research, Salt 

Lake City, UT 

297 Clinical Assessment Using Magnetic Resonance Imaging 

Detects Brain Injury to Regions that Control Memory 

and Executive Function in Heart Failure 

Alan Pan 1 , Rajesh Kumar 3 , Paul M. Macey 1 , 2 , Gregg C. 

Fonarow 4 , Ronald M. Harper 2 , 3 , Mary A. Woo 1 ; 1 School of 

Nursing, UCLA, Los Angeles, CA; 2 Brain Research Institute, 

UCLA, Los Angeles, CA; 3 Neurobiology, David Geffen School 

of Medicine, UCLA, Los Angeles, CA; 4 Cardiology, David 

Geffen School of Medicine, UCLA, Los Angeles, CA 

299 Early International Normalized Ratio (INR) Monitoring 

and Long-Term Clinical Outcomes in Warfarin Users 

with Heart Failure: Findings from ADHERE Linked 

with Medicare Claims 

Laura G. Qualls 1 , Melissa A. Greiner 1 , Zubin J. Eapen 1 , Gregg 

C. Fonarow 2 , Roger M. Mills 3 , Winslow Klaskala 4 , Adrian 

F. Hernandez 1 , Lesley H. Curtis 1 ; 1 Duke Clinical Research 

Institute, Durham, NC; 2 Ahmanson-UCLA Cardiomyopathy 

Center, University of California Los Angeles, CA; 3 Janssen 

Research and Development,LLC, Raritan, NJ; 4 Janssen 

Pharmaceuticals,Inc., Titusville, NJ 

300 Factors Associated with Chronic Worsening of Renal 

Function in Stable Heart Failure Patients in an 

Ambulatory Setting 

Shawn W. Robinson 1 , Stephen S. Gottlieb 1 , Joanne Marshall 1 , 

Liobov Poliakova 1 , Devadatta Sarwate 1 ; 1 Cardiology, University 

of Maryland School of Medicine, Baltimore, MD 

301 Is Trastuzumab Chemotherapy-Induced 

Cardiomyopathy Always Reversible? 

Chen D.M. Tang 1 , Edmund Tsui 1 , Virginia L. Beggs 2 , Jeremiah 

R. Brown 2 , Gary N. Schwartz 3 , Alan T. Kono 2 ; 1 Cardiology, 

Dartmouth Medical School, Hanover, NH; 2 Cardiology, 

Dartmouth Hitchcock Medical Center, Lebanon, NH; 

3 

Hematology Oncology, Dartmouth Hitchcock Medical Center, 

Lebanon, NH 

Monday 

82 

83

Sept. 10 

Monday 

Posters 

Posters 


Posters 


Sept. 10 

Monday 

Posters 

Monday 

302 Elevated Discharge Copeptin Is Highly Predictive of 

90 Day Mortality in Acute Heart Failure Patients: 

Secondary Results from the Biomarkers in Acute Heart 

Failure (BACH) Trial 

Yang Xue 1 , Devin Kehl 1 , Paul Clopton 2 , Alan 

Maisel 2 ; 1 Cardiology, UC San Diego Medical Center, San Diego, 

CA; 2 Cardiology, VA San Diego Healthcare System, San Diego, 

CA 

303 Application of the Seattle Heart Failure Model in an 

Elderly Population Enrolled in a Tertiary Care Heart 

Failure Clinic 

Hanne Benbarkat 1 , Karima Addetia 1 , Mark J. Eisenberg 2 , 3 , 

Richard Sheppard 2 , Caroline Michel 2 ; 1 Cardiology, McGill 

University Health Center (MUHC), Montreal, QC, Canada; 

2 

Cardiology, Jewish General Hospital/McGill University, 

Montreal, QC, Canada; 3 Epidemiology, Jewish General Hospital/ 

McGill University, Montreal, QC, Canada 

304 Survey of Treatment Choices in Acute Decompensated 

Heart Failure Suggests Vasodilators Underused 

Compared to Guideline Recommendations 

Michelle D. Carlson 1 , Peter M. Eckman 1 ; 1 Medicine, 

Cardiology Division, University of Minnesota Medical School, 


305 Hospital Management of Hyponatremia in Patients 

with Heart Failure: Interim Data from a Multi-Center 

Registry 

Jun R. Chiong 1 , Paul J. Hauptman 2 , Joseph Chiodo, III 3 ; 1 Loma 

Linda University, Loma Linda, CA; 2 Saint Louis University 

School of Medicine, St. Louis, MO; 3 Otsuka America 

Pharmaceuticals, Inc., Princeton, NJ 

306 Outcome of Ultrafiltration Stratified by Admitting 

Serum Creatinine 

Gregory F. Egnaczyk 1 , Thomas M. O’Brien 1 , Santosh Menon 1 , 

Cheryl Bartone 1 , Eugene S. Chung 1 ; 1 The Heart and Vascular 

Center, The Christ Hospital, Cincinnati, OH 

307 Endomyocardial Biopsy (EMB) Has Diagnostic and 

Clinical Utility in Acute Onset Cardiomyopathy 

Nisha A. Gilotra 1 , Mosi K. Bennett 1 , Justin M. Dunn 1 , Colleen 

M. Harrington 1 , Shaline Rao 1 , Tasha Beck Freitag 1 , Marc K. 

Halushka 1 , Stuart D. Russell 1 ; 1 Medicine and Pathology, Johns 

Hopkins Hospital, Baltimore, MD 

308 Can We Identify Patients with Low Levels of Knowledge 

about Heart Failure (HF) and Poor Self-Care Behaviors? 

Boyoung Hwang 1 , Debra K. Moser 2 , Kathleen 

Dracup 3 ; 1 University of California Los Angeles, CA; 2 University 

of Kentucky, Lexington, KY; 3 University of California San 

Francisco, CA 

309 Effects of Renal Transplantation on Left Ventricular 

Remodeling Are Dissociated with Hypertension Control 

Lazaros A. Nikolaidis 1 , Mohamad Alkhouli 1 , Morad 

Abdulrahman 1 , Esha Oommen 1 , Armando L. 

Samuels 1 ; 1 Medicine, Cardiology and Nephrology, Temple 

University School of Medicine, Philadelphia, PA 

310 Prognostic Value of New-Onset Anemia in Patients with 

Acute Decompensated Heart Failure and Severe Renal 

Dysfunction 

Namki Hong 1 , Jong Chan Youn 1 , Jaewon Oh 1 , Seok-Min 

Kang 1 ; 1 Cardiovascular Division, Severance Cardiovascular 

Hospital and Cardiovascular Research Institute, Yonsei 

University College of Medicine, Seoul, Korea 

311 Blood Urea Nitrogen to Creatinine Ratio Does Not 

Predict Intravasular Volume Status in Patients with 


Molham Aldeiri 1 , Anas Khanfar 1 , Poorna Nalibuto 1 , Mohamed 

Morsy 1 , Wissam Khalife 1 ; 1 Cardiology, University of Texas 

Medical Branch, Galveston, TX 

312 Changes in Body Compartments during Hospitalization 

for Acute Decompensated Heart Failure 

Fernanda D. Alves 1 , Lucas Ries 1 , Gabriela C. Souza 1 , Luis E. 

Rohde 1 , Nadine Clausell 1 , Andreia Biolo 1 ; 1 Cardiology, Hospital 

de Clínicas de Porto Alegre, RS, Brazil 

313 Safe and Effective Volume Removal and Reduction in 

Thirty-Day Readmission for Diuretic Resistant Patients 

in the Outpatient Setting 

Deborah J. Crawford 1 , Alan M. Kaneshige 1 ; 1 Heart Failure CARE 

Center, Oklahoma Heart Institute, Tulsa, OK 

314 Extracorporeal Ultrafiltration vs. Intravenous Diuretics 

for Treatment of Acute Decompensated Heart Failure: A 

Meta-Analysis of Randomized Controlled Trials 

Khagendra B. Dahal 1 , Cristian Riella 1 , Fouad Chebib 1 , Diana 

Revenco 2 , Paweena Susantitaphong 1 , Lana Tsao 1 , Michael 

Maysky 2 , Bertrand Jaber 1 ; 1 Internal Medicine, St. Elizabeth’s 

Medical Center, Tufts University, Boston, MA; 2 Division of 

Cardiology, St. Elizabeth’s Medical Center, Boston, MA 

Monday 

84 

85

Sept. 10 

Monday 

Posters 

Posters 


Posters 


Sept. 10 

Monday 

Posters 

Monday 

315 Iron Metabolic Alterations in Chronic Heart Failure 

Jaqueline R.S. Gentil 1 , Vivian M.M. Suen 1 , Pedro V. 

Schwartzmann 1 , Fabiana Marques 1 , Angela R. Silva 1 , Julio S. 

Marchini 1 , Marcus V. Simoes 1 ; 1 Sao Paulo University, Ribeirão 

Preto, Brazil 

316 Atrial Fibrillation Is Found in over 60% of Heart 

Failure Patients Who Have Strokes 

Jacob I. Haft 1 , Louis E. Teichholz 1 ; 1 Cardiology, Hackensack 

University Medical Center, Hackensack, NJ 

317 A Continuing Evolution: Palliative Content in Major 

North American and European Heart Failure Guidelines 

between 1994 and 2011 

Bonita Huiskes 1 , Kathleen Dracup 2 , Thomas Heywood 3 ; 1 Azusa 

Pacific University, Azusa, CA; 2 University of California San 

Francisco, CA; 3 Scripps Clinic, La Jolla, CA 

321 The Presence of Left Ventricular Inotropic Reserve 

Correlates with Improvement of Left Ventricular Systolic 

Function in Non-Ischemic Cardiomyopathy Patients 

after Long-Term Oral Administration of Dipyridamole 

Pedro V. Schwartzmann 1 , Eduardo V. Carvalho 1 , Antonio O. 

Pintya 1 , Alexandre B. Figueiredo 1 , Marcus V. Simoes 1 ; 1 Internal 

Medicine, Cardiology Division, Ribeirao Preto School of 

Medicine - University of Sao Paulo, Ribeirao Preto, SP, Brazil 

322 Rural Heart Failure Management by Telemedicine: 

Lessons Learned 

Mark R. Stampehl 1 , Claire F. Call 2 , Susan M. Pope 2 , Marita 

Hartwig 2 , Stephen Jennison 3 ; 1 Prairie Cardiovascular Consultants, 

Springfield, IL; 2 St. John’s Hospital, Springfield, IL; 3 Medicine 

Department, Whangerei Hospital, Whangerei, New Zealand 

Monday 

318 In-Hospital Inotropes and Outcomes in Ischemic vs. 

Nonischemic Cardiomyopathy: Insights from the 

ESCAPE Trial 

Andreas Kalogeropoulos 1 , Raquel Bennett-Gittens 1 , Deepali N. 

Tukaye 1 , Robert T. Cole 1 , Divya Gupta 1 , Catherine N. Marti 1 , 

Vasiliki Georgiopoulou 1 , Javed Butler 1 ; 1 Department of Medicine, 

Division of Cardiology, Emory University, Atlanta, GA 

319 Different Characteristics between ‘Real’ Stress-Induced 

Cardiomyopathy and ‘Clinically Diagnosed’ Stress- 

Induced Cardiomyopathy with Significant Coronary 

Artery Disease 

Sun Hwa Lee 1 , Lae Young Jung 1 , E-Sik Kim 1 , Hae Eun Yun 1 , 

Won Ho Kim 1 , Jae Ki Ko 1 ; 1 Cardiology, Chonbuk National 

University Hospital, Jeonju, Jeollabuk-do, Korea 

320 Elderly Hospitalized Heart Failure Patients Have 

Profound Impairments in Physical Function 

Gordon R. Reeves 1 , Mahesh J. Patel 2 , David J. Whellan 1 , 

Christopher M. O’Connor 2 , Joel D. Eggebeen 3 , Pamela Duncan 3 , 

Leigh Ann Hewston 1 , Amy Pastva 2 , Suzanne Adams 1 , Vinay 

Thohan 3 , Dalane W. Kitzman 3 ; 1 Jefferson Medical College, 

Philadelphia, PA; 2 Duke University School of Medicine, 

Durham, NC; 3 Wake Forest University, Winston-Salem, NC 

86 

87

Sept. 11 

Tuesday 

AM 



7:00-8:00 AM 

Ballroom 6A 

SYMPOSIUM 


7:00-8:15 AM 


Sept. 11 

Tuesday 

AM 

Tuesday 

Current and Emerging Therapies for Heart 

Failure Patients with Mitral Regurgitation 

Moderator: JoAnn Lindenfeld, Denver, CO 

7:00 Welcome and Introduction: The Scope of the Problem 

JoAnn Lindenfeld, Denver, CO 

7:05 What Is the Evidence Base for Management of Mitral 

Regurgitation in Patients with Heart Failure? 

Robert O. Bonow, Chicago, IL 

7:20 High Risk Patients with Mitral Regurgitation: Severe LV 

Dysfunction and Comorbidities 

Steven F. Bolling, Ann Arbor, MI 

7:35 Percutaneous Therapies for Mitral Regurgitation: 

Current Data and Future Possibilities 

John D. Carroll, Denver, CO 


Faculty 


1. Define specific types of mitral regurgitation 

2. Identify guidelines for the management of mitral 

regurgitation (MR) in patients with heart failure 

3. Identify ambiguous terms or areas not explicitly 

addressed by the guidelines 

4. Describe high risk patients with MR 

5. Follow appropriate treatment strategies for managing MR 

in patients with heart failure 

6. Discuss emerging therapeutic options in the treatment of 

MR in patients with heart failure 

Supported by an educational grant from Abbott Vascular 

CLINICAL FUNDAMENTALS 

Strategies for National Heart Failure Care 

Moderators: Clyde W. Yancy, Chicago, IL 

7:00 The View from Washington 

Marvin A. Konstam, Boston, MA 


7:15 How Many Patients, How Many Staff? 

Mariell L. Jessup, Philadelphia, PA 

7:23 Nurses, Nurse Practitioners, or Physician Assistants 

Suzanne J. Wingate, Gaithersburg, MD 

7:31 What Costs for Transplant and VADS are Sustainable? 


7:39 The Michigan Model 

Keith D. Aaronson, Ann Arbor, MI 

7:47 The VA System as a Database Model 



Learning Objective: Identify factors affecting the transition 

from hospital to home for patients with heart failure and 

describe ways to manage them. 

Tuesday 

This symposium is not part of the scientific program as planned by 

the HFSA Scientific Program Committee. 

88 89

Sept. 11 

Tuesday 

AM 



7:00-8:15 AM 


SYMPOSIUM 


8:30-10:00 AM 

Ballroom 6C 

Sept. 11 

Tuesday 

AM 

Tuesday 

Clinical Fundamentals: Management 

of Arrhythmia Devices, and Pulmonary 

Hypertension 

Moderators: Daniel J. Lenihan, Nashville, TN 

Ayan R. Patel, Boston, MA 

7:00 CRT – Wider Indications, Wider QRS 

Jagmeet P. Singh, Boston, MA 

7:10 ICD-Common and Uncommon Indications and 

Complications 

Sanjiv Narayan, La Jolla, CA 

7:20 ICD Shocks: Evaluating and Secondary Prevention 

William G. Stevenson, Boston, MA 

7:30 Device Questions 

7:40 Evaluation of Pulmonary Hypertension and Right 

Ventricular Function 

Myung H. Park, Baltimore, MD 

7:50 Specific Causes of Pulmonary Hypertension 

Teresa De Marco, San Francisco, CA 

8:00 Newer Management of Primary and Secondary 

Pulmonary Hypertension 

Robert Frantz, Rochester, MN 


Learning Objective: Describe strategies for care of the 

patient with advanced heart failure, including mechanical 

circulatory support and transplantation. 

Advanced Therapy: Getting It Right 

Moderators: Sharon A. Hunt, Stanford, CA 

Leslie W. Miller, Tampa, FL 

8:30 Referral to Advanced Heart Failure Programs 

Mark J. Zucker, Newark, NJ 

8:40 Significance of ICD Shocks for Prognosis 

Jeanne E. Poole, Seattle, WA 

8:50 Listing for Transplant Depends on Length of List 

Mario C. Deng, Los Angeles, CA 

9:00 Serial Monitoring of the Right Ventricle During HF 

Progression 


9:10 Not Too Sick or Too Well for a VAD 



9:30 Preventing Rejection and Vasculopathy Without 

Infection or Cancer 

David O. Taylor, Cleveland, OH 


9:45 What is the Right Time for End-of-Life Discussion 

Kelly Ann Light-McGroary, Iowa City, IA 


Learning Objective: Describe approaches to key 

management decisions in care of the patient with advanced 


Tuesday 



90 91

Sept. 11 

Tuesday 

AM 

SYMPOSIUM 


8:30-10:00 AM 

Ballroom 6B 

SYMPOSIUM 


8:30-10:00 AM 

Ballroom 6A 

Sept. 11 

Tuesday 

AM 

Tuesday 

Atrial Fibrillation in Heart Failure 

Joint Session with HRS 

Moderators: William G. Stevenson, Boston, MA 

Jagmeet P. Singh, Boston, MA 

8:30 Prevalence of Atrial Fibrillation in HF All EF 

Denis Roy, Montréal, QC Canada 

8:45 Anticoagulation in AF: Dosing New and Old 

Michael D. Ezekowitz, Wynnewood, PA 

9:00 Anxiety Sensitivity and Benefit of AF Rhythm Control 

Mario Talajic, Montreal, QC Canada 


Three Approaches to Atrial Fibrillation 

9:20 Anti-arrhythmic Drugs and Rate Control 

William G. Stevenson, Boston, MA 

9:30 Ablation of the Atrial Fibrillation 

Sanjiv Narayan, La Jolla, CA 

9:40 AV Node Ablation and CRT 

Bruce L. Wilkoff, Cleveland, OH 


Learning Objective: Recognize clinical issues in the care 

of patients with atrial fibrillation and choose the best 

management options. 

Restricting Sodium: Truth or Tradition? 

Moderators: Biykem Bozkurt, Houston, TX 


8:30 Hyponatremia: Marker or Target? 

James E. Udelson, Boston, MA 

Point/Counter Point 

8:40 Sodium Restriction is Beneficial in Patients with Heart 


Stuart D. Katz, New York, NY 

8:50 Sodium Restriction Can Be Harmful in Patients with 


Giuseppe Licata, Palermo, Italy 


9:05 Can We Develop a Drug to Diminish Thirst 

Robert J. Cody, Raritan, NJ 


9:25 Fluid Restriction in Patients with Heart Failure: When 

is it Needed? 

J. Thomas Heywood, La Jolla, CA 

9:45 One Size Does Not Fit All 

Terry A. Lennie, Lexington, KY 


Learning Objective: Discuss what is known about the role 

of sodium restriction in heart failure and selected strategies 

for successful implementation. 

Tuesday 





92 93

Sept. 11 

Tuesday 

AM 

SYMPOSIUM 


8:30-10:00 AM 


SYMPOSIUM 


8:30-10:00 AM 


Sept. 11 

Tuesday 

AM 

Tuesday 

Connecting the Dots Between The Disease and 

The Symptoms 

Moderators: Katherine J. Hoercher, Cleveland, OH 

Mark D. Sullivan, Seattle, WA 

8:30 How Does EF Affect the Symptoms of Heart Failure? 

Michael R. Zile, Charleston, SC 

8:40 Who Knows Best? Using The Patient Symptom Report 

Corrine Y. Jurgens, Miller Place, NY 

8:50 I am Short of Breath - Clinical and Hemodynamic 

Diagnosis 

Stuart D. Russell, Baltimore, MD 

9:05 BNP Fragments: Potent or Passengers? 

Horng H. Chen, Rochester, MN 

9:15 Discussion of Diagnosis 

9:20 Tracking Changes at Home 

Eugene S. Chung, Cincinnati, OH 

9:35 PDE-5 Inhibitors – Treating the Disease or the 

Symptoms? 

Gregory D. Lewis, Boston, MA 

9:45 Symptom Burden and Palliation 

James N. Kirkpatrick, Philadelphia, PA 


How Should We Improve Pump Function? 

Moderators: Burns C. Blaxall, Cincinnati, OH 


8:30* Contractility Modulation or Smaller Assist Devices for 

Earlier Use? 


8:45* Autonomic Modulation – For The Periphery or The 

Heart? 

Mark E. Dunlap, Cleveland, OH 

9:00* New Targets for Inotropic Therapy 

Walter J. Koch, Philadelphia, PA 

9:15* How Can Negative Inotropic Agents Improve Cardiac 

Function 

Joshua I. Goldhaber, Los Angeles, CA 

9:30* IV Inotropic Therapy at Home 

Lenore J. Blank, Mahwah, New Jersey 

9:45* Can CaMKII Inhibitors Affect the Function of the 

Failing Heart? 

Donald M. Bers, Davis, CA 

*12 minute presentation, 3 minute discussion 

Learning Objective: Describe ways in which emerging 

devices and inotropic therapy can impact cardiac function in 


Tuesday 

Learning Objective: Describe the physiological basis of 

heart failure symptoms and the role of selected symptoms in 

patient care. 





94 95

Sept. 11 

Tuesday 

AM 

oral abstract session 


8:30-10:00 AM 


POSTERS DISPLAYED 


9:30 AM-7:00 PM 


Sept. 11 

Tuesday 

AM 

Tuesday 

Featured Oral Abstract Session 

Moderators: Lynne V. Doering, Los Angeles, CA 


8:30* Randomized Controlled Trial of a Biobehavioral 221 

Intervention for Depression in Patients with 


Debra K. Moser, Jia-Rong Wu, Misook L. Chung, Martha 

J. Biddle, Mary Schooler, Terry A. Lennie; College of 

Nursing, University of Kentucky, Lexington, KY; College 

of Nursing, University of North Carolina-Chapel Hill, NC 

8:45* Marked Changes in Right Marked Changes in 022 

Right after Cardiac Surgery May Be Secondary 

to Pericardial Incision: Implications for the Post- 

Surgical Assessment of Right Ventricular Function 

Amresh Raina, Anjali V. Fields, Susan Chambers, Zachary 

M. Gertz, Paul R. Forfia; Cardiovascular Institute, 

Allegheny General Hospital, Pittsburgh, PA; Cardiovascular 

Division, Hospital of the University of Pennsylvania, 


9:00* Metformin, but Not Diet-Induced Weight Loss, 017 

Decreases Myocardial Fibrosis in a Murine Model 

of Diet-Induced Insulin Resistance and 


Tomasz Wietecha, Jinkyu Kim, Antonio Sta Teresa, Kelly 

Hudkins, Charles E. Alpers, Kevin D. O’Brien; Medicine 

(Cardiology), University of Washington, Seattle, WA; 

Pathology, University of Washington, Seattle, WA 

9:15* Algisyl-LVR Reduces Left Ventricular Wall 183 

Stress and Improves Function in the Failing 

Human Heart 

Lik Chuan Lee, Doron Klepach, Andy Hinson, Randall 

Lee, Julius Guccione; UCSF, San Francisco, CA; LoneStar 

Heart, Inc., Laguna Hills, CA 

9:30* Cardiac Specific Gene Delivery of a Dual 076 

GC-A and GC-B Agonist, CD-NP, Mediates Anti- 

Hypertrophic Actions in a Model of Hypertensive 

Heart Disease beyond GC-A Activation Alone Via BNP 

Alessandro Cataliotti, Jason M. Tonne, Sarah Mangiafico, 

John C. Burnett, Jr., Yasuhiro Ikeda; Cardiorenal Research 

Laboratory, Mayo Clinic, Rochester, MN; Molecular 

Medicine, Mayo Clinic, Rochester, MN 

9:45* Discordance between Peak Metabolic Demand 114 

and LVAD Flow Rate during Upright 

Symptom-Limited Exercise 

Dennis J. Kerrigan, Celeste T. Williams, Jonathan K. 

Ehrman, Matthew A. Saval, Kyle Bronsteen, John R. 

Schairer, Cheryl Smith, Steven J. Keteyian; Division of 

Cardiovascular Medicine, Henry Ford Hospital, Detroit, MI 

*15 minutes each (10 minute presentation, 5 minutes 

discussion) 

Learning Objective: Discuss findings from recent 

research in heart failure and their implications for heart 

failure research and treatment. 

PRESENTERS AT POSTERS 5:45 PM-6:45 PM 

Categories Poster # 

Cardiovascular Physiology 016, 018, 024, 026, 039-061 

Cardiovascular Structure 069-075 

Neurohormones/Cytokines 082, 086-095 

Molecular Biology and Genetics 104-111 

VADs/transplant/surgery 134-154 

Electrophysiology and rhythm devices 157, 168-181 

Clinical Trials 184, 189-197 

Cardiovascular Pharmacology 204-208 

Epidemiology, Prevention 215-220 

Outcomes 226, 230, 255-287 

Clinical Care/ 288, 290-297, 299-322 

Management Strategies 

Listing for Monday posters begins on page 62 

Listing for Tuesday posters begins on page 115 

Tuesday 





96 97

Sept. 11 

Tuesday 

AM 

Tuesday 

CASE DISCUSSION 


10:30 AM-NOON 

Ballroom 6B 

Case Presenters: James C. Fang, Cleveland, OH 

Gary S. Francis, Minneapolis, MN 

10:30 Case 1: A 27 y/o healthy mother delivers a healthy infant 

who quickly develops a severe, dilated cardiomyopathy and 

undergoes successful heart transplantation at one month of 

age. During this time the mom develops symptoms of early 

heart failure and the echo indicates features of an early, 

mild, dilated cardiomyopathy (LVEDd=58mm and the EF 

=42% with global hypokinesis). The mother, an RN, asks 

you whether she has post-partum cardiomyopathy, or if she 

has familial dilated cardiomyopathy. 

10:48 Case 2: An 18 y/o high school All-American basketball 

player from Chicago comes to see you because he felt 

lighted on the basketball court during a game. All the 

findings are consistent with HCM, but there is no LVOT 

obstruction at rest or during provocation or maximal 

exercise. There are no risk factors for sudden death. A 

MRI indicates minimal fibrosis of the heart. He has a full 

scholarship to Kentucky, Michigan and Duke. His local 

cardiologist, a well-known professor in Chicago, strongly 

believes that the patient should have an ICD and be allowed 

to play in college, and his parents also favor this pathway. 

The patient wants your opinion. 

11:06 Case 3: 75 year old man is admitted for 3rd time with 

appropriate ICD shocks. Underwent previous CABG 5 

yrs ago; all grafts patent. Underwent VT ablation last 

admission; on amiodarone. RHC notable for RA 6, PCW 

18, PA 45/20/25, CI 2.1. Echo EF 15%, EDD 7.0 cm. 

BUN 35, Cr 1.5. Patient maintains he is NYHA II between 

shocks. Primary cardiologist suggests LVAD after hearing 

your recent CME talk about LVADs. 

CASE DISCUSSION 

11:42 Case 5: A 37 y/o woman blood type O with advanced 

dilated cardiomyopathy (EF=22%, NYHA Class III) is 

referred to you for management. There are two issues that 

the referring physician wants you to clarify: The patient 

has a dilated LV with an LVIDd of 64 mm, and severe 

4+ MR with restricted mitral valve leaflet motion. The 

PVR, TPG and PA pressure indicate she is an acceptable 

transplant candidate. Can or should the MV be considered 

for repair? The other problem is that she is not tolerating 

her medications (carvedilol, lisinopril, spironolactone and 

furosemide) very well due to symptomatic hypotension. 

These are being down-titrated. How does one down-titrate? 

He asks you “is it time for an LVAD, or even MV repair and 

then an LVAD”? He is from the University of Michigan 

where MV repair for severe MR and a low EF is frequently 

performed. 

Panelists: 

Michele A. Hamilton, Los Angeles, CA 

Soon Park, Rochester, MN 

Patricia A. Uber, Baltimore, MD 

Sarah C. Paul, Hickory, NC 

Mario Talajic, Montreal, QC Canada 

Learning Objective: Using practice guidelines, research 

findings and clinical experience, make decisions about the 

management of difficult cases in heart failure. 

Sept. 11 

Tuesday 

AM 

Tuesday 

11:24 Case 4: 60 year old woman is referred for coronary 

angiography for new onset heart failure. Has been NYHA 

II-III for past month. Echo shows EF 25%, moderate MR, 

EDD 6.5 cm. No angina. Initiated on lisinopril 5mg, 

bisoprolol 2.5 mg, furosemide 40 mg. Cath shows 70% mid 

LAD, 80% ramus, and 90% lesion in proximal dominant 

RCA. RHC notable for RA 12, PCW 22, PA 50/25/30, CI 

2.4. Interventionalist pages you to let you know he is ready 

to stent RCA. Husband wants patient to see senior cardiac 

surgeon he personally knows. 


98 99

Sept. 11 

Tuesday 

AM 

SYMPOSIUM 


10:30 AM-NOON 


SYMPOSIUM 


10:30 AM-NOON 


Sept. 11 

Tuesday 

AM 

Tuesday 

Cardiac Metabolism in Heart Failure 

Moderators: Michael A. Portman, Seattle, WA 

Rong Tian, Seattle, WA 

10:30* Metabolic Remodeling in Human Heart Failure 

Robert J. Gropler, St. Louis, MO 

10:48* Novel Metabolic Therapies on the Horizon? 

E. Douglas Lewandowski, Chicago, IL 

11:06* Mitochondrial Metabolism in HF 


11:34* Metabolic Therapeutics in the Failing Heart 

Robert G. Weiss, Seattle, WA 

11:52* Perturbations of Mitochondrial Proteome in the Failing 

Myocardium 

Peipei Ping, Los Angeles, CA 


Learning Objective: Describe the role of cardiac metabolism 

in remodeling and cardio-protection and the role of 

emerging metabolic therapies. 

Why and How to Develop New Drugs and 

Devices for Heart Failure 

Moderators: Mihai Gheorghiade, Chicago, IL 

10:30 Overview of the Issues 

Mihai Gheorghiade, Chicago, IL 

Industry Point of View: Impediments and Challenges to Bringing 

New Heart Failure Drugs and Devices to Market 

10:35 Stuart Kupfer, Deerfield, IL 

10:45 Frank Misselwitz, Wuppertal, Germany 

10:55 Arjun Sharma, St. Paul, MN 

FDA/EMA Point of View: Regulatory Issues 

11:05 Felipe Aguel, Silver Spring, MD 

11:15 Guiseppe Rosano, Rome, Italy 

The Payer’s Perspective 

11:25 Scott R. Taylor, Danville, PA 


Moderator: Mihai Gheorghiade, Chicago, IL 

Faculty: Gregg C. Fonarow, Los Angeles, CA 

Learning Objective: Describe the role of national policies 

on the development of new heart failure therapies in the 

US and Europe and discuss ways to enhance research and 

development. 

Tuesday 

100 101

Sept. 11 

Tuesday 

AM 

SYMPOSIUM 


10:30 AM-NOON 

Ballroom 6A 

SYMPOSIUM 


10:30-NOON 

Ballroom 6C 

Sept. 11 

Tuesday 

AM 

Tuesday 

Approach to Myocarditis/Strategy to Recover 

LV with LVAD 

HFSA/European Joint Session 

Moderators: Stefan D. Anker, Berlin, Germany 


Role of Anti-Myocardial Antibodies: Cause or Result of Injury? 

10:30 Anti-myocardial Antibodies and Persistent Virus in 


Carsten Tschöpe, Berlin, Germany 

10:45 The Role of Biopsy and Testing for Antibodies 



Recovery is Real with VADs 

11:15 European Experience with VAD Recovery – Different 

Patients or Different Patience? 

Piotr Ponikowski, Wroclaw, Poland 

11:30 US Experience with Recovery 

Simon W. Maybaum, Bronx, NY 


The Patient with Heart Failure and Severe 

Valvular Heart Disease 

Moderators: Blase A. Carabello, Houston, TX 


10:30 The Low Gradient Low EF AS Patient 

Philippe Pibarot,Québec, QC, Canada 

10:45 Dogs and People with Functional MR 

Blase A. Carabello, Houston, TX 

11:00 The Patient with Advanced AR 

Jeffery S. Borer, Brooklyn, NY 

11:15 The Patient with Valvular Heart Disease and Lung 

Disease: When Will Fixing the Valve Fix the Dyspnea? 

Barbara A. Cockrill Boston, MA 

11:30 Can I Ignore TR in My Patient with Left-Sided Valvular 

Heart Disease? 

Edwin C. McGee, Jr., Chicago, IL 


Learning Objective: Describe surgical approaches to the 

heart failure patient with valvular disease. 

Tuesday 

Learning Objective: Describe approaches to myocarditis 

and LV recovery for patients with LVADs 

102 103

Sept. 11 

Tuesday 

PM 



12:30-1:30 PM 

Ballroom 6A 



12:30-1:30 PM 

Ballroom 6A 

Sept. 11 

Tuesday 

PM 

Rapid Fire Abstracts 

Rapid Fire Abstracts (cont.) 

Tuesday 

Moderators: Arthur M. Feldman, Philadelphia, PA 

Carl V. Leier, Columbus, OH 

12:30* Results of the RISK Trial: Renal Function and 184 

Female Gender Are Strongly Associated with 

Early Response to Cardiac Resynchronization 

Therapy 

Alaa A. Shalaby, John Gorcsan, Gregg Fonarow, Jagmeet 

Singh, Malcolm Bersohn, Jasmina Halilovic, Manish Gupta, 

Ali Sonel, Samir Saba, William Abraham, Alan Kadish; 

University of Pittsburgh, PA; UCLA, Los Angeles, CA; 

Massachusetts General Hospital, Boston, MA; St. Jude 

Medical, Sunnyvale/Sylmar, CA; The Ohio State University, 

Columbus, OH; Touro College, New York, NY 

12:35* The Impact of Isolated Diastolic Dysfunction 157 

on Atrial Fibrillation Recurrence after Catheter 

Ablation 

Rosita Zakeri, Jia H. Wu, David O. Hodge, Kristi H. 

Monahan, Yong-Mei Cha, Douglas L. Packer, Margaret 

M. Redfield; Division of Cardiovascular Diseases, Mayo 

Clinic, Rochester, MN 

12:40* Tetrahydrobiopterin Improves Diastolic 018 

Heart Failure by Increasing Myofilament 

Calcium Sensitivity 

Euy-Myoung Jeong, Michelle M. Monasky, Lianzhi Gu, 

Domenico M. Taglieri, Bindiya G. Patel, Qiongying Wang, 

Harvey Lardin, Ian Greener, R. John Solaro, Samuel C. 

Dudley, Jr; Section of Cardiology, College of Medicine, 

University of Illinois at Chicago, IL; Department of 

Physiology and Biophysics and Center for Cardiovascular 

Research, University of Illinois at Chicago, IL 

12:45* Activation of Pulmonary Arterial Endothelium 016 

in Heart Failure with Preserved Ejection Fraction 

Induced Pulmonary Hypertension Similar to 

Pulmonary Arterial Hypertension 

Jason N. Salamon, Jeremy Mazurek, Ronald Zolty; Jacobi 

Medical Center/Albert Einstein College of Medicine, 

Bronx, NY; Cardiology, Montefiore Medical Center, Albert 

Einstein College of Medicine, Bronx, NY 

12:50* Therapy with a DPP-4 Inhibitor Increases 026 

Myocardial Glucose Uptake in Nonischemic 


Ronald M. Witteles, Khun V. Keu, Andrew Quon, Homa 

Tavana, Michael B. Fowler; Stanford University School of 

Medicine, Stanford, CA 

12:55* Urokinase Induces Pro-Fibrotic/M2 Phenotype 082 

in Cardiac Macrophages 

Laura Malchodi, Deri Helterline, Jessica Meznarich, 

April Stempien-Otero; Medicine Division of Cardiology, 

University of Washington, Seattle, WA; Pediatrics, 

University of Utah, Salt Lake City, UT 



1:00* Incidence, Predictors and Outcomes Related 181 

to Hypo and Hyperkalemia in Severe Heart 

Failure Patients Treated with an 

Aldosterone Antagonist 

Orly Vardeny, DongHong Wu, Brian Claggett, Akshay 

Desai, Patrick Rossignol, Faiez Zannad, Bertram Pitt5, 

Scott D. Solomon; University of Wisconsin, Madison, WI; 

Brigham and Women’s Hospital, Boston, MA; INSERM, 

Centre d’Investigations Cliniques-950 and Nancy- 

Universite, Nancy, France; University of Michigan School 

of Medicine, Ann Arbor, MI 

1:05* Inpatient Initiation and Target Dosing of ACE 298 

Inhibitors and Beta-Blockers in Children with 


Jack F. Price, BreAnn N. Taylor, Aamir Jeewa, William J. 

Dreyer, Susan W. Denfield, Antonio G. Cabrera, Brady S. 

Moffett; Pediatric Cardiology, Baylor College of Medicine, 

Houston, TX; Pharmacy, Texas Children’s Hospital, 

Houston, TX 

1:10* Adverse In-Hospital Outcomes by Systolic 289 

Blood Pressure at Admission in Patients 

Hospitalized with Acute Heart Failure 

Syndromes − Data from RO AHFS Registry 

Ovidiu Chioncel, Dragos Vinereanu, Serban Bubenek, 

Andrew Ambrosy, Cezar Macarie, Mihai Gheorghiade; 

Institute of Emergency for Cardiovascular Diseases “Prof. 

Dr. C.C. Iliescu”, Bucharest, Romania; Universitary 

Emergency Hospital, Bucharest, Romania; Department 

of Medicine, Stanford University School of Medicine, 

Stanford, CA; Center for Cardiovascular Innovation, 

Northwestern University, Feinberg School of Medicine, 

Chicago, IL 

1:15* The Timing of Hemoconcentration During 230 

Treatment of Decompensated Heart Failure 

Influences Subsequent Survival 

Meredith A. Brisco, Steve Coca, Stephen Kimmel, Jeffrey 

M. Testani; Department of Medicine, Cardiovascular 

Division, University of Pennsylvania School of Medicine, 

Philadelphia, PA; Department of Medicine, Yale University 

School of Medicine, New Haven, CT 

1:20* Stimulation of β2 Adrenergic Receptors 

Clears Lung Fluid in Patients with Heart Failure 

024 

Bryan J. Taylor, Maile L. Ceridon, Eric M. Snyder, Bruce 

D. Johnson; Cardiovascular Diseases, Mayo Clinic, 

Rochester, MN; Pharmacy Practice and Science, University 

of Arizona, Tucson, AZ 

1:25* Obesity Paradox Does Not Apply to 

Acute Heart Failure 

226 

Maya Guglin, Ren Chen; Cardiology, University of South 

Florida, Tampa, FL 


Learning Objective: Discuss findings from recent research 

in HF and their implications for heart failure research and 

treatment. 

Tuesday 

104 105

Sept. 11 

Tuesday 

PM 

HOW TO SESSIONS 


12:30-1:30 PM 

Location 

Hyde Park 


2:00-3:30 PM 

Ballroom 6B 

Sept. 11 

Tuesday 

PM 

Tuesday 

6. Using Apps for Self-Care Room 616 

Jill Howie Esquivel, San Francisco, CA 

Lorraine S. Evangelista, Los Angeles, CA 

Learning Objective: Describe the role of electronic applications in 

patient self-management of heart failure 

7. Cardiotoxicity of Chemotherapy: Room 612 

Evaluation and Therapy 

Jean-Bernard Durand, Houston, TX 

Anju Nohria, Boston, MA 

Learning Objective: Evaluate heart failure patients undergoing or 

recovering from chemotherapy and manage their disease. 

8. How to Read and Interpret the Results of 

Genetic Testing Room 603 

Neal Lakdawala, Boston, MA 

Daniel L. Jacoby, New Haven, CT 

Learning Objective: Identify the components of genetic testing 

results, their meaning, and their implications for patient care 

9. How to Identify and Use Simple Tools for Room 6189 

Assessment of Health Literacy 

Pamela N. Peterson, Denver, CO 

Ann S. Laramee, South Burhington, VT 

Learning Objective: Identify and use tools to assess 

health literacy and improve care in patients with heart failure. 

10. Heart Failure Physicians Learn to Read the Room 608/609 

ICD/CR Device Reports 

Bruce L. Wilkoff, Cleveland, OH 

William H. Sauer, Aurora, CO 

Learning Objective: To identify the components in the device reports 

most important for managing heart failure. 

1:45 Announcement of Awards 

Jay N. Cohn New Investigator Awards 

Nursing Investigator Research Award 

2012 Nursing Clinical Excellence Award 

2012-2013 HFSA Research Fellowship Awards 


Corrine Jurgens, Stony Brook, NY 

Martin LeWinter, Burington, VT 



Hyde Park Session 

Moderators: John G.F. Cleland, Kingston-Upon-Hull, UK 

Douglas D. Schocken, Durham, NC 

2:00* Digoxin Curse or Cure? 

Mihai Gheorghiade, Chicago, IL 

2:12* Basic Science Does Not Matter: The Negligible Potential 

of Molecular Research 

Eric S. Ambrecht, St. Louis, MO 

2:24* Another New Training Program in Diastolic 

Predominant Heart Failure 

Matthew Wheeler, Stanford, CA 

2:36* We Should Not Be Preventing Heart Failure 

Jay N. Cohn, Minneapolis, MN 

2:48* Can Horse Drink the Water Please? 

Narendra C. Bhalodkar, Bronx, NY 

3:00* An “Epic” Move to Automated Medical Documentation: 

Copying and Pasting Our Way Into Oblivion 

Larry A. Allen, Denver, CO 

3:12* Zen and the Art of Heart Failure 

William G. Cotts, Chicago, IL 


Learning objective: Discuss new insights and perspectives 

on heart failure research, education, and clinical practice. 

Tuesday 



106 107

Sept. 11 

Tuesday 

PM 

SYMPOSIUM 


2:00-3:30 PM 

Ballroom 6C 

SYMPOSIUM 


2:00-3:30 PM 


Sept. 11 

Tuesday 

PM 

Back in the Hospital 

Therapies in Development 

Moderators: Alan Jansujwicz, Bangor, ME 

Debra K. Moser, Lexington, KY 

Moderators: Steven Goldman, Tucson, AZ 

Michael J. Sole, Toronto, ON, Canada 

2:00 Leading Up to Admission (ADHERE) 


2:00* Where is there a Clinical Need? 

Arthur M. Feldman, Philadelphia, PA 

2:15 Why is the Patient Back? 

Jason W. Ryan, Farmington, CT 

2:18* PKC Inhibitors are Ready for Heart Failure Trials! 

Jeffrey D. Molkentin, Cincinnati, OH 

Tuesday 

2:25 How is Comorbidity Associated with Readmission? 

Jill Howie Esquivel, San Francisco, CA 

2:35 What Else Can DOSE and ASCEND Teach Us? 

G. Michael Felker, Durham, NC 

2:45 ED Decision: Admit or Discharge to Early Follow-Up 

Peter S. Pang, Chicago, IL 

3:00 How Much Patient Education and When? 

Lorraine S. Evangelista, Los Angeles, CA 

2:36* Enough with the Kinases; Phosphatase Inhibitors for 

Heart Failure Therapy 

Yibin Wang, Los Angeles, CA 

2:54* Cell-Free Regenerative Therapies 

Annarosa Leri, Boston, MA 

3:12* Angiogenesis for Ischemic Heart Disease 

Douglas W. Losordo, Chicago, IL 


Tuesday 


Learning Objective: Describe emerging therapies for heart 

failure and how they might be used to improve patient care. 

Learning Objective: Describe factors affecting readmission 

of patients with heart failure and implement strategies to 

improve readmission rates. 





108 109

Sept. 11 

Tuesday 

PM 

SYMPOSIUM 


2:00-3:30 PM 

Ballroom 6A 

DEBATES 


4:00-5:30 PM 

Ballroom 6B 

Sept. 11 

Tuesday 

PM 

From Left to Right 

Moderators: Marvin A. Konstam, Boston, MA 


Tuesday 

Moderators: Paul R. Forfia, Philadelphia, PA 

Robert Frantz, Rochester, MN 

2:00* Pulmonary Hypertension From HFpEF 

Margaret M. Redfield, Rochester, MN 

2:15* Primary, Reactive or Passive Pulmonary Hypertension 

Myung H. Park, Baltimore, MD 

2:30* Lessons from Experimental Pulmonary Hypertension 

Jane A. Leopold, Boston, MA 

2:45* What Does the Right Ventricle Look Like? 


3:00* Animal Models of Right Ventricle Overload 

Emily J. Tsai, Philadelphia, PA 

3:15* Right Ventricular Recovery 



Learning Objective: Describe pulmonary hypertension 

and right ventricular failure and identify appropriate 

management options. 

DEBATE: Oxford Style 

Oral Inotropic Agents Should be Available for Palliative Care 

4:00 Pro: Milton Packer, Dallas, TX 

4:15 Con: Milton Packer, Dallas, TX 

4:30 Questions from Moderators 

DEBATE: Clinical Care 

4:45 Clinical Care Should Focus More on Risk Stratification 

Wayne C. Levy, Seattle, WA 

5:00 Clinical Care Should Focus More on Assessing Quality of 

Life 

Eldrin F. Lewis, Boston, MA 

5:15 Questions from Moderators 

Learning Objective: Outline considerations influencing 

the use of inotropic agents in palliative care and tools for 

assessing risk and quality of life in patients with heart 

failure. 

Tuesday 







110 111

Sept. 11 

Tuesday 

PM 

SYMPOSIUM 


4:00-5:30 PM 

Ballroom 6C 

SYMPOSIUM 


4:00-5:30 PM 


Sept. 11 

Tuesday 

PM 

Tuesday 

Revised AHA/ACC Performance Measures and 

Evidence That Supports Changes 

Moderators: Nancy M. Albert, Cleveland, OH 

Mariell L. Jessup, Philadelphia, PA 

4:00 Impact of Performance Measures on Outcomes 


4:10 Heterogeneity of Performance 


4:20 Can We Adjust Populations to Measure Effectiveness 

Soko Setoguchi-Iwata, Durham, NC 

4:30 When Guidelines Can Be Performance Measures 

Frederick A. Masoudi, Aurora, CO 

4:40 What the Community Physician Needs to Know 

Donald E. Casey, Jr., New York, NY 

5:00 Strategy for Implementation of Outpatient Measures 

Clyde W. Yancy, Chicago, IL 


Faculty 

Remodeling in Reverse 

Moderators: Michael R Bristow, Denver, CO 


4:00 Changing Gene Expression with Medications 

Peter Buttrick, Denver, CO 

4:15 Changing Gene Expression with LVAD Support 

Kenneth B. Margulies, Philadelphia, PA 


4:35 The Dynamic Right Ventricle 

Michael R. Bristow, Denver, CO 


4:55 What Happens to Ventricular Function with Heart 

Failure Self Care 

Christopher S. Lee, Portland, OR 

5:10 Hemodynamic Remodeling During Home Monitoring 



Tuesday 

Learning Objective: Identify and assess current performance 

measures in heart failure and implement strategies for 

adherence. 

Learning Objective: Describe ways in which therapy can 

influence the genetic and physiological basis of heart failure 

and improve patient care. 









112 113

Sept. 11 

Tuesday 

PM 

Tuesday 

SYMPOSIUM 


4:00-5:30 PM 

Ballroom 6A 

Drugs Don’t Work in Patients Who Don’t Take 

Them: Why Aren’t Patients Adherent? 

Moderators: Prakash C. Deedwania, Fresno, CA 

Mona Fiuzat, Durham, NC 

4:00 How Can Medication Adherence be Measured? 

Patricia A. Uber, Baltimore, MD 

4:18 Dosing Regimens 

Michael D. Murray, Indianapolis, IN 

4:36 Predicting Nonadherence 


4:54 Consequences of Poor Adherence 

Paul J. Hauptman, St. Louis, MO 

5:12 What Can We Do to Improve Adherence? 

Debra K. Moser, Lexington, KY 

Learning Objective: Measure patient adherence, identify 

variables contributing to non-adherence, and implement 

measures to improve adherence. 

Posters 


016 Activation of Pulmonary Arterial Endothelium in Heart 

Failure with Preserved Ejection Fraction Induced 

Pulmonary Hypertension Similar to Pulmonary Arterial 

Hypertension 

Jason N. Salamon 1 , Jeremy Mazurek 1 , Ronald Zolty 2 ; 1 Jacobi 

Medical Center/Albert Einstein College of Medicine, Bronx, 

NY; 2 Cardiology, Montefiore Medical Center, Albert Einstein 

College of Medicine, Bronx, NY 

018 Tetrahydrobiopterin Improves Diastolic Heart Failure by 

Increasing Myofilament Calcium Sensitivity 

Euy-Myoung Jeong 1 , Michelle M. Monasky 2 , Lianzhi Gu 1 , 

Domenico M. Taglieri 2 , Bindiya G. Patel 2 , Qiongying Wang 1 , 

Harvey Lardin 1 , Ian Greener 1 , R. John Solaro 2 , Samuel C. 

Dudley, Jr 1 ; 1 Section of Cardiology, College of Medicine, 

University of Illinois at Chicago, IL; 2 Department of Physiology 

and Biophysics and Center for Cardiovascular Research, 

University of Illinois at Chicago, IL 

024 Stimulation of β2 Adrenergic Receptors Clears Lung 

Fluid in Patients with Heart Failure 

Bryan J. Taylor 1 , Maile L. Ceridon 1 , Eric M. Snyder 2 , Bruce D. 

Johnson 1 ; 1 Cardiovascular Diseases, Mayo Clinic, Rochester, 

MN; 2 Pharmacy Practice and Science, University of Arizona, 

Tucson, AZ 

026 Therapy with a DPP-4 Inhibitor Increases Myocardial 

Glucose Uptake in Nonischemic Cardiomyopathy 

Ronald M. Witteles 1 , Khun V. Keu 1 , Andrew Quon 1 , Homa 

Tavana 1 , Michael B. Fowler 1 ; 1 Stanford University School of 

Medicine, Stanford, CA 

Sept. 11 

Tuesday 

Posters 

tuesday 

040 Pattern of Delayed Hyperenhancement and Diastolic 

Dysfuction of Cardiac Amyloidosis 

Ga Yeon Lee 1 , Jin-Oh Choi 1 , Kihyun Kim 2 , Seok-Jin Kim 2 , Hye 

Ryoun Jang 3 , Hee-Jin Kim 4 , Soo-Youn Lee 4 , Byoung-Joon Kim 5 , 

Ju-Hong Min 5 , Eun-Seok Jeon 1 ; 1 Cardiology, Samsung Medical 

Center, Seoul, Korea; 2 Hemato-oncology, Samsung Medical 

Center, Seoul, Korea; 3 Nephrology, Samsung Medical Center, 

Seoul, Korea; 4 Laboratory Medicine, Samsung Medical Center, 

Seoul, Korea; 5 Neurology, Samsung Medical Center, Seoul, 

Korea 





114 

040 Predictors at Admission and Impact of Worsening Renal 

Function in Acute Decompensate Heart Failure Patients 

Who Underwent Ultrafiltration Therapy 

Niyada Naksuk 1 , Prangthip Charoenpong 1 , Monica Colvin- 

Adams 2 , Michael Petty 2 , Marc Priztker 2 , S. Carolina 

Masri 2 ; 1 Department of Medicine, University of Minnesota, 

Minneapolis, MN; 2 Cardiology Division, University of 

Minnesota, Minneapolis, MN 

115

Sept. 11 

Tuesday 

Posters 

Posters 


Posters 


Sept. 11 

Tuesday 

Posters 

tuesday 

041 Non-Invasive Hemodynamic Measurements for Acute 

Decompensated Heart Failure 

Marcelo E. Ochiai 1 , Marcelo V. Lima 1 , Euler O. Brancalhao 1 , 

Raphael S. Puig 1 , Kelly N. Viera 1 , Juliano N. Cardoso 1 , 

Antonio P. Barretto 1 ; 1 Cotoxo Hospital, Heart Institute(INCOR), 

University of Sao Paulo, SP, Brazil 

042 Increased Muscarinic Receptors Impair Beta Adrenergic 

Response in Failing Human Heart 

Wendy E. Sweet 1 , Matthew T. Baumann 1 , Jessica A. French 1 , 

Christine S. Moravec 1 ; 1 Kaufman Center for Heart Failure, 

Cleveland Clinic, Cleveland, OH 

043 Phrenic Nerve Stimulation Improves Circulatory Delay 

in Patients with Heart Failure and Central Sleep Apnea 

William T. Abraham 1 , Olaf Oldenburg 2 , Piotr Ponikowski 3 , 

Alan Schwartz 4 , Bradley Bart 5 , Danuta Czarnecka 6 , Dariusz 

Michalkiewicz 7 , Ayesha Hasan 1 , David Bourn 8 ; 1 The Ohio 

State University, Columbus, OH; 2 Ruhr-University of 

Bochum, Bad Oeynhausen, Germany; 34 th Militry Hospital, 

Medical University, Wroclaw, Poland; 4 Johns Hopkins 

University, Bayview, MD; 5 Hennepin County Medical Center, 

Minneapolis, MN; 6 Jagiellonian University Medical College, 

Krackow, Poland; 7 Military Medical Institute, Warsaw, Poland; 

8 

Respicardia, Inc, Minnetonka, MN 

044 Myocardial Dysfunction Affects Males and Females 

Equally in Diabetic Rodent Model 

Syed Ameenuddin 1 , Elise A. Oehler 1 , Sarah Mangiafico 1 , Horng 

H. Chen 1 ; 1 Cardiorenal Research Laboratory, Mayo Clinic, 

Rochester, MN 

045 Changes in Transmural Filling Pressure with Exercise 

in Patients with Diastolic Dysfunction and Preserved 

Systolic Function after Myocardial Infarction 

Mads J. Andersen 1 , Mads Ersboll 1 , John Bro-Jeppesen 1 , 

Finn Gustaffson 1 , Christian Hassager 1 , Lars Kober 1 , Barry 

A. Borlaug 2 , Soren Boesgaard 1 , Jesper Kjargaard 1 , Jacob E. 

Moller 1 ; 1 Department of Cardiology, Copenhagen University 

Hospital, Rigshospitalet, Copenhagen, Denmark; 2 Division of 

Cardiovascular Diseases, Mayo Clinic, Rochester, MN 

046 Laboratory Markers of Congestive Hepatopathy Identify 

Patients Likely To Experience Improvement in Renal 

Function with Treatment of Decompensated Heart 


Meredith A. Brisco 1 , Esther Vorovich 1 , Steve Coca 2 , Stephen 





047 Aerobic Physical Training Ameliorates Myocardial 

Perfusion Defects but Do Not Improve inotropic Reserve 

in Patients with Coronary Microvascular Dysfunction 

Eduardo E.V. Carvalho 1 , Luciano F.L. Oliveira 1 , Julio C. 

Crescencio 1 , Moyses O. Lima-Filho 1 , Lourenco Gallo-Junior 1 , 

Jose A. Marin-Neto 1 , Marcus V. Simoes 1 ; 1 Internal Medicine 

Department, Medical School of Ribeirao Preto - University of 

Sao Paulo, Ribeirão Preto, SP, Brazil 

048 Hemodynamic Significance of a Follow-Up TAPSE 

Value of 2.0 cm or Greater at One Year on PH Specific 

Therapy in Patients with PAH 

Anjali V. Fields 1 , Justin D. Roberts 2 , Paul R. Forfia 1 ; 1 Medicine/ 

Cardiovascular Division, University of Pennsylvania, 

Philadelphia, PA; 2 Medicine/Cardiovascular Division, Lehigh 

Valley Medical Center, Allentown, PA 

049 Echocardiographic Characteristics of Left Ventricular 

Diastolic Dysfunction Are Different among Different 

Etiologies 

Sharma Kattel 1 , Keiko Saito 1 , Yuji Saito 1 ; 1 Department of 

Medicine, University at Buffalo, NY 

050 Progressive Bi-Ventricular Dysfunction in a Large 

Animal Model of Heart Failure with Rapid Ventricular 

Pacing: Echocardiographic Parameters and Invasive 

Characterization 

Sarah Mangiafico 1 , Diego Bellavia 1 , Lisa C. Costello- 

Boerrigter 1 , Guido Boerrigter 1 , Gail Harty 1 , Elise Oehler 1 , 

Alessandro Cataliotti 1 , Corrado Tamburino 2 , John C. Burnett, 

Jr 1 ; 1 Cardiorenal Research Laboratory, Mayo Clinic, Rochester, 

MN; 2 University of Catania, Italy 

051 Association between Coronary Heart Disease and 

Inflammatory Biomarker YKL-40 in Type 2 Diabetes 

Subjects 

Hyun Min Kim 1 , Chang Hee Jung 2 , Bong Soo Cha 1 , Hyun 

Chul Lee 1 , Byung-Wan Lee 1 ; 1 Department of Internal Medicine, 

Yonsei University College of Medicine, Seoul, Republic of 

Korea; 2 Department of Internal Medicine, Asan Medical Center, 

University of Ulsan College of Medicine, Seoul, Republic of 

Korea 

052 Modifiable Predictors of a Peak Oxygen Consumption 

Sept. 11 

Tuesday 

Posters 

Posters 


Posters 


Sept. 11 

Tuesday 

Posters 

tuesday 

053 Increased Oxidized Apolipoprotein A1 Levels in the 

Failing Human Heart 

Zhili Shao 1 , Ying Huang 1 , Christine S. Moravec 1 , Stanley L. 

Hazen 1 , W.H. Wilson Tang 1 ; 1 Cleveland Clinic, Cleveland, OH 

054 Circulating Levels of 4-1BB and 4-1BB Ligand Are Not 

Elevated in Human Heart Failure 

Haiyan Tan 1 , Andres Schuster 2 , W.H. Wilson Tang 3 ; 1 Structural 

Biology, St. Jude Children’s Research Hospital, Memphis, TN; 

2 

Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH 

055 Pulmonary Hypertension Is a Manifestation of 

Congestive Heart Failure in Octogenarians with Severe 

Aortic Stenosis 

Amresh Raina 1 , Zachary M. Gertz 2 , William T. O’Donnell 2 , 

Kerri A. Smith 2 , Howard C. Herrmann 2 , Paul R. 

Forfia 2 ; 1 Cardiovascular Institute, Allegheny General Hospital, 

Pittsburgh, PA; 2 Cardiovascular Division, Hospital of the 

University of Pennsylvania, Philadelphia, PA 

056 Right Ventricular Systolic Pressure Is Associated with 

Renal Insufficiency and Predicts Long-Term Clinical 

Outcomes Independent of Right Atrial Pressure and Left 

Sided Cardiac Indices 

Kevin Shrestha 1 , Matthias Dupont 1 , Allen G. Borowski 1 , Richard 




057 Device-Based Sensors in the MultiSENSE Study: A 

Preliminary View 

John Boehmer 1 , Viktoria Averina 2 , Pramodsingh Thakur 2 , Yi 

Zhang 2 , Robert Sweeney 2 , Julie Thompson 2 ; 1 Penn State Hershey 

Medical Center, Hershey, PA; 2 Boston Scientific CRV, Saint 

Paul, MN 

058 Preclinical Systolic and Diastolic Dysfunction 

Are Characterized by Differences in Radial and 

Circumferential Strain 

David R. Fermin 1 , Hector R. Villarraga 1 , Paul M. McKie 1 , John 

A. Schirger 1 , Horng H. Chen 1 ; 1 Cardiovascular Diseases, Mayo 


059 Biofeedback Training in Patients with Advanced Heart 


Dana L. Schneeberger 1 , Alison K. Reynard 2 , Gregory J. Bolwell 1 , 

Elizabeth F. Grossman 1 , Jerome Kiffer 2 , W.H. Wilson Tang 1 , 

James B. Young 1 , Randall C. Starling 1 , Michael G. McKee 1 , 

Christine S. Moravec 1 ; 1 Cardiovascular Medicine, Cleveland 

Clinic, Cleveland, OH; 2 Psychiatry and Psychology, Cleveland 

Clinic, Cleveland, OH 

118 

060 Red Cell Distribution Width as a Marker of Ventilatory 

Inefficiency in Patients with Chronic Heart Failure 

Jong-Chan Youn 1 , Jaewon Oh 1 , Namki Hong 1 , Sung-Jin 

Hong 1 , Seok-Min Kang 1 ; 1 Cardiology Division, Severance 

Cardiovascular Hospital, Yonse University College of Medicine, 

Seoul, Republic of Korea 

061 Protection of Cardiac Function by Immune Cells: A 

Role for Mast Cells in Both Normal Function and Post- 

Ischemic Repair 

Mozow Y. Zuidema 1 , Kevin C. Dellsperger 1 , Michael A. 

Hill 1 ; 1 Internal Medicine - Cardiovascular Disease, Dalton CV 

Research Center, Medical Pharmacology and Physiology, 

University of Missouri School of Medicine, Columbia, MO 


069 16 Weeks of Diabetogenic Diet Are Sufficient To Induce 

Cardiac Hypertrophy and Fibrosis in a Murine Model of 

Diet-Induced Insulin Resistance and Cardiomyopathy 

Antonio Sta Teresa 1 , Jinkyu Kim 1 , Tomasz Wietecha 1 , 2 , Kelly 

Hudkins 2 , Charles E. Alpers 2 , Kevin D. O’Brien 1 ; 1 Medicine 

(Cardiology), University of Washington, Seattle, WA; 

2 

Pathology, University of Washington, Seattle, WA 

070 Decreased Proximal Aortic Diameter Is Associated with 

Higher Central Pulse Pressure and Poor Prognosis of 

Patients with Congestive Heart Failure 

Daisuke Kamimura 1 , Kazuaki Uchino 1 , Hideyuki Ogawa 1 , 

Makoto Shimizu 2 , Tomohiko Shigemasa 3 , Yukiko Morita 4 , 

Tetsuji Kaneko 5 , Kazuo Kimura 6 , Satoshi Umemura 1 ; 1 Medical 

Science and Cardiorenal Medicine, Yokohama City University 

Graduate School of Medicine, Yokohama, Japan; 2 Cardiology, 

International Goodwill Hospital, Yokohama, Japan; 3 Cardiology, 

International Goodwill Hospital, Atami, Japan; 4 Cardiology, 

National Sagamihara National Hospital, Sagamihara, Japan; 

5 

Biostatistics and Epidemiology, Yokohama City University 

Graduate School of Medicine Advanced Medical Research 

Center, Yokohama, Japan; 6 Cardiology, Yokohama City 

University Medical Center, Yokohama, Japan 

071 The Role of Erythropoietin upon Myocardial Fibrosis 

Fernanda G. Pessoa 1 , Felix J.A. Ramires 1 , Adriana M.O. Fonoff 1 , 

Keila C.B. Fonseca 1 , Vera M.C. Salemi 1 , Fabio Fernandes 1 , 

Charles Mady 1 ; 1 Cardiomyopathy Unit, Heart Institute, Sao 

Paulo, SP, Brazil 

072 Prevalence of Ventricular Systolic Dysfunction in Adults 

with Congenital Heart Disease 

Nandita C. Gupta 1 , Craig S. Broberg 1 ; 1 Division of 

Cardiovascular Medicine, Oregon Health and Science 

University, Portland, OR 

119 

tuesday

Sept. 11 

Tuesday 

Posters 

Posters 


Posters 


Sept. 11 

Tuesday 

Posters 

tuesday 

073 Correlation between Aortic Root Dilatation and Diastolic 

Dysfunction 

Wissam Khalife 1 , Mohamed Morsy 1 , Poorna Nalabothu 1 , 

Sangeeta Mutnuri 1 , Syed Hussein 1 , Adnan Khan 1 ; 1 Cardiology, 

University of Texas Medical Branch, Galveston, TX 

074 Lack of Effect of Simvastatin on Structural Remodeling 

in Animal Model of Chagas Cardiomyopathy 

Barbara M. Ianni 1 , Felix J.A. Ramires 1 , Vera M.C. Salemi 1 , 

Fabio Fernandes 1 , Adriana M. Oliveira 1 , Fernanda G. Pessoa 1 , 

Keila C.B. Fonseca 1 , Edmundo Arteaga 1 , Luciano Nastari 1 , 

Charles Mady 1 ; 1 Heart Institute (InCor), University of Sao Paulo 

Medical School, Sao Paulo, SP, Brazil 

075 Role of Left Atrial Size in Distinguishing Diastolic 

Heart Failure-Induced Pulmonary Hypertension from 

Pulmonary Arterial Hypertension 

Jason N. Salamon 1 , Jeremy A. Mazurek 1 , Farbod Raiszadeh 2 , 

Iosif Kelesidis 2 , Ronald Zolty 2 ; 1 Department of Medicine, Jacobi 

Medical Center, Bronx, NY; 2 Division of Cardiology, Montefiore 

Medical Center, Bronx, NY 

Neurohormones/Ctyokines 

082 Urokinase Induces Pro-Fibrotic/M2 Phenotype in 

Cardiac Macrophages 

Laura Malchodi 1 , Deri Helterline 1 , Jessica Meznarich 2 , April 

Stempien-Otero 1 ; 1 Medicine Division of Cardiology, University 

of Washington, Seattle, WA; 2 Pediatrics, University of Utah, Salt 

Lake City, UT 

086 Integrating Plasma Myeloperoxidase and Global 

Arginine Bioavailability Ratio for Risk Prediction in 

Chronic Systolic Heart Failure 

Kevin Shrestha 1 , Zenang Wang 1 , Allen G. Borowski 1 , Richard 

W. Troughton 2 , Allan L. Klein 1 , Stanley L. Hazen 1 , W.H. Wilson 

Tang 1 ; 1 Cleveland Clinic, Cleveland, OH; 2 Christchurch School 

of Medicine and Health Sciences, Christchurch, New Zealand 

087 Depressive Symptoms in Heart Failure: What Is the 

Relationship with Inflammation and Fibrosis? 

Stephen J. Synowski 1 , 2 , Willem J. Kop 3 , Jennifer M. Marshall 1 , 

Scott D. Jerome 1 , Stephen S. Gottlieb 1 ; 1 Medicine, University 

of Maryland, Baltimore, MD; 2 Psychology, Tilburg University, 

Tilburg, Netherlands 

120 

088 Admission Values of Urinary Neutrophil Gelatinase- 

Associated Lipocalin, Kidney Injury Molecule-1 

and Interleukin-18 Do Not Predict Worsening Renal 

Function 

Matthias Dupont 1 , Kevin Shrestha 1 , Dssraj Singh 1 , Michael 

Finucan 1 , W.H. Wilson Tang 1 ; 1 Heart Failure, Heart and Vascular 

Institute, Cleveland Clinic Foundation, Cleveland, OH 

089 Stable Plasma Myeloperoxidase Levels during Treatment 

of Acute Decompensated Heart Failure Despite 

Decongestion and a Decrease in B-Type Natriuretic 

Peptide 

Matthias Dupont 1 , Kevin Shrestha 1 , Dhssraj Singh 1 , Michael 

Finucan 1 , Adiveh Awad 2 , Cynthia Kovach 2 , Mario Scarcipino 2 , 

Stanley L. Hazen 1 , Anjli P. Maroo 2 , W.H. Wilson Tang 1 ; 1 Heart 

Failure, Heart and Vascular Institute, Cleveland Clinic 

Foundation, Cleveland, OH; 2 Department of Cardiology, 

Fairview Hospital, Cleveland, OH 

090 Anti-Cyclic Citrullinated Peptide Antibodies Are 

Not Elevated in a Heart Failure Population without 

Rheumatoid Arthritis 

Naveed S. Iqbal 1 , Yuping Wu 2 , Stanley Hazen 1 , 3 , W.H. Wilson 

Tang 1 , 3 ; 1 Cardiovascular Medicine, Cleveland Clinic, Cleveland, 

OH; 2 Department of Mathematics, Cleveland State University, 

Cleveland, OH; 3 Department of Cell Biology, Lerner Research 

Institute, Cleveland, OH 

091 Endothelin-1 Levels in COPD-Induced Pulmonary 

Hypertension 

Jeremy A. Mazurek 1 , Thiago Jabuonski 1 , Ronald 

Zolty 2 ; 1 Department of Medicine, Jacobi Medical Center, 

Bronx, NY; 2 Department of Medicine, Division of Cardiology, 

Montefiore Medical Center, Bronx, NY 

092 Adiponectin Is Associated with Reduced Muscular 

Strength in Elderly Heart Failure Patients 

Alexandra Zavin 1 , Karla Daniels 2 , Ross Arena 3 , Stewart Lecker 4 , 

Kelly Allsup 1 , Jacob Joseph 2 , 5 , Antonio Lazzari 1 , 6 , Samuel 

Davis 1 , P. Christian Schulze 7 , Daniel E. Forman 1 , 2 , 5 ; 1 VA Boston 

Healthcare System, Boston, MA; 2 Division of Cardiovascular 

Medicine, Brigham and Women’s Hospital, Harvard Medical 

School, Boston, MA; 3 Department of Orthopaedics and 

Rehabilitation – Physical Therapy Program and Department of 

Internal Medicine – Division of Cardiology, University of New 

Mexico School of Medicine, Albuquerque, NM; 4 Division of 

Nephrology, Beth Israel Deaconess Medical Center, Harvard 

Medical School, Boston, MA; 5 Division of Cardiovascular 

Medicine, VA Boston Healthcare System, Boston, MA; 6 Boston 

University School of Medicine, Boston, MA; 7 Division of 

Cardiology, Columbia University Medical Center, New York 

City, NY 

121 

tuesday

Sept. 11 

Tuesday 

Posters 

Posters 

Neurohormones/Ctyokines 

Posters 


Sept. 11 

Tuesday 

Posters 

tuesday 

093 Initiation and Up-Titration of Beta Blockers Guided by 

B-Natriuretic Peptide in Patients with Systolic Heart 


Min-Seok Kim 1 , Jae-Joong Kim 1 ; 1 Dept. of Cardiology, Asan 

Medical Center Heart Institute, Seoul, Republic of Korea 

094 Cardiomyopathy in Mitral Valve Prolapse 

Eduard Malev 1 , Eduard Zemtsovsky 1 , Asiyet Pshepiy 1 , Lyubov 

Vasina 1 ; 1 Almazov Federal Heart, Blood and Endocrinology 

Centre, Saint-Petersburg, Russian Federation 

095 Dysregulated Arginine Methylation Is Associated with 

Deregulated Proangiogenic Progenitor Activity and 

Reduced Adaptive Vascular Response in Patients with 

Advanced Left Sided Heart Failure 

Yenal Harper 1 , Jia Xu 2 , Kewal Asosingh 2 , Serpil C. Erzurum 3 , 

W.H. Wilson Tang 1 ; 1 Heart Failure, Heart and Vascular Institute, 

Cleveland Clinic Foundation, Cleveland, OH; 2 Pathobiology, 

Cleveland Clinic Foundation, Cleveland, OH; 3 Lerner Research 

Institute, Respiratory Institute and Pathobiology, Cleveland 

Clinic Foundation, Cleveland, OH 


104 Right Ventricular Proteome in End-Stage Heart Failure 

Yan Ru Su 1 , David Friedman 1 , Chee Lim 1 , Thomas G. Di 

Salvo 1 ; 1 Division of Cardiovascular Medicine, Vanderbilt, 

Nashville, TN 

105 Angiotensin Converting Enzyme Inhibition Prevents 

Diet-Induced Obesity and Cardiac Hypertrophy in Mice 

Lihong Cheng 1 , Zhe Jiao 1 , Atsuko Tanaka 1 , Qianhong 

Qin 1 , Torahiro Matsuda 1 , Alexandru Barbulescu 1 , Dan 

Sorescu 1 ; 1 Division of Cardiology, Emory University School of 

Medicine, Atlanta, GA 

106 Monocyte-Lineage Cells Contribute to Collagen 

Accumulation in Fibrotic Mouse and Human Hearts 

Deri Helterline 1 , Creighton Don 1 , Laura Asbe 1 , April Stempien- 

Otero 1 ; 1 Medicine Division of Cardiology, University of 

Washington, Seattle, WA 

107 Myocardial Gene Expression Associated with Right- and 

Left-Ventricular Remodeling with Beta-Blockade in 

Idiopathic Dilated Cardiomyopathy 

David P. Kao 1 , Ronald Zolty 2 , Edward M. Gilbert 3 , Brian 

D. Lowes 4 , Michael R. Bristow 1 ; 1 Cardiology, University of 

Colorado, Aurora, CO; 2 Cardiology, Albert Einstein College 

of Medicine, Bronx, NY; 3 Cardiology, University of Utah, Salt 

Lake City, UT; 4 Cardiology, University of Nebraska, Omaha, NE 

108 Wasting Processes in the Myocardium of Patients 

with End-Stage Dilative Cardiomyopathy Include 

Up-Regulation of Myostatin 

Anna Baumgarten 1 , Volker Adams 2 , Reinhold Pregla 3 , Roland 

Hetzer 3 , Stefan D. Anker 1 , Jochen Springer 1 , 4 ; 1 Applied Cachexia 

Research, Department of Cardiology, Charite Medical School, 

Berlin, Germany; 2 Department of Cardiology, University 

Leipzig, Heart Center Leipzig, Germany; 3 German Heart Center 

Berlin, Germany; 4 Norwich Medical School, University of East 

Anglia, Norwich, United Kingdom 

109 Transcardiac Gradient of miR-423-5p: Evidence of 

Altered Myocardial Expression in Patients with Heart 


Livia Goldraich 1 , 2 , Nidiane Martinelli 1 , 2 , Carolina 

Cohen 1 , 2 , Ursula Matte 1 , Mauricio Pimentel 1 , 2 , Michael 

Andrades 1 , 2 , Andreia Biolo 1 , 2 , Nadine Clausell 1 , 2 , Luis E. 

Rohde 1 , 2 ; 1 Cardiovascular Experimental and Molecular 

Laboratory, Heart Failure and Cardiac Transplant Program, 

Hospital de Clinicas de Porto Alegre, Brazil; 2 Cardiovascular 

Sciences Graduate Program, Federal University of Rio Grande 

do Sul, Porto Alegre, Brazil 

110 Efficacy of Genetic Profile Testing Using Allomap® in 

Combined Heart-Kidney Transplant Recipients 

Robert L. Scott 1 , Diane L. Kasper 1 , Francisco A. Arabia 1 , 

Radha S. Gopalan 1 , Carol S. Bachtel 1 , Dawn E. Jaroszewski 1 , 

Stacie M. Attig 1 , Louis A. Lanza 1 , Patrick A. DeValeria 1 , Eric 

Steidley 1 ; 1 Cardiac Transplant, Mayo Clinic Arizona, Phoenix, 

AZ 

111 No Evidence of Th17-Specific Cellular Autoimmune 

Responses Following Cardiac Troponin Exposure in 

Patients with Ischemic Cardiomyopathy and Acute 

Coronary Syndrome 

Andres Schuster 1 , Haiyan Tan 1 , Anne C. Cotleur 1 , W.H. Wilson 

Tang 1 ; 1 Cleveland Clinic Foundation, Cleveland, OH 

VADs/Transplant/Surgery 

134 CircuLite® Synergy® System Experience in Circulatory 

Support for Elderly Chronic Heart Failure Patients 

Alessandro Barbone 1 , Filip Rega 2 , Diego Ornaghi 1 , Ettore Vitlai 2 , 

Bart Meyns 1 , Daniel Burkhoff 3 ; 1 Istitutio Clinico Humanitas, 

Rozzano, Italy; 2 University Hospital Leuven, Belgium; 

3 

Columbia University, New York, NY 

tuesday 

122 

123

Sept. 11 

Tuesday 

Posters 

Posters 


Posters 


Sept. 11 

Tuesday 

Posters 

tuesday 

135 Mitral Valve Pathology in Severe Impaired Left 

Ventricles Can Be Successfully Managed Using the Right 

Side Minimally Invasive Surgical Approach 

Jens Garbade 1 , Joerg Seeburger 1 , Bettina Pfannmueller 1 , Sven 

Lehmann 1 , Markus J. Barten 1 , Michael A. Borger 1 , Friedrich- 

Wilhelm Mohr 1 ; 1 Cardiac Surgery, Heart Center, University of 

Leipzig, Germany 

136 Can the Seattle Heart Failure Score (SHFS) Be Used 

To Select Non-Inotrope Dependent Severe Heart 

Failure Patients with Appropriate Risk for Mechanical 

Circulatory Support? 

Bart Meyns 1 , Filip Rega 1 , Alessandro Barbone 2 , Ettore Vitali 2 , 

Deborah Morley 3 , Daniel Burkhoff 4 ; 1 University Hospital 

Leuven, Belgium; 2 Istitutio Clinico Humanitas, Rozzano, Italy; 

3 

CircuLite, Saddle Brook, NJ; 4 Columbia University, New York, 

NY 

137 The Choice for Patients “without a Choice”: Interviews 

with Patients Who Received a Left Ventricular Assist 

Device as Destination Therapy 

Keith M. Swetz 1 , 2 , Abigale L. Ottenberg 2 , Katlyn E. Cook 1 , 2 , 

Luke A. Mueller 1 , Nou Chang 1 , Paul S. Mueller 1 , 2 ; 1 Division 

of General Internal Medicine, Mayo Clinic, Rochester, 

MN; 2 Program in Professionalism and Ethics, Mayo Clinic, 

Rochester, MN 

138 Hospital to Home: LVAD Patient Management 

Lindsey J. Carroll 1 , Julie H. Webster 1 , Shelina Merali 1 ; 1 Advanced 

Heart Failure Center, Piedmont Heart Institute, Atlanta, GA 

139 Successful Use of Ultrafiltration for Decompensated 

Heart Failure in LVAD Patients 

Sitaramesh Emani 1 , Darla Talbott 2 , Donald Kikta 3 , Yazhini Ravi 2 , 

Robert Higgins 2 , Pallavi Solanki 1 , Garrie Haas 1 , Chittoor Sai- 

Sudhakar 2 ; 1 Internal Medicine, The Ohio State University Wexner 

Medical Center, Columbus, OH; 2 Surgery, The Ohio State 

University Wexner Medical Center, Columbus, OH; 3 Internal 

Medicine, University Hospitals, Cleveland, OH 

140 New Safety Concerns with Higher Dose Statin Therapy 

in Heart Transplantation: Time To Panic? 

Stacey D. Frampton 1 , Rami A. Alharethi 1 , Kimberly D. 

Brunisholz 1 , Benjamin D. Horne 1 , Kyle D. Balling 1 , Deborah 

Budge 1 , Bruce B. Reid 1 , Jen L. Nixon 1 , Josef Stehlik 1 , Joe 

Tuinei 1 , Kismet D. Rasmusson 1 , Melanie Everitt 1 , William 

Caine 1 , Abdallah G. Kfoury 1 ; 1 UTAH Cardiac Transplant 

Program, Salt Lake City, UT 

124 

141 Impact of Left Ventricular Assist Device Implantation on 

Renal Function in Patients with Advanced Heart Failure 

Ankit Gupta 1 , Ashim Aggarwal 1 , Antone Tatooles 1 , Pat Pappas 1 , 

Geetha Bhat 1 ; 1 Advocate Christ Medical Center, Chicago, IL 

142 Outcomes of LVAD Insertion in Ischemic vs Non- 

Ischemic Cardiomyopathy Patients 

Sanjay Kumar 1 , Charisse Ward 1 , Sharven Taghavi 2 , Lynn 

Wilson 1 , Abeel A. Mangi 1 ; 1 Section of Cardiac Surgery, Yale 

University School of Medicine, New Haven, CT; 2 Division of 

Cardiothoracic Surgery, Temple University School of Medicine, 


143 Long Term Outcome of Arteriovenous Malformation 

Bleeding in Patients with HeartMateII Left Ventricular 

Assist Device 

Niyada Naksuk 1 , Andrew Rosenbaum 1 , Prangthip Charoenpong 1 , 

Ranjit John 2 , Peter M. Eckman 1 ; 1 Cardiology Division, University 

of Minnesota, Minneapolis, MN; 2 Division of Cardiothoracic 

Surgery, University of Minnesota, Minneapolis, MN 

144 Resource Utilization in HeartMate II Left Ventricular 

Assist Device Patients with Gastrointestinal Bleeding 

Niyada Naksuk 1 , Eva Tone 1 , Prangthip Charoenpong 1 , Brian S. 

Milavitz 1 , Ranjit John 1 , Peter M. Eckman 1 ; 1 Cardiology Division, 

University of Minnesota, Minneapolis, MN 

145 An Aggressive, Targeted Perioperative Management 

Strategy Results in Low Rates of Postoperative Right 

Ventricular Failure after Left Ventricular Assist Device 

Implantation 

Amresh Raina 1 , Manreet Kanwar 1 , George Sokos 1 , Robert 

Moraca 1 , Stephen Bailey 1 , Raymond L. Benza 1 , Srinivas 

Murali 1 ; 1 Cardiovascular Institute, Allegheny General Hospital, 


146 Increased Right Ventricle/Left Ventricle Diameter Ratio 

Is Associated with Lack of Right Ventricular Contractile 

Reserve in Patients with Continuous-Flow Left 

Ventricular Assist Devices 

Rey P. Vivo 1 , 2 , Andrea M. Cordero-Reyes 1 , Matthias Loebe 1 , 

Brian A. Bruckner 1 , Guillermo Torre-Amione 1 , Arvind 

Bhimaraj 1 , Jerry D. Estep 1 ; 1 Cardiology, Methodist DeBakey 

Heart Vascular Center, Houston, TX; 2 Cardiology, University 

of Texas Medical Branch, Galveston, TX 

147 Muscular Strength Is Associated with Functional 

Capacity and Quality of Life in Patients with Recently 

Implanted Continuous-Flow LVADs 

Celeste T. Williams 1 , Dennis J. Kerrigan 1 , Jonathan K. Ehrman 1 , 

Kyle Bronsteen 1 , Matthew A. Saval 1 , John R. Schairer 1 , Cheryl 

Smith 1 , Steven J. Keteyian 1 ; 1 Division of Cardiovascular 

Medicine, Henry Ford Hospital, Detroit, MI 

125 

tuesday

Sept. 11 

Tuesday 

Posters 

Posters 


Posters 


Sept. 11 

Tuesday 

Posters 

tuesday 

148 Which Is Better, Percutaneous Miniaturized Ventricular 

Assist Devices or Extracorporeal Membrane Oxygenator 

(ECMO) for Patients with Cardiogenic Shock? 

Themistokles Chamogeorgakis 1 , Alexis Shafii 1 , Aldo Rafael 1 , 

Brian Lima 1 , Julie A. Pokersnik 1 , Dave Nagpal 1 , Maria Mountis 2 , 

Gonzalo V. Gonzalez-Stawinski 1 ; 1 Thoracic and Cardiovascular 

Surgery, Cleveland Clinic Foundation, Cleveland, OH; 

2 

Kauffman Heart failure Center, Cleveland Clinic Foundation, 

Cleveland, OH 

149 Clinical Markers Associated with Sustained 

Improvement in Renal Function after 1-Year of 

Continuous Flow Left Ventricular Assist Device 

(CF-LVAD) Support 

Nadia Fida 1 , Omar Saeed 1 , Danielle Casazza 1 , Daniel J. 

Goldstein 2 , Ronald Zolty 1 ; 1 Department of Medicine, Division of 

Cardiology, Montefiore Medical Center, Albert Einstein College 

of Medicine, Bronx, NY; 2 Department of Cardiothoracic and 

Vascular Surgery, Montefiore Medical Center, Albert Einstein 

College of Medicine, Bronx, NY 

150 Reducing Length of Stay in the Heartmate II Era 

Shelley Hall 1 , Brian Hardaway 1 , Dan Meyer 2 , Brian Bethea 2 , 

Johannes Kuiper 1 ; 1 Cardiac Transplant and Mechanical Assist 

Device Program, Baylor University Medical Center, Dallas, TX; 

2 

Cardiovascular Surgery, UT Southwestern, Dallas, TX 

151 Longitudinal Data Analysis Suggests Improved End- 

Organ Function in Continuous Versus Pulsatile-Flow 

Left Ventricular Assist Device (LVAD) Patients 

Sanjay Maniar 1 , Abhishek Sharma 1 , Eric Novak 1 , Susan 

Joseph 1 , Scott C. Silvestry 2 , Gregory A. Ewald 1 , Veli K. 

Topkara 1 ; 1 Cardiology, Washington University School of 

Medicine, Saint Louis, MO; 2 Cardiothoracic Surgery, 

Washington University School of Medicine, Saint Louis, MO 

152 “Bridging Strategies” Allow Successful Management of 

INTERMACS Profile 1 and 2 Patients 

Sharven Taghavi 1 , Matthew Jenkins 1 , Lynn Wilson 2 , Rachael 

Clark 3 , Lynne Benish 1 , Abeel Mangi 3 ; 1 Department of Surgery, 

Temple University Hospital, Philadelphia, PA; 2 Department of 

Cardiac Surgery, Yale-New Haven Hospital, New Haven, CT; 

3 

Temple University School of Medicine, Philadelphia, PA 

153 The Use of Impellas 5.0/LD in the Management of 

Heart Failure Patients with Cardiogenic Shock: A 

Multidisciplinary Team Approach 

Shelley Hall 1 , Johannes Kuiper 1 , Brad Grimsley 2 , Greg Pearl 2 , 

Greg Matter 3 , Baron Hamman 3 , Brian Hardaway 1 ; 1 Cardiac 

Transplantation and Mechanical Assist Device Program, Baylor 

University Medical Center, Dallas, TX; 2 Vascular Surgeryq, 

Baylor Heart and Vascular Hospital, Dallas, TX; 3 Cardiovascular 

Surgery, Baylor University Medical Center, Dallas, TX 

126 

154 Increasing LVAD Patient Distance from Implanting 

Center Does Not Negatively Impact Clinical Outcomes 

Shuja U. Rehman 1 , Hongbo Lin 1 , Changyu Shen 1 , Susan Straka 1 , 

Jeanette Pickrell 1 , M. Azam Hadi 1 , Irmina Gradus-Pizlo 1 , Adnan 

S. Malik 1 ; 1 Krannert Institute of Cardiology, Indiana University 

School of Medicine, Indianapolis, IN 


157 The Impact of Isolated Diastolic Dysfunction on Atrial 

Fibrillation Recurrence after Catheter Ablation 

Rosita Zakeri 1 , Jia H. Wu 1 , David O. Hodge 1 , Kristi H. 

Monahan 1 , Yong-Mei Cha 1 , Douglas L. Packer 1 , Margaret M. 

Redfield 1 ; 1 Division of Cardiovascular Diseases, Mayo Clinic, 

Rochester, MN 

168 B-Type Natriuretic Peptide Predicts the Outcome of 

Cardiac Resynchronization Therapy 

Kelly L. Brooke 1 , Tracy L. Webster 1 , Ying Hsiang Lee 1 , John 

Burnett 1 , Horng Chen 1 , David O. Hodge 1 , Heather J. Wiste 1 , 

Paul Friedman 1 , Yong-Mei Cha 1 ; 1 Cardiovascular Diseases, Mayo 


169 P-Wave and QRS-Complex Durations Can be Measured 

Automatically from Far-Field Implantable Cardioverter 

Defibrillator Electrograms 

Saul Greenhut 1 , Alex Sambelashvili 1 , Vadim Levin 2 , Robin 

Germany 3 ; 1 Medtronic, Inc., Mounds View, MN; 2 Lehigh Valley 

Hospital, Allentown, PA; 3 University of Oklahoma, Oklahoma 

City, OK 

170 Electrocardiographic (ECG) Manifestations of Diastolic 

Dysfunction 

Wissam Khalife 1 , Mohamed Morsy 1 , Poorna Nalabothu 1 , 

Adnan Khan 1 , Syed Hussain 1 , Sangeeta Mutnuri 1 ; 1 Cardiology, 

University of Texas Medical Branch, Galveston, TX 

171 Comparison of Cardiac Resynchronization Therapy 

Optimization Methods with Respect to Biventricular 

Pacing Percentage: Sub-Analysis of Adaptive CRT Trial 

Bernd Lemke 1 , David Birnie 2 , Kazutaka Aonuma 3 , Mahmoud 

Houmsse 4 , Alex Sambelashvili 5 ; 1 Luedenscheid Clinic, 

Luedenscheid, Germany; 2 University of Ottawa Heart Institute, 

Ottawa, ON, Canada; 3 Tsukuba University Hospital, Tsukuba, 

Japan; 4 Ohio State University, Columbus, OH; 5 Medtronic Inc., 

Mounds View, MN 

127 

tuesday

Sept. 11 

Tuesday 

Posters 

Posters 


Posters 


Sept. 11 

Tuesday 

Posters 

tuesday 

172 Optimal Atrio-Ventricular Delay in CRT Patients Can 

Be Approximated from Surface ECG P-Wave Duration 

Vadim Levin 1 , Mehdi Razavi 2 , Robert Call 3 , Alex Sambelashvili 3 , 

James Coles 3 ; 1 Lehigh Valley Hospital, Allentown, PA; 2 Texas 

Heart Institute/St. Luke’s Episcopal Hospital, Houston, TX; 

3 

Medtronic, Inc, Mounds View, MN 

173 The Effect of Acute Volume Changes on Heart Rate 

Variability 

Roja R. Mulamalla 1 , Gowd Pampana 1 , Sood Nitesh 1 , Jason 

Gluck 1 , Joseph Radojevic 1 , Christopher Clyne 1 , Wencker 

Detlef 1 ; 1 Cardiology, University of Connecticut-Hartford 

Hospital, Hartford, CT 

174 Incidence of Appropriate and Inappropriate Shocks in 

Implantable Cardioverter-Defibrillator Patients with 

Obstructive Sleep Apnea 

Niyada Naksuk 1 , Adabag Selcuk 2 ; 1 Department of Medicine 

Minneapolis, University of Minnesota Medical School, 

Minneapolis, MN; 2 Division of Cardiology, Veterans 

Administration Medical Center, Minneapolis, MN 

175 Cardiac Resynchronization Therapy Is Beneficial to 

Patients with Mild to Moderate Heart Failure 

Tracy L. Webster 1 , Kelly L. Brooke 1 , Yong Hsiang Lee 1 , Avishay 

Grupper 2 , Paul A. Friedman 1 , Brian D. Powell 1 , Micha Feinberg 2 , 

David Luria 2 , Yoni Buber 2 , David O. Hodge 1 , Heather J. Wiste 1 , 

Michael Glikson 2 , Yong-Mei Cha 1 ; 1 Cardiovascular Diseases, 

Mayo Clinic, Rochester, MN; 2 Department of Electrophysiology 

and Pacing, Heart Institute - Sheba Medical Center, Tal 

Hashomer, Israel 

176 The Effect of Atrial-Ventricular and Interventricular 

Delays on Gas Exchange during Excercise 

Chul-Ho Kim 1 , Yong-Mei Cha 1 , Lyle J. Olson 1 , Kathy A. 

O’Malley 1 , Dean MacCarter 1 , Bruce D. Johnson 1 ; 1 Cardiovascular 

Diseases, Mayo Clinic, Rochester, MN 

177 Are Unipolar Pacing Thresholds Lower Than Bipolar 

Pacing Thresholds in Multipolar Left Ventricular Leads? 

Imran Niazi 1 , Gery Tomassoni 2 , James Baker 3 , Raffaele 

Corbisiero 4 , Charles Love 5 , David Martin 6 , Robert Sheppard 7 , 

Seth Worley 8 , Nicole Harbert 9 ; 1 Aurora Cardiovascular Services, 

Aurora Sinai/Aurora St. Luke’s Medical Centers, University of 

Wisconsin School of Medicine and Public Health, Milwaukee, 

WI; 2 Lexington Cardiology Consultants, Lexington, KY; 

3 

St. Thomas Hospital, Nashville, TN; 4 Deborah Heart and 

Lung Center, Browns Mills, NJ; 5 The Ohio State University 

Medical Center, Columbus, OH; 6 Lahey Clinic Medical Center, 

Burlington, MA; 7 The Heart and Vascular Institute of Florida, 

St. Petersburg, FL; 8 Lancaster Heart Foundation, Lancaster, PA; 

9 

St. Jude Medical Center, Sylmar, CA 

178 Can Anodal Pacing Be Utilized To Reduce Energy 

Requirements during Cardiac Resynchronization 

Therapy? 

Imran Niazi 1 , Kyungmoo Ryu 2 , Rebecca Dahme 2 , Indrajit 

Choudhuri 1 , Arshad Jahangir 1 , Masood Akhtar 1 , Jasbir 

Sra 1 ; 1 Aurora Cardiovascular Services, Aurora Sinai/Aurora St. 

Luke’s Medical Centers, University of Wisconsin School of 

Medicine and Public Health, Milwaukee, WI; 2 St. Jude Medical 

Inc., St. Paul, MN 

179 Accumulative Premature Ventricular Contractions Can 

Be a Predictor of Heart Failure Hospitalization 

Omid Souresrafil 1 , Parviz Souresrafil 2 ; 1 SCH Cardiac Hospital/ 

University of Sydney, Maple Grove, MN; 2 Cardiology, SCH 

Cardiac Hospital, Sydney, Australia 

180 Epicardial Map of the Absolute QRST Integral in 

Systolic Heart Failure with Left Bundle Branch Block: 

Comparison with Native QRST Integral Map 

Larisa G. Tereshchenko 1 , Fady Dawoud 1 , Markus Kowalsky 1 , 

Sindhoora Murthy 1 , Subham Ghosh 2 , Jeffrey Gillberg 2 , David 

Spragg 1 , Ronald D. Berger 1 , Albert Lardo 1 ; 1 Cardiology, Johns 

Hopkins University School of Medicine, Baltimore, MD; 

2 

Medtronic, Inc, Minneapolis, MN 

181 Incidence, Predictors and Outcomes Related to Hypo 

and Hyperkalemia in Severe Heart Failure Patients 

Treated with an Aldosterone Antagonist 

Orly Vardeny 1 , DongHong Wu 2 , Brian Claggett 2 , Akshay Desai 2 , 

Patrick Rossignol 3 , Faiez Zannad 4 , Bertram Pitt 5 , Scott D. 

Solomon 2 ; 1 University of Wisconsin, Madison, WI; 2 Brigham 

and Women’s Hospital, Boston, MA; 3 INSERM, Centre 

d’Investigations Cliniques -9501and Nancy-Universite, Nancy, 

France; 4 University of Michigan School of Medicine, Ann 

Arbor, MI 


184 Results of the RISK Trial: Renal Function and Female 

Gender Are Strongly Associated with Early Response to 

Cardiac Resynchronization Therapy 

Alaa A. Shalaby 1 , John Gorcsan 1 , Gregg Fonarow 2 , Jagmeet 

Singh 3 , Malcolm Bersohn 2 , Jasmina Halilovic 4 , Manish 

Gupta 4 , Ali Sonel 1 , Samir Saba 1 , William Abraham 6 , Alan 

Kadish 7 ; 1 University of Pittsburgh, PA; 2 UCLA, Los Angeles, 

CA; 3 Massachusetts General Hospital, Boston, MA; 4 St. Jude 

Medical, Sunnyvale/Sylmar, CA; 5 The Ohio State University, 

Columbus, OH; 6 Touro College, New York, NY 

tuesday 

128 

129

Sept. 11 

Tuesday 

Posters 

Posters 


Posters 


Sept. 11 

Tuesday 

Posters 

tuesday 

189 Evaluation of the Long-Term Effects of AAV1/SERCA2a 

Gene Therapy on Clinical Events in Heart Failure 

Patients Using a Novel Statistical Model: Results and 

Implications for Future Trials 

Barry Greenberg 1 , Alex Yaroshinsky 2 , Howard Dittrich 2 , Jeff 

Rudy 2 , Krisztina Zsebo 2 ; 1 Cardiology, University of California, 

San Diego, CA; 2 Celladon, La Jolla, CA 

190 Re-Establishment of SDF-1 Expression through Non- 

Viral Gene Therapy Improves Clinical Parameters 

through 12 Months in Patients with Ischemic Class III 


Marc S. Penn 1 , Farrell O. Mendelsohn 2 , Gary L. Schaer 3 , 

Warren Sherman 4 , MaryJane Farr 4 , Joseph M. Pastore 5 , Rahul 

Aras 5 , Didier Rouy 6 , Ruth Clemens 5 , William Cotts 7 ; 1 Summa 

Cardiovascular Institute, Akron, OH; 2 Center for Therapeutic 

Angiogenesis, Birmingham, AL; 3 Rush Univ. Medical Center, 

Chicago, IL; 4 Columbia Univ. Medical Center, New York, NY; 

5 

Juventas Therapeutics, Inc., Cleveland, OH; 6 BioCardia,Inc., 

San Carlos, CA; 7 Northwestern Memorial Hosp., Chicago, IL 

191 First Human Dosing Experience with TRV027, a Novel 

Therapy for Acute Heart Failure 

David G. Soergel 1 , Ruth Ann Subach 1 , Jonathan D. Violin 1 , 

Dennis Yamashita 1 , Maxine Gowen 1 , Michael W. Lark 1 ; 1 Trevena, 

King of Prussia, PA 

192 Evaluating Treatment Efficacy by Multiple Endpoints in 

Phase II Acute Heart Failure Clinical Trials: Analyzing 

Data Using a Global Method 

Hengrui Sun 1 , 2 , Beth Davison 1 , Gad Cotter 1 , Michael 

Pencina 3 , Gary Koch 2 ; 1 Momentum Research, Inc., Durham, 

NC; 2 Biostatistics, Gillings School of Global Public Health, 

University of North Carolina at Chapel Hill, NC; 3 Harvard 

Clinical Research Institute, Boston, MA 

193 Acute HF in the Elderly: Different Characteristics, 

Outcomes and Prognostic Markers: Is It a Different 

Disease? Results from the VERITAS Study 

Veritas Steering Committee and Investigators 1 ; 1 Momentum 

Research Incorporated, Durham, NC 

194 Percutaneous Ventricular Restoration Therapy Using 

the Parachute Device in Patients with Ischemic Heart 

Failure and Dilated Left Ventricles: The U.S. Pivotal 

Trial Design 

William T. Abraham 1 , Michael Pencia 2 , Serjan Nikolic 3 , 

Thomas Engels 3 , Marco A. Costa 4 ; 1 Division of Cardiovascular 

Medicine, The Ohio State University, Columbus, OH; 2 Harvard 

Clinical Research Institute, Harvard University, Boston, MA; 

3 

Cardikinetix Inc., Menlo Park, CA; 4 Division of Cardiology, 

Case Western Reserve University, Cleveland, OH 

130 

195 Noninvasive Monitoring of Pulmonary Congestion 

Using a Remote Dielectric Sensing (ReDS) System: A 

Prospective Single-Arm Study in Patients Suffering from 


Dan Rappaport 1 ; 1 Sensible-Medical Innovations LTD, Netanya, 

Israel 

196 Comparison of the Predictive Values of NT-proBNP and 

Lung Impedance Measurements in the Course of BNP- 

Guided Treatment of CHF Patients 


Asif 1 , Iris Dahan 1 , Ilia Shochat 1 , Yaniv Levy 1 , David Blondheim 1 , 


Israel 

197 Short-Term Add-On Therapy with Angiotensin Receptor 

Blocker for End-Stage Inotrope-Dependent Heart 

Failure Patients: B-Type Natriuretic Peptide Reduction 

in a Randomized Clinical Trial 

Marcelo E. Ochiai 1 , Euler O. Brancalhao 1 , Raphael S. Puig 1 , 

Kelly N. Viera 1 , Marcelo V. Lima 1 , Juliano N. Cardoso 1 , 

Antonio P. Barretto 1 ; 1 Cotoxo Hospital, Heart Institute(INCOR), 

University of Sao Paulo, SP, Brazil 


204 Activation of Heme-Free Soluble Guanylate Cyclase with 

Cinaciguat Has Beneficial Cardiorenal Actions When 

Added to Furosemide in Experimental Heart Failure 

Guido Boerrigter 1 , Elizabeth C. Costello 1 , Alessandro 

Cataliotti 1 , Harald Lapp 2 , Johannes-Peter Stasch 3 , John C. 

Burnett 1 ; 1 Cardiovascular Diseases, Mayo Clinic, Rochester, MN; 

2 

Helios-Clinic, Erfurt, Germany; 3 Bayer Schering Pharma AG, 

Wuppertal, Germany 

205 Sustained Delivery of a Novel Natriuretic Peptide for 

Three Weeks with In Situ Polymer Precipitation Delivery 

System 

Soo G. Lim 1 , Syed Ameenuddin 2 , John C. Burnett, Jr 2 , Subbu 

S. Venkatraman 1 , Horng H. Chen 2 ; 1 School of Material Science 

and Engineering, Nanyang Technological University, Singapore, 

Singapore; 2 Cardiorenal Research Laboratory, Mayo Clinic, 

Rochester, MN 

206 Subcutaneous Deliver of M-ANP in Conscious Canines: 

An Innovative Designer Guanylyl Cyclase A Receptor 

Activator for Cardiovascular Disease 

Paul M. McKie 1 , Alessandro Cataliotti 1 , Tomoko Ichiki 1 , 

Horng H. Chen 1 , S. Jeson Sangaralingham 1 , John C. 

Burnett 1 ; 1 Cardiorenal Research Laboratory, Division of 

Cardiovascular Disease, Mayo Clinic, Rochester, MN 

131 

tuesday

Sept. 11 

Tuesday 

Posters 

Posters 


Posters 

Epidemiology/Prevention 

Sept. 11 

Tuesday 

Posters 

tuesday 

207 Safety of Acute Vagus Nerve Stimulation Therapy with 

Chronic Ivabradine Therapy 

Hani N. Sabbah 1 , Itamar Ilsar 2 , Mengjun Wang 1 , Keife 

Zhang 1 ; 1 Division of Cardiovascular Medicine, Department of 

Medicine, Henry Ford Heart and Vascular Institute, Detroit, MI; 

2 

BioControl Medical, Inc, New Hope, MN 

208 Role and Effect of Phosphodiesterase-5 Inhibitors and 

Endothelin Receptor Antagonists in the Treatment of 

Moderate Pulmonary Hypertension 

Thiago Jabuonski 1 , Jeremy A. Mazurek 1 , Ronald 

Zolty 2 ; 1 Department of Medicine, Jacobi Medical Center, Bronx, 

NY; 2 Division of Cardiology, Montefiore Medical Center, 

Bronx, NY 

Epidemiology/Prevention 

215 Characteristics, Management and Outcomes of 

Patients Hospitalized for Acute Heart Failure in Korea: 

Preliminary Results of the Korean Acute Heart Failure 

Registry (KorAHF) 

Sang Eun Lee 1 , Hyun-Jai Cho 1 , Hae-Young Lee 1 , Han-Mo Yang 1 , 

Jin Oh Choi 2 , Eun-Seok Jeon 2 , Min-Seok Kim 3 , Jae-Joong Kim 3 , 

Kyung-Kook Hwang 4 , Shung Chull Chae 5 , Sang Hong Baek 6 , 

Suk Min Seo 6 , Seok-Min Kang 7 , Dong-Ju Choi 8 , Kyu-Hyung 

Ryu 9 , Byung-Su Yoo 10 , Youngkyun Ahn 11 , Hyun-Young Park 12 , 

Myeong-Chan Cho 4 , 12 , Byung-Hee Oh Oh 1 ; 1 Seoul National 

University, Seoul, Korea; 2 Sungkyunkwan University, Korea; 

3 

University of Ulsan, Korea; 4 Chungbuk National University, 

Korea; 5 Kyungpook National University, Korea; 6 The Catholic 

University of Korea, Korea; 7 Yonsei University, Korea; 8 Seoul 

National University Bundang Hospital, Korea; 9 Konkuk 

University, Korea; 10 Yonsei University Wonju Christian Hospital, 

Korea; 11 Chonnam National University, Korea; 12 National 

Institute of Health, Korea 

216 Low Disease Prevalence May Influence the Diagnostic 

Accuracy of Cardiac Magnetic Resonance Imaging in 

Detecting Cardiac Sarcoidosis 

Sulaiman M. Mapara 1 , Abhishek Deshpande 2 , Vinay Pasupuleti 2 , 

Adrian V. Hernandez 4 , W.H. Wilson Tang 3 ; 1 Internal Medicine, 

Saint Vincent Charity Medical Center, Cleveland, OH; 2 Case 

Western Reserve University School of Medicine, Cleveland, 

OH; 3 Cardiovascular Medicine, Cleveland Clinic, Cleveland, 

OH; 4 Cleveland Clinic, Cleveland, OH 

132 

217 Race and Age Impacts Treatment Cost of Heart Failure 

in Tennessee 

Baqar A. Husaini 1 , Van A. Cain 1 , Zahid Samad 1 , Robert S. 

Levine 2 ; 1 Center for Prevention Research, College of Agriculture, 

Human, and Natural Sciences, TN State University, Nashville, 

TN; 2 Department of Family and Community Medicine, Meharry 

Medical College, Nashville, TN 

218 Inflammatory Syndrome and Dental State (Missing 

Tooth and Carries) in Patients with Cardiovascular 

Disease and Atrial Fibrillation; Possible Role in Atrial 

Fibrillation Pathogenesis 

Ioan A. Gutiu 1 , Laurentiu I. Gutiu 2 , Flavian S. Radulescu 1 , 

Manole Cojocaru 3 ; 1 Medical Emergencies, “Carol Davila” 

University of Medicine and Pharmacy, Bucharest, Romania; 

2 

Neurology, Central Emergencies Military Hospital, Bucharest, 

Romania; 3 Laboratory, “Titu Maiorescu” University, Bucharest, 

Romania 

219 Cardiovascular Abnormalities and Modifiable Risk 

Factors among First Responders: The Cleveland 

Firefighters’ Health Study 

Yenal Harper 1 , Tracy Kovach 2 , Chistopher Kovach 2 , Alan 

G. Borowski 1 , Carmel M. Halley 1 , Kevin Shrestha 1 , Mario 

Scarcipino 2 , W.H. Wilson Tang 1 , Anjli P. Maroo 2 ; 1 Cardiovascular 

Medicine, Heart and Vascular Institute, Cleveland Clinic 

Foundation, Cleveland, OH; 2 Fairview Hospital, Cleveland, OH 

220 Clinical and Echocardiographic Profile and Outcomes of 

Peripartum Cardiomyopathy: The Philippine General 

Hospital Experience 

Vim I. Samonte 1 , Queenie G. Ngalob 2 , Divine Ghea B. Mata 3 , 

Felix Eduardo R. Punzalan 1 , Eugenio P. Reyes 1 ; 1 Section 

of Cardiology, Department of Medicine, University of the 

Philippines-Philippine General Hospital, Manila, Philippines; 

2 

Section of Endocrinology, Department of Medicine, University 

of the Philippines-Philippine General Hospital, Manila, 

Philippines; 3 Obstetrics and Gynecology, University of the 

Philippines-Philippine General Hospital, Manila, Philippines 

Outcomes 

226 Obesity Paradox Does Not Apply to Acute Heart Failure 

Obesity Paradox Does Not Apply to Acute Heart Failure 

230 The Timing of Hemoconcentration during Treatment of 

Decompensated Heart Failure Influences Subsequent 

Survival 

Meredith A. Brisco 1 , Steve Coca 2 , Stephen Kimmel 1 , Jeffrey 

M. Testani 1 ; 1 Department of Medicine, Cardiovascular Division, 

University of Pennsylvania School of Medicine, Philadelphia, 

PA; 2 Department of Medicine, Yale University School of 

Medicine, New Haven, CT 

133 

tuesday

Sept. 11 

Tuesday 

Posters 

Posters 

Outcomes 

Posters 

Outcomes 

Sept. 11 

Tuesday 

Posters 

tuesday 

255 Changes in the Minnesota Living with Heart Failure 

Questionnaire Score and Clinical Outcomes in a Large 

Contemporary Population of Ambulatory Heart Failure 

Patients in the Canadian Heart Failure Network 

Malcolm Arnold 1 , Miroslaw Rajda 6 , Andrew Ignaszewski 2 , 

Jonathan Howlett 3 , Marie-Helene Leblanc 4 , Peter Liu 5 , 

Annemarie Kaan 2 , Shelley Zieroth 7 , Estrellita Estrella-Holder 7 , 

Marian Molloy 6 , Gord Marchiori 1 ; 1 London Health Sciences 

Centre, London, ON, Canada; 2 St. Paul’s Hospital, Vancouver, 

BC, Canada; 3 Foothills Medical Centre, Calgary, AB, Canada; 

4 

Institut de Cardiologie de Québec, Quebec City, QC, Canada; 

5 

The Toronto Hospital (University Health Network), Toronto, 

ON, Canada; 6 QEII Health Sciences Centre, Halifax, NS, 

Canada; 7 St. Boniface General Hospital, Winnipeg, MB, Canada 

256 Elevated Serum Cobalamin (B12) Levels Identify a 

Sicker Population of Patients with Advanced Heart 


Clay A. Cauthen 1 , Vijaiganesh Nagarajan 1 , Randall C. Starling 1 , 

W.H. Wilson Tang 1 ; 1 Department of Cardiovascular Medicine, 

Heart and Vascular Institute, Cleveland Clinic, Cleveland, OH 

257 Adverse In-Hospital Outcomes by Clinical Profile at 

Admission in Patients Hospitalized with Acute Heart 

Failure Syndromes – Data from Romanian Acute Heart 

Failure Syndromes (RO AHFS) Registry 

Ionela Codoiu 1 , Serban Bubenek 1 , Daniela Filipescu 1 , Anca 

Florian 1 , Dragos Vinereanu 2 , Andrew Ambrosy 3 , Mihai 

Gheorghiade 4 , Cezar Macarie 1 ; 1 Institute of Emergency for 


2 

Universitary Emergency Hospital, Bucharest, Romania; 

3 




258 Integrating Palliative Care into the Outpatient Heart 

Failure Disease Management Setting: A Feasibility 

Study? 

Lorraine Evangelista 1 , Dawn Lombardo 2 , Shaista Malik 2 , 

Jennifer Ballard-Hernandez 3 , Marjan Motie 1 , JoAnn Prause 1 , 

Solomon Liao 2 , Eric Adler 4 ; 1 UC Irvine, Irvine, CA; 2 UC 

Irvine Medical Center, Irvine, CA; 3 Hoag Memorial Hospital 

Presbyterian, Newport Beach, CA; 4 UC San Diego Medical 

Center, San Diego, CA 

259 Acute Cardiac Dysfunction during First 24 Hours of 

Mechanical Ventilation Is Associated with ICU Mortality 

in Patients with Acute Respiratory Failure 

Susan K. Frazier 1 , Melanie Hardin Pierce 1 ; 1 College of Nursing, 

University of Kentucky, Lexington, KY 

260 Do BNP Levels and Prognostic Value Vary by Race/ 

Ethnicity in Patients Hospitalized with Heart Failure? 

Selim R. Krim 1 , Rey P. Vivo 2 , Nassim R. Krim 3 , Feng Qian 4 , 

Margueritte Cox 5 , Hector Ventura 1 , Adrian F. Hernandez 5 , 

Deepak L. Bhatt 6 , Gregg C. Fonarow 7 ; 1 Ochsner Heart and 

Vascular Institute, New Orleans, LA; 2 University of Texas 

Medical Branch/Methodist DeBakey Heart and Vascular Center, 

Galveston, TX; 3 Bronx Lebanon Hospital/Montefiore Medical 

Center, Bronx, NY; 4 University of Rochester Medical Center, 

Rochester, NY; 5 Duke Clinical Research Institute, Durham, NC; 

6 

VA Boston Healthcare System/Brigham and Women’s Hospital, 

Boston, MA; 7 UCLA Medical Center, Los Angeles, CA 

261 Seattle Heart Failure Model Scores Are Significantly 

Predictive of Health Utilities and Their Change over 

Time 

Yanhong Li 1 , Matthew Neilson 2 , David J. Whellan 3 , Kevin 

A. Schulman 1 , Wayne C. Levy 4 , Shelby D. Reed 1 ; 1 Duke 

University, Durham, NC; 2 University of Glasgow, Scotland, 

United Kingdom; 3 Jefferson University College of Medicine, 

Philadelphia, PA; 4 University of Washington, Seattle, WA 

262 Preoperative Left Ventricular Function in Degenerative 

Mitral Valve Disease 

Eduard Malev 1 , Gleb Kim 2 , Marina Omelchenko 1 , Lyubov 

Mitrofanova 1 , Eduard Zemtsovsky 1 ; 1 Almazov Federal Heart, 

Blood and Endocrinology Centre, Saint-Petersburg, Russian 

Federation; 2 Saint-Petersburg State University, Saint-Petersburg, 

Russian Federation 

263 Serial Re-Admissions among Patients with Acute Heart 

Failure (AHF) in the US 

Prakash Navaratnam 1 , Carl DeMoor 1 , Paula Chakravarti 2 , Feride 

Frech-Tamas 2 ; 1 DataMed Solutions LLC, New York, NY; 2 HEOR, 

Novartis Corporation, East Hanover, NJ 

264 Incremental Prognostic Value of Heart-Type Fatty 

Acid-Binding Protein in Addition to B-Type Natriuretic 

Peptide for Prediction of Cardiac Mortality and Heart 

Failure Hospitalization after ST-Elevation Myocardial 

Infarction 

Kazuhiro Yajima 1 , Nobuyuki Ohte 2 , Yuichiro Yamase 1 , Kento 

Mori 1 , Kazuomi Ono 1 , Naohiko Inagaki 1 , Toshimasa Shigeta 1 , 

Hideki Horibe 1 , Takeshi Hibino 1 , Kiyoshi Yokoi 1 ; 1 Department 

of Cardiology, Gifu Prefectural Tajimi Hospital, Tajimi, Japan; 

2 

Department of Cardio-Renal Medicine and Hypertension, 

Nagoya City University Graduate School of Medical Sciences, 

Nagoya, Japan 

tuesday 

134 

135

Sept. 11 

Tuesday 

Posters 

Posters 

Outcomes 

Posters 

Outcomes 

Sept. 11 

Tuesday 

Posters 

tuesday 

265 Intensive Peri-Discharge Intervention Reduces 30-Day 

Readmissions in an Underserved Heart Failure 

Population: Demonstration of a Validated Risk Score 

Hong-Jun F. Yun 1 , Jill Downing 1 , Carol Colozzi 1 , Justin 

Saulino 1 , Diane F. Gauthier 1 , Wilson S. Colucci 1 , Chang-Seng 

Liang 1 ; 1 Section of Cardiology, Department of Medicine, Boston 

University Medical Center, Boston, MA 

266 Impact of Patient Education Class for Inpatients 

Admitted for Heart Failure on Rates of 30 Day 

Readmission 

Narendra Bhalodkar 1 , Sherry Megalla 1 , Harish Patel 1 , Aniwaa 

Obeng 1 , Jason J. Chedda 1 , Charles McCaleb 1 , Usman Khan 1 , 

Jonathan Bella 1 ; 1 Medicine, Bronx Lebanon Hospital Center, 

Bronx, NY 

267 Perceived Benefits of, but Not Barriers to, Following 

a Low Sodium Diet Predict Long-Term Adherence in 

Patients with Heart Failure 

Misook L. Chung 1 , Terry A. Lennie 1 , Susan K. Frazier 1 , Debra 

K. Moser 1 ; 1 College of Nursing, University of Kentucky, 

Lexington, KY 

268 Depression Symptoms Evaluated by the PHQ-9 

Instrument in Outpatients with Heart Failure in the 

Atlanta Cardiomyopathy Consortium (TACC) Study: 

Association with Health Care Resource Utilization and 

Quality of Life 

Vasiliki Georgiopoulou 1 , Ali A. Azeem 1 , Song Li 1 , Catherine 

N. Marti 1 , Andreas Kalogeropoulos 1 , Sandra B. Dunbar 1 , Javed 

Butler 1 ; 1 Department of Medicine, Division of Cardiology, Emory 

University, Atlanta, GA 

269 Impaired Cell-Mediated Immunity Portends Poor 

Prognosis in Advanced Heart Failure 

Vijaiganesh Nagarajan 1 , Clay A. Cauthen 1 , Randall C. Starling 1 , 

W.H. Wilson Tang 1 ; 1 Heart and Vascular Institute, Cleveland 


270 The Caregiver Burden Questionnaire for Chronic Heart 

Failure (CBQ-CHF): Development and Validation 

S. Blackburn 1 , L. Humphrey 1 , L. Maguire 1 , C. Deschasaux 2 , A. 

Stromberg 3 ; 1 Adelphi Values, Macclesfield, United Kingdom; 

2 

Novartis, Basel, Switzerland; 3 Linköping University, Linköping, 

Sweden 

271 Predictors of Worsening Renal Function during 

Hospitalization for Acute Heart Failure Syndromes: 

Insights from RO-AHFS Registry 

Ovidiu Chioncel 1 , Serban Bubenek 1 , Dragos Vinereanu 2 , Andrew 

Ambrosy 3 , Cezar Macarie 1 , Mihai Gheorghiade 4 ; 1 Institute of 

Emergency for Cardiovascular Diseases C.C.Iliescu, Bucharest, 

Romania; 2 Universitary Emergency Hospital, Bucharest, 

Romania; 3 Department of Medicine, Stanford University 

School of Medicine, Stanford, IL; 4 Center for Cardiovascular 

Innovation, Northwestern University, Feinberg School of 

Medicine, Chicago, IL 

272 Measuring CME Outcomes: Assessment of an HFSA 

Annual Meeting Symposium 

Barry H. Greenberg 1 , Joseph G. Verbalis 2 , Gregg C. Fonarow 3 , 

Margaret A. Clark 4 , Judith Lenhart 5 , Steve Eckert 6 ; 1 Cardiology, 

UCSD Medical Center, San Diego, CA; 2 Endocrinology, 

Georgetown University Medical Center, Washington, DC; 

3 

Cardiology, UCLA, Los Angeles, CA; 4 Clark Medical Writing, 

LLC, Tucker, GA; 5 Global Scientific Communications, 

Celgene Corporation, Berkeley Heights, NJ; 6 CME-University, 

Northfield, IL 

273 Sufficient Decrease in Pulmonary Arterial Pressure 

Markedly Improves Long-Term Prognosis of Patients 

with Pulmonary Arterial Hypertension 

Masaru Hatano 1 , Atsushi Yao 1 , Hisataka Maki 1 , Toshiro Inaba 1 , 

Koichiro Kinugawa 1 ; 1 Cardiovascular Medicine, The University 

of Tokyo, Tokyo, Japan 

274 Body Mass Index Predict Heart Failure Patients’ Long- 

Term Survival in Taiwan 

Tsuey-Yuan Huang 1 , Ming-Fen Tsai 1 , Mei-Ling Yeh 2 , Hui- 

Chu Yu 3 , Shiow-Li Hwang 2 , Terry A. Lennie 4 ; 1 Nursing, Chang 

Gung University of Science and Technology, Taoyuan, Taiwan; 

2 

Nursing, National Taipei University of Nursing & Health 

Sciences, Taipei, Taiwan; 3 Nursing, National Taiwan University 

Hospital, Taipei, Taiwan; 4 Nursing, University of Kentucky, 

Lexington, KY 

275 Ethnicity, Functional Cass, Depression, Anxiety, and 

Perceived Control Are Predictors of Health-Related 

Quality of Life in Patients with Heart Failure 

Tsuey-Yuan Huang 1 , Hui-Chu Yu 2 , Ming-Fen Tsai 1 , Mei- 

Ling Yeh 3 , Shiow-Li Hwang 3 , Terry A. Lennie 4 , Debra K. 

Moser 4 ; 1 Nursing, Chang Gung University of Science and 

Technology, Taoyuan, Taiwan; 2 Nursing, National Taiwan 

University Hospital, Taipei, Taiwan; 3 Nursing, National Taipei 

University of Nursing Health Sciences, Taipei, Taiwan; 

4 

Nursing, University of Kentucky, Lexington, KY 

tuesday 

136 

137

Sept. 11 

Tuesday 

Posters 

Posters 

Outcomes 

Posters 

Outcomes 

Sept. 11 

Tuesday 

Posters 

tuesday 

276 Prior Heart Failure Admissions Have Opposite Effects 

on 30-Day All-Cause Readmission and Mortality 

Scott L. Hummel 1 , Todd M. Koelling 1 ; 1 Medicine/Cardiovascular 

Medicine, University of Michigan, Ann Arbor, MI 

277 Does Systematic Adherence to Joint Commission and 

AHA Heart Failure Performance Measures Improve 

Patient Outcomes? 

Brian E. Jaski 1 , Miriam Bender 2 , Dale Glaser 3 , Valorie Thomas 4 , 

DeAnn S. Cary 2 , Sidney C. Smith, Jr 5 ; 1 Cardiology, Sharp 

Memorial Hospital, San Diego, CA; 2 Outcomes Research 

Institute, Sharp HealthCare, San Diego, CA; 3 University of San 

Diego, CA; 4 Public Reporting, Sharp HealthCare, San Diego, 

CA; 5 Medicine, University of North Carolina, Chapel Hill, NC 

278 Impact of Depression on Survival, Rejection, and 

Hospitalization Rates after Heart Transplantation 

Ike S. Okwuosa 1 , Dara Pumphrey 1 , Kathy Grady 1 , Clyde Yancy 1 , 

Edwin McGee 1 , William Cotts 1 ; 1 Northwestern University, 


279 Patterns of Change in Cognitive Function over Six 

Months in Adults with Chronic Heart Failure 

Barbara Riegel 1 , Christopher S. Lee 2 ; 1 School of Nursing, 

University of Pennsylvania, Philadelphia, PA; 2 School of 

Nursing, Oregon Health Science University, Portland, OR 

280 Serum Serotonin Level Can Predict Outcomes in Heart 


Ahmed M. Selim 2 , Nitasha Sarswat 1 , Ramesh Chandra 1 , Norma 

Christian 1 , Catherine Galvin 1 , Ronald Zolty 1 ; 1 Cardiology, Albert 

Einstein College of Medicine, Bronx, NY; 2 Internal Medicine, 

Bronx Lebanon Hospital Center, Bronx, NY 

281 Use of Bioelectrical Impedance Analysis To Assess Body 

Composition in Heart Failure Patients 

Elizabeth Thomas 1 , Adrienne L. Clark 1 , Gregg C. Fonarow 1 , 

Tamara B. Horwich 1 ; 1 Medicine/Cardiology, David Geffen 

School of Medicine, Los Angeles, CA 

282 Lower Heart Rate Associated with Improved Outcomes 

in Heart Failure with Preserved Ejection Fraction 

Luke Cunningham 1 , Anita Deswal 2 , Wenyaw Chan 3 , David 

Augilar 2 , Biykem Bozkurt 2 , Kumudha Ramasubbu 2 ; 1 Internal 

Medicine, Baylor College of Medicine, Houston, TX; 

2 

Cardiology, Veterans Affiars Medical Center, Houston, TX; 

3 

Statistics, University of Texas, Houston, TX 

138 

283 Elevated Plasma Homocysteine Identifies Patients with 

Chronic Heart Failure at Increased Cardiovascular Risk 

Naveed S. Iqbal 1 , Yuping Wu 2 , Stanley Hazen 1 , 3 , W.H. Wilson 

Tang 1 , 3 ; 1 Cardiovascular Medicine, Cleveland Clinic, Cleveland, 

OH; 2 Department of Mathematics, Cleveland State University, 

Cleveland, OH; 3 Department of Cell Biology, Lerner Research 

Institute, Cleveland, OH 

284 Outcome Measures of Heart Failure Telemedicine Clinic 

vs. Face to Face Therapy 

Vijayendra R. Jaligam 1 , Laura C. Scott 1 , Stephanie C. El Hajj 1 , 

Frank Smart 1 ; 1 Internal Medicine, LSU School of Medicine, New 

Orleans, LA 

285 Cardio-Hepatic Dysfunction Predicts Mortality in Stage 

D HF Patients 

Vijaiganesh Nagarajan 1 , Clay A. Cauthen 1 , Randall C. Starling 1 , 

W.H. Wilson Tang 1 ; 1 Heart and Vascular Institute, Cleveland 


286 HFpEF: When You Don’t Know What To Do; Clinicians 

Do What They Know How to Do 

Frank W. Smart 1 , Ronald Horswell 1 , Vijayendra Jaligam 1 ; 1 Section 

of Cardiology, LSU School of Medicine, New Orleans, LA 

287 Heart Failure Program Participation Improves Survival 

Linda Wick 1 , Colleen Renier 1 , Kimberly Boddicker 1 , Carl 

Heltne 1 , Jeanette Palcher 1 ; 1 Heart and Vascular, Essentia Health, 

Duluth, MN 


289 Adverse In-Hospital Outcomes by Systolic Blood 

Pressure at Admission in Patients Hospitalized with 

Acute Heart Failure Syndromes – Data from RO AHFS 

Registry 

Ovidiu Chioncel 1 , Dragos Vinereanu 2 , Serban Bubenek 1 , Andrew 

Ambrosy 3 , Cezar Macarie 1 , Mihai Gheorghiade 4 ; 1 Institute of 

Emergency for Cardiovascular Diseases “Prof. Dr. C.C. Iliescu”, 

Bucharest, Romania; 2 Universitary Emergency Hospital, 

Bucharest, Romania; 3 Department of Medicine, Stanford 

University School of Medicine, Stanford, CA; 4 Center for 

Cardiovascular Innovation, Northwestern University, Feinberg 

School of Medicine, Chicago, IL 

298 Inpatient Initiation and Target Dosing of ACE Inhibitors 

and Beta-Blockers in Children with Heart Failure 

Jack F. Price 1 , BreAnn N. Taylor 2 , Aamir Jeewa 1 , William J. 

Dreyer 1 , Susan W. Denfield 1 , Antonio G. Cabrera 1 , Brady S. 

Moffett 2 ; 1 Pediatric Cardiology, Baylor College of Medicine, 

Houston, TX; 2 Pharmacy, Texas Children’s Hospital, Houston, 

TX 

139 

tuesday

Sept. 11 

Tuesday 

Posters 

Posters 


Posters 


Sept. 11 

Tuesday 

Posters 

tuesday 

323 Heart Failure Hospitalizations Are Reduced in 

Heart Failure Patients with Comorbid Pulmonary 

Hypertension Using a Wireless Implanted Pulmonary 

Artery Pressure Monitoring System 

Raymond Benza 1 , Robert Bourge 2 , Philip Adamson 3 , William 

Abraham 4 , Jay Yadav 5 ; 1 Allegheny General Hospital, Pittsburgh, 

PA; 2 University of Alabama at Birmingham, AL; 3 Oklahoma 

Heart Institute, Oklahoma City, OK; 4 Ohio State University, 

Columbus, OH; 5 CardioMEMS, Inc., Atlanta, GA 

324 Submaximal Cardiopulmonary Exercise Testing for 

Unexplained Dyspnea 

Digant V. Bhatt 1 , Jae Cho 1 , Abraham Kocheril 1 ; 1 Medicine, 

University of Illinois College of Medicine, Urbana, IL 

325 Clinical Predictors of Intensive Care Unit Admission in 

Patients Hospitalized for Pulmonary Edema – Data from 

the RO-AHFS Registry 

Ovidiu Chioncel 1 , Serban Bubenek 1 , Andrew Ambrosy 3 , Cezar 

Macarie 1 , Mihai Gheorghiade 4 ; 1 Institute of Emergency for 


2 




326 Prognostic Utility of Procalcitonin in Guiding Antibiotic 

Use in Acute Heart Failure Patients Presenting to the 

Emergency Department with Dyspnea 

Rajiv Choudhary 1 , Paul Clopton 1 , Stefan D. Anker 3 , Sean- 

Xavier Neath 2 , Oliver Hartmann 4 , Andreas Bergmann 5 , Alan S. 

Maisel 1 , 2 ; 1 Cardiology, VA San Diego Healthcare System, San 

Diego, CA; 2 Medicine, University of California, San Diego, CA; 

3 

Center fot Clinical and Basic Research IRCCS San Raffaele, 

Roma, Italy; 4 BRAHMS GmbH, Biotechnology Centre, 

Hennigsdorf/Berlin, Germany; 5 Waltrout-Bergmann Foundation, 

Hohen Neuendorf, Germany 

327 Cardio-Oncology: Cardiac Risk Profile in Breast Cancer 

Patients with Stage A Heart Failure 

Monica DaSilva 1 , Wissam Abdallah 1 , VaNdana Abramson 1 , 

Ingrid Mayer 1 , Julie Means-Powell 1 , Darla Freehardt 1 , Brenda 

White 1 , Daniel Lenihan 1 , David Slosky 1 , Douglas Sawyer 1 , 

Carrie Geisberg 1 ; 1 Cardiology and Oncology, Vanderbilt 

University, Nashville, TN 

328 Ultrafiltration in Patients with Acute Decompensated 

Heart Failure and Pulmonary Hypertension 

Gregory F. Egnaczyk 1 , Cheryl Bartone 1 , Santosh Menon 1 , 

Thomas O’Brien 1 , Peter Engel 1 , Eugene S. Chung 1 ; 1 The Christ 

Hospital, Cincinnati, OH 

329 Comparative Cost Analysis of LVAD vs. Axillary 

Intraaortic Balloon Pump (IABP) as a Bridge to 

Transplantation – A Single Center Experience 

Jerry D. Estep 1 , Andrea M. Cordero-Reyes 1 , Arvind 

Bhimaraj 1 , Laurie P. Loza 1 , Matthias Loebe 1 , Guillermo Torre- 

Amione 1 , 2 ; 1 Methodist DeBakey Heart and Vascular Center, The 

Methodist Hospital, Houston, TX; 2 Catedra de Cardiologia y 

Medicina Vascular, Tecnologico de Monterrey, NL, Mexico 

330 A Hospital-Wide Program To Reduce Heart Failure 

Readmissions 

Aline Iskander 1 , Priti Mehla 1 , Jason Ryan 1 ; 1 Division of 

Cardiology, University of Connecticut Health Center, 


331 Percutaneous Hemodynamic Support (Impella) 

in Patients with Advanced Heart Failure and/or 

Cardiogenic Shock Not Eligible to PROTECT II Trial 

Wei LIu 1 , N.A. Barbagelata 1 , Ken Fujise 1 ; 1 Cardiology, University 

of Texas Medical Branch, Galveston, TX 

332 Extremely Low Dose Amiodarone Is a Safe and Effective 

Strategy in AF Management 

Frank A. McGrew 1 , Jessica Foon 1 , Sandra B. 

Charlton 2 ; 1 Cardiovascular Research Department, Stern 

Cardiovascular Clinic, Germantown, TN; 2 Cardiac Rhythm 

Disease Management, Medtronic, Inc., Mounds View, MN 

333 Is the Right Ventricular Performance Altered in Patients 

with Malignant Tumors Treated with Epirubicin? A 

Doppler Echocardiographic Study 

Dan Radulescu 1 , Paula Mitrea 2 ; 1 Cardiology, Medicala V, 

University of Medicine and Pharmacy, Cluj Napoca, Romania; 

2 

Computer Sciences, Technical University, Cluj, Romania 

334 Obesity Paradox of NT proBNP in Heart Failure with 

Preserved EF (HFpEF) 

Rajesh Ramineni 1 , Khalife Wissam 1 , Poorna Nalabothu 1 , 

Mohamed Morsy 1 ; 1 Division of Cardiology/Department of 

Internal Medicine, University of Texas Medical Branch, 

Galveston, TX 

335 Masked Polycythemia in Patients with Heart Failure: An 

Underappreciated Phenotype? 

Sahadeo D. Ramnauth 1 , Sergio Teruya 1 , Steve Helmke 1 , Mathew 

S. Maurer 1 ; 1 Medicine, Columbia University Medical Center, 

New York, NY 

tuesday 

140 

141

Sept. 11 

Tuesday 

Posters 

Posters 


Posters 


Sept. 11 

Tuesday 

Posters 

tuesday 

336 The Impact of Nutritional Risk on Health-Related 

Quality of Life in Patients with Heart Failure beyond 

Daily Sodium Intake 

Eun Kyeung Song 1 , Debra K. Moser 2 , Terry A. 

Lennie 2 ; 1 Department of Nursing, University of Ulsan, Ulsan, 

Korea; 2 College of Nursing, University of Kentucky, Lexington, 

KY 

337 Outpatient Ultrafiltration for Acute Decompensated 

Heart Failure: Single Center Experience 

Sitaramesh Emani 1 , Jennifer Host 1 , Gina Mentzer 1 , Donald 

Kikta 2 , Todd Yamokoski 1 , Garrie Haas 1 ; 1 Internal Medicine, The 

Ohio State University Wexner Medical Center, Columbus, OH; 

2 

Internal Medicine, University Hospitals, Cleveland, OH 

338 Who Are at Risk of Diastolic Heart Failure in Response 

to Volume Load? 

Seong Woo Han 1 , Hong Seog Seo 1 , Chang Gyu Park 1 , Jin Oh 

Na 1 , Eung Ju Kim 1 , Dong Joo Oh 1 ; 1 Cardiovascular Medicine, 

Korea University Guro Hospital, Seoul, Republic of Korea 

339 Bioimpedance Vector Analysis in the Diagnosis of 

Acute Decompensated Heart Failure in the Emergency 

Department 

Devin W. Kehl 1 , 2 , Rajiv Choudhary 2 , Bryan Dieffenbach 1 , 

Paul Clopton 2 , Pam R. Taub 1 , 2 , Alan S. Maisel 1 , 2 ; 1 University 

of California at San Diego, CA; 2 Veterans Affairs San Diego 

Healthcare System, San Diego, CA 

340 Beta-Blocker Dose Reduction in Acute Decompensated 

Heart Failure Requiring Milrinone Treatment 

Brent C. Lampert 1 , Jeffrey J. Teuteberg 1 , Michael Mathier 1 , Ravi 

Ramani 1 , Marc Simon 1 , Hunter Champion 1 , Jessica Pisarcik 1 , 

Dennis McNamara 1 ; 1 Heart and Vascular Institute, University of 


341 Single Centre Study Examines Illness Beliefs, Coping 

and Self-Management in an Ambulatory Irish Heart 

Failure Population 

Clare Lewis 1 , Jonathan Gallagher 2 , Mark Heverin 2 , 

Caroline McHugh 2 , Frank Doyle 3 , Niall Pender 2 , Brendan 

McAdam 1 ; 1 Supportive Heart Unit, Beaumont Hospital, Dublin, 

Ireland; 2 Psychology, Beaumont Hospital, Dublin, Ireland; 

3 

Royal College of Surgeons Ireland, Dublin, Ireland 

342 Implementation of Tailored Intravenous Heart Failure 

Therapy in a Non-Dedicated Outpatient Infusion Center 

Judith E. Schipper 1 , Grace R. Domingo 1 , Victoria V. Dickson 1 , 

Stuart D. Katz 1 ; 1 Medicine, New York University Langone 

Medical Center, New York, NY 

142 

343 Lung Impedance Guided Preemptive Treatment of 

Evolving Pulmonary Congestion-Edema in Course of 

Acute Myocardial Infarction Reduces Use of Furosemide 


Asif 1 , Iris Dahan 1 , Yaniv Levy 1 , David Blondheim 1 , Simcha 

Meisel 1 ; 1 Cardiology, Hillel Yaffe Heart Institute, Hadera, Israel 

344 Daily Activity in Heart Failure: Clinically Meaningful 

Change and Relationship to Prognosis 

Michael J. Shoemaker 1 , Amy B. Curtis 1 , Eric Vangsnes 1 , Michael 

G. Dickinson 2 ; 1 Western Michigan University, Kalamazoo, MI; 

2 

Frederik Meijer Heart and Vascular Institute, Grand Rapids, MI 

345 What Is the Trigger for Hydralazine Isosorbide Use in 

Systolic Heart Failure? 

Frank Smart 1 , Elizabeth Langlois 2 , Ronald Horswell 1 ; 1 Medicine/ 

Cardiology, LSU School of Medicine, New Orleans, LA; 

2 

Cardiology, Summit Medical Group, Berkeley Heights, NJ 

346 Developing a Culturally-Relevant Self-Care Intervention 

for Hispanic Adults with Heart Failure 

Victoria Vaughan Dickson 1 , Joan L. Combellick 1 , Marnie 

Malley 1 , Luis Sanchez 1 , Allison Squires 1 , Stuart Katz 3 , Barbara 

Riegel 2 ; 1 New York University, College of Nursing, New 

York, NY; 2 University of Pennsylvania, School of Nursing, 

Philadelphia, PA; 3 School of Medicine, New York University, 

New York, NY 

347 Cardiac Resynchronization Therapy (CRT) in Heart 

Failure Patients on Maximal and Sub-Maximal Doses of 

Beta-Blockers 

Rami Abo-Shasha 1 , Ross A. Davies 1 , Lisa M. Mielniczuk 1 , 

Haissam A. Haddad 1 ; 1 Cardiology, University of Ottawa Heart 

Institute, Ottawa, ON, Canada 

348 Cross-Cultural Adaptation and Validation of Self-Care of 

Heart Failure Index Version 6.2 for Its Use in Brazil 

Christiane W. Avila 1 , 2 , Karina S.M. d’Almeida 2 , 3 , Eneida R. 

Rabelo 1 , 2 , 3 ; 1 School of Nursing - Postgraduate Program, Federal 

University of Rio Grande do Sul, Porto Alegre, RS, Brazil; 

2 

Cardiology Division - Heart Failure Clinic, Hospital de Clínicas 

de Porto Alegre, RS, Brazil 

349 Home Monitoring Using a Novel Under-the-Mattress 

Piezoelectric Sensor 

Mosi K. Bennett 1 , Eiran Z. Gorodeski 1 ; 1 Cardiovascular 

Medicine, Cleveland Clinic, Cleveland, OH 

350 Validity and Reliability of the Brazilian Version of the 

Dietary Sodium Restriction Questionnaire 

Karina S.M. d’Almeida 1 , 2 , Gabriela C. Souza 1 , 2 , 4 , Christiane W. 

Avila 1 , 3 , Eneida R. Rabelo 1 , 2 , 3 ; 1 Postgraduate Program in Health 

Sciences - Cardiology and Cardiovascular Sciences, Federal 

University of Rio Grande do Sul, Porto Alegre, RS, Brazil; 

2 

Cardiology Division - Heart Failure Clinic, Hospital de Clínicas 

de Porto Alegre, RS, Brazil; 3 School of Nursing - Postgraduate 

Program, Federal University of Rio Grande do Sul, Porto 

Alegre, RS, Brazil; 4 Internal Medicine Department, Federal 

University of Rio Grande do Sul, Porto Alegre, RS, Brazil 

143 

tuesday

Sept. 11 

Tuesday 

Posters 

tuesday 

Posters 


351 Uninsured Patients with Nonischemic Heart Failure 

Have Higher Rates of Erectile Dysfunction 

Tracy L. Finegan 1 , Mahmoud I. Traina 1 , Daniel R. 

Sanchez 1 , Gisele Munoz 1 , Salvador Hernandez 1 , Sheba K. 

Meymandi 1 ; 1 Olive View-UCLA Medical Center, Sylmar, CA 

352 Multidisciplinary Heart Failure Discharge Protocol 

Decreases 30 Day Readmission 

Andrea C. Hall 1 , Erin K. Donaho 2 , Jennifer A. Gass 1 , Deborah E. 

Meyers 2 ; 1 Memorial Hermann-TMC, Houston, TX; 2 UTHealth, 

Houston, TX 

353 Long Term Continuous Milrinone as Destination 

Therapy in Patients with Advanced Heart Failure 

Saurabh Kapoor 1 , Matthew Porac 1 , Bernard Kim 1 , Fatima 

Samad 1 , Robert Berkowitz 1 ; 1 Heart Failure and Pulmonary 

Hypertension Program, Heart and Vascular Hospital at 

Hackensack University Medical Center, Hackensack, NJ 

354 Chart Review To Determine Which Heart Failure 

Readmissions Are Preventable 

Priti Mehla 1 , Aline Iskandar 1 , Rebecca Andrews 1 , Marybeth 

Barry 1 , Jason Ryan 1 ; 1 University of Connecticut Health Center, 


355 Self-Reported Awareness of Chronic Heart Failure 

(CHF) in a VA Population Diagnosed with CHF: 

Implications for Individual Patients, Caregivers, 

Providers, and Organizations 

Nancy L. Oliva 1 , 2 , Laura Gaskin 2 , Anju Sahay 2 , Parisa Gholami 2 , 

Paul Heidenreich 2 , 3 ; 1 Geriatric Research, Education & Clinical 

Center, VA Palo Alto Health System, Palo Alto, CA; 2 VA 

CHF-QUERI, @VA Palo Alto Health System, Palo Alto, CA; 

3 

Medicine-Cardiovascular Medicine/Health Research & Policy, 

Stanford University School of Medicine, Stanford, CA 

356 Increased Mortality in Diabetic Patients with Elevated 

Copeptin Levels: Secondary Analysis of the Biomarkers 

in Acute Heart Failure (BACH) Trial 

Kevin Shah 1 , Rajiv Choudhary 1 , Alaeddin Ayyad 1 , Paul Clopton 1 , 

Alan S. Maisel 1 , 2 ; 1 Cardiology, VA San Diego Healthcare System, 

San Diego, CA; 2 Medicine, University of California-San Diego, 

CA 

357 Heart Failure with Preserved Ejection Fraction 

(HFPEF): Comorbidity Screening and Adherence to 

Guidelines at Portland Veterans Affairs Medical Center 

(PVAMC) 

Harleen Singh 1 , Jessina C. McGregor 1 , Sarah J. Nigro 1 , Abby 

E. Floeter 1 , Jiangi J. Yang 2 , Greg C. Larsen 2 ; 1 Oregon State 

University College of Pharmacy, Portland, OR; 2 Veterans Affairs 

Medical Center, Portland, OR 

358 Levosimendan Is Associated with Reduction in Hospital 

Admissions in Palliation of Patients with End-Stage 


Poh Shuan Daniel Yeo 1 , Yee May Wong 2 , Lay Hong 

Goh 2 ; 1 Cardiology, Tan Tock Seng Hospital, Singapore, 

Singapore; 2 Pharmacy, Tan Tock Seng Hospital, Singapore, 

Singapore 



7:00-8:30 AM 


Clinical Fundamentals: Options for Advanced 

Heart Failure and Clinical Pearls 

Moderators: Tamara B. Horwich, Los Angeles, CA 

Josef Stehlik, Salt Lake City, UT 

7:00 When Is It Appropriate to Consider Referral for 

Advanced Heart Failure Therapies? 

Garrick C. Stewart, Boston, MA 

7:10 A Bridge to What? Choosing the Right Destination 

Jennifer Cowger, Ann Arbor, MI 

7:20 Mechanical Circulatory Support: Complications and 

Troubleshooting 


7:35 Cardiac Transplantation: Short and Long-Term 

Outcomes and Implications for Patient Selection 

David DeNofrio, Boston, MA 

7:45 Cardiac Transplantation: Individualizing Immune 

Suppression 

Jon A. Kobashigawa, Los Angeles, CA 

8:00 Palliative Care and Shared Decision Making in 

Advanced Heart Failure 

Sarah J. Goodlin, Portland, OR 


Faculty 

8:15 Clinical Pearls 

Carl V. Leier, Columbus, OH 

Learning Objective: Evaluate heart failure patients for 

device implantation, manage implanted devices, and 

diagnose and treat pulmonary hypertension. 

8:15 HFSA Annual Business Meeting 

Room 608 



Sept. 12 

Wednesday 

AM 

WEDNESDAY 

144 

145

Sept. 12 

Wednesday 

AM 

SYMPOSIUM 


8:30-10:00 AM 

Ballroom 6A 

SYMPOSIUM 


8:30-10:00 AM 


Sept. 12 

Wednesday 

AM 

WEDNESDAY 

Cardiotoxicity 

Moderators: Anju Nohria, Boston, MA 

Paul Rosenberg, Durham, NC 

8:30* Why So Many Tyrosine Kinases? 

Thomas Force, Philadelphia, PA 

8:45* Cardiac Effects of Cytokines 


9:00* Cardiomopathy of Substance Abuse 

George G. Philippides, Boston, MA 

9:15* Decreasing Toxicity of Anthracyclines 

Douglas B. Sawyer, Nashville, TN 

9:30* Toxicity of Nitric Oxide 

Mark T. Ziolo, Columbus, OH 

9:45* Cardiac Risk of High Intensity Exercise 

Joseph R. Libonati, Philadelphia, PA 


Learning Objective: Evaluate heart failure patients for 

device implantation, manage implanted devices, and 

diagnose and treat pulmonary hypertension. 

Advances in Diagnosis and Targeted 

Management Strategies of Specific 


Moderators: Edward M. Gilbert, Salt Lake City, UH 

Jacob Joseph, Boston, MA 

8:30 Current Management Strategies in Peripartum 

Cardiomopathy 

Uri Elkayam, Los Angeles, CA 

8:45 Host Factors in Human Viral Cardiomyopathy 

Toshitaka Yajima, La Jolla, CA 

9:00 Treatment of Thalassemia and Iron Load 

Cardiomyopathies: What is New? 

JonDavid Menteer, Los Angeles, CA 

9:15 Prevention and Monitoring of Chemotherapy Induced 


Jean-Bernard Durand, Houston, TX 

9:30 Rhythm Devices for Sarcoidosis 

William H. Sauer, Aurora, CO 

9:45 Panel Discussion: Role of Registries for Specific 

Conditions 

WEDNESDAY 

Learning Objective: Diagnose selected cardiomyopathies 

and evaluate available treatment strategies. 


Room 608 


Room 608 





146 147

Sept. 12 

Wednesday 

AM 

SYMPOSIUM 


8:30-10:00 AM 


SYMPOSIUM 


10:30 AM-12:15 

Ballroom 6A 

Sept. 12 

Wednesday 

AM 

Decreasing Readmission from Home 

Envisioning Therapy in Heart Failure 

WEDNESDAY 

Moderators: Peter E. Carson, Washington, DC 

Mariann R. Piano, Chicago, IL 

8:30* Facing the Front Line: Use of Community Health 

Workers 

Gia Mudd-Martin, Lexington, KY 

8:43* Integrating Care of Depression and Anxiety Into the 

Clinic 

Jared L. Skillings, Grand Rapids, MI 

8:56* Value Based Purchasing - Objects in your mirror are 

closer than you think! 

Mitchell T. Saltzberg, Newark, DE 


9:10 Old and New Biomarkers for Triage or Therapy? 

Alan S. Maisel, La Jolla, CA 

9:23 Update on Diuretic Infusions for Frequent Flyers 

Marie Galvao, Westport, CT 

9:35 Non-Invasive Monitoring is Most Effective 

John G.F. Cleland, Kingston-Upon-Hull, UK 

9:45 Invasive Home Monitoring is Most Effective 

Robert C. Bourge, Birmingham, AL 


Learning Objective: Use home-based and community-based 

strategies to reduce readmission of the heart failure patient. 

Moderators: Eugene Braunwald, Boston, MA 

Gordon W. Moe, Toronto, ON Canada 

10:30 Autonomic Modulation With Devices 

W.H. Wilson Tang, Cleveland, OH 

10:40 The Leadless Defibrillator 

Gust H. Bardy, Bellevue, WA 


10:55 Cardiology Patient Communities in Social Networks 


11:05 Tracking Rate and Rhythm on Smart Phones 

David E. Albert, Oklahoma City, OK 


11:20 Destination Therapy with Miniaturized Percutaneous 

VADs 



11:35 Bio-Nano-Chip Technology for Biomarker Assessment in 


John T. McDevitt, Houston, TX 

11:45 Implantable Monitoring Devices Close the Loop Directly 

With Patients 



NOON 

Comments: Vision for the Future: New and Renewed 

Eugene Braunwald, Boston, MA 

WEDNESDAY 

Learning Objective: Discuss emerging devices and networks 

and their potential impact on care of patients with heart 

failure. 


Room 608 



148 149

Sept. 12 

Wednesday 

AM 

SYMPOSIUM 


10:30 AM-NOON 


SYMPOSIUM 


10:30 AM-NOON 


Sept. 12 

Wednesday 

AM 

Re-defining Success 

Common Sense and Personalized Medicine 

Moderators: Steven R. Goldsmith, Minneapolis, MN 

Milton Packer, Dallas, TX 

Moderators: Biykem Bozkurt, Houston, TX 


10:30 Better Endpoints for New Therapies 


10:30 Do Survival Models Help in Decision Making? 

Larry A. Allen, Denver, CO 

WEDNESDAY 

10:40 Six Minute Walk for Pulmonary Hypertension, Why Not 

For Heart Failure? 



10:55 Evidence for Improved Quality of Care 

Nancy M. Albert, Cleveland, OH 


11:08 Prevalence and Prognosis of Heart Failure: Better EF 

Akshay S. Desai, Boston, MA 

11:18 Which Medications Can Be Stopped for Improvement 

and How? 

Mark A. Munger, Salt Lake City, UT 


11:35 Defining A Good Death 

Theo E. Meyer, Worcester, MA 


10:43 Do Guidelines Distinguish Inpatients from Outpatients? 

Sharon A. Hunt, Stanford, CA 


10:56 When Do You Withhold a Recommended Therapy? 

Jalal K. Ghali, Detroit, MI 


11:25 When Does Quality of Life Conflict with Otherwise 

Optimal Therapy? 

Ronald M. Witteles, Stanford, CA 

11:40 Case Discussion 

Douglas D. Schocken, Durham, NC (Moderator) 

Eugene S. Chung, Cincinnati, OH 

John Chin, Sacramento, CA 

WEDNESDAY 

11:45 Evidence for Improving Survival in the Heart Failure 

Population 

Jonathan G. Howlett, Calgary, AB, Canada 

Learning Objective: Discuss optimal care of selected 

patients with heart failure based on evidence, guidelines, and 

reasonable outcomes. 


Learning Objective:Reassess common care endpoint in the 

treatment of heart failure and determine optimal approaches 

to care and management. 

150 151

Thank you for coming – 

see you next year! 


September 9 – 12, 2012 

Washington State Convention and Trade Center 

Seattle, WA 

153 

www.hfsa.org


10:00 AM-4:00 PM 


Hands-on Workshop 

Aquapheresis: Best Practices and Real World 

Experiences 

Hands-on Workshop 

10:00-10:30 AM Living in the Real World: Interactive Case Studies in Aquapheresis 

10:30-11:00 AM Best Practices: Hands-on Troubleshooting and Using Aquapheresis 

11:00-11:30 AM Living in the Real World: Interactive Case Studies in Aquapheresis 


12:45-1:30 PM 


Product Theaters 

New Indications for CRT: Lesson Learned from Mild 

Heart Failure Studies 

Michael Gold, MD, PhD 

Professor and Chief of Cardiology 

Director, Heart and Vascular Center 

Medical University of South Carolina 


Sponsored by Medtronic, Inc. 

11:30-NOON 

Best Practices: Hands-on Troubleshooting and Using Aquapheresis 

NOON-1:00 PM 

Managing the Aquapheresis Patient: The Nursing Perspectives 

1:00-1:30 PM Living in the Real World: Interactive Case Studies in Aquapheresis 

1:30-2: 00 PM Best Practices: Hands-on Troubleshooting and Using Aquapheresis 

2:00-3:00 PM Managing the Aquapheresis Patient: The Nursing Perspective 

3:00-3:30 PM Living in the Real World: Interactive Case Studies in Aquapheresis 

3:30-4:00 PM Best Practices: Hands-on Troubleshooting and Using Aquapheresis 

This non-CME Workshop is designed to provide hands-on experience 

in the use of the Aquadex FlexFlow Fluid Removal System to safely, 

predictably, and effectively remove excess fluid from patients with 

fluid overload. The interactive discussions will address: 


12:45-1:30 PM 


To be specified later. 

Sponsored by GE Healthcare 

• Aquapheresis: how it works 

• Patient selection considerations 

• Selecting the optimal access site for aquapheresis (peripheral 

and central venous access options and catheter selection) 

• Setting up and troubleshooting the Aquadex FlexFlow Fluid 

Removal System 

• The Nurse’s role in managing the aquapheresis patient 

Participants will gain a thorough understanding of aquapheresis, 

hands-on experience setting-up and troubleshooting the system, and 

have an opportunity to interact with their peers who have successfully 

utilized the Aquadex FlexFlow Fluid Removal System for their 

patients´ care. 

The schedule of events will be posted onsite. No advanced registration 

is required. However, participants must be registered with the HFSA 

Annual Scientific Meeting. 

Sponsored by Gambro UF Solutions 

154 155

Clinical Trial Row 

Clinical Trial Row 

Abbott Vascular 

B1 

Amgen 

B2 


B3 

Jarvik Heart, Inc. 

B4 

COAPT 

Clinical Outcomes Assessment of the MitraClip 

Percutaneous Therapy for High Surgical Risk 

ATOMIC-AHF 

Acute Treatment with Omecamtiv Mecarbil to 

Increase Contractility in Acute Heart Failure 

MultiSENSE 

Multisensor Chronic Evaluations in Ambulatory 


RELIVE 

Randomized Evaluation of Long-Term 

Intraventricular VAD Effectiveness 

Reata Pharmaceuticals 

B10 

BEACON 

Bardoxolone Methyl Evaluation in Patients with 

Chronic Kidney Disease in Type 2 Diabetes 

BioControl Medical, Ltd. 

B11 

INOVATE-HF 

Increase of VAgal Tone in chronic Heart Failure 

Gambro UF Solutions, Inc. 

B12 

AVOID-HF 

Aquapheresis Versus Intravenous Diuretics and 

Hospitalizations for Heart Failure 

National Heart, Lung, and Blood Institute - 

Heart Failure Network 

B13 

EXACT-HF 

Xanthine Oxidase for Hyperuricemic Heart Failure 

Patients 

Sorbent Therapeutics, Inc. 

B5 

STEP WISE 

A Phase 2b, Randomized, Double-blind, 

Multi-center Study Comparing Cross-linked 

Polyelectrolyte (CLP) with Placebo in Heart Failure 

Subjects 

Medtronic CRDM 

B6 


BLOCK HF 

Biventricular Versus Right Ventricular Pacing in 

Heart Failure Patients with Atrioventricular Block 

B14 

B15 

ROSE-AHF 

Renal Optimization Strategies Evaluation in Acute 


RED ROSE 

Reliable Evaluation of Dyspnea in the Heart Failure 

Network ROSE Study 

B7 

MEDTRONIC HF RESEARCH 

No Descriptor 


B8 

REFINE ICD 

Efficacy of Implantable Defibrillator Therapy After 

a Myocardial Infarction 

CVRX, Inc. 

B9 

HOPE4HF 

Barostim HOPE4HF Trial 

156 

157

EXHIBIT FLOOR PLAN 

HFSA Exhibitor Booth # 

Abiomed ..........................................Booth #311 

Ambry Genetics ....................................Booth #227 

American Heart Association ...........................Booth #119 

Arbor Pharmaceuticals, Inc. ...........................Booth #319 

BG Medicine, Inc ...................................Booth #412 

BioScrip, Inc. ......................................Booth #225 

BIOTRONIK .......................................Booth #324 

CardiacAssist, Inc. ..................................Booth #218 

Cytokinetics, Inc. ...................................Booth #105 

DAXOR Corporation. ................................Booth #410 

DrFirst, Inc. ........................................Booth #326 

Elsevier Publishing ..................................Booth #603 

Gambro. ..........................................Booth #510 

Gilead Sciences, Inc.. ................................Booth #210 

Heart Failure Society of America .......................Booth #601 

HFSA E-mail Retrieval Stations ........................Booth #125 

HeartWare, Inc. .....................................Booth #213 

Janssen Pharmaceuticals, Inc. ..........................Booth #205 

LabCorp. ..........................................Booth #216 

Lippincott Williams & Wilkins - WRH .................Booth #608 

Medtronic, Inc. .....................................Booth #505 

Miller Pharmacal Group, Inc. ..........................Booth #416 

NeuMeDx ........................................ Booth #513 

NxStage Medical ....................................Booth #117 

OnTrack to Health ...................................Booth #511 

Otsuka America Pharmaceutical, Inc.. ...................Booth #305 

Otsuka America Pharmaceutical, Inc. ....................Booth #220 

Oxford University Press ..............................Booth #609 

PromptCare Home Infusion ...........................Booth #322 

Response Biomedical Corporation ......................Booth #317 

St. Jude Medical ....................................Booth #313 

Shape Medical Systems ..............................Booth #610 

Sunshine Heart. .....................................Booth #223 

SynCardia Systems, Inc. . .............................Booth #316 

The Joint Commission. ...............................Booth #607 

Thoratec Corporation . ...............................Booth #411 

XDx, Inc. ..........................................Booth #217 

ZOLL ............................................Booth #312 

158 

159

EXHIBITORS 

EXHIBITORS 

ABIOMED ...........................................311 

22 Cherry Hill Drive 

Danvers, MA 01923 

Website: www.abiomed.com 

Abiomed, Inc. is a leading provider of breakthrough heart support 

technologies enabling safer revascularization, heart muscle recovery 

and cost-effective patient care. 

Ambry Genetics .......................................227 

15 Argonaut 

Aliso Viejo, CA 92656 

Website: www.ambrygen.com 

Ambry Genetics is a leading provider of diagnostic genetic testing and 

genomic services. We offer patients and clinicians a comprehensive 

test menu, which includes the Clinical Diagnostic Exome and next 

generation sequencing panels for cardiomyopathies, channelopathies, 

Marfan, aneurysm and related disorders. 

American Heart Association .............................119 

7272 Greenville Avenue 

Dallas, TX 75231 

Website: www.heart.org/quality 

The American Heart Association/American Stroke Association offers 

a complete portfolio of quality improvement programs dedicated to 

bettering patient care through guideline adherence. The programs 

address improving quality of patient care for patients of heart disease 

and stroke from primary prevention all the way through outpatient 

care. 

Arbor Pharmaceuticals Inc. .............................319 

980 Hammond Drive 

Suite 1250 

Atlanta, GA 30328 

Arbor Pharmaceuticals, headquartered in Atlanta, Georgia, is 

a specialty pharmaceutical company currently focused on the 

cardiovascular and pediatric markets. The company intends to become 

a leading specialty pharmaceutical company by actively licensing, 

developing and commercializing late-stage products for specialty 

focused conditions. Arbor currently markets multiple NDA and ANDA 

approved products with several more in development. For more 

information regarding Arbor Pharmaceuticals, visit www.arborpharma. 

com or send email inquiries to info@arborpharma.com. 

BG Medicine, Inc ......................................412 

610 N. Lincoln Street 

Waltham, MA 02451 

Website: www.bg-medicine.com 

BG Medicine (NASDAQ:BGMD) is a life sciences company focused 

on the discovery, development, and commercialization of novel 

diagnostics to improve patient outcomes and contain healthcare 

costs. BG Medicine’s galectin-3 blood test identifies patients 

with an inherently progressive form of heart failure resulting from 

fibrogenesis. 

BioScrip, Inc. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 225 

100 Clearbrook Road 

Elmsford, NY 10523 

Website: www.bioscrip.com 

BioScrip is a national specialty home infusion provider that partners 

with patients, physicians, and healthcare payors to provide access 

to medications and management solutions to optimize outcomes 

for chronic and other complex healthcare conditions. For more 

information, please call 402-250-4296 or stop by our exhibit! Bring 

your business card and we will make you a luggage tag! 

BIOTRONIK, Inc. .....................................324 

6024 Jean Road 

Lake Oswego, OR 97035 

Website: www.biotronik.com 

CardiacAssist, Inc .....................................218 

240 Alpha Drive 

Pittsburgh, PA 15238 

Website: www.cardiacassist.com 

CardiacAssist’s TandemHeart system enables both Surgeons and 

Cardiologists to initiate high flow circulatory support in minutes, 

with optimal unloading of the left ventricle. As the most versatile 

extracorporeal circulatory support system available, TandemHeart 

offers multiple configurations to customize support for each individual 

patient’s needs. 

160 

161

Cytokinetics, Inc ......................................105 

280 E Grand Ave 

South San Francisco, CA 94080 

Website: www.cytokinetics.com 

EXHIBITORS 

Cytokinetics is a clinical-stage biopharmaceutical company focused on 

the discovery and development of novel small molecule therapeutics 

that modulate muscle function for the potential treatment of serious 

diseases and medical conditions. Our cardiac muscle contractility 

program is focused on the cardiac sarcomere, the basic unit of muscle 

contraction in the heart. 

EXHIBITORS 

Gambro ..............................................510 

14143 Denver West Parkway, Suite 400 

Lakewood, CO 80401 

Website: www.gambro.com 

Gambro is a global medical technology company with an innovative 

portfolio of products for extracorporeal therapies for Acute and 

Chronic patients. Gambro pioneered Aquapheresis terapy with the 

Aquadex FlexFlowTM system. Aquapheresis is a safe, predictable, and 

effective form of ultrafiltration for patients with fluid overload who 

have failed diuretic therapy 

Daxor Corporation ....................................410 

350 Fifth Avenue 

Suite 7120 

New York, NY 10118 

Website: www.daxor.com 

Daxor Corporation’s BVA-100® Blood Volume Analyzer is a 

semi-automated instrument patented for direct measurement of 

blood volume, red cell and plasma volume. The system utilizes 

the Volumex® injection kit for a multi-sample blood volume. 

Measurement of blood volume is applicable for hypertension, CHF, 

transfusion, ICU/CCU, anemia, orthostatic hypotension and syncope. 

DrFirst, Inc. ..........................................326 

9420 Key West Avenue, Suite 230 

Rockville, MD 20850 

Website: www.drfirst.com 

DrFirst is a Health IT platform company specializing in: e-prescribing, 

medication reconciliation, patient outcomes, secure messaging, 

e-prescribing of controlled substances, and Meaningful Use. 

Elsevier Publishing ....................................603 

1600 JFK Blvd., Suite 1800 

Philadelphia, PA 19103 

Website: www.elsevier.com 

ELSEVIER, proud publisher of the Journal of Cardiac Failure, official 

journal of the HFSA. Come view the latest issue of the Journal and 

browse our books such as the NEW Braunwald’s Textbook of Heart 

Disease, Mann’s Heart Failure Textbook, Heart Failure Clinics, and 

many other new and exciting periodicals and online solutions in the 

field of cardiology. 

Gilead Sciences, Inc .................................... 111 

333 Lakeside Drive 

Foster City, CA 94404 

Website: www.gilead.com 

Gilead Sciences is a biopharmaceutical company that discovers, 

develops and commercializes medicines in areas of unmet need. With 

each new discovery we seek to improve the care of patients suffering 

from life-threatening diseases worldwide. Headquartered in Foster 

City, California, Gilead has operations in North America, Europe, and 

Asia Pacific. 

Gilead Sciences, Inc ...................................210 

333 Lakeside Drive 

Foster City, CA 94404 

Website: www.gilead.com 

Gilead Sciences is a biopharmaceutical company that discovers, 

develops and commercializes medicines in areas of unmet need. With 

each new discovery we seek to improve the care of patients suffering 

from life-threatening diseases worldwide. Headquartered in Foster 

City, California, Gilead has operations in North America, Europe, and 

Asia Pacific. 

Heart Failure Society of America .........................601 

Court International, Suite 240 South 



Website: www.hfsa.org 

The Society welcomes you to our 16th Annual Scientific Meeting. We 

hope you enjoy your stay in Seattle and look forward to seeing you 

at the 17th Annual Scientific Meeting, September 22-25, 2013, The 

Peabody Orlando Hotel Orlando, Florida. Please visit our booth for 

more information about the Society. 

162 

163

HFSA E-mail Retrieval Stations ..........................125 

During exhibit hours, this booth will have computers available for 

attendees to retrieve their e-mail. 

HeartWare, Inc .......................................213 

205 Newbury Street 

Framingham, MA 01701 

Website: www.heartware.com 

HeartWare, Inc. is developing a family of implantable mechanical 

circulatory support systems for the treatment of advanced heart 

failure. HeartWare’s lead device, the HeartWare® Ventricular Assist 

System, incorporates state-of-the-art peripherals and features the 

only full-output pump designed to be implanted less invasively in the 

pericardial space. The HeartWare® System is commercially available 

in Europe and is the subject of a 150-patient US IDE trial. 

Janssen Pharmaceuticals, Inc ............................205 

1000 Route 202 

Raritan, NJ 08869 

Website: www.janssenpharmaceuticalsinc.com 

Janssen Pharmaceuticals, Inc., a pharmaceutical company of Johnson 

& Johnson, provides medicines for an array of health concerns in 

several therapeutic areas, including: attention deficit hyperactivity 

disorder (ADHD), general medicine (acid reflux disease, infectious 

diseases), mental health (bipolar I disorder, schizophrenia), 

neurologics (Alzheimer’s disease, epilepsy, migraine prevention and 

treatment), pain management, cardiovascular, and women’s health. 

LabCorp .............................................216 

531 S. Spring Street, 3rd Floor 

Burlington, NC 27523 

EXHIBITORS 

Lippincott Williams & Wilkins/Wolters Kluwer Health .......608 

Two Commerce Square 

2001 Market Street 

Philadelphia, PA 19103 

Website: www.wolterskluwer.com 

Wolters Kluwer Health/Lippincott Williams & Wilkins is proud 

to publish the American Heart Association (AHA) journals. Visit 

us to demo Circulation: Heart Failure for the iPad®, learn about 

the journal’s Mobile View and paper submissions, and pick up 

Circulation: Heart Failure samples. Visit http://circheartfailure. 

ahajournals.org for more information!. 

Medtronic, Inc ........................................505 

710 Medtronic Parkway 

Minneapolis, MN 55432 

Website: www.medtronic.com 

EXHIBITORS 

At Medtronic (www.medtronic.com), we’re committed to Innovating 

for life by pushing the boundaries of medical technology and actually 

changing the way the world treats and manages heart failure. Visit 

booth #505 to see how our newest products and therapies are solving 

unmet needs by diagnosing, monitoring, and treating patients. 

Miller Pharmacal Group, Inc ............................416 

350 Randy Road, Suite 2 

Carol Stream, IL 60188 

Website: www.millerpharmacal.com 

Miller Pharmacal’s ‘MG PLUS PROTEIN’ magnesium supplement 

treats and prevents the hypomagnesemia caused by diuretics (or 

immunosuppressants) without causing the GI disturbances common 

with magnesium oxide. Each easy-to-swallow, glazed, non-enteric 

coated tablet contains 133 mg of elemental magnesium, at a fraction 

of the cose of SLOW-MAG . 

LabCorp provides leading-edge tests and services through a national 

network of primary clinical and specialized laboratories to support 

cardiovascular disease prevention, diagnosis and management. 

Services include traditional and advanced lipids; markers of 

inflammation, acute ischemia and heart failure; genetic tests for 

inherited diseases and conditions; genetic counseling and ambulatory 

electrocardiography. 

164 

165

NeuMeDx ............................................513 

2014 Ford Road, Unit G 

Bristol, PA 19007 

Website: www.neumedx.com 

EXHIBITORS 

NeuMeDx presents the PhysioFlow NICO monitor; beneficial in 

assisting clinicians in optimizing stroke volume, usage for EGDT and 

fluid management. It is noninvasive, user independent and can receive 

data in less than five minutes. Used everywhere from the ER to the 

ICU for the critically ill or in your office! 

EXHIBITORS 

Otsuka America Pharmaceutical, Inc ......................220 

1 University Square Drive Suite 500 

Princeton, NJ 08540 

Website: www.otsuka-us.com 

Otsuka America Pharmaceutical, Inc. (OAPI) is a successful, 

innovative, fast-growing healthcare company that commercializes 

Otsuka-discovered and other product opportunities in North 

America, with a strong focus on and commitment to neuroscience, 

cardiovascular, oncologic, and gastrointestinal therapeutic treatments. 

For additional information, please visit www.otsuka-us.com. 

NxStage Medical ......................................117 

350 Merrimack Street 

Lawrence, MA 01843 

www.nxstage.com 

More than 900,000 hospitalizations annually in the US are due to 

fluid volume overload. While most patients are successfully treated 

with diuretics, nearly one-third fail this therapy. The NxStage System 

One is indicated for the treatment of fluid overload using mechanical 

ultrafiltration. For more information visit our exhibit or www.nxstage. 

com. 

OnTrack to Health .....................................511 

23896 N. Lakeshore Drive 

Glenwood, MN 56334 

Website: www.ontrack2health.com 

OnTrack to Health engages patients with their health regimens through 

an iPhone/iPad application that connects to a patient portal managed 

by your heart failure team. Developed by clinicians at an award 

winning heart and vascular institute, OnTrack addresses both sides of 

the value equation: improved outcomes and reduced cost. 

Oxford University Press ................................609 

2001 Evans Road 

Cary, NC 27513 

Website: www.oup.com 

Oxford University Press publishes some of the most respected medical 

and scientific books and journals in the world, including The ESC 

Textbook of Cardiovascular Medicine and the European Journal 

of Heart Failure, the official international journal of the European 

Society of Cardiology. Visit www.oup.com for more information 

PromptCare Home Infusion .............................322 

51 Terminal Avenue 

Clark, NJ 07066 

Website: www.promptcare.net 

PromptCare offers a program that utilizes an innovative team approach 

in the delivery of IV inotropic therapy and the care of the advanced 

Stage D heart failure patient. 

PromptCare’s Cardiac Transitions Program supports both patients 

awaiting transplant, as well as those with advanced heart failure. 

The goal is to support overall improvement of quality of life, while 

servicing these patients in the home setting. Close clinical monitoring 

will assist the physician in identifying potential triggers that may lead 

to re-hospitalization. 

Otsuka America Pharmaceutical, Inc. . . . . . . . . . . . . . . . . . . . . . 305 

1 University Square Drive Suite 500 

Princeton, NJ 08540 

Website: www.otsuka-us.com 

Otsuka America Pharmaceutical, Inc. (OAPI) is a successful, 

innovative, fast-growing healthcare company that commercializes 

Otsuka-discovered and other product opportunities in North 

America, with a strong focus on and commitment to neuroscience, 

cardiovascular, oncologic, and gastrointestinal therapeutic treatments. 

For additional information, please visit www.otsuka-us.com. 

166 

Response Biomedical Corporation ........................317 

1781 - 75th Avenue West 

Vancouver, BC V6P 6P2 

Canada 

Response Biomedical develops, manufactures and markets rapid point-of-care 

(POC) diagnostic tests for use with its proprietary RAMP® (Rapid Analyte 

Measurement Platform) System for clinical and non-clinical applications. 

RAMP® has set a new performance standard in rapid diagnostic cardiac 

biomarker testing by providing lab quality information in minutes. 

167

St. Jude Medical. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 313 

6300 Bee Cave Road 

Austin, TX 78746 

Website: www.sjm.com 

Author index 

St. Jude Medical develops medical technology designed to put 

more control into the hands of those who treat cardiac, neurological 

and chronic pain patients worldwide. The company is dedicated to 

advancing the practice of medicine by reducing risk wherever possible 

and contributing to successful patient outcomes. Learn more at sjm. 

com. 

Author index 

The Joint Commission ..................................607 

One Renaissance Blvd 

Oakbrook Terrace, IL 60181 

Website: www.jointcommission.org 

The Joint Commission’s advanced certification for heart failure uses 

Get With The Guidelines heart failure measures as the clinical practice 

requirement. Advanced certification for heart failure provides a 

comprehensive evaluation of this patient population. Certification of 

your heart failure program demonstrates excellence in fostering better 

outcomes. 

Shape Medical Systems, Inc .............................610 

5000 Township Parkway 


Website: www.shapemedsystems.com 

Shape Medical Systems provides predictive modeling to improve 

the detection and therapeutic outcome assessment of heart and lung 

disease. Technology assesses cardiopulmonary function, defines the 

probable source of heart or lung limitations, quantifies prognosis, 

predicts future risk, provides recommendations regarding future 

treatment and monitors the ongoing clinical response to therapy. 

Thoratec Corporation ..................................411 

6035 Stoneridge Drive 

Pleasanton, CA 94588 

Website: www.thoratec.com 

Thoratec is a world leader in mechanical circulatory support with the 

broadest product portfolio to treat patients suffering from advanced 

heart failure. The company’s products include the HeartMate LVAS 

and Thoratec VAD, with more than 20,000 devices implanted in 

patients suffering from heart failure. Thoratec also manufactures and 

distributes the CentriMag and PediMag/OeduVAS product lines. 

Sunshine Heart ........................................223 

12988 Valley View Road 

Eden Prairie, MN 55344 

Website: www.sunshineheart.com 

C-Pulse is an extra-aortic balloon pump using counterpulsation 

technology to treat moderate to severe heart failure. It can be 

performed minimally invasively, outside the bloodstream, and the 

patient can disconnect from the system. It is designed to improve heart 

function by increasing cardiac output, increasing coronary perfusion, 

and decreasing afterload. 

SynCardia Systems, Inc .................................316 

1992 E. Silverlake Rd. 

Tucson, AZ 85713 

Website: www.syncardia.com 

The SynCardia temporary Total Artificial Heart (TAH-t) is the world’s 

only FDA, Health Canada and CE approved Total Artificial Heart. It 

is approved as a bridge to transplant for patients dying from end-stage 

biventricular failure. Visit our booth for updates on the Freedom 

portable driver, 50cc TAH-t and destination therapy. 

XDx, Inc. ............................................217 

3260 Bayshore Blvd. 

Brisbane, CA 94005 

Website: www.xdx.com 

XDx is a molecular diagnostics company focused on the discovery, 

development and commercialization of gene expression testing in 

the areas of transplant medicine and autoimmunity. XDx is the 

developer of AlloMap®, a non-invasive boimarker test that aids in the 

management of stable heart transplant patients. 

ZOLL ...............................................312 

121 Gamma Road 

Pittsburgh, PA 15238 

Website: www.zoll.com 

The ZOLL® LifeVest® wearable defibrillator protects patients at risk 

of sudden cardiac arrest, during a patient’s changing condition and 

when permanent SCA risk has not been established. The LifeVest 

provides patients constant monitoring, immediate protection, and 

peace of mind. 

168 169

AUTHOR INDEX 

AUTHOR INDEX 



“P” preceding number indicates a poster 

Aaronson, Keith D. 089 

Abdallah, Wissam 

P327 

Abdulrahman, Morad 

P309 

Abo-Shasha, Rami 

P347 

Abraham, William 

P184, P323 

Abraham, William T. 

039, 113, 149, P043, P065, P160, P194 

Abramson, VaNdana 

P327 

Acker, Michael A. 049, 091, 145 

Adams, Suzanne 

P320 

Adams, Volker 

P108 

Adamson, Philip 

P323 

Adamson, Philip B. 054 

Addetia, Karima 

P303 

Adler, Eric 

P251, P258 

Afshar, Maryam 

P242 

Aggarwal, Ashim 

P120, P141 

Aguel, Felipe 101 

Aguilar, David 057 

Ahmed, Ali 050 

Ahn, MinSoo 

P236 

Ahn, Sylvie A. 

P084, P233, P234 

Ahn, Youngkyun 

P215 

Akashi, Hirokazu 

P100 

Akhtar, Masood 

P178 

Albert, David E. 149 

Albert, Nancy M. 112, 150 

Alberti, Luca 

P182 

Aldeiri, Molham 

P126, P311 

Aleong, Ryan 

P162 

Alharethi, R. 

P124 

Alharethi, Rami 

044, P127 

Alharethi, Rami A. 

P140 

Ali, Omaima 

P250 

Alkhouli, Mohamad 

P309 

Allen, Larry A. 032, 107, 151 

Allsup, Kelly 

P092 

Almond, Christopher S. 

P125, P133 

Alo, Ken 

P188 

Alpers, Charles E. 

096, P069 

Alves, Fernanda D. 

P312 

Alvi, Raza 

P242 

Ambrecht, Eric S. 107 

Ambrosy, Andrew 105, P223, P243, P257, P271, 

P289, P325 

Ameenuddin, Syed 

P044, P205 

An, Qi 

P294 

Anand, Inder 

P254 

Anand, Inder S. 057 

Anania, Frank A. 

P098 

Andersen, Ingrid A. 

P030 

Andersen, Mads J. 

P045 

Andrades, Michael 

P109 

Andrei, Adin-Cristian 

P253 

Andrews, Rebecca 

P354 

Anisimov, Sergey 

P102 

Anker, Stefan D. 

057, 102, P025, P080, P108, P326 

Aonuma, Kazutaka 

P171 

Arabia, Francisco A. 

034, P110 

Aras, Rahul 

P190 

Ardell, Jeffrey L. 

P067 

Arena, Ross 

050, P092 

Armbrecht, Eric 

P295 

Arnold, Malcolm 

P255 

Arnold, Sue 

P200 

Arteaga, Edmundo 

P074 

Asbe, Laura 

P106 

Ashrith, Guha 

P064 

Asif, Aya 

P185, P186, P196, P290, P293, P343 

Asosingh, Kewal 

P095 

Assad-Kottner, Christian 061 

Attig, Stacie M. 

P110 

Augilar, David 

P282 

Averina, Viktoria 

P057, P294 

Averna, Maurizio 

P212 

Avila, Christiane W. 

P348, P350 

Awad, Adiveh 

P089 

Ayyad, Alaeddin 

P356 

Azeem, Ali A. 

P077, P268 

Baas, A. 044 

Babaliaros, Vasilis 

P292 

Bachtel, Carol S. 

P110 

Bader, F. 

P124 

Bader, Feras M. 

P127 

Baek, Sang Hong 

P182, P215 

Bahl, Joseph 

P033, P129 

Bai, Shasha 

P065 

Bailey, Kent R. 

P212 

Bailey, Stephen 

P145 

Bair, Tami 044 

Baker, James 

P177 

Ballard-Hernandez, Jennifer 

P251, P258 

Balling, Kyle 044 

Balling, Kyle D. 

P140 

170 171

AUTHOR INDEX 

AUTHOR INDEX 

Balling, Louise 

P201 

Bangdiwala, Shrikant I. 

P234 

Barbagelata, N.A. 

P331 

Barbone, Alessandro 

P119, P134, P136 

Barbulescu, Alexandru 

P098, P105 

Bardy, Gust H. 149 

Barg, Frances 

P117 

Barnard, Denise D. 032 

Barretto, Antonio P. 

P041, P197 

Barry, Marybeth 

P354 

Bart, Bradley 

P043 

Barten, Markus J. 

P135 

Bartone, Cheryl 

P306, P328 

Bastardi, Heather 

P125 

Battiprolu, Pavan 

P101 

Bauernschmitt, Robert 

P187 

Baumann, Matthew T. 

P042 

Baumgarten, Anna 

P108 

Beadle, John 

P025 

Beck Freitag, Tasha 

P307 

Beggs, Virginia L. 

P301 

Begin, Sylvie 

P224 

Belardinelli, Romualdo 

P182 

Bella, Jonathan 

P242, P266 

Bellavia, Diego 

P050 

Benard, Ludovic 

P097 

Benbarkat, Hanne 

P303 

Bender, Miriam 

P277 

Benish, Lynne 

P152 

Bennett, Mosi K. 

P307, P349 

Bennett-Gittens, Raquel 

P318 

Benza, Raymond 

P323 

Benza, Raymond L. 

P145 

Berger, Ronald D. 

P180 

Bergmann, Andreas 

P326 

Berkowitz, Robert 

P353 

Bers, Donald M. 095 

Bersohn, Malcolm 

P184 

Bethea, Brian 

P115, P150 

Betts, Tim 

P156 

Bhalla, Vikas 

P229 

Bhalodkar, Narendra 

107, P242, P266 

Bhandari, Manoj 

P242 

Bhargava, Prateek 

P198 

Bhat, Geetha 

P120, P141 

Bhatia, Atul 

P163 

Bhatt, Deepak L. 

P237, P260 

Bhatt, Digant V. 

P324 

Bhimaraj, Arvind 061, P027, P126, P146, P188, 

P228, P329 

Biddle, Martha J. 096 

Bidwell, Julie T. 

P245 

Biffi, Mauro 

P167 

Biolo, Andreia 

P109, P312 

Birnie, David 

P171 

Blackburn, S. 

P270 

Blackstone, Eugene H. 

P123 

Blanco, R. 

P166 

Blank, Lenore J. 095 

Blaxall, Burns C. 055, 095 

Blondheim, David 

P185, P186, P196, P290, P293, P343 

Bloom, H. L. 

P166 

Bocirnea, Cristina 

P211 

Boddicker, Kimberly 

P287 

Boehmer, John 

048, P057, P294 

Boehmer, John P. 

037, P020 

Boerrigter, Guido 

P030, P050, P079, P083, P198, P204 

Boesgaard, Soren 

P045 

Boilson, Barry A. 

P202 

Bolger, Ann 045 

Bolling, Steven F. 088 

Bolwell, Gregory J. 

P059 

Bondar, Galyna 

P100 

Bonow, Robert O. 088 

Bordachar, Pierre 

P156 

Borer, Jeffrey S. 103 

Borger, Michael A. 

P135 

Borlaug, Barry A. 

P045 

Borowski, Alan G. 

P219 

Borowski, Allen G. 

P028, P029, P035, P036, P056, P086 

Bourge, Robert 

P323 

Bourge, Robert C. 149 

Bourn, David 

P043 

Boyce, Steven W. 036 

Boyle, Andrew 

P160 

Bozkurt, Biykem 

057, 093, 151, P282 

Bradley, Mark 

P131 

Brancalhao, Euler O. 

P041, P197 

Braunwald, Eugene 149 

Brisco, Meredith A. 

105, P046, P121, P122, P230 

Bristow, Michael R. 

055, 113, P107, P162 

Broberg, Craig S. 

P072 

Bro-Jeppesen, John 

P045 

Bronsteen, Kyle 

096, P147 

Brooke, Kelly L. 

P168, P175 

Brown, Jennifer R. 

047, P199 

Brown, Jeremiah R. 

P301 

172 173

AUTHOR INDEX 

AUTHOR INDEX 

Bruckner, Brian A. 

P126, P146 

Brunisholz, K. 

P124 

Brunisholz, Kim 044 

Brunisholz, Kimberley 

P127 

Brunisholz, Kimberly D. 

P140 

Bubenek, Serban 

P223, P243, P257, P271, P289, P325 

Buber, Yoni 

P175 

Buck, Harleah G. 

049, P245 

Budge, D. 

P124 

Budge, Deborah 

044, P127, P140 

Bui, Anh L. 

P237 

Burke, Martin C 037 

Burkhoff, Daniel 

043, 095, 149, P119, P134, P136 

Burnett, John 

P168 

Burnett, John C. 

047, 053, P019, P198, P204, P206 

Burnett, Jr, John C. 053, P030, P050, P066, P076, 

P079, P083, P205, P212 

Butler, Javed 040, 056, 096, 108, P077, 

P229, P268, P318 

Butler, Kenneth R. 

P209 

Butterfield, John 

P288 

Buttrick, Peter 113 

Cabrera, Antonio G. 

P298 

Cadeiras, Martin 

P100 

Cain, Van A. 

P217 

Caine, William 

P140 

Caldwell, James H. 045 

Call, Claire F. 

P322 

Call, Robert 

P172 

Calo, Leonardo 

P167 

Calori, Giliola 

P182 

Cannone, Valentina 

P019, P212 

Canossa-Terris, Maria A. 

P079 

Canteli-Alvarez, Angela 

P247 

Cappola, Thomas P. 058 

Carabello, Blasé A. 103 

Cardoso, Juliano N. 

P041, P197 

Carlson, Michelle D. 

P304 

Carroll, John D. 088 

Carroll, Lindsey J. 

P138 

Carson, Peter E. 056, 148 

Carvalho, Eduardo E.V. 

P047 

Carvalho, Eduardo V. 

P321 

Cary, DeAnn S. 

P277 

Casazza, Danielle 

P149 

Casey, Jr., Donald E. 112 

Cassan, Denise 

P224 

Castagno, Davide 

P209, P252 

Castrillo, Cristina 

P247 

Cataliotti, Alessandro 

096, P030, P050, P083, P204, P206 

Cauthen, Clay A. 

P256, P269, P285 

Cavera, Giovanni 

P212 

Cefalu’, Angelo Baldassare 

P212 

Ceridon, Maile L. 

P024 

Cha, Bong Soo 

P051 

Cha, Yong-Mei 

P157, P168, P175, P176 

Chaanine, Antoine H. 

047, P097 

Chacko, Simi M. 

P132 

Chae, Shung Chull 

P215 

Chakravarti, Paula 

P263 

Chambers, Susan 096 

Chamogeorgakis, Themistokles P148 

Champion, Hunter 

P340 

Chan, Jeffrey 

047, P288 

Chan, Wenyaw 

P282 

Chandra, Ramesh 

P280 

Chang, Nou 

P137 

Charlton, Sandra B. 

P332 

Charoenpong, Prangthip 

P040, P143, P144 

Chebib, Fouad 

P314 

Chedda, Jason J. 

P266 

Chen, Horng 

094, P168 

Chen, Horng H. 

094, 053, P044, P058, P205, P206 

Chen, Ren 

P226 

Cheng, Lihong 

P098, P105 

Cheng, R. 044 

Cheng, Richard K. 

P100 

Chew, Eric 

P078 

Chibnall, John 

P295 

Chillcott, Suzanne 036 

Chin, John 151 

Chiodo, III, Joseph 

P305 

Chioncel, Ovidiu 

P271, P289, P325 

Chiong, Jun R. 

P305 

Chiswell, K. 

P246 

Chiu, Michael 

P224 

Cho, Hyun-Jai 

P215 

Cho, Jae 

P324 

Cho, Myeong-Chan 

P215 

Choe, KyungHoon 

P236 

Choi, Dong-Ju 

P215 

Choi, Jin Oh 

P215 

Choi, Jin-Oh 

P039, P081 

Choksy, Pratik 

P032 

Choudhary, Rajiv 

P326, P339, P356 

Choudhuri, Indrajit 

P163, P178 

Chow, Sheryl L. 

P078 

Christensen, Dawn M. 036 

174 175

AUTHOR INDEX 

AUTHOR INDEX 

Christian, Norma 

P280 

Chung, Eugene S. 

151, P306, P328 

Chung, Misook L. 

096, P231, P267 

Chyu, Jennifer 

047, P222 

Claggett, Brian 

P181 

Clark, Adrienne L. 

P281 

Clark, Margaret A. 

P272 

Clark, Rachael 

P152 

Clark, Robyn A. 

P291 

Clausell, Nadine 

P109, P312 

Cleland, J. 

P246 

Cleland, John G.F. 043, 057, 107, 148 

Clemens, Ruth 

P190 

Clermont, Edward 

P292 

Clopton, Paul 

P302, P326, P339, P356 

Clyne, Christopher 

P173 

Coats, Andrew J.S. 

P025 

Coca, Steve 

P046, P121, P122, P230 

Cockrill, Barbara A. 103 

Codoiu, Ionela 

P223, P243, P257 

Cody, Robert J. 093 

Coffee, Neil 

P291 

Cohen, Carolina 

P109 

Cohn, Jay N. 041, 043, 053, 107 

Cojocaru, Manole 

P218 

Cole, Robert T. 

P229, P318 

Coles, James 

P172 

Collins, Billy 041 

Collins, Sean 

P253 

Colozzi, Carol 

P265 

Colucci, Wilson S. 

P265 

Colvin-Adams, Monica 

056, P040 

Combellick, Joan L. 

P346 

Cook, Katlyn E. 

P137 

Cooley, Ryan 

P163 

Corbisiero, Raffaele 

P177 

Cordero-Reyes, Andrea M. 

061 P027, P126, P146, P228, P329 

Cosgrove, Christine 

P103 

Costa, Marco A. 

P194 

Costello, Elizabeth C. 

P079, P198, P204 

Costello-Boerrigter, Lisa C. 

P050 

Cotleur, Anne C. 

P111 

Cotter, G. 

P246 

Cotter, Gad 

P192 

Cotts, William 

P190, P278 

Cotts, William G. 032, 107 

Coulas, Sherry 

P224 

Cowger, Jennifer 145 

Cox, Margueritte 

P260 

Crawford, Deborah J. 

P313 

Creaser, J. W. 044 

Crescencio, Julio C. 

P047 

Cress, Elaine 

P238 

Crestanello, Juan 

P132 

Cui, Taixing 061 

Cundrle, Ivan 

P031, P155 

Cunningham, Luke 

P282 

Curtis, Amy B. 

P344 

Curtis, Lesley H. 

P299 

Czarnecka, Danuta 

P043 

Dahal, Khagendra B. 

P314 

Dahan, Iris 

P185, P186, P196, P290, P293, P343 

Dahme, Rebecca 

P178 

Daifallah, Suleiman 

P250 

d’Almeida, Karina S.M. 

P348, P350 

Dandamudi, Sanjay 053 

Daniels, Karla 

P092 

Dardas, Todd 

P159, P254 

DaSilva, Monica 

P327 

Davies, Ross A. 

P224, P347 

Davis, Gordon 

P162 

Davis, Harry 

P032 

Davis, Samuel 

P092 

Davison, B. 

P246 

Davison, Beth 

P192 

Dawoud, Fady 

P180 

Day, Sharlene M. 058 

De Marco, Teresa 033, 090 

Deedwania, Prakash C. 114 

del Rio, Carlos L. 

P200 

Delaney, Colleen 050 

Dell’Italia, Louis 004 

Dellsperger, Kevin C. 

P061 

DeMoor, Carl 

P263 

Denfeld, Quin E. 

P245 

Denfield, Susan W. 

P298 

Deng, M. 044 

Deng, Mario C. 

091, P100 

DeNofrio, David 145 

DePasquale, Eugene C. 

P128 

Desai, Akshay 

P181 

Desai, Akshay S. 032, 150 

Deschasaux, C. 

P270 

Deshmukh, Abhishek 

P063 

Deshpande, Abhishek 

P216 

Deswal, Anita 

P282 

Detlef, Wencker 

P173 

DeValeria, Patrick A. 

P110 

176 177

AUTHOR INDEX 

AUTHOR INDEX 

Dhala, Anwer 

P163 

Dhar, Sunil 

P254 

Di Salvo, Thomas G. 

P104 

Diakos, Nikolaos 

P127 

Dickinson, Michael G. 

059, P344 

Dickson, Victoria V. 

P342 

Dieffenbach, Bryan 

P339 

Dittrich, Howard 

P189 

Djelmami-Hani, Mohamed 

P163 

Dmitrieva, Renata 

P102 

Doehner, Wolfram 

P080 

Doering, Lynn V. 096 

Domingo, Grace R. 

P342 

Don, Creighton 

P106 

Donaho, Erin K. 

P352 

Dostal, David E. 061 

Doty, John 044 

Downing, Jill 

P265 

Doyle, Frank 

P341 

Dracup, Kathleen 

P308, P317 

Dracup, Kathleen A. 043 

Drakos, Stavros G. 

P127 

Drazner, Mark H. 032 

Dreyer, William J. 

P298 

Dries, Daniel L. 032 

Ducharme, Anique 059 

Dudley, S. C. 

P166 

Dudley, Jr, Samuel C. 

P018 

Dumitru, Ioana 

P239 

Dunbar, Sandra 

P238 

Dunbar, Sandra B. 

P268 

Duncan, Pamela 

P320 

Dunlap, Mark 

P211 

Dunlap, Mark E. 095 

Dunn, Justin M. 

P307 

Dupont, Matthias P028, P036, P056, P085, P088, 

P089, P225 

Durand, Jean-Bernard 106, 147 

Dzau, Victor J. 046 

Eapen, Zubin J. 

P299 

Ebner, Nicole 

048, P080 

Eckert, Steve 

P272 

Eckman, Peter 

P116 

Eckman, Peter M. 

P143, P144, P304 

Eggebeen, Joel D. 

P320 

Egnaczyk, Gregory F. 

P306, P328 

Ehrman, Jonathan K. 

096, P147 

Eisenberg, Mark J. 

P303 

El Hajj, Stephanie C. 

P284 

Elkayam, Uri 147 

Ellis, S. J. 

P203 

Ellis, Stephen 

P159 

Emani, Sitaramesh 

P068, P132, P139, P337 

Engel, Peter 

P328 

Engels, Thomas 

P194 

Ermis, Peter R. 

P118 

Ersboll, Mads 

P045 

Erzurum, Serpil C. 

P095 

Escobedo, Daniel 

P164 

Esquivel, Jill Howie 106, 108 

Essa, Essa M. 

P037 

Estep, Jerry D. 061, P027, P126, P146, P188, 

P228, P329 

Estrella-Holder, Estrellita 

P255 

Evangelista, Lorraine 

108, P251, P258 

Evangelista, Lorraine S. 106 

Everitt, M. 

P124 

Everitt, Melanie 

P130, P140 

Ewald, Gregory A. 

P113, P151 

Ezekowitz, Justin A. 

032, P113, P151 

Ezekowitz, Michael D. 092 

Fang, James C. 054, 098 

Farah, Jareer 

P250 

Farazi, Taraneh 

P156 

Farazi, Taraneh G. 

P067, P188 

Fard, Arrash 

P288 

Farnan, Rory 

P127 

Farr, MaryJane 

P190 

Fatica, Richard 

P062 

Fedewa, Michelle 

P163 

Feinberg, Micha 

P175 

Feldman, Arthur M. 104, 109 

Feldman, Marc D. 

P164 

Felker, G. Michael 108 

Fermin, David R. 

P058 

Fernandes, Fabio 

P071, P074 

Fida, Nadia 

P149 

Fields, Anjali V. 

096, P048 

Figueiredo, Alexandre B. 

P321 

Filipescu, Daniela 

P223, P243, P257 

Finegan, Tracy L. 

P351 

Finucan, Michael 

P085, P088, P089, P225 

Fiuzat, M. 

P203, P246 

Fiuzal, Mona 051 

Fleg, J. L. 

P203 

Floeter, Abby E. 

P357 

Floras, John S. 039 

Flores-Arredondo, Jose H. 061 

178 179

AUTHOR INDEX 

AUTHOR INDEX 

Florian, Anca 

P243, P257 

Foldes, Gabor 

P080 

Fonarow, G. C. 044 

Fonarow, Gregg 

P184 

Fonarow, Gregg C. 040, 056, 112, P237, P260, 

P272, P281, P297, P299 

Fonoff, Adriana M.O. 

P071 

Fonseca, Keila C.B. 

P071, P074 

Foon, Jessica 

P332 

Force, Thomas 041, 146 

Forfia, Paul R. 033, 091, 096, 110, P021, 

P048, P055 

Forman, Daniel E. 

054, P092 

Foster, Donald M. 061 

Fowler, Michael B. 

P026 

Fox, Ervin 

P209 

Fragasso, Gabriele 

P182 

Frampton, Stacey D. 

P140 

Francis, Gary S. 047, 098 

Frangoul, Haydar 

P227 

Franklin, Wayne J. 

P118 

Frantz, Robert P. 090, 110 

Frazier, O. H. 

P118 

Frazier, Susan K. 

P259, P267 

Frech-Tamas, Feride 

P263 

Freehardt, Darla 

P327 

French, Jessica A. 

P042, P112 

Friderici, Jennifer 053 

Friedman, David 

P104 

Friedman, Paul 

P168 

Friedman, Paul A. 

P175 

From, Aaron M. 053 

Fujise, Ken 

P331 

Fynn-Thompson, Francis 

P133 

Gabi, Alaa 

P225 

Gadiraju, Taraka V. 053 

Gallagher, Jonathan 

P341 

Gallo-Junior, Lourenco 

P047 

Galvao, Marie 148 

Galvin, Catherine 

P280 

Ganga, Harsha V. 

P214 

Garbade, Jens 

P135 

Garcia-Morales, Luis J. 

P228 

Gary, Rebecca 

P238 

Gaskin, Laura 

P355 

Gass, Jennifer A. 

P352 

Gauthier, Diane F. 

P265 

Gauvreau, Kimberlee 

P125 

Geisberg, Carrie 

P327 

Geisberg, Carrie A. 

P227 

Gelow, Jill M. 

P245 

Genth-Zotz, Sabine 

P080 

Gentil, Jaqueline R.S. 

P315 

Gentile, Kevin M. 

P052 

George, M. Patricia 

P213 

Georgiopoulou, Vasiliki 

P077, P229, P268, P318 

Georgopoulos, Lynne 

P200 

Gepstein, Lior 046 

Germany, Robin 

P169 

Gertz, Zachary M. 

096, P021, P055 

Geske, Jennifer R. 

P202 

Ghali, Jalal K. 

151, P250 

Ghalib, Hussam H. 

P232 

Gheorghiade, Mihai 101, 107, P223, P243, P253, 

P257, P271, P289, P325 

Gholami, Parisa 

P355 

Ghosh, Subham 

P180 

Giamouzis, Gregory 

P077 

Gilbert, E. 

P124 

Gilbert, Edward M. 

147, P107, P127 

Gillberg, Jeffrey 

P180 

Gilotra, Nisha A. 

P307 

Giri, Shivraman 

P068 

Givertz, M. 

P246 

Givertz, Michael M. 036, 049 

Glaser, Dale 

P277 

Glikson, Michael 

P167, P175 

Gluck, Jason 

P173 

Goddard, Mark 044 

Goetz, Thomas 041 

Goh, Lay Hong 

P358 

Gold, Michael R. 037 

Goldberg, D. J. 

P235 

Golden, Honey B. 061 

Goldhaber, Joshua I. 095 

Goldman, Steven 

109, P033, P129 

Goldraich, Livia 

P109 

Goldsmith, Steven R. 032, 150 

Goldstein, Daniel J. 

P149 

Gong, Nan 

P096 

Gonzalez-Stawinski, Gonzalo V. P148 

Gonzalez-Stawinski, Gonzo 

P115 

Goodlin, Sarah 

P296 

Goodlin, Sarah J. 145 

Gopalan, Radha S. 

P110 

Gorcsan, John 

P184 

Gordon, Ronald E. 

P097 

Gorodeski, Eiran Z. 

P349 

180 181

AUTHOR INDEX 

AUTHOR INDEX 

Gottlieb, Daniel J. 039 

Gottlieb, Stephen S. 

043, 055, P087, P199, P300 

Gowen, Maxine 

P191 

Gradus-Pizlo, Irmina 

P154 

Grady, Kathy 

P278 

Granger, Christopher B. 

P252 

Grau-Sepulveda, Maria V. 

P237 

Greenberg, Barry 

P189 

Greenberg, Barry H. 

036, 043, 051, 053, 089, P272 

Greener, Ian 

P018 

Greenhut, Saul 

P169 

Greiner, Melissa A. 

P299 

Grimsley, Brad 

P153 

Gropler, Robert J. 100 

Grossman, Elizabeth F. 

P059 

Grupper, Avishay 

P175 

Gruson, Damien 

P084, P233 

Gu, Lianzhi 

P018 

Guccione, Julius 096 

Guglin, Maya 

105, P226 

Guild, Camille 

P295 

Gumina, Richard J. 

P037 

Gupta, Ankit 

P120, P141 

Gupta, Deepak K. 

P209, P252 

Gupta, Dipti 

P064 

Gupta, Divya 

P229, P318 

Gupta, Manish 

P184 

Gupta, Nandita C. 

P072 

Gupte, Anisha 

P027 

Gustaffson, Finn 

P045 

Gustafsson, Finn 

P201 

Gutiu, Ioan A. 

P218 

Gutiu, Laurentiu I. 

P218 

Gutleben, Klaus-Juergen 

P156 

Gutmann, R. 

P166 

Haas, Garrie 

P139, P337 

Haddad, Haissam 

P224 

Haddad, Haissam A. 

P347 

Hadi, M. Azam 

P154 

Haft, Jacob I. 

P316 

Haglund, Nicholas 

P239 

Hajjar, Roger J. 

P097 

Halilovic, Jasmina 

P184 

Hall, Andrea C. 

P352 

Hall, Shelley 

P115, P150, P153 

Halley, Carmel M. 

P219 

Halushka, Marc K. 

P307 

Hamilton, Dale J. 

P027 

Hamilton, Michele A. 099 

Hamlin, Robert L. 

P200 

Hamman, Baron 

P153 

Hammond, M. 

P124 

Hammond, M. Elizabeth 

P130 

Han, Seong Woo 

P338 

Hanmer, Janel 

P064 

Harbert, Nicole 

P177 

Hardaway, Brian 

P115, P150, P153 

Harders, Gerald E. 

P019 

Hardin Pierce, Melanie 

P259 

Harkness, Karen 

048, P210 

Harper, Ronald M. 

P297 

Harper, Yenal 

P095, P219, P225 

Harrington, Colleen M. 

P307 

Harrison, T. 044 

Harshfield, Gregory 

P032 

Hartmann, Oliver 

P326 

Hartwig, Marita 

P322 

Harty, Gail 

P030, P050 

Hasan, Ayesha 

P043 

Hassager, Christian 

P045 

Hatano, Masaru 

P273 

Hatlestad, John 

048, P020 

Hauptman, Paul J. 

038, 048, 114, P295, P305 

Hawwa, Nael 

P062 

Hayes, Christopher 

P163 

Hayes, Kevin 

P063 

Hazen, Stanley 

P090, P283 

Hazen, Stanley L. 

P053, P086, P089, P225 

Heckman, George 

P210 

Heidenreich, Paul 

P355 

Helmke, Steve 

P335 

Helterline, Deri 

P082, P106 

Heltne, Carl 

P287 

Henderson, Rebecca 

P117 

Hernandez, Adrian F. 

055, P237, P260, P299 

Hernandez, Adrian V. 

P216 

Hernandez, Salvador 

P351 

Herrmann, Howard C. 

P055 

Hershberger, Ray E. 058 

Hetzer, Roland 

P108 

Heublein, Denise M. 

053, P019 

Heverin, Mark 

P341 

Hewston, Leigh Ann 

P320 

Heywood, J. Thomas 

095, P078 

Heywood, Thomas 

P317 

Hibino, Takeshi 

P264 

Hickey, A. 044 

Higgins, Melinda 

P238 

182 183

AUTHOR INDEX 

AUTHOR INDEX 

Higgins, Robert 

P132, P139 

Icenogle, Timothy B. 036 

Hill, Joseph 

P101 

Ichiki, Tomoko 

053, P066, P206 

Hill, Michael A. 

P061 

Ignaszewski, Andrew 

P255 

Hinson, Andy 

096, P187 

Ikeda, Yasuhiro 096 

Hodge, David O. 

P157, P168, P175 

Ilsar, Itamar 

P207 

Hoercher, Katherine J. 094 

Inaba, Toshiro 

P273 

Hollander, Judd 

P253 

Inagaki, Naohiko 

P264 

Homma, Shunichi 043 

Iqbal, Navaid 

P288 

Hong, Namki 

P060, P310 

Iqbal, Naveed S. 

P090, P283 

Hong, Sung-Jin 

P060 

Iskandar, Aline 

P354 

Hoopes, Charles W. 

P131 

Iskander, Aline 

P330 

Horibe, Hideki 

P264 

Isobe, Mitsuaki 

P249 

Horne, Benjamin D. 

P140 

Jaber, Bertrand 

P314 

Horstmanshof, Douglas A. 

P158 

Jabuonski, Thiago 

P091, P208 

Horswell, Ronald 

P286, P345 

Jacoby, Daniel L. 

106, P128 

Horton, J. 

P246 

Jahangir, Arshad 

P178 

Horvath, Gary 061 

Jaligam, Vijayendra 

P286 

Horwich, Tamara B. 

145, P222, P281 

Jaligam, Vijayendra R. 

P284 

Horwitz, Leora I. 059 

James, Jeanne 

P096 

Host, Jennifer 

P337 

Jang, Hye Ryoun 

P039 

Houmsse, Mahmoud 

P171 

Jankowska, Ewa 

P080 

Houser, Steven R. 035, 041, 057 

Jansujwicz, Alan 108 

Howell, E. 044 

Januzzi, James 

P032 

Howlett, Jonathan 

P255 

Jaroszewski, Dawn E. 

P110 

Howlett, Jonathan G. 150 

Jaski, Brian E. 

P277 

Hozayen, Sameh 

P116 

Jeewa, Aamir 

P298 

Hsich, Eileen 

047, P123 

Jenkins, Matthew 

P152 

Hsueh, Willa 

P027 

Jennison, Stephen 

P322 

Huang, Pei-Hsiu 

P113 

Jeon, Eun-Seok 

P039, P081, P215 

Huang, Tsuey-Yuan 

044, P244, P274, P275 

Jeong, Euy-Myoung 

104, P018 

Huang, Ying 

P053 

Jerome, Scott D. 

P087 

Huby, Anne-Cecile 

P096 

Jessup, Mariell 

112, P121, P122 

Hudkins, Kelly 

096, P069 

Jessup, Mariell L. 089 

Huie, N. 044 

Jiang, Nan 

P101 

Huiskes, Bonita 

P317 

Jiao, Zhe 

P098, P099, P105 

Hull, Sarah 

P117 

John, Ranjit 

036, P116, P143, P144 

Hummel, Scott L. 

P232, P276 

Johnson, Bruce D. 

P024, P031, P155, P176 

Humphrey, L. 

P270 

Johnston, Michael 

P239 

Hunt, Sharon A. 091, 151 

Jong, Philip 

P234 

Hunter, Claire 059 

Joseph, Jacob 

147, P092 

Huntley, Brenda K. 

053, P019, P083 

Joseph, Susan 

P151 

Husaini, Baqar A. 

P217 

Juneman, Elizabeth 

P033, P129 

Hussain, Syed 

P170 

Jung, Chang Hee 

P038, P051 

Hussein, Syed 

P073 

Jung, Lae Young 

P319 

Hwang, Boyoung 

P308 

Jurgens, Corrine Y. 050, 094 

Hwang, Jenie 

P038 

Kaan, Annemarie 

036, P255 

Hwang, Kyung-Kook 

P215 

Kacet, Salem 

P156 

Hwang, Shiow-Li 

044, P244, P274, P275 

Kadish, Alan 

P184 

Ianni, Barbara M. 

P074 

Kalogeropoulos, Andreas 

P077, P229, P268, P318 

184 185

AUTHOR INDEX 

AUTHOR INDEX 

Kamimura, Daisuke 

P070 

Kim, Jae-Joong 

P093, P215 

Kamouh, Abdallah 

P116 

Kim, JangYoung 

P236 

Kaneko, Tetsuji 

P070 

Kim, Jinkyu 096, 069 

Kaneshige, Alan M. 

P313 

Kim, Kihyun 

P039 

Kang, Seok-Min 

P060, P182, P215, P310 

Kim, Min-Seok 

P093, P215 

Kang, Youjeong 044 

Kim, Seok-Jin 

P039 

Kanwar, Manreet 

P145 

Kim, Won Ho 

P319 

Kao, David 

P162 

Kimmel, Stephen 

P046, P121, P122, P230 

Kao, David P. 

P107 

Kimura, Kazuo 

P070 

Kapoor, Saurabh 

P353 

Kinugawa, Koichiro 

P273 

Kapuku, Gaston 

P032 

Kirkpatrick, James 

048, P117 

Kasper, Diane L. 

P110 

Kirkpatrick, James N. 050, 094 

Kattel, Sharma 

P049 

Kittleson, Michelle M. 032 

Katz, Stuart 

P346 

Kitzman, D. W. 

P203 

Katz, Stuart D. 

093, P342 

Kitzman, Dalane W. 

P209, P320 

Kaufman, B. D. 

P235 

Kjargaard, Jesper 

P045 

Kazatsker, Mark 

P185, P186, P196, P290, P293, P343 

Klaskala, Winslow 

P299 

Keel, Allen 

P156 

Klein, Allan L. 

P035, P036, P056, P086 

Keel, Allen J. 

P067 

Klepach, Doron 096 

Kehl, Devin 

P302 

Ko, Jae Ki 

P319 

Kehl, Devin W. 

P339 

Kobashigawa, Jon A. 145 

Kelesidis, Iosif 

P075 

Kober, Lars 

P045, P201 

Kellom, Katherine 

P117 

Koch, Gary 

P192 

Kerrigan, Dennis J. 

096, P147 

Koch, Walter J. 055, 061, 095 

Ketelslegers, Jean-Marie 

P233 

Kocheril, Abraham 

P324 

Keteyian, S. J. 

P203 

Koehler, Jodi 

P160 

Keteyian, Steven J. 

096, P147 

Koelling, Todd M. 

P232, P276 

Keu, Khun V. 

P026 

Kohlbrenner, Erik 

P097 

Key, Kemisha 053 

Kong, Yongli 

P101 

Kfoury, A.G. 

P124 

Kono, Alan T. 

P301 

Kfoury, Abdallah 

P130 

Konstam, Marvin 

P240 

Kfoury, Abdallah G. 

044, P127, P140 

Konstam, Marvin A. 038, 045, 089, 111 

Khalife, Wissam 

P073, P170, P311 

Kop, Willem J. 

P087 

Khalil, Nashwa 

P188 

Kormos, Robert L. 036, 043, 103 

Khan, Adnan 

P073, P170 

Kovach, Chistopher 

P219 

Khan, Usman 

P266 

Kovach, Cynthia 

P089 

Khanfar, Anas 

P311 

Kovach, Tracy 

P219 

Khuchua, Zaza 

P096 

Kowalsky, Markus 

P180 

Kiffer, Jerome 

P059 

Kramer, Daniel 

P240 

Kikta, Donald 

P139, P337 

Kramer, Kristen 

P096 

Kilic, Ahmet 

P132 

Kranig, Wolfgang 

P156 

Kim, Bernard 

P353 

Kraus, W. E. 

P203 

Kim, Byoung-Joon 

P039 

Kremers, Walter K. 

P202 

Kim, Chul-Ho 

P176 

Krim, Nassim R. 

P260 

Kim, E-Sik 

P319 

Krim, Selim R. 

P260 

Kim, Eung Ju 

P338 

Kuiper, Johannes 

P115, P150, P153 

Kim, Gleb 

P262 

Kumar, Rajesh 

P297 

Kim, Hee-Jin 

P039 

Kumar, Sanjay 

P142 

Kim, Hyun Min 

P051 

Kupfer, Stuart 101 

186 187

AUTHOR INDEX 

AUTHOR INDEX 

Kurlansky, Paul A. 

P079 

Kwon, Caroline 

P241 

Lacomis, Christopher D. 

P213 

Lakdawala, Neal 032, 106 

Lam, Wilson 

P118 

Lampert, Brent C. 

P340 

Lampert, Rachel J. 050 

Lancaster, Jordan 

P129 

Lancaster, Jordan J. 

P033 

Landzberg, Michael 033 

Lanfear, David E. 

049, 055, P023 

Langlois, Elizabeth 

P345 

Lanza, Louis A. 

P110 

Lapp, Harald 

P204 

Laramee, Ann S. 106 

Lardin, Harvey 

P018 

Lardo, Albert 

P180 

Lark, Michael W. 

P191 

Larsen, Greg C. 

P357 

Larson, Erik R. 

P164 

Latif, Farhana 

P100 

Lazzari, Antonio 

P092 

Lazzarini, V. 

P246 

Lebedev, Dmitriy S. 

P034 

Leblanc, Marie-Helene 

P255 

Lecker, Stewart 

P092 

Leclercq, Christophe 

P156 

Lee, Byung-Wan 

P051 

Lee, Candace 

P083 

Lee, Christopher S. 

113, P245, P279 

Lee, Daniel 045 

Lee, Ga Yeon 

P039 

Lee, Hae-Young 

P215 

Lee, Hyun Chul 

P051 

Lee, Ki-Up 

P038 

Lee, Kyoung Suk 044 

Lee, Lik Chuan 096 

Lee, Mirae 

P081 

Lee, Randall 096 

Lee, Randall J. 

P187 

Lee, Sang Eun 

P215 

Lee, SeungHwan 

P236 

Lee, Soo-Youn 

P039 

Lee, Sun Hwa 

P319 

Lee, William 

P052 

Lee, Woo Je 

P038 

Lee, Ying Hsiang 

P168 

Lee, Yong Hsiang 

P175 

LeFrancois, Darlene 

P241 

Lehmann, Sven 

P135 

Leier, Carl V. 

104, 145, P037 

Lemke, Bernd 

P171 

Lenhart, Judith 

P272 

Lenihan, Daniel 

P327 

Lenihan, Daniel J. 090 

Lenneman, Andrew J. 

P227 

Lennie, Terry A. 044, 093, 096, P231, P267, 

P274, P275, P336 

Leopold, Jane A. 110 

Lepoutre, Thibault 

P084, P233 

Leri, Annarosa 046, 109 

Lerman, Amir 

P066 

Leung, Sharon 

P241 

Levin, Vadim 

P169, P172 

Levine, Robert S. 

P217 

Levy, Wayne 

P254 

Levy, Wayne C. 

111, P159, P261 

Levy, Yaniv 

P185, P186, P196, P290, P293, P343 

Lewandowski, E. Douglas 100 

Lewis, Clare 

P341 

Lewis, Eldrin F. 040, 054, 111 

Lewis, Gregory D. 094 

Li, Dean Y. 

P127 

Li, Jia 

P023 

Li, Siying 061 

Li, Song 

P077, P268 

Li, Yanhong 

P159, P261 

Liang, Chang-Seng 

P265 

Liang, Jackson J. 

P202 

Liao, Ronglih 046 

Liao, Solomon 

P251, P258 

Libonati, Joseph R. 146 

Licata, Guiseppe 093 

Light-McGroary, Kelly Ann 091 

Lill, Z. 

047, P124 

Lim, Chee 

P104 

Lim, Soo G. 

P205 

Lima, Brian 

P148 

Lima, Marcelo V. 

P041, P197 

Lima-Filho, Moyses O. 

P047 

Lin, Hongbo 

P154 

Lin, K. Y. 

P235 

Lindenfeld, JoAnn 059, 088 

Linker, David 

P254 

Liu, Peter 

162, P255 

Liu, Peter P. 045, 047 

LIu, Wei 

P331 

Liu, Yuchuan 061 

188 189

AUTHOR INDEX 

AUTHOR INDEX 

Livingston, N. 044 

Loebe, Matthias 

P027, P126, P146, P329 

Loehr, Laura R. 

P209 

Lomardo, Dawn 

P251 

Lombardo, Dawn 

P258 

London, B. 

P166 

Lopez-Mattei, Juan C. 

P126 

Losordo, Douglas W. 046, 109 

Love, Charles 

P177 

Lowes, Brian 

P239 

Lowes, Brian D. 

P107 

Loza, Laurie P. 

P329 

Luria, David 

P175 

Macarie, Cezar 

P223, P243, P257, P271, P289, P325 

MacCarter, Dean 

P176 

Macey, Paul M. 

P297 

Mack, Joan 

P239 

MacKenzie, Gail 

P210 

MacLean, Emma 

P210 

MacLellan, W. R. 044 

MacLellan, W. Robb 045, 061, 100 

MacRae, Calum A. 058 

Mady, Charles 

P071, P074 

Maggioni, Aldo 

P254 

Maguire, L. 

P270 

Mahmud, Asma 

P247 

Mahoney, Douglas W. 053 

Maisel, Alan 

148, P288, P302 

Maisel, Alan S. 

P326, P339, P356 

Maki, Hisataka 

P273 

Malchodi, Laura 

P082 

Malev, Eduard 

P094, P262 

Malhotra, Rajeev 

P247 

Malik, Adnan S. 

P154 

Malik, Shaista 

P251, P258 

Malley, Marnie 

P346 

Malliaras, Konstantinos 061 

Mangi, Abeel 

P152 

Mangi, Abeel A. 

P142 

Mangiafico, Sarah 

096, P030, P044, P050 

Maniar, Sanjay 

P151 

Mann, Douglas L. 040, 095, 113, 146 

Mansoor, G. 

P246 

Mapara, Sulaiman M. 

P216 

Marazzi, Giuseppe 

P182 

Marban, Eduardo 035, 061 

Marchini, Julio S. 

P315 

Marchiori, Gord 

P255 

Margonato, Alberto 

P182 

Margulies, Kenneth B. 058, 113 

Marin-Neto, Jose A. 

P047 

Maroo, Anjli P. 

P089, P219 

Marques, Fabiana 

P315 

Marshall, Jennifer M. 

P087 

Marshall, Joanne 

P300 

Martherus, Ruben 

P096 

Marti, Catherine N. 

P077, P229, P268, P318 

Martin, David 

P177 

Martin, Edward 

P296 

Martin, Fernando L. 

P019 

Martinelli, Nidiane 

P109 

Masoudi, Frederick A. 112 

Masri, S. Carolina 

P040 

Massie, B. 

P246 

Massie, Barry M. 041, 043, 089, 102 

Masterson Creber, Ruth 

P245 

Masterson Creber, Ruth M. 044 

Mata, Divine Ghea B. 

P220 

Mathier, Michael 

P340 

Matschke, Klaus 

P187 

Matsuda, Torahiro 

P098, P105 

Matte, Ursula 

P109 

Matter, Greg 

P153 

Maurer, Mathew S. 

P335 

Mavromatis, Kreton 

P292 

May, Herman 

P101 

Maybaum, Simon 

P052 

Maybaum, Simon W. 102 

Mayer, Ingrid 

P327 

Maysky, Michael 

P314 

Mazurek, Jeremy 

P016 

Mazurek, Jeremy A. 

P075, P091, P208 

McAdam, Brendan 

P341 

McCabe, Aaron 

P167 

McCaleb, Charles 

P266 

McCarthy, Beth 

P068 

McDevitt, John T. 149 

McGee, Edwin 

P278 

McGee, Edwin C. 103 

McGregor, Jessina C. 

P357 

McGrew, Frank A. 

P332 

McHugh, Caroline 

P341 

McKee, Michael G. 

P059 

McKelvie, Robert 

P210 

McKie, Paul M. 

P058, P066, P206 

McMurray, John J.V. 

P252 

McNally, Elizabeth M. 058 

McNamara, Dennis 

P340 

190 191

AUTHOR INDEX 

AUTHOR INDEX 

Means-Powell, Julie 

P327 

Moorman, Alec 

P254 

Mebazaa, Alexander 

P253 

Moraca, Robert 

P145 

Megalla, Sherry 

P266 

Moravec, Christine S. 

P042, P053, P059, P112 

Mehla, Priti 

P330, P354 

Mori, Kento 

P264 

Mehra, Mandeep R. 033, 110, 150 

Morine, Kevin 

P240 

Mehta, Ramila A. 

P079 

Morita, Yukiko 

P070 

Mehta, Sharda 

P020 

Morley, Deborah 

P136 

Meisel, Simcha 

P185, P196, P290, P293, P343 

Morris, Alison M. 

P213 

Mells, Jamie E. 

P098 

Morsy, Mohamed 

P073, P170, P311, P334 

Mendelsohn, Farrell O. 

P190 

Mortada, M. Eyman 

P163 

Menon, Santosh 

P306, P328 

Moser, Debra K. 044, 096, 108, 114, P231, 

Menteer, JonDavid 147 

P267, P275, P308, P336 

Mentz, R. J. 

P203 

Mosley, Thomas H. 

P209 

Mentzer, Gina 

P337 

Motie, Marjan 

P251, P258 

Mentzer, Gina G. 

P068 

Motoki, Hirohiko 

P035 

Merali, Shelina 

P138 

Mott, A. R. 

P235 

Metra, M. 

P246 

Mountis, Maria 

P148 

Meyer, Dan 

P115, P150 

Mozaffarian, Dariush 

P254 

Meyer, Theo E. 150 

Mudd, James O. 

P245 

Meyers, Deborah E. 

P352 

Mudd-Martin, Gia 148 

Meymandi, Sheba K. 

P351 

Mueller, Luke A. 

P137 

Meyns, Bart 

P119, P134, P136 

Mueller, Paul S. 

P137 

Meznarich, Jessica 

P082 

Mulamalla, Roja 

P103 

Michalkiewicz, Dariusz 

P043 

Mulamalla, Roja R. 

P173 

Michel, Caroline 

P303 

Munger, Mark A. 150 

Mielniczuk, Lisa M. 

P224, P347 

Munoz, Gisele 

P351 

Milavitz, Brian S. 

P144 

Murali, Srinivas 

P145 

Miller, Alan B. 059 

Murray, Michael D. 054, 114 

Miller, Chad 

P253 

Murry, Charles E. 035, 046 

Miller, D. 

P124 

Murthy, Sindhoora 

P180 

Miller, Dylan 

P130 

Musham, Chaitanya 

P063 

Miller, Leslie W. 091 

Mutnuri, Sangeeta 

P073, P170 

Mills, Roger M. 

P299 

Na, Jin Oh 

P338 

Min, Ju-Hong 

P039 

Nagaraja, Haikady 

P065 

Minullina, Izida 

P102 

Nagarajan, Vijaiganesh 

P256, P269, P285 

Misselwitz, Frank 101 

Nagpal, Dave 

P148 

Mitchell, William 

P251 

Nair, Sanjeev 

P214 

Mitrea, Paula 

P333 

Naksuk, Niyada 

P040, P143, P144, P174 

Mitrofanova, Lyubov 

P262 

Nalabothu, Poorna 

P073, P170, P334 

Moe, Gordon W. 149 

Nalibuto, Poorna 

P311 

Moffett, Brady S. 

P298 

Nangia, Vikram 

P163 

Mohr, Friedrich-Wilhelm 

P135 

Napoli, Pericle Di 

P182 

Molina, K. 

P124 

Naqvi, Tasneem 

P156 

Molina, Kimberly 

P130 

Narayan, Sanjiv M. 090, 092 

Molkentin, Jeffery D. 035, 109 

Nastari, Luciano 

P074 

Moller, Jacob E. 

P045 

Navaratnam, Prakash 

P263 

Molloy, Marian 

P255 

Neath, Sean-Xavier 

P326 

Monahan, Kristi H. 

P157 

Neilson, Matthew 

P159, P261 

Monasky, Michelle M. 

P018 

Ness, Lanitia L. 

P188 

192 193

AUTHOR INDEX 

AUTHOR INDEX 

Ng, Tien M.H. 051 

Ong, Kai Xin 

P248 

Ngalob, Queenie G. 

P220 

Ono, Kazuomi 

P264 

Niazi, Imran 

P163, P177, P178 

Oommen, Esha 

P309 

Nigro, Sarah J. 

P357 

Ordway, Linda J. 038 

Nikolaidis, Lazaros A. 

P309 

Ornaghi, Diego 

P119, P134 

Nikolic, Serjan 

P194 

Orrego, Carlos M. 

P228 

Nitesh, Sood 

P173 

Ottenberg, Abigale L. 

P137 

Nixon, Jen L. 

P140 

Packer, Douglas L. 

P157 

Nixon, Jennifer L. 044 

Packer, Milton 033, 111, 150 

Noack, Thilo 

P135 

Pagano, Michele 

P212 

Nohria, Anju 106, 146 

Pak, Firooz 

P078 

Nonogi, Hiroshi 

P249 

Palcher, Jeanette 

P287 

Noto, Davide 

P212 

Palus, Sandra 

P025 

Novak, Eric 

P151 

Pampana, Gowd 

P173 

Nowak, Richard 

P253 

Pan, Alan 

P297 

Nsair, A. 044 

Pang, Peter S. 

108, P253 

O’Barr, Stephen A. 

P078 

Pant, Sadip 

P063 

Obeng, Aniwaa 

P266 

Pappas, Pat 

P120, P141 

O’Brien, Kevin D. 

096, P069 

Parekh, Dhaval R. 

P118 

O’Brien, Thomas 

P328 

Park, Chang Gyu 

P338 

O’Brien, Thomas M. 

P306 

Park, Hyun-Young 

P215 

Ochiai, Marcelo E. 

P041, P197 

Park, Joong-Yeol 

P038 

O’Connell, John B. 050 

Park, Myung H. 090, 110 

O’Connor, C. 

P246 

Park, PyoWon 

P081 

O’Connor, C. M. 

P203 

Park, Soon J. 099 

O’Connor, Chris M. 

112, P159 

Parks, Kimberly 

P247 

O’Connor, Christopher M. 

039, P320 

Pastore, Joseph M. 

P190 

Oczkowski, Wieslaw 

P210 

Pastva, Amy 

P320 

O’Donnell, William T. 

P055 

Pasupuleti, Vinay 

P216 

Oehler, Elise 

P050 

Patel, Aalok D. 

P292 

Oehler, Elise A. 

P044 

Patel, Ayan R. 090 

Ogawa, Hideyuki 

P070 

Patel, Bindiya G. 

P018 

Ogunneye, Owolabi 053 

Patel, Harish 

P266 

Oh, Byung-Hee Oh 

P215 

Patel, Jigar 

P052 

Oh, Dong Joo 

P338 

Patel, Mahesh J. 

P320 

Oh, Jae K. 

P081 

Patel, Paryus 

P078 

Oh, Jaewon 

P060, P310 

Patel, Snehal R. 

P052 

Ohte, Nobuyuki 

P264 

Patterson, J. Herbert 

055, P078 

Okwuosa, Ike S. 

P278 

Paul, Sara C. 039, 049, 099 

Oldenburg, Olaf 

P043 

Peacock, Frank 

P253 

Oliva, Melissa 

P125 

Pearce, John A. 

P164 

Oliva, Nancy L. 

P355 

Pearl, Greg 

P153 

Oliveira, Adriana M. 

P074 

Peh, Leticia 

P248 

Oliveira, Luciano F.L. 

P047 

Pencia, Michael 

P194 

Olson, Eric N. 035 

Pencina, Michael 

P192 

Olson, Lyle J. 

P031, P155, P176 

Pender, Niall 

P341 

O’Malley, Kathy A. 

P176 

Penn, Marc S. 

P190 

Omelchenko, Marina 

P262 

Pereira, Naveen L. 

P202 

Onat, Duygu 

P100 

Pessoa, Fernanda G. 

P071, P074 

194 195

AUTHOR INDEX 

AUTHOR INDEX 

Peterson, Eric D. 

P237 

Peterson, Pamela N. 106 

Petty, Michael 

P040 

Petty, Michael G. 036 

Pfannmueller, Bettina 

P135 

Pfeffer, Marc A. 

P252 

Philippides, George J. 146 

Piano, Mariann R. 057, 148 

Pibarot, Philippe 103 

Pickrell, Jeanette 

P154 

Piercy, Gary E. 

P133 

Pimentel, Mauricio 

P109 

Pina, I. L. 

P203 

Piña, Ileana L. 052, 060 

Ping, Peipei 100 

Pintya, Antonio O. 

P321 

Pisarcik, Jessica 

P340 

Pitt, Bertram 

056, 093, P181 

Poetsch, Mareike 

P025 

Pokersnik, Julie A. 

P148 

Poliakova, Liobov 

P300 

Polsani, Venkateshwar R. 

P228 

Ponikowski, P. 

P246 

Ponikowski, Piotr 

102, P043 

Poole, Jeanne E. 091 

Pope, Susan M. 

P322 

Porac, Matthew 

P353 

Porterfield, John E. 

P164 

Portman, Michael A. 100 

Pothineni, Naga Venkata 

P063 

Pouleur, Anne-Catherine 

P084, P233 

Powell, Brian D. 

P175 

Prause, JoAnn 

P251, P258 

Pregla, Reinhold 

P108 

Pressler, Susan J. 044, 054 

Price, Jack F. 

105, P298 

Pritzker, Marc 

P116 

Priztker, Marc 

P040 

Pshepiy, Asiyet 

P094 

Puig, Raphael S. 

P041, P197 

Pumphrey, Dara 

P278 

Punzalan, Felix Eduardo R. 

P220 

Purevjav, Enkhsaikhan 

P096 

Qian, Feng 

P260 

Qin, Qianhong 

P098, P105 

Qualls, Laura G. 

P299 

Quon, Andrew 

P026 

Rabelo, Eneida R. 

P348, P350 

Radojevic, Joseph 

P173 

Radulescu, Dan 

P333 

Radulescu, Flavian S. 

P218 

Rafael, Aldo 

P148 

Raichlin, Eugenia 

P239 

Raina, Amresh 

096, P021, P055, P145 

Raiszadeh, Farbod 

P075 

Rajagopal, Satish K. 

P133 

Rajagopalan, Navin 

P131 

Rajda, Miroslaw 

P255 

Raman, Subha V. 

P068 

Ramani, Ravi 

P340 

Ramasubbu, Kumudha 

P282 

Rame, J. Eduardo 034 

Ramesh, Gupta C. 

P023 

Ramineni, Rajesh 

P334 

Ramires, Felix J.A. 

P071, P074 

Ramnauth, Sahadeo D. 

P335 

Rao, Shaline 

P307 

Rappaport, Dan 

P195 

Ras, Aleksandra 

P103 

Rasmusson, Brad 044 

Rasmusson, Kismet D. 

P140 

Rastogi, Sharad 

P023 

Ratz, David P. 

P232 

Ravi, Yazhini 

P132, P139 

Razaei, RaminP 044 

Razavi, Mehdi 

P172 

Rea, Robert F. 

P031, P155 

Redfield, Margaret M. 

043, 110, P157 

Redfield, Margret M. 053 

Reed, Shelby 

P159 

Reed, Shelby D. 

049, P261 

Reeves, Gordon R. 

P320 

Rega, Filip 

P119, P134, P136 

Rehman, Shuja U. 

P154 

Reid, Bruce 044 

Reid, Bruce B. 

P127, P140 

Renier, Colleen 

P287 

Revelo, P. 

P124 

Revenco, Diana 

P314 

Reyes, Eugenio P. 

P220 

Reynard, Alison K. 

P059 

Reznickova, Nora 

P296 

Rice, Allison 

P037 

Rich, Michael W. 051 

Riegel, Barbara 

044, P279, P346 

Riegel, Barbara J. 041, 043, 114, 151 

Riella, Cristian 

P314 

Ries, Lucas 

P312 

196 197

AUTHOR INDEX 

AUTHOR INDEX 

Rifai, Luay 053 

Saltzberg, Mitchell T. 148 

Riley, Gary I. 

P198 

Samad, Fatima 

P353 

Rinaldi, Aldo 

P156 

Samad, Zahid 

P217 

Ritman, Erik L. 

P066 

Sambelashvili, Alex 

P169, P171, P172 

Rivera, Argelis 

P052 

Samonte, Vim I. 

P220 

Rizzo, Victor 061 

Samuels, Armando L. 

P309 

Roberts, Justin D. 

P048 

Sanchez, Daniel R. 

P351 

Robinson, Shawn W. 

P300 

Sanchez, Luis 

P346 

Rockweiler, Holly 

P167 

Sandberg, Sharon M. 

053, P019, P083 

Rodeheffer, Richard 053 

Sandek, Anja 

P080 

Rodgers, Jo Ellen 051 

Sangaralingham, Jeson S. 

P019 

Rodriguez, Fred H. 

P118 

Sangaralingham, S. Jeson 

053, P066, P206 

Rogers, Joseph G. 034, 089 

Sanosyan, Armen 

P182 

Rohde, Luis E. 

P109, P312 

Sapienza, Michelangelo 

P212 

Rosano, Giuseppe 

101, P182 

Sarkar, Shantanu 

P160 

Rosenbaum, Andrew 

P143 

Sarswat, Nitasha 

P280 

Rosenberg, Paul 146 

Sarwate, Devadatta 

P300 

Rosenberg, Stuart 

P067 

Sasaoka, Taro 

P249 

Rosenberg, Stuart P. 

P188 

Sauer, William 

P162 

Rosenthal, David N. 

P125 

Sauer, William H. 106, 147 

Rossano, J. W. 

P235 

Saulino, Justin 

P265 

Rossignol, Patrick 

P181 

Sauser, Kori 

P253 

Rothberg, Michael 053 

Saval, Matthew A. 

096, P147 

Rotman, Brigitte 

P167 

Sawyer, Douglas 

P327 

Rourke, D. 044 

Sawyer, Douglas B. 

146, P227 

Rousseau, Michel F. 

P084, P233, P234 

Saxon, Leslie A. 037, 057, 149 

Rouy, Didier 

P190 

Scarcipino, Mario 

P089, P219 

Roy, Denis 092 

Schaer, Gary L. 

P190 

Rudy, Jeff 

P189 

Schaefer, Kristen G. 036, 049 

Russell, Stuart D. 

094, P307 

Schafer, Kristen 

P296 

Ryan, Jason 

P330, P354 

Schairer, John R. 

096, P147 

Ryan, Jason W. 108 

Schipper, Judith E. 

P342 

Rychik, J. 

P235 

Schirger, John A. 

P058 

Ryu, Kyu-Hyung 

P215 

Schmitto, Jan 

P119 

Ryu, Kyungmoo 

P156, P178 

Schneeberger, Dana L. 

P059 

Saba, Samir 

P184 

Schocken, Douglas D. 059, 107, 151 

Sabbah, Hani N. 

051, P023, P207 

Schold, Jesse D. 

P123 

Sabri, Abdelkarim 061 

Schomburg, Lutz 

P080 

Saeed, Omar 

P052, P149 

Schooler, Mary 096 

Saha, Sunipa 

P167 

Schou, Morten 

P201 

Sahakyan, Laura 

P182 

Schulman, Kevin 

P159 

Sahay, Anju 

P355 

Schulman, Kevin A. 

P261 

Sahlas, Demetrios J. 

P210 

Schulte, P. J. 

P203 

Sai-Sudhakar, Chittoor 

P139 

Schulze, P. Christian 

P092 

Sai-Sudhakar, Chittoor B. 

P132 

Schuster, Andres 

P054, P111 

Saito, Keiko 

P049 

Schwartz, Alan 

P043 

Saito, Yuji 

P049 

Schwartz, Gary N. 

P301 

Salamon, Jason N. 

104, P016, P075 

Schwartzmann, Pedro V. 

P315, P321 

Salemi, Vera M.C. 

P071, P074 

Scott, Christopher G. 

P066, P079, P212 

198 199

AUTHOR INDEX 

AUTHOR INDEX 

Scott, Laura C. 

P284 

Scott, Robert L. 

P110 

Seeburger, Joerg 

P135 

Selcuk, Adabag 

P174 

Selim, Ahmed M. 

P280 

Selzman, Craig H. 

P127 

Semigran, Marc J. 

052, 060, P247 

Seo, Hong Seog 

P338 

Seo, Suk Min 

P215 

Setoguchi-Iwata, Soko 112 

Shaddy, R. E. 

P235 

Shadman, Ramin 

P159 

Shafii, Alexis 

P148 

Shah, Amil M. 

P209 

Shah, Dipan 

P228 

Shah, Furqan 061 

Shah, Kevin 

P356 

Shah, Nishant R. 

P118 

Shahzad, Khurram 

P100 

Shalaby, Alaa A. 

104, P184 

Shankar, Ravi 

P020 

Shao, Zhili 

P053 

Sharma, Abhishek 

P151 

Sharma, Arjan 101 

Shemin, R. 044 

Shen, Changyu 

P154 

Shenoy, Maithili 

P250 

Shenoy, Maithili H. 

P063 

Sheppard, Richard 

P303 

Sheppard, Robert 

P177 

Sherman, Warren 

P190 

Shigemasa, Tomohiko 

P070 

Shigeta, Toshimasa 

P264 

Shimizu, Makoto 

P070 

Shin, Jooyoung J. 

P052 

Shlyakhto, Eugene 

P102 

Shlyakhto, Eugene V. 

P034 

Shochat, Elena 

P185, P290 

Shochat, Ilia 

P186, P196, P293 

Shochat, Michael 048, P185, P186, P196, P290, 

P293, P343 

Shoemaker, Michael J. 

P344 

Shotan, Avraham 

P185, P186, P196, P290, P293, P343 

Shrestha, Kevin P029, P035, P036, P056, P085, 

P086, P088, P089, P219 

Shukradas, Shweta 

P100 

Silva, Angela R. 

P315 

Silver, Marc A. 049, 053 

Silvestry, Scott C. 

P151 

Simoes, Marcus V. 

P047, P315, P321 

Simon, Andre 

P119 

Simon, Marc 

P340 

Simon, Marc A. 

049, P213 

Simon, Marcus 

P156 

Simonetti, Orlando P. 

P068 

Simpson, Leo 

P118 

Singh, Dhssraj 

P085, P089 

Singh, Dssraj 

P088 

Singh, Harleen 

P357 

Singh, Jagmeet 

P184 

Singh, Jagmeet P. 090, 092 

Singh, Manjeet 

P242 

Singh, Tajinder P. 

P125, P133 

Sisakian, Hamayak 

P182 

Sitnikova, Maria Y. 

P034 

Skillings, Jared L. 148 

Slaughter, Mark S. 034 

Slawsky, Mara 053 

Slosky, David 

P327 

Slusser, Joshua 053 

Small, Roy S. 

P160 

Smart, Frank 

P284, P345 

Smart, Frank W. 

P286 

Smith, Andrew 

P238 

Smith, Cheryl 

096, P147 

Smith, Hildegard 044 

Smith, Kerri A. 

P055 

Smith, Sakima A. 

P065 

Smith, Jr, Sidney C. 

P277 

Smoot, Leslie B. 

P125 

Smusz, Tina 

P296 

Snow, G. 

P124 

Snyder, Eric M. 

P024 

Soergel, David G. 

P191 

Sokos, George 

P145 

Solanki, Pallavi 

P139 

Solaro, R. John 

P018 

Sole, Michael J. 054, 109 

Solomon, Scott D. 

043, P181, P209, P252 

Somers, Virend K. 

P031, P155 

Sonel, Ali 

P184 

Song, Eun Kyeung 

P336 

Sorescu, Dan 

P098, P099, P105 

Souresafil, Omid 

P161, P165 

Souresafil, Parviz 

P165 

Souresrafil, Omid 

P179 

Souresrafil, Parviz 

P179 

Southerland, Marie 

P067 

200 201

AUTHOR INDEX 

AUTHOR INDEX 

Souza, Gabriela C. 

P312, P350 

Spinale, Francis G. 

P037 

Spragg, David 

P180 

Springer, Jochen 

P025, P080, P108 

Squires, Allison 

P346 

Sra, Jasbir 

P163, P178 

Sta Teresa, Antonio 

096, P069 

Stampehl, Mark R. 

P322 

Starling, Randall C. 034, 056, P059, P123, P256, 

P269, P285 

Stasch, Johannes-Peter 

P204 

Statz, Cara 

P103 

Stefan, Mihaela 053 

Stehlik, J. 

P124 

Stehlik, Josef 

049, 145, P127, P140 

Steidley, Eric 

P110 

Stelik, Josef 

P130 

Stempien-Otero, April 

104, P082, P106 

Stevenson, Lynne Warner 034, 037, 041, 110 

Stevenson, William G. 090, 092 

Stewart, Garrick C. 145 

Stewart, Jim 

P292 

Storrow, Alan 

P253 

Stough, Wendy Gattis 056 

Straka, Susan 

P154 

Streuber, Martin 

P119 

Stromberg, A. 

P270 

Stroud, Robert E. 

P037 

Su, Yan Ru 

P104 

Subach, Ruth Ann 

P191 

Suen, Vivian M.M. 

P315 

Sullivan, Mark D. 094 

Sun, Hengrui 

P192 

Sunkara, Bipin 

P023 

Susantitaphong, Paweena 

P314 

Swedberg, Karl 

P252 

Sweeney, Robert 

P057, P294 

Sweet, Wendy E. 

P042, P112 

Sweitzer, Nancy K. 056 

Swetz, Keith M. 

P137 

Synowski, Stephen J. 

P087 

Szymkiewicz, Steven 

P158 

Taghavi, Sharven 

P142, P152 

Taglieri, Domenico M. 

P018 

Takagi, Ken 

P096 

Takeuchi, Madoka 

P209 

Talajic, Mario 092, 099 

Talbott, Darla 

P139 

Tamburino, Corrado 

P050 

Tan, Haiyan 

P054, P111 

Tan, Wei 

P101 

Tanaka, Atsuko 

P098, P105 

Tang, Chen D.M. 

P301 

Tang, W.H. Wilson 149, P028, P029, P035, P036, 

P053, P054, P056, P059, P062, 

P085, P086, P088, P089, P090, 

P095, P111, P216, P219, P225, 

P229, P256, P269, P283, P285 

Tanna, Monique 

P241 

Tatooles, Antone 

P120, P141 

Taub, Pam R. 

P339 

Tavana, Homa 

P026 

Tavares, Miguel 

P253 

Taylor, BreAnn N. 

P298 

Taylor, Bryan J. 

105, P024 

Taylor, David O. 

091, P123 

Taylor, Scott 101 

Taylor, Winna 053 

Teerlink, J. 

P246 

Teerlink, John R. 038, 150 

Teichholz, Louis E. 

P316 

Tereshchenko, Larisa G. 

P180 

Teruya, Sergio 

P335 

Terzic, Andre 035 

Testani, Jeffrey M. 

P046, P121, P122, P230 

Teuteberg, Jeffrey J. 

036, P340 

Thakur, Pramodsingh 

P057, P294 

Thiagarajan, Ravi R. 

P133 

Thohan, Vinay 

P320 

Thomas, Elizabeth 

P281 

Thomas, James D. 

P028, P029 

Thomas, Valorie 

P277 

Thompson, Julie 

P057, P294 

Thomsen, George 044 

Tian, Rong 045, 100 

Tomassoni, Gery 

P177 

Tone, Eva 

P144 

Tonne, Jason M. 096 

Topaz, Maxim 044 

Topkara, Veli K. 

P113, P151 

Torp-Pedersen, Christian 

P201 

Torre-Amione, Guillermo 061, P027, P126, P146, P188, 

P228, P329 

Towbin, Jeffrey 

P096 

Traina, Mahmoud I. 

P351 

Trevino, Alejandro R. 061 

Troughton, Richard W. 

P035, P036, P056, P086 

Trukshina, Maria A. 

P034 

202 203

AUTHOR INDEX 

AUTHOR INDEX 

Trupp, Robin J. 059 

Tsai, Emily J. 061, 110 

Tsai, Ming-Fen 

044, P244, P274, P275 

Tsao, Lana 

P314 

Tschirner, Anika 

P025 

Tschöpe, Carsten 102 

Tseng, Chi-Hong 

P222 

Tsui, Edmund 

P301 

Tuinei, Joe 

P140 

Tukaye, Deepali N. 

P318 

Tuliani, Tushar A. 

P063 

Turer, Aslan 

P101 

Uber, Patricia A. 099, 114 

Uchino, Kazuaki 

P070 

Udelson, James 

P240 

Udelson, James E. 032, 093 

Umemura, Satoshi 

P070 

Vakil, Kairav 

P254 

Valadri, R. 

P166 

Valvano, Jonathan W. 

P164 

Vandenbogaart, E. 044 

VanderPluym, Christina 

P125 

VanderPluym, Christina J. 

P133 

Vangsnes, Eric 

P344 

Vardeny, Orly 

051, 105, P181 

Varghese, Binoy 

P214 

Vasina, Lyubov 

P094 

Vaughan Dickson, Victoria 

044, P346 

Veledar, E. 

P166 

Venkatraman, Subbu S. 

P205 

Ventura, Hector 

P260 

Verbalis, Joseph G. 

038, P272 

Verhaert, David 

P068 

Veritas Steering Committee and Investigators P193 

Vest, R. 

P166 

Viera, Kelly N. 

P041, P197 

Villarraga, Hector R. 

P058 

Viltali, Ettore 

P119 

Vinereanu, Dragos 

P243, P257, P271, P289 

Violin, Jonathan D. 

P191 

Vitale, Cristina 

P182 

Vitali, Ettore 

P136 

Vitlai, Ettore 

P134 

Vivo, Rey P. 

P126, P146, P260 

von Haehling, Stephan 

P080 

Voors, A. 

P246 

Vorovich, Esther 

P046 

Wallery, Jeff 

P200 

Walsh, Mary N. 49, 56 

Wan, Chingping 

P158 

Wang, Mengjun 

P207 

Wang, Qian 061 

Wang, Qiongying 

P018 

Wang, Thomas J. 058 

Wang, Wenjuan 061 

Wang, Yibin 109 

Wang, Zenang 

P086 

Ward, Charisse 

P142 

Wariar, Ramesh 

P294 

Warman, Eduardo N. 

P160 

Watson, Linley E. 061 

Webster, Julie H. 

P138 

Webster, Tracy L. 

P168, P175 

Weiss, Robert 

P064 

Weiss, Robert G. 100 

Wencker, Detlef 

P103 

Weng, Cindy 

P130 

Wessler, Benjamin 

P240 

Westlake, Cheryl A. 056 

Wever-Pinzon, Omar 

P127 

Wheeler, Matthew 107 

Whelan-Schwartz, Joan 

P020 

Whellan, D. J. 

P203 

Whellan, David 

P159 

Whellan, David J. 

P160, P261, P320 

White, Brenda 

P327 

Wick, Linda 

P287 

Wietecha, Tomasz 

096, P069 

Wilkoff, Bruce L. 092, 106 

Williams, Celeste T. 

096, P147 

Wilson, Lynn 

P142, P152 

Wingate, Suzanne J. 089 

Wisniewski, Nicholas 

P100 

Wissam, Khalife 

P334 

Wiste, Heather J. 

P168, P175 

Witte, Russell 

P129 

Witteles, Ronald M. 

104, 151, P026 

Wong, Yee May 

P358 

Woo, Mary A. 

054, P297 

Wood, Malissa 

P247 

Worley, Seth 

P177 

Wu, DongHong 

P181 

Wu, Jia H. 

P157 

Wu, Jia-Rong 096 

Wu, Joseph 046 

Wu, Yuping 

P090, P283 

Xie, Min 

047, P101 

Xie, Yan Yan Sally 

P241 

204 205

AUTHOR INDEX 

Xing, Yifan 061 

Xu, Jia 

P095 

Xue, Yang 

P302 

Yadav, Jay 

P323 

Yajima, Kazuhiro 

P264 

Yajima, Toshitaka 147 

Yamase, Yuichiro 

P264 

Yamashita, Dennis 

P191 

Yamokoski, Todd 

P337 

Yanagida, Roh 

P131 

Yancy, Clyde 

P278 

Yancy, Clyde W. 

089, 112, P237 

Yang, Eric 

P228 

Yang, Han-Mo 

P215 

Yang, Jiangi J. 

P357 

Yao, Atsushi 

P273 

Yaroshinsky, Alex 

P189 

Yeh, Mei-Ling 

044 P244, P274, P275 

Yeh, Steven T. 

P200 

Yeo, Daniel 

P062 

Yeo, Poh Shuan Daniel 

P248, P358 

Yeung, Michael 

P113 

Yokoi, Kiyoshi 

P264 

Yokoyama, Hiroyuki 

P249 

Yonemoto, Naohiro 

P249 

Yoo, ByungSu 

P236 

Yoo, Byung-Su 

P215 

Yoon, Hyun Ah 

P241 

Youker, Keith A. 

061 P027 

Youn, Jong Chan 

P310 

Youn, Jong-Chan 

P060 

Young, James B. 

P059 

Youngblood, Bradley 

P200 

Yu, Hui-Chu 

044, P244, P274, P275 

Yun, Hae Eun 

P319 

Yun, Hong-Jun F. 

P265 

Yusuf, Salim 

P252 

Zafari, M. A. 

P166 

Zakeri, Rosita 

104, P157 

Zalawadiya, Sandip 

P250 

Zannad, Faiez 

P181 

Zaritskey, Andrey 

P102 

Zavin, Alexandra 

P092 

Zemtsovsky, Eduard 

P094, P262 

Zhang, Keife 

P207 

Zhang, Yi 

P057, P294 

Zieroth, Shelley 

P255 

Zile, Michael 

P159 

AUTHOR INDEX 

Zile, Michael R. 

094, P037 

Ziolo, Mark T. 146 

Zmily, Hammam 

P250 

Zolty, Ronald P016, P075, P091, P107, P149, 

P208, P280 

Zsebo, Krisztina 

P189 

Zucker, Mark J. 091 

Zuidema, Mozow Y. 

P061 

206 207

Washington AUTHOR State Convention INDEX Center 

Washington AUTHOR State convention INDEX center 

Second Level 

Third Level 

208 209

Notes 

Notes 

210 211

Notes 

Notes 

212 213

October 2012 

S M T W T F S 

1 2 3 4 5 6 

7 8 9 10 11 12 13 

14 15 16 17 18 19 20 

21 22 23 24 25 26 27 

28 29 30 31 

2012 – 2013 

April 2013 

S M T W T F S 

1 2 3 4 5 6 

7 8 9 10 11 12 13 

14 15 16 17 18 19 20 

21 22 23 24 25 26 27 

28 29 30 

November 2012 

S M T W T F S 

1 2 3 

4 5 6 7 8 9 10 

11 12 13 14 15 16 17 

18 19 20 21 22 23 24 

25 26 27 28 29 30 

December 2012 

S M T W T F S 

1 

2 3 4 5 6 7 8 

9 10 11 12 13 14 15 

16 17 18 19 20 21 22 

23 24 25 26 27 29 29 

30 31 

January 2013 

S M T W T F S 

1 2 3 4 5 

6 7 8 9 10 11 12 

13 14 15 16 17 18 19 

20 21 22 23 24 25 26 

27 28 29 30 31 

February 2013 

S M T W T F S 

1 2 

3 4 5 6 7 8 9 

10 11 12 13 14 15 16 

17 18 19 20 21 22 23 

24 25 26 27 28 

March 2013 

S M T W T F S 

1 2 

3 4 5 6 7 8 9 

10 11 12 13 14 15 16 

17 18 19 20 21 22 23 

24 25 26 27 28 29 30 

31 

Cover Design by Leir Design, Inc. 

May 2013 

S M T W T F S 

1 2 3 4 

5 6 7 8 9 10 11 

12 13 14 15 16 17 18 

19 20 21 22 23 24 25 

26 27 28 29 30 31 

June 2013 

S M T W T F S 

1 

2 3 4 5 6 7 8 

9 10 11 12 13 14 15 

16 17 18 19 20 21 22 

23 24 25 26 27 28 29 

30 

July 2013 

S M T W T F S 

1 2 3 4 5 6 

7 8 9 10 11 12 13 

14 15 16 17 18 19 20 

21 22 23 24 25 26 27 

28 29 30 31 

August 2013 

S M T W T F S 

1 2 3 

4 5 6 7 8 9 10 

11 12 13 14 15 16 17 

18 19 20 21 22 23 24 

25 26 27 28 29 30 31 

September 2013 

HFSA ’13 

Mark Your 

Calendar 

S M T W T F S 

1 2 3 4 5 6 7 

8 9 10 11 12 13 14 

15 16 17 18 19 20 21 

22 23 24 25 26 27 28 

29 30

16th Annual Scientific Meeting - Heart Failure Society of America

Create successful ePaper yourself

Delete template?

Save as template?